cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
57513,"1,3-Difluoro-5-iodobenzene",607-122-9,2265-91-0,,Notified C&L,8,H315:8;H319:8;H335:7
57518,5-nitro-o-anisidine,202-770-5,99-59-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,47,H315:40;H319:40;H335:38;H332:4;H351:4;H302:4;H312:4;H373:3
57519,Bromobutylmagnesium,211-737-4,693-03-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:2;H314:2;H260:1;H372:1;H302:1;H335:1;H225:1;H371:1
57520,2-[(4-hydrazinophenyl)sulphonyl]ethanol,247-750-7,26505-12-4,Acute Tox. 4,REACH registration C&L,38,H302:38
57521,Dodecyldiethoxymethylsilane,262-170-4,60317-40-0,,Notified C&L,1,H315:1;H319:1;H335:1
57523,N-(dodecylphenyl)naphthalen-1-amine,437-450-6,,STOT RE 1;STOT RE 1;Aquatic Chronic 4,REACH registration C&L,1,H413:1;H372:1
57526,2-bromo-α-methylbenzyl alcohol,226-491-3,5411-56-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57529,"2,5-diaminobenzyl alcohol",277-611-6,73793-80-3,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H301:1;H410:1;H400:1
57530,"1-bromo-2,6-dichlorobenzene",243-018-6,19393-92-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134,H315:134;H319:134;H335:133
57534,"Alcohols, C8-16, ethoxylated",820-226-0,71243-46-4,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,89,H302:89;H400:89;H318:89
57536,DL-serinohydrazide monohydrochloride,259-839-8,55819-71-1,Self-heat. 2;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,7,H319:5;H402:3;H302:4;H252:3;H315:2;H335:2;H412:1
57541,Morantel tartrate,247-481-5,26155-31-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38
57543,"Marrubium nigrum, ext.",283-896-8,84775-67-7,Not Classified,Notified C&L,25,Not classified:25
57544,Glycerol tristearate,209-097-6,555-43-1,Not Classified,REACH registration C&L,208,Not classified:208
57546,"4,5-dichloro-2,2,4-trifluoro-5-(trifluoromethoxy) -1,3-dioxolane",605-262-5,161611-73-0,Not Classified,Notified C&L,1,Not classified:1
57549,"Thiourea S,S-dioxide",224-065-1,4189-44-0,Self-heat. 2;Acute Tox. 4;Eye Irrit. 2,Notified C&L,36,H319:36;H302:36;H252:36
57551,"2,2'-(biphenyl-3-ylmethylazanediyl)diethanol",617-255-4,817165-06-3,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,42,H319:42;H302:42;H317:42
57552,Pentane-2-thiol,218-224-4,2084-19-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,115,H225:115;H315:114;H319:114;H335:114;H312:1;H302:1;H332:1
57553,Sodium 2-methylbutan-2-olate,238-639-4,14593-46-5,Flam. Sol. 1;Self-heat. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;STOT SE 3;STOT SE 3,REACH registration C&L,252,H312:182;H314:252;H251:226;H335:182;H228:212;H318:184;H332:182
57554,"Molybdenum, citrate oxo cobalt complexes",291-618-1,90431-89-3,Not Classified,Notified C&L,1,Not classified:1
57557,"O,O-diisobutyl hydrogen dithiophosphate",218-849-2,2253-52-3,Met. Corr. 1;Skin Corr. 1B;Aquatic Chronic 3,REACH registration C&L,2,H412:1;H290:1;H314:1;Not classified:1
57559,Diammonium hexanitratocerate,240-827-6,16774-21-3,Ox. Sol. 2;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,148,H317:6;H314:8;H400:4;H302:135;H410:5;H272:147;H318:94;H290:6;H315:132;H335:130;H319:51
57561,"1,4-di-tert-butylbenzene",213-790-9,1012-72-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
57563,"4,4,4-trifluoro-1-(2-furyl)butane-1,3-dione",206-315-1,326-90-9,,Notified C&L,7,H315:7;H319:7;H335:6
57566,"Perylene-3,4:9,10-tetracarboxylic dianhydride",204-905-3,128-69-8,Not Classified,REACH registration C&L,221,Not classified:168;H315:53;H319:53;H335:52
57573,"2-phenylindole-4',6-dicarboxamidine dihydrohydrochloride (hydrate)",249-186-7,28718-90-3,Skin Irrit. 2;Skin Sens. 1;STOT SE 3,Notified C&L,121,H315:120;H335:119;H317:118;Not classified:1;H319:2
57575,Ethyl (4-methylphenoxy)acetate,266-554-2,67028-40-4,Not Classified,REACH registration C&L,93,Not classified:92;H315:1;H319:1
57576,Disilver oxalate,208-568-3,533-51-7,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,88,H201:83;H312:83;H400:83;H302:83;H410:83;Not classified:5
57580,"Naphthenic acids, barium salts",263-077-1,61789-67-1,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,4,H332:3;H413:2;H302:3;H315:1;Not classified:1
57585,"Amines, methylditallow alkyl",271-670-1,68603-65-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H315:1;H400:1;H318:1
57588,"3,3-dimethoxypropene",227-936-4,6044-68-4,Flam. Liq. 2,Notified C&L,39,H225:39;H315:1;H319:1
57589,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane",614-177-2,67924-34-9,Not Classified,Notified C&L,85,Not classified:57;H315:28;H319:28;H317:28
57590,Cadmium tellurium trioxide,239-963-9,15851-44-2,,Notified C&L,4,H332:4;H302:4;H312:4
57595,4-(2-pyridylazo)resorcinol,214-528-6,1141-59-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:45;H319:45;H335:44;Not classified:2;H301:1;H311:1;H331:1
57597,[(E)-9-oxonon-7-enyl]acetate,617-744-2,85685-13-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H315:2;H319:2;H335:2
57601,4-methylmorpholine,203-640-0,109-02-4,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,651,H225:573;H318:221;H302:550;H314:637;H312:463;H332:340;H373:36;H412:36;H331:46;H226:64;Not classified:15;H311:10
57605,2-chloro p-phenylenediamine sulphate,262-915-3,61702-44-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48,H315:42;H312:41;H335:41;H319:48;H332:41;H317:7;H301:6;H311:6;H331:6;H302:2;H400:1
57609,sodium cyanate,213-030-6,917-61-3,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
57613,N-methyl-2-(methylamino)acetamide,610-197-0,44565-47-1,Not Classified,Notified C&L,2,Not classified:1;H315:1;H302:1;H335:1;H318:1
57615,"N-benzylpropane-1,3-diamine",237-680-5,13910-48-0,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
57616,"N,N,α-trimethylbenzylamine",219-511-7,2449-49-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:42;H312:38;H315:4;H311:4;H335:4;H319:4
57618,"Trimethylcyclododeca-1,5,9-triene",248-311-2,27193-69-7,Acute Tox. 4,Notified C&L,113,H332:88;H410:25;H315:25
57620,Octacos-1-ene,242-616-4,18835-34-2,Not Classified,REACH registration C&L,14,Not classified:14
57625,Sodium undec-10-enoate,222-264-8,3398-33-2,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,5,H315:2;H311:2;H302:2;H413:2;H319:2;Not classified:3
57630,"Oxirane, methyl-, polymer with oxirane, ether with 2,2-(oxidoimino)bis(ethanol) (2:1), N-(3-(C9-11-isoalkyloxy)propyl) derivs., C10-",606-841-5,218141-49-2,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,44,H319:44;H412:43;H315:1
57634,lead hexafluorosilicate,247-278-1,25808-74-6,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0,H400:0;H373:0;H302:0;H410:0;H332:0;H360:0
57635,"Glycerides, C8-10 mono-",293-207-2,91052-46-9,Not Classified,Notified C&L,2,Not classified:2
57636,(chloromethyl)ethylbenzene,248-148-7,26968-58-1,Skin Corr. 1B;STOT SE 3;Carc. 2,Notified C&L,41,H351:25;H335:41;H314:25;H319:16;H315:16;H302:16;H290:6
57637,Di[(2H3)methyl] sulphoxide,218-617-0,2206-27-1,Not Classified,REACH registration C&L,8,Not classified:5;H315:3;H319:3
57638,"Trisodium naphthalene-1,3,6-trisulphonate",225-962-0,5182-30-9,Not Classified,Notified C&L,60,Not classified:55;H315:5;H319:5
57640,Methyl 4-acetamido-5-chloro-o-anisate,223-840-1,4093-31-6,Not Classified,REACH registration C&L,59,Not classified:15;H332:39;H302:40;H312:39;H315:4;H319:4;H335:4
57641,3-aminophthalic acid hydrochloride,230-106-4,6946-22-1,Acute Tox. 4,Notified C&L,42,H302:38;H315:4;H319:4;H335:4
57643,"Fatty acids, C12-18 and C18-unsatd., reaction products with acrylonitrile, diethylenetriamine and urea",295-167-1,91844-97-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
57644,"Phosphoric acid, C12-18-alkyl esters, potassium salts",291-905-1,90506-43-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,7,H315:7;H319:2;H318:5
57648,"Esterase, carboxyl",232-773-7,9016-18-6,Resp. Sens. 1,Notified C&L,46,H334:46;H317:1
57650,"4,5,6,7-tetrachloro-3-[[3-methyl-4-[[4-[(4,5,6,7-tetrachloro-1-oxo-1H-isoindol-3-yl)amino]phenyl]azo]phenyl]amino]-1H-isoindol-1-one",255-052-9,40716-47-0,Not Classified,Notified C&L,124,Not classified:124
57652,"Sugarcane, ext.",294-424-5,91722-22-4,Flam. Liq. 3,Notified C&L,1471,H226:1340;Not classified:131
57656,2-methylpropyl 2-[(2-nitrophenyl)methylidene]-3-oxobutanoate,612-113-8,61312-59-2,Skin Sens. 1;Eye Irrit. 2;Repr. 2;Aquatic Chronic 2,REACH registration C&L,3,H411:2;H319:2;H361:2;H317:2;Not classified:1
57657,(S)-2-hydroxy-4-[[(phenylmethoxy)carbonyl]amino]butyric acid,254-892-3,40371-50-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57658,(E)-hex-3-enal,273-874-6,69112-21-6,Not Classified,Notified C&L,135,Not classified:135
57659,Hex-2-ene,209-755-2,592-43-8,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,62,H225:62;H304:61;H315:1;H319:1;H335:1
57661,Chlorure de magnesium hydrate,616-575-1,7791-18-6,Not Classified,Notified C&L,232,Not classified:228;H315:4;H319:4;H335:4
57663,"3-bromopropane-1,2-diol",225-186-2,4704-77-2,Skin Corr. 1B,Notified C&L,38,H314:38
57674,"3,5-diamino-2,4,6-triiodobenzoic acid",226-845-7,5505-16-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H319:1;H315:1;H302:1;H335:1
57675,5-ethylidenebicyclo[2.2.1]hept-2-yl propionate,277-392-7,73347-77-0,Not Classified,Notified C&L,88,Not classified:88
57676,"D-Glucopyranuronic acid, polymer with 6-deoxy-L-mannose, D-glucose and D-mannose, calcium potassium sodium salt",615-719-0,72121-88-1,STOT SE 3,Notified C&L,9,H335:9
57679,"4-(4-hydroxyphenoxy)-3,5-diiodophenylacetic acid",214-582-0,1155-40-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
57683,"1,4-butanediylbis[oxy(2-hydroxy-3,1-propanediyl)] diacrylate",257-900-3,52408-42-1,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,114,H318:100;H412:96;H302:113;H317:114;H319:14;H315:14;H312:1
57685,N-methyl-N-(pyridine-2-yl)formamide,266-616-9,67242-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57687,Sodium formate,205-488-0,141-53-7,Not Classified,REACH registration C&L,2667,Not classified:2588;H315:63;H319:79;H335:60;H302:1
57690,Pentadec-1-ene,236-414-5,13360-61-7,Not Classified,Notified C&L,6,Not classified:3;H304:2;H315:1;H319:2;H335:2
57692,"Pyrimidine, 2-(4'-fluoro[1,1'-biphenyl]-4-yl)-5-propyl-",619-133-6,95495-15-1,Not Classified,Notified C&L,1,Not classified:1
57700,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-(1-amino-4-sulfo-2-naphthalenyl)diazenyl]-5-hydroxy-3-[2-[4-[2-[2-oxo-1-[(phenylamino)carbonyl]propyl]diazenyl]phenyl]diazenyl]-, sodium salt (1:3)",611-650-5,58419-36-6,Not Classified,Notified C&L,3,Not classified:3
57701,Methyl N-(1-phenylethyl)glycinate,280-597-4,83732-50-7,Acute Tox. 4,Notified C&L,38,H302:38
57702,"1 alpha-Methyl-4-androstene-3,17-dione",609-915-5,4136-62-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1
57705,(undec-10-enoylamino)acetic acid,427-430-5,54301-26-7,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,6,H412:6;H318:6
57706,2-ethylaminoethyldimethylamine,204-656-0,123-83-1,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,43,H226:43;H314:43
57712,ethirimol (ISO);5-butyl-2-ethylamino-6-methylpyrimidin-4-ol,245-949-3,23947-60-6,Acute Tox. 4,Harmonised C&L,0,H312:0
57713,Trimethyloctylammonium methyl sulphate,265-332-2,65059-42-9,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2A;Expl. 1.6,Notified C&L,1,H319:1;Not classified:1;H302:1;H317:1
57717,Humic acids,215-809-6,1415-93-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,110,H315:99;H319:99;H335:98;Not classified:11
57722,p-iodocumene,241-384-1,17356-09-1,,Notified C&L,4,H315:4;H319:4
57729,"N,N-bis(phenylmethyl)acetamide",233-977-9,10479-30-8,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,Notified C&L,39,H302:39;H400:38;H317:38;H319:1;H315:1;H335:1
57732,Dimethyl pentasulphide,230-823-2,7330-31-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H315:1;H412:1;H302:1;H226:1;H319:1;H332:1
57733,tert-butyl succinimido carbonate,236-071-1,13139-12-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
57742,(methoxymethyl)oxirane,213-216-7,930-37-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H311:2;H302:2;H226:1;H319:2;H335:1;H225:1
57747,"N,N',N''-trimethyl-1,3,5-triazine-2,4,6-triamine",220-588-4,2827-46-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H302:2;H312:2;H319:1
57748,"Tetrasodium 3-hydroxy-4-(2-sulphonato-4-(4-sulphonatophenylazo)phenylazo)naphthalene-2,7-disulphonate",228-319-2,6226-79-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H315:47;H319:47;H335:47;Not classified:8
57750,monocrotophos (ISO);dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate,230-042-7,6923-22-4,Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H341:0;H330:0;H400:0;H311:0;H410:0;H300:0
57760,"Hydrocarbons, C4-5;Petroleum gas",270-682-4,68476-42-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
57763,"2-[[7-[(2-arsonophenyl)azo]-1,8-dihydroxy-3,6-disulpho-2-naphthyl]azo]benzoic acid",223-216-9,3772-44-9,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H331:38;H410:38;H400:38
57769,"Alkanes, C1-4, C3-rich;Petroleum gas",292-456-4,90622-55-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
57770,4-nitrobenzonitrile,210-610-0,619-72-7,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3,Notified C&L,76,H331:38;H300:43;H311:42;Not classified:33;H315:1;H319:1
57771,Pent-2-en-4-yn-1-ol,226-922-5,5557-88-0,,Notified C&L,4,H319:4;H315:4;H302:4;H335:4
57775,Bromo(diphenyl)methane,212-279-8,776-74-9,Skin Corr. 1B,REACH registration C&L,64,H314:64;H290:11;H335:11;H318:2;H302:1
57776,reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II),407-700-9,101408-30-4,Skin Sens. 1,Harmonised C&L,0,H317:0
57777,"monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate",411-360-7,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
57778,"1,2-dinitrobenzene",208-431-8,528-29-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H310:0;H330:0;H400:0;H373:0;H410:0;H300:0
57779,4-nitro-N-phenylaniline,212-646-2,836-30-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78,H315:71;H319:71;H335:71;H411:37;Not classified:3
57781,Antazoline mesylate,221-523-2,3131-32-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:40;H312:40;H302:40;H335:40;H319:40;H332:40
57785,Tin dipalmitate,252-364-7,35104-88-2,Not Classified,Notified C&L,2,Not classified:2
57786,2-[[4-[(2-cyanoethyl)(2-phenylethyl)amino]phenyl]azo]-5-nitrobenzonitrile,246-352-0,24610-00-2,Eye Irrit. 2,REACH registration C&L,10,H319:1;H412:7;Not classified:2
57788,"2-bromomethyl-1,3-dioxolane",224-443-6,4360-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45;H227:1
57789,"sodium N-[(3α,5β,12α)-3,12-dihydroxy-24-oxocholan-24-yl]aminoacetate",240-455-4,16409-34-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
57790,"Hexanedioic acid, ester with 2,2-dimethyl-1,3-propanediol, isodecanol and 1,2-propanediol",283-736-7,84712-46-9,Not Classified,Notified C&L,1,Not classified:1
57792,2-phenoxyethanol,204-589-7,122-99-6,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H319:0;H302:0
57794,"Alkanes, C",292-454-3,90622-53-0,Carc. 1B,Harmonised C&L,0,H350:0
57799,2-Ethylhexyl (R)-2-(2-methyl-4chlorophenoxy)propionate,920-412-2,,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1;H400:1;H317:1
57800,"Sodium 2-[[4-(cyclohexylamino)-9,10-dihydro-9,10-dioxo-1-anthryl]amino]-5-ethoxybenzenesulphonate",269-304-0,68214-62-0,Aquatic Chronic 3,REACH registration C&L,41,H412:4;Not classified:37
57801,Pivalamide,212-043-4,754-10-9,Acute Tox. 4,Notified C&L,38,H302:38
57802,"N,N'-hexane-1,6-diylbis[bis(2-hydroxyethyl)methylammonium] dichloride",285-644-2,85117-93-7,Eye Dam. 1,Notified C&L,1,H318:1
57805,ethyl 2-(isocyanatosulfonyl)benzoate,410-220-2,77375-79-2,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1;STOT RE 2,Harmonised C&L,0,H334:0;H317:0;H373:0;H302:0;H318:0
57809,"(R)-10-β-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)anthracen-9(10H)-one",215-808-0,1415-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H315:43;H319:43;H335:43;H302:6;H317:2;H332:1;H334:1
57814,3-methylundecanoic acid,265-925-6,65781-38-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
57825,"2,2'-[(2,2',5,5'-tetrachloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-3-oxobutyramide]",244-776-0,22094-93-5,Not Classified,Notified C&L,126,Not classified:126
57826,"9,10-dihydrophenanthrene",212-278-2,776-35-2,Aquatic Acute 1,Notified C&L,38,H400:38
57829,2-propynyl acrylate,233-975-8,10477-47-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H226:46;H319:58;H335:58;H315:58;H411:19;H332:1;H302:1;H312:1
57830,Bis(2-ethylhexyl) ether,233-412-6,10143-60-9,,Notified C&L,44,Not classified:44
57835,"(3-carbamoyl-3,3-diphenylpropyl)diisopropylmethylammonium",231-316-9,7492-32-2,Acute Tox. 4,Notified C&L,1,H302:1
57836,Sodium 4-aminonaphthalene-1-sulphonate,204-975-5,130-13-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,17,H315:9;H319:10;Not classified:6;H412:1;H334:1;H317:1
57837,Lead diperchlorate,237-125-7,13637-76-8,Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H373:1;H302:1;H410:1;H360:1
57839,Piperidine-3-ol hydrochloride,264-644-6,64051-79-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
57840,Morpholinium sulphamate,258-061-6,52636-67-6,Not Classified,REACH registration C&L,4,Not classified:4
57841,Dipotassium heptafluorotantalate,240-986-1,16924-00-8,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT SE 2,REACH registration C&L,45,H332:1;H302:1;H335:6;H318:1;H301:44;H331:39;H315:5;H319:5
57844,Dimethyl telluride,209-809-5,593-80-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H331:38;H301:38;H311:38
57846,"Tannins, sulfomethylated",269-229-3,68201-64-9,Aquatic Chronic 3,Notified C&L,8,H412:8
57847,3-acetamido-4-methoxybenzenesulphonyl chloride,223-141-1,3746-67-6,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H302:1;H314:1
57853,Oct-1-en-3-yl acetate,219-474-7,2442-10-6,Acute Tox. 4;Skin Sens. 1,Notified C&L,1653,H302:1653;H317:1653
57855,"6-chloro-1,4-dihydroquinoxaline-2,3-dione",229-647-9,6639-79-8,,Notified C&L,4,H315:4;H319:4;H335:4
57858,Molybdenum boride,234-492-5,12006-98-3,Not Classified,Notified C&L,4,Not classified:4
57865,Tridecyl methacrylate,219-671-8,2495-25-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,498,H315:495;H319:495;H335:494;H317:458;H334:2;H411:2;H400:1;H410:1;Not classified:2
57867,"Rosin, reaction products with formaldehyde",293-659-0,91081-53-7,Not Classified,REACH registration C&L,138,Not classified:138
57869,benzyl N-(2-cyanopropan-2-yl)carbamate,600-032-0,100134-82-5,Acute Tox. 4,REACH registration C&L,91,H302:91
57872,"2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butenal",271-439-5,68555-62-4,Not Classified,Notified C&L,113,Not classified:88;H411:25;H317:25
57875,"Reaction products of diazotised 4'-aminoazobenzene-4-sulphonic acid, coupled with resorcinol and diazotised sodium 4-aminobenzenesulfonate, sodium salts",612-722-9,61931-07-5,Not Classified,REACH registration C&L,2,Not classified:2
57876,Alverine,205-763-5,150-59-4,Not Classified,REACH registration C&L,3,Not classified:2;H332:1;H302:1;H312:1
57877,"Cymbopogon schoenanthus, ext.",289-754-1,89998-16-3,Asp. Tox. 1;Skin Sens. 1,Notified C&L,14,H317:14;H304:14
57879,[(tridecyloxy)methyl]oxirane,276-765-1,72689-40-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H317:1
57880,"4-hydroxy-7-methyl-1,8-naphthyridine-3-carboxylic acid",236-235-2,13250-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
57882,"5-[[4-(diethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium chloride",277-455-9,73398-77-3,Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H319:1;H332:1;H302:1;Not classified:1
57883,"Lavender, Lavandula intermedia, ext.",296-408-3,92623-76-2,Not Classified,Notified C&L,26,Not classified:26
57884,Bromofluoromethane,609-414-1,373-52-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;Ozone 1,Notified C&L,4,H310:2;H300:2;H330:2;H420:2;H059:1;H331:1;H301:1;H311:1;H315:1;H312:1;H220:1;H302:1;H335:1;H280:1;H319:1;H332:1
57885,Metirosine,211-599-5,672-87-7,Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H335:1
57888,Succimer,206-155-2,304-55-2,,Notified C&L,6,H361:5;H315:6;H319:6;H335:5
57889,"2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline",225-240-5,4733-39-5,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,39,H413:38;H302:39
57890,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers, reaction products with 2-hydroxyethyl carbamate",917-338-8,,Acute Tox. 4;Acute Tox. 4,Notified C&L,83,H302:83;H312:83
57891,"Quaternary ammonium compounds, coco alkylbis(hydroxyethyl)methyl, ethoxylated, Me sulfates (salts)",614-875-7,68989-03-7,Eye Dam. 1,Notified C&L,30,H318:30;H411:8;H315:8
57893,Carvacrol,207-889-6,499-75-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1718,H411:29;H318:27;H302:1716;H314:66;H319:1647;H315:1649;H317:1671;Not classified:2
57894,"[4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonato(3-)]iron",276-681-5,72479-34-6,Not Classified,Notified C&L,44,Not classified:41;H319:2;H315:1
57897,4-[[(2-aminophenyl)methyl]amino]cyclohexyl acetate,298-842-9,93839-71-5,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,2,H334:2;H317:2
57899,Trisodium 2-[bis(carboxylatomethyl)amino]propanoate,423-270-5,,Not Classified,REACH registration C&L,95,Not classified:95
57901,4-(1-methyl-1-phenylethyl)-N-[4-(1-methyl-1-phenylethyl)phenyl]aniline,233-215-5,10081-67-1,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,848,H413:169;H317:155;Not classified:678
57902,"Sodium 3-[[3-[[(2,4-dimethylphenyl)amino]carbonyl]-2-hydroxy-1-naphthyl]azo]-4-hydroxybenzenesulphonate",239-012-8,14936-97-1,Not Classified,Notified C&L,2,Not classified:2
57905,2-(2-propoxyethoxy)ethanol,229-985-7,6881-94-3,Eye Irrit. 2,Notified C&L,47,H319:39;Not classified:5;H302:3;H312:3;H314:3
57907,Diisopropyl bicarbamate,243-263-9,19740-72-8,Acute Tox. 3,REACH registration C&L,2,H301:2
57908,"(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one",428-690-2,1668-86-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H302:0;H412:0
57910,p-[(2-chloroethyl)ethylamino]benzaldehyde,220-150-2,2643-07-4,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H315:83;H312:83;H400:83;H317:83;H301:83;H410:83
57914,"2-Propenoic acid, polymer with 2-propenamide",618-351-9,9003-06-9,Not Classified,Notified C&L,87,Not classified:86;H319:1;H302:1
57915,ethyl formate,203-721-0,109-94-4,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H302:0;H335:0;H225:0;H319:0;H332:0
57917,p-[2-(dimethylamino)ethoxy]benzylamine,243-491-9,20059-73-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,96,H318:85;H412:84;H302:94;H314:87;H341:9;H315:9;H400:9;H317:9;H312:1
57922,"Phosphoric acid, C16-18-alkyl esters, potassium salts",291-907-2,90506-45-9,Eye Irrit. 2,REACH registration C&L,61,H319:7;H315:30;H318:28;Not classified:26
57923,"4-[(4-amino-5-methoxy-o-tolyl)azo]-5-[(phenylsulphonyl)oxy]naphthalene-2,7-disulphonic acid",204-190-8,117-44-2,Not Classified,REACH registration C&L,2,Not classified:2
57924,Ethyl hydrazinoacetate hydrochloride,230-104-3,6945-92-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H315:3;H302:3;H335:3
57926,Menthol Propyleneglycol Carbonate,608-456-8,30304-82-6,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,113,H411:113;H319:113
57927,Octyl 2-furoate,254-378-9,39251-88-2,Not Classified,Notified C&L,88,Not classified:88
57928,"3-(6-O-(6-desoxy-α-.sc.l.sc.-mannopyranosyl-O-(α-.sc.d.sc.-glucopyranosyl)-(β-.sc.d.sc.-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one",424-170-4,130603-71-3,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
57930,".alpha.-D-Glucopyranoside, 2-ethylhexyl",603-082-1,125590-73-0,Eye Dam. 1,Notified C&L,148,H318:148
57931,"Diammine[cyclobutane-1,1-dicarboxylato(2-)-O,O']platinum",255-446-0,41575-94-4,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 1B;Repr. 1B,Notified C&L,59,H334:56;H312:54;H317:57;H302:59;H340:55;H332:44;H360:48;H362:12;H319:17;H315:6;H372:4;H351:3;H341:2;H335:3;H361:2;H370:1;H350:2;H290:1
57933,Bis(2-methylisouronium) sulphate,257-851-8,52328-05-9,Muta. 2,REACH registration C&L,7,H341:5;H319:3;H315:1;H335:1
57934,(isooctadecanoato-O)bis(methacrylato-O)(propan-2-olato)titanium,262-836-4,61548-33-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H335:1
57936,"2,3,4,5,6-pentafluorostyrene",211-500-5,653-34-9,Flam. Liq. 3,Notified C&L,48,H226:48;H318:1;H335:1;H315:1
57945,"3,3'-[(4-{(E)-[2-bromo-4-nitro-6-(trifluoromethyl)phenyl]diazenyl}phenyl)imino]dipropanenitrile",435-190-8,246871-16-9,Skin Sens. 1B,REACH registration C&L,32,H317:32;H413:31
57948,"Amides, coco, N-[3-(dimethylamino)propyl], alkylation products with chloroacetic acid, sodium salts",274-923-4,70851-07-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,145,H412:121;H315:140;H318:136;H319:9
57949,Cobalt zinc oxide green,232-381-6,8011-87-8,Not Classified,Notified C&L,10,Not classified:8;H334:2;H410:2;H400:2
57951,Tris(2-hydroxypropyl)ammonium chloride,261-485-4,58901-12-5,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,6,H319:6;H412:6
57953,"menazon (ISO);S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate",201-123-4,78-57-9,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
57958,"Triglycerides, C12-24, even, saturated and unsaturated, oxidized",614-270-8,68082-79-1,Not Classified,REACH registration C&L,576,Not classified:451;H319:125
57960,"(3,4-dichlorophenyl)methoxyacetic acid",237-682-6,13911-20-1,Acute Tox. 4,Notified C&L,38,H302:38
57962,boron tribromide,233-657-9,10294-33-4,Acute Tox. 2;Skin Corr. 1A;Acute Tox. 2,Harmonised C&L,0,H300:0;H330:0;H314:0
57972,"2,3,5,6-tetrafluorophenol",212-209-6,769-39-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:40;H319:40;H335:39;H302:7;H312:7;H314:7;H332:3;H301:1;H318:1;H311:1
57975,"1,3,5-Triazine-2,4,6-triamine, N2,N2'-1,2-ethanediylbis[N2-[3-[[4,6-bis[butyl(1,2,2,6,6-pentamethyl-4-piperidinyl)amino]-1,3,5-triazin-2-yl]amino]propyl]-N4,N6-dibutyl-N4,N6-bis(1,2,2,6,6-pentamethyl-4-piperidinyl)-",600-792-3,106990-43-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,179,H411:179;H317:112;H373:1
57977,(S)-methylpyrrolidine-2-methanol,251-981-9,34381-71-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
57978,"α,α,4-trimethyl-3-(1-methylvinyl)-4-vinylcyclohexylmethyl acetate",282-865-6,84434-64-0,Not Classified,Notified C&L,88,Not classified:88
57981,(hydroxymethyl)triphenylphosphonium chloride,226-138-3,5293-83-4,,Notified C&L,4,H315:4;H319:4;H335:4
57982,3-(octylamino)propiononitrile,249-669-2,29504-89-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
57990,Isovalerophenone,209-489-7,582-62-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39;H302:1
57991,"Fatty acids, C12-20, potassium salts",274-067-1,69669-25-6,Not Classified,Notified C&L,7,Not classified:7
57992,Bromotriethylsilane,214-191-5,1112-48-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,40,H226:40;H314:40;H318:2;H290:1
57993,"(Z)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl)allylamine dihydrochloride",262-279-7,60525-15-7,Acute Tox. 4,Notified C&L,1,H302:1
57994,Pregnenolone,205-647-4,145-13-1,Not Classified,REACH registration C&L,22,Not classified:3;H312:19;H302:19;H361:19;H351:19;H332:19
57995,Bis(4-chlorophenyl) sulphone,201-247-9,80-07-9,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,251,H411:127;H319:141;Not classified:101;H413:14;H410:9;H400:9
57997,Corticotropin,232-659-7,9002-60-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,55,H332:55;H351:38;H302:38;H312:38;H334:17;H317:17
58000,Bis(acetonitrile)dichloropalladium,238-637-3,14592-56-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,57,H331:49;H301:39;H311:49;H315:16;H302:17;H335:15;H319:16;H312:6;H332:7;H228:1;H413:1;H317:1
58001,"6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid",258-422-8,53188-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,87,H315:87;H319:87;H335:86
58004,"Tetraethyl 2,2'-[methylenebis(4,1-phenyleneiminocarbonyl)]bismalonate",261-092-8,58067-54-2,,Notified C&L,25,Not classified:25
58005,C.I. Acid Blue 209,602-805-8,12269-81-7,Not Classified,Notified C&L,1,Not classified:1
58008,"2-hydroxypropyl (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl carbonate",607-858-0,260781-16-6,Eye Irrit. 2,REACH registration C&L,4,H319:4
58011,"Silicic acid, magnesium salt",215-681-1,1343-88-0,Not Classified,Notified C&L,333,Not classified:186;H319:143;H332:5;H226:1;H315:1
58016,"Ethyl 2-[(3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]benzoate",214-645-2,1176-74-5,Not Classified,Notified C&L,5,Not classified:5
58018,"(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide dihydrochloride",611-780-2,59046-78-5,Eye Irrit. 2;Repr. 2,Notified C&L,1,H362:1;H319:1;H361:1
58019,Ethyl N-(phenylmethyl)glycinate,229-218-6,6436-90-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,3,H318:2;H314:3
58028,2-aminophenylarsonic acid,218-064-5,2045-00-3,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H301:39;H331:39;H410:39;H400:39;H350:1
58030,"1,4-Dioxaspiro[4.5]decane-2-methanol, 9-methyl-6-(1-methylethyl)-",613-178-5,63187-91-7,Skin Irrit. 2,Notified C&L,35,H315:35;H412:10;H318:10
58031,"Disodium 4,5-dihydroxy-3-(p-nitrophenylazo)naphthalene-2,7-disulphonate",208-959-9,548-80-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
58032,2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethyl prop-2-enoate,610-592-8,50974-47-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,18,H315:18;H319:18;H335:1
58033,"Soaps, stocks, fish-oil, acidulated, hydrogenated",309-355-9,100209-48-1,Not Classified,Notified C&L,1,Not classified:1
58034,Epoxy Resin,920-018-0,,Not Classified,Notified C&L,2,Not classified:1;H315:1;H319:1;H317:1
58035,(phenylthio)acetic acid,203-073-9,103-04-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
58037,Diisopentylamine,208-856-9,544-00-3,,Notified C&L,7,H226:7;H314:7;H318:2;H312:1;H301:1;H331:1
58039,1-(triphenylmethyl)pyridinium tetrafluoroborate,247-482-0,26156-84-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
58040,"3,4-dihydro-6,7-dimethoxyisoquinoline",222-185-9,3382-18-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
58043,3-methoxyphenylacetic acid,217-282-8,1798-09-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,66,H315:66;H319:66;H335:65;H302:11
58044,"2,2,4-trifluoro-5-(trifluoromethoxy)-1,3-dioxole",605-263-0,161611-74-1,Flam. Liq. 1;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H224:2;H221:2;H317:2
58046,Octachlorocyclopentene,211-894-9,706-78-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H302:1
58048,"(+-)-2,4-dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one",607-685-0,252964-68-4,Skin Sens. 1B,REACH registration C&L,2,H317:1;H302:1
58050,"Imidazolium compounds, 2-(C15 and C17-unsatd. alkyl)-1-[2-(C16 and C18-unsatd. amido)ethyl]-1-ethyl-4,5-dihydro, Et sulfates",273-102-8,68937-95-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
58051,Epidermal growth factor,263-468-7,62229-50-9,Not Classified,Notified C&L,1,Not classified:1
58055,"9,10-dihydro-1-nitro-9,10-dioxoanthracene-2-carboxylic acid",204-904-8,128-67-6,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H302:38;H400:38
58056,"cis-1-[[4-(allyloxy)methyl-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl]-1H-imidazole monohydrochloride",263-777-7,62973-77-7,Acute Tox. 3,Notified C&L,8,H301:8
58058,N-[4-phenyl-1-(phenylmethyl)-4-piperidylmethyl]formamide,230-490-3,7152-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H319:38;H335:38;H400:38
58061,4-nitrophenoxyacetic acid,217-283-3,1798-11-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:1
58064,"Lanthanum(3+) 2-hydroxypropane-1,2,3-tricarboxylate",221-095-7,3002-52-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
58065,Thermolysin,232-973-4,9073-78-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,51,H334:51;H315:51;H317:38;H335:51;H319:51
58067,6-chloro-9-β-D-ribofuranosyl-9H-purine,226-438-4,5399-87-1,Not Classified,Notified C&L,1,Not classified:1
58068,Potassium (R)-(4-hydroxyphenyl)[(3-methoxy-1-methyl-3-oxoprop-1-enyl)amino]acetate,273-992-8,69416-61-1,Eye Irrit. 2,REACH registration C&L,5,H319:4;Not classified:1
58069,Hex-1-yne,211-736-9,693-02-7,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:41;H335:40;H225:43;H319:41;H304:43;H302:2
58076,"Orthoboric acid, zinc salt",233-803-1,10361-94-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
58079,2-(2-methyl-3-nitrophenyl)acetic acid,607-283-5,23876-15-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3;H335:2
58084,"Citric acid, ammonium salt",231-560-6,7632-50-0,Not Classified,Notified C&L,59,Not classified:59
58085,"Sulfuric acid, esters with high-boiling C6-10-alkene hydroformylation products, sodium salts",615-263-2,71243-45-3,Not Classified,Notified C&L,1,Not classified:1
58086,"bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate",414-840-4,147783-69-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
58088,Dimethyl(2-(methylamino)ethyl)amine,205-529-2,142-25-6,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,45,H225:45;H314:45;H318:2;H312:2;H302:2;H332:2
58089,Glycerol tripalmitate,209-098-1,555-44-2,Aquatic Chronic 2,Notified C&L,21,H411:18;Not classified:3
58095,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, reaction products with 4-[(4-aminophenyl)azo]benzenesulfonic acid, reduced, oxidized, potassium sodium salts",290-714-0,90218-39-6,Not Classified,REACH registration C&L,10,Not classified:10
58097,"Licorice, Glycyrrhiza glabra, ext.",283-895-2,84775-66-6,Not Classified,Notified C&L,88,Not classified:79;H226:8;H225:2
58098,Bis(2-hydroxyethyl)ammonium sulphamate,256-067-3,43052-68-2,Not Classified,Notified C&L,2,Not classified:2
58100,Cochineal (dye),215-680-6,1343-78-8,Not Classified,Notified C&L,95,Not classified:95
58101,"(1R,2S,4R)-borneol",207-352-6,464-43-7,Flam. Sol. 2,Notified C&L,43,H228:43
58102,Ornidazole,240-826-0,16773-42-5,Acute Tox. 4,Notified C&L,96,H302:96;H371:1;H412:1
58103,α-(allyloxy)toluene,238-638-9,14593-43-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
58106,"p-methoxy-N,α-dimethylphenethylamine hydrochloride",222-265-3,3398-68-3,Acute Tox. 4,Notified C&L,1,H302:1
58107,"2,6-diacetyl-1,2,3,9b-tetrahydro-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3-dione",204-740-7,125-46-2,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,222,H301:194;H410:194;H400:194;H302:28;H332:1;H312:1;H370:1
58108,"Decanoic acid, ester with triglycerol",603-759-1,133654-02-1,,Notified C&L,2,Not classified:1;H315:1;H319:1;H317:1
58109,N-(4-bromo-2-fluorophenyl)acetamide,206-314-6,326-66-9,,Notified C&L,6,H319:6;H315:6;H302:5;H335:5
58111,4-chlororesorcinol,202-462-0,95-88-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,98,H411:12;H315:92;H317:38;H302:89;H401:9;H318:35;H412:15;H319:61;H312:41;H335:57;H332:49;Not classified:3;H400:1
58114,Calcium molybdate,232-192-9,7789-82-4,Not Classified,REACH registration C&L,177,Not classified:138;H351:32;H361:32;H315:7;H319:7;H335:7;H301:2;H311:2;H331:2
58120,Potassium selenocyanate,222-320-1,3425-46-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,87,H400:86;H373:87;H301:69;H331:87;H410:87;H300:18;H310:2
58122,"ipconazole (ISO); (1RS,2SR,5RS;1RS,2S­R,5SR)-2-(4-chloro­benzyl)-5-isopropyl-1- (1H-1,2,4-triazol-1-yl­methyl)cyclopentanol",603-038-1,125225-28-7,Acute Tox. 4;STOT RE 2;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H373:0;H410:0;H302:0;H360:0
58123,Zinc bis(dinonylnaphthalenesulphonate),248-778-2,28016-00-4,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,283,H315:254;H318:1;H319:253;Not classified:29;H335:25;H410:22;H400:22;H317:7;H413:3
58124,2-iodophenol,208-569-9,533-58-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H315:45;H312:40;H302:40;H335:44;H319:45;H332:40
58125,"(E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol",255-053-4,40716-66-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,245,H410:205;H400:169;H315:40;H319:93;H335:40;H317:12
58126,"Quaternary ammonium compounds, benzylcoco alkylbis(hydroxyethyl), chlorides",263-078-7,61789-68-2,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,497,H411:446;H312:496;H314:497;H301:447;H318:476;H400:51;H302:29;H410:1
58133,"2-Propenoic acid, 2-methyl-, C10-18-alkyl esters",292-088-4,90530-47-5,Not Classified,Notified C&L,441,Not classified:441
58138,"3,3'-dithiobis[6-nitrobenzoic] acid",200-714-4,69-78-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:51;H319:51;H335:50
58143,Bis(2-nitrophenyl) disulphide,214-581-5,1155-00-6,,Notified C&L,33,Not classified:33
58145,Vinyl neononanoate,259-160-7,54423-67-5,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,22,H332:21;H411:20;H361:18;H410:1;H400:1;Not classified:1
58146,2-bromothioanisole,243-183-4,19614-16-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:42
58149,2-bromopyridine,203-641-6,109-04-6,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,57,H310:52;H315:56;H301:57;H335:54;H226:9;H319:56;H311:5;Not classified:2;H371:1;H331:3
58151,N-propylcyclopropanemethylamine,247-646-1,26389-60-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H226:38;H319:38;H335:38;H315:38
58153,α-phenylpiperidine-2-acetamide,243-019-1,19395-39-2,Acute Tox. 4,REACH registration C&L,7,H302:6;H315:1;H319:1
58157,"(1,1,3,3-tetramethylbutyl)phenol",248-310-7,27193-28-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,71,H315:66;H312:66;H318:66;Not classified:5
58160,"1,2,4,5-tetramethyl-3,6-dinitrobenzene",226-766-8,5465-13-4,Acute Tox. 3;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H310:38;H330:38;H400:38;H301:38;H410:38
58165,2-methoxy-5-nitroanilinium chloride,267-234-5,67827-72-9,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,2,H302:2;H317:2
58170,"Amines, polyethylenepoly-, reaction products with benzyl chloride",271-671-7,68603-67-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,84,H318:60;H302:62;H400:60;H314:82;H319:1;H315:1;H335:1;H312:1
58171,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers reaction product with 3-(cyclohexylamino)propane-1-sulfonic acid and N,N-dimethylcyclohexanamine",926-601-6,,Not Classified,REACH registration C&L,2,Not classified:2
58172,"Phosphoric acid, C10-14-alkyl esters, potassium salts",302-247-2,94095-40-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
58174,N-[3-(trimethoxysilyl)propyl]butylamine,250-437-8,31024-56-3,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,61,H315:56;H318:9;Not classified:5
58175,"2,4,6-trimethyl-4-phenyl-1,3-dioxane",225-963-6,5182-36-5,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1647,H302:1611;H412:1611;Not classified:36;H319:1;H315:1
58178,Benzenesulphonyl fluoride,206-707-2,368-43-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3,Notified C&L,43,H331:39;H302:43;H312:43;H314:43;H332:4
58179,Thiosulfonated sulfurized nitrophenols,215-447-9,1326-86-9,Not Classified,Notified C&L,2,Not classified:2
58180,"Phosphoric acid, C14-22-alkyl esters, potassium salts",291-906-7,90506-44-8,,Notified C&L,6,H319:6
58181,"2,5-dihydro-2-isopropyl-4-methylthiazole",267-816-9,67936-13-4,Skin Sens. 1,Notified C&L,10,H317:10
58182,"Molybdenum, citrate oxo complexes",291-619-7,90431-90-6,Not Classified,Notified C&L,1,Not classified:1
58183,Ethyl 2-bromobenzoate,228-034-3,6091-64-1,,Notified C&L,1,H332:1;H302:1;H312:1
58184,tert-butyl carbamate,224-209-3,4248-19-5,Eye Irrit. 2,Notified C&L,4,H319:4;H315:2;H335:2;H312:1;H302:1;H332:1
58185,3-hydroxy-4-methyl-2-nitrobenzoic acid,230-105-9,6946-15-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
58186,[2H3]acetonitrile,218-616-5,2206-26-0,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,55,H312:50;H302:45;H225:53;H319:51;H332:44;H300:4;H301:3;H311:4;H330:3;H226:1;Not classified:1;H224:1;H373:1;H370:1
58188,"3,4,5-trichlorophenol",210-183-0,609-19-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H315:41;H312:41;H400:38;H302:41;H335:41;H410:38;H318:38;H332:41;H319:3;Not classified:1
58189,"Undecanol, branched and linear",603-309-4,128973-77-3,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,90,H411:35;H319:90;H400:90;H410:88
58193,"1,1-dichlorosilacyclobutane",219-084-7,2351-33-9,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B,Notified C&L,60,H225:60;H260:38;H314:60
58194,"2,2-bis[[(1-oxoheptyl)oxy]methyl]propane-1,3-diyl bisheptanoate",247-279-7,25811-35-2,Not Classified,REACH registration C&L,1,Not classified:1
58195,"Glycerides, C16-18 mono-",293-208-8,91052-47-0,Not Classified,REACH registration C&L,155,Not classified:155
58197,4-Bromo-2-iodoaniline,613-931-8,66416-72-6,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,41,H411:39;H315:41;H301:41;H335:39;H318:39;H311:2;H331:2;H319:2
58199,Trimethyltetradecylammonium methyl sulphate,265-333-8,65059-43-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H302:1;H400:1;H314:1
58205,Zinc o-toluate,249-185-1,28716-15-6,Not Classified,Notified C&L,1,Not classified:1
58206,"Alcohols, C16-18, ethoxylated, phosphates, bis(2-hydroxyethyl) ammonium salts",500-766-0,162567-77-3,Not Classified,Notified C&L,2,Not classified:2
58208,m-phenylenediacetic acid,243-332-3,19806-17-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
58209,"3-Morpholinone, 4-(4-aminophenyl)-",610-147-8,438056-69-0,Aquatic Chronic 2,Notified C&L,24,H411:19;H315:5;H319:5;H335:4
58213,"2,2'-dithiodianiline",214-529-1,1141-88-4,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,76,H301:41;H410:41;H400:41;H318:76;H411:33;H315:34;H317:33;H302:33
58214,C36 fatty diol,604-608-2,147853-32-5,Not Classified,REACH registration C&L,69,Not classified:53;H317:16
58217,Anilinoacetonitrile,221-129-0,3009-97-0,Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,85,H301:85;H412:83;H318:85
58218,Ethyl difluoroacetate,207-223-4,454-31-9,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,175,H225:119;H318:118;H411:118;H314:171;H226:56;H315:2;H312:2;H302:2;H335:2;H319:3;H332:2
58231,Hexacos-1-ene,242-615-9,18835-33-1,Not Classified,REACH registration C&L,68,Not classified:68
58232,Antimony triacetate,230-043-2,6923-52-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,51,H411:51;H315:41;H302:51;H319:39;H332:51;H335:2;H290:2
58236,"3,6-dimethylphenanthrene",216-409-4,1576-67-6,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:38;H319:39;H400:38;Not classified:3;H315:1
58238,"Fatty acids, tall-oil, reaction products with diethanolamine",268-886-3,68153-57-1,Eye Irrit. 2,Notified C&L,481,H319:445;H373:33;Not classified:33;H315:35;H318:36
58239,2-ethoxybenzoic acid,205-130-3,134-11-2,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,16,H319:15;H302:5;H315:11;H335:6;Not classified:1
58240,Trichloro(propyl)silane,205-489-6,141-57-1,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,76,H314:76;H302:31;H331:31;H226:76;H318:7;H290:1
58242,"2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid",236-236-8,13252-13-6,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT SE 3,Notified C&L,117,H318:79;H302:79;H335:79;H314:84;Not classified:33
58243,"2,5-dihydro-1-methyl-1H-phosphole 1-oxide",213-217-2,930-38-1,Eye Irrit. 2,Notified C&L,33,H319:33
58245,"4-ethyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane",212-523-3,824-11-3,Acute Tox. 2;Acute Tox. 3,Notified C&L,72,H300:72;H311:72;H370:33
58246,1-[(2-aminoethyl)amino]propan-2-ol,204-657-6,123-84-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H315:38;H335:38;H318:39;H314:1
58250,2-methyl-2-phenylpropanenitrile,601-624-1,1195-98-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
58266,1-ethynylcyclopentanol,241-385-7,17356-19-3,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H226:38;H319:43;H335:39;H315:5;H302:5;H228:4;H312:1;H332:1
58267,"2,2,5-trimethyl-5-pentylcyclopentan-1-one",265-779-3,65443-14-3,Aquatic Chronic 2,REACH registration C&L,1697,H411:1697;H412:1
58268,"Hexa-1,5-diene",209-754-7,592-42-7,Flam. Liq. 2;Asp. Tox. 1,REACH registration C&L,134,H225:134;H304:108;H315:72;H335:98;H319:77;H336:22;H411:1
58269,Bis(benzonitrile)dichloroplatinum,238-943-7,14873-63-3,Not Classified,Notified C&L,10,Not classified:5;H334:4;H330:4;H317:4;H301:4;H311:4;H315:1;H319:1;H335:1
58273,Ferrous sulfate monohydrate,605-688-1,17375-41-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,167,H319:108;H315:108;H302:108;Not classified:59;H335:1
58276,4-nitrophthaldiamide,236-070-6,13138-53-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
58279,"Amides, palm kernel-oil, N,N-bis(hydroxyethyl)",277-612-1,73807-15-5,Not Classified,Notified C&L,3,Not classified:2;H411:1;H315:1;H319:1;H318:1
58282,1-phenyl-2-buten-1-one,207-800-0,495-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
58286,"Sodium 1-amino-9,10-dihydro-4-[[4-[[methyl[(4-methylphenyl)sulphonyl]amino]methyl]phenyl]amino]-9,10-dioxoanthracene-2-sulphonate",276-889-6,72828-82-1,Aquatic Chronic 1,REACH registration C&L,41,H410:1;Not classified:40
58296,C.I. acid red 003,611-706-9,5858-64-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
58297,1-(dichloromethyl)-2-fluorobenzene,206-279-7,320-65-0,Skin Corr. 1B;Eye Irrit. 2,Notified C&L,1,H319:1;H314:1
58298,Oct-7-enyloxirane,288-437-5,85721-25-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H315:43;H335:42;H318:42;H319:1
58300,"Hydrocarbons, C3-4;Petroleum gas",270-681-9,68476-40-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
58306,nickel silicate (3:4),250-788-7,31748-25-1,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H400:0;H317:0;H372:0;H350:0;H410:0
58309,"4-Methyl-4'-((E)-3-pentenyl)-1,1'-biphenyl",610-386-8,478385-88-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
58312,1-[4-(trans-5-Pentylcyclohexyl)-1-cyclohexen-1-yl]-4-trifluo rmethoxybenzen,604-396-1,144120-82-1,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
58313,pentasodium 4-hydroxy-7-[(sulfonatomethyl)amino]-3-[(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]-8-[(2-sulfonato-4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]naphthalene-2-sulfonate,443-940-0,,Not Classified,REACH registration C&L,1,Not classified:1
58315,4-nitrobenzyl alcohol,210-611-6,619-73-8,Acute Tox. 4,Notified C&L,51,H302:44;H315:8;H319:8;H335:7;Not classified:2;H312:1;H332:1
58316,Tetrahydro-3-methylfuran,236-537-4,13423-15-9,Flam. Liq. 2;Skin Corr. 1C;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,91,H225:91;H318:87;H336:87;H314:87;H319:4;H335:3;H315:1
58319,(2-bromophenyl)methanamine hydrochloride,611-181-6,5465-63-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44;H312:2;H302:2
58320,N-(4-methoxybenzylidene)aniline,212-647-8,836-41-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
58321,"reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(",434-290-9,69486-14-2,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
58323,"4-(4-trans-vinyl-[1,1'-bicyclohexyl]-4'-trans-yl)-1,2-difluorobenzene",430-860-6,,Not Classified,Notified C&L,1,Not classified:1
58326,"Benzene-1,2,4-tricarboxylic acid",208-432-3,528-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,285,H315:250;H319:251;H335:249;Not classified:33;H302:1
58328,2-[(phenylmethyl)amino]benzoic acid,229-572-1,6622-55-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H302:39;H335:40
58329,1-phenylprop-2-yn-1-ol,224-064-6,4187-87-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H319:79;H315:79;H302:80;H335:74;H332:1;H312:1
58330,"1,2,3,4-tetrahydro-2-(trifluoroacetyl)isoquinoline-7-sulfonyl chloride",616-073-2,74291-57-9,,Notified C&L,5,H314:5
58335,2-bromo-5-isothiocyanatotoluene,242-907-6,19241-38-4,,Notified C&L,5,H332:5;H302:5;H312:5;H314:4;H315:1;H335:1;H319:1
58336,Germanium oxide,243-922-0,20619-16-3,,Notified C&L,1,Not classified:1
58337,"(9,9-Dimethyl-9H-xanthane-4-5-diyl)bis(diphenylphosphine)",605-249-4,161265-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,141,H315:105;H319:138;H335:137;Not classified:2;H302:4;H332:3;H317:1
58339,"1,2,3,6-tetrahydro-4-methylphthalic anhydride",222-323-8,3425-89-6,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H334:0;H317:0;H318:0
58340,Butyrohydrazide,222-579-0,3538-65-6,Acute Tox. 3,Notified C&L,44,H301:38;H315:6;H319:6;H335:6;H302:1
58344,"6α,9-difluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-acetate",220-581-6,2823-42-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,Notified C&L,2,H315:1;H312:1;H302:1;H335:1;H361:1;H319:1;H332:1;H373:1;H360:1
58347,Tris(3-methylphenyl)phosphine,228-312-4,6224-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78,H315:78;H319:78;H335:42
58348,"Lactamase, β-",232-970-8,9073-60-3,,Notified C&L,39,Not classified:38;H334:1;H317:1
58349,Dibismuth tris(tetraoxowolframate),237-033-7,13595-87-4,Not Classified,Notified C&L,32,Not classified:32
58353,3-tert-butyl-6-methyluracil,229-522-9,6589-37-3,Eye Irrit. 2,Notified C&L,38,H319:38
58355,"Triphenyl(P,P,P-triphenylphosphine imidato)phosphorus(1+) chloride",244-170-6,21050-13-5,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H332:38;H315:42;H319:42;H335:42
58358,"2,2'-dichloro-4,4'-methylenedianiline;4,4'-methylene bis(2-chloroaniline)",202-918-9,101-14-4,Acute Tox. 4;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H350:0;H410:0;H302:0;H400:0
58362,"1,5-diphenylcarbonohydrazide",205-403-7,140-22-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,60,H315:56;H319:56;H335:44;Not classified:3;H351:1;H302:1
58367,Ammonium trioxovanadate,232-261-3,7803-55-6,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 4;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,816,H411:29;H301:771;H372:29;H361:112;H319:744;H332:36;H341:451;H315:629;H330:617;H335:634;H412:83;H331:84;H351:83;Not classified:40;H300:5;H318:2;H302:1
58371,4-chloro-β-methylphenethylamine hydrochloride,225-365-5,4806-79-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
58374,"7-methoxybenzo-1,3-dioxole-5-carboxaldehyde",227-304-8,5780-07-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
58376,Iron tristearate,209-095-5,555-36-2,Not Classified,Notified C&L,15,Not classified:15
58378,4-butylbenzoyl chloride,249-224-2,28788-62-7,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,43,H318:39;H335:38;H314:43;H290:1
58380,Allyl phenylacetate,217-281-2,1797-74-6,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1583,H315:1583;H317:1544;H311:1544;H302:1583;H319:1582;H312:38;H335:38;H332:38
58383,"Stannate (Sn(OH)62-), zinc (1:1), (OC-6-11)-",601-692-2,12027-96-2,Not Classified,Notified C&L,22,Not classified:22
58387,N-(3-amino-4-chlorophenyl)acetamide,257-485-9,51867-83-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
58388,naptalam-sodium (ISO);sodium N-naphth-1-ylphthalamate,205-073-4,132-67-2,Acute Tox. 4,Harmonised C&L,0,H302:0
58389,Vinylamine,209-802-7,593-67-9,Not Classified,Notified C&L,36,Not classified:36
58390,"Benzoic acid, 4-[[[4-[(1-oxo-2-propenyl)oxy]butoxy]carbonyl]oxy]-, 2-methyl-1,4-phenylene ester",428-570-1,187585-64-4,Skin Sens. 1B,REACH registration C&L,84,H317:84
58392,Pipenzolate bromide,204-741-2,125-51-9,Acute Tox. 4,Notified C&L,41,H302:41
58394,m-phenylenediamine,203-584-7,108-45-2,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H341:0;H317:0;H400:0;H301:0;H311:0;H331:0;H410:0;H319:0
58395,"5(or 6)-carboxy-4-hexylcyclohex-2-ene-1-octanoic acid, compound with 2-aminoethanol",282-471-4,84235-45-0,Not Classified,Notified C&L,1,Not classified:1
58400,"p-(2,2-dimethoxyethoxy)toluene",228-689-5,6324-78-3,Flam. Liq. 3,Notified C&L,88,H226:88
58404,Heptadecafluorooctanesulphonamide,212-046-0,754-91-6,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H301:1;H410:1;H400:1;Not classified:1;H315:1;H319:1;H335:1
58405,2-methylallyl isobutyrate,212-437-6,816-73-9,Flam. Liq. 3,Notified C&L,88,H226:88
58411,Aluminium 2-ethylhexanoate,221-098-3,3002-63-9,Not Classified,REACH registration C&L,86,Not classified:3;H361:83
58414,m-toluamide,210-553-1,618-47-3,,Notified C&L,4,H315:4;H319:4;H335:4
58415,"Sodium hydrogen 4-amino-5-hydroxynaphthalene-1,7-disulphonate",254-940-3,40492-14-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,14,H315:4;H319:14;H302:2
58417,4-methoxybenzenediazonium tetrafluoroborate,207-296-2,459-64-3,Skin Corr. 1B,Notified C&L,40,H314:40;H318:1
58418,Sulphoethyl methacrylate,234-207-4,10595-80-9,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,150,H317:147;H318:148;H314:150;H304:89;H335:1
58419,N-(1-oxododecyl)-L-glutamic acid,222-261-1,3397-65-7,Not Classified,Notified C&L,2,Not classified:2
58426,"Benzene-1,3,5-tricarbonitrile",233-806-8,10365-94-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H315:1;H301:1;H311:1;H331:1;H319:1
58434,3-bromobenzaldehyde,221-526-9,3132-99-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H315:50;H302:50;H335:45;H312:2;H332:2
58435,"Methyl 3-oxo1,2-benzisothiazole-2(3H)-acetate 1,1-dioxide",229-646-3,6639-62-9,Not Classified,REACH registration C&L,41,Not classified:2;H319:38;H302:39
58436,Potassium pentaborate,234-371-7,11128-29-3,Repr. 2,REACH registration C&L,49,H361:9;H360:38;Not classified:2
58437,"Gases (petroleum), alkylation feed;Petroleum gas;[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]",271-737-5,68606-27-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
58438,Cadmium telluride,215-149-9,1306-25-8,Aquatic Chronic 3,REACH registration C&L,288,H412:8;H332:287;H411:175;H312:105;H400:105;H302:105;H410:105;H372:7
58442,"Benzenesulfonic acid, hydroxy-, monosodium salt, reaction products with formaldehyde and sulfonylbis[phenol], sodium salts",290-719-8,90218-44-3,Aquatic Chronic 2,Notified C&L,52,H411:50;H317:2;H311:1;H302:2;H331:1;H351:2;H318:1
58445,Isooctadecyl acrylate,299-018-1,93841-48-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,15,H411:14;H315:15;H319:15;H335:14
58447,Sodium hexafluoroantimonate,240-989-8,16925-25-0,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,65,H332:62;H411:62;H302:62;H331:1;H301:1;H311:1;H314:1;Not classified:2
58450,Benzyl 2-methylcrotonate,253-544-8,37526-88-8,Not Classified,Notified C&L,187,Not classified:120;H315:67;H319:67;H335:67
58452,"Biphenyl-2,2'-diol",217-303-0,1806-29-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,49,H315:40;H335:39;H318:40;H319:9;H302:10
58456,Gold monoiodide,233-656-3,10294-31-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:38;H319:38;H335:38;H314:4
58457,"D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)",408-120-9,,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H302:0;H318:0
58458,"4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine",411-400-3,102089-33-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H315:0;H412:0;H373:0;H302:0;H318:0
58465,Perfluoroacetyl fluoride,206-558-3,354-34-7,Acute Tox. 2;STOT SE 2;STOT RE 2,Notified C&L,79,H373:79;H371:79;H330:79
58470,"Fatty acids, tall-oil, compds. with 4,5-dihydro-2-nortall-oil alkyl-1H-imidazole-1-ethanol",268-641-0,68132-48-9,Not Classified,Notified C&L,35,Not classified:35
58473,ACID BLACK 194,612-723-4,61931-08-6,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
58475,"Quaternary ammonium compounds, (hydrogenated tallow alkyl)trimethyl, chlorides",263-005-9,61788-78-1,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,21,H400:15;H314:18;H302:18;H410:14;H318:13;Not classified:3;H311:1
58477,Carbazamidine sulphate,220-605-5,2834-84-6,Acute Tox. 4,REACH registration C&L,3,H302:2;Not classified:1
58479,"Chloro-29H,31H-phthalocyanine",250-004-3,30023-13-3,Not Classified,Notified C&L,7,Not classified:7
58480,"Alcohols, C>14",275-983-4,71750-71-5,Not Classified,Notified C&L,356,Not classified:356
58481,Dialuminium copper tetraoxide,234-934-7,12042-92-1,Not Classified,Notified C&L,32,Not classified:32
58482,"Urea, polymer with ammonium chloride ((NH4)Cl), cyanoguanidine and formaldehyde",618-639-4,9075-85-8,Aquatic Chronic 2,Notified C&L,89,H411:89
58485,5-chlorovaleryl chloride,216-403-1,1575-61-7,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,51,H290:6;H302:48;H314:51;H319:1;H335:1;H318:1;H330:1
58486,"2-amino-1H-imidazole-4,5-dicarbonitrile",255-163-2,40953-34-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H315:40;H312:40;H302:40;H335:39;H319:40;H332:40
58491,"2,2',4,4',6,6'-hexanitrostilbene",243-494-5,20062-22-0,Expl. 1.1,REACH registration C&L,49,H201:29;H410:20;H204:20;H400:20;H317:20;H332:8;H302:8;H312:8
58492,tert-butyl acrylate,216-768-7,1663-39-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0;H312:0;H317:0;H302:0;H335:0;H225:0;H332:0
58494,"trans-4'-ethyl-2-fluoro-4-(4-pentylcyclohexyl)-1,1'-biphenyl",280-208-8,83171-55-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
58497,2-bromo-3-chloropropene,240-452-8,16400-63-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H302:38;H335:38;H226:38;H318:38
58499,"2,2-diphenylpropiononitrile",226-925-1,5558-67-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:43;H302:43;H312:43;H315:1;H319:1
58501,2-anilinoethanol,204-588-1,122-98-5,Acute Tox. 3;Acute Tox. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,195,H310:157;H411:117;H301:151;H311:72;H318:188;H373:28;H331:34;H317:13;H400:9;H351:13;H371:9;H319:6;H315:2
58503,Curine,207-109-4,436-05-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H310:38;H300:38;H330:38
58507,Potassium perfluorohexane-1-sulphonate,223-393-2,3871-99-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
58510,ethyl nitrite,203-722-6,109-95-5,Press. Gas;Flam. Gas 1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H312:0;H220:0;H302:0;Not classified:0;H332:0
58513,"Poly[oxy(methyl-1,2-ethanediyl)], α-(2-aminomethylethyl)-ω-(2-aminomethylethoxy)-, sulfopropyl derivs., sodium salts",606-057-3,185701-93-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2,Notified C&L,1,H315:1;H302:1;H312:1
58515,"Strawberry, Fragaria virginiana, ext.",290-347-6,90131-36-5,Not Classified,Notified C&L,123,Not classified:72;H224:25;H226:25;H319:1
58519,Sodium 7-aminonaphthalene-2-sulphonate,226-498-1,5412-82-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H315:39;H319:39
58521,Bis(4-nitrophenyl) sulphone,214-589-9,1156-50-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
58522,"2,2',2''-nitrilotrisethyl tris(dihydrogen phosphate), sodium salt",269-020-7,68171-29-9,Not Classified,Notified C&L,5,Not classified:5
58525,"(Z)-N-(3-aminopropyl)-N'-[3-(9-octadecenylamino)propyl]propane-1,3-diamine",266-613-2,67228-83-5,Acute Tox. 4;Skin Corr. 1C;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H373:1;H314:1;H302:1;H410:1
58526,"N,N'-(dithiodi-4,1-phenylene)bisacetamide",240-821-3,16766-09-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
58529,"1,6,7,8-tetrahydro-1,4,6,6,8,8-hexamethyl-as-indacen-3(2H)-one",269-556-1,68298-33-9,Not Classified,Notified C&L,1374,Not classified:1374
58533,Sodium O-isobutyl dithiocarbonate,246-805-2,25306-75-6,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,132,H411:19;H314:3;H311:3;H372:3;H302:131;H228:17;H318:3;H332:58;H315:128;H312:71;H242:57;H319:126;H260:55;H335:55;H251:14;H317:14;H400:14;Not classified:1
58534,"Residue, Nickel matte leaching",927-629-1,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H341:3;H315:3;H317:3;H373:3;H400:3;H302:3;H350:3;H410:3;H319:3
58536,C.I. Disperse Yellow 184:1,605-367-6,164578-37-4,Not Classified,Notified C&L,2,Not classified:2
58541,(R)-sec-butylamine;(R)-2-aminobutane,236-232-6,13250-12-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H400:0;H314:0;H302:0;H225:0;H332:0
58544,"4-propylcyclohexyl [trans[trans(trans)]]-4'-butyl[1,1'-bicyclohexyl]-4-carboxylate",289-470-8,89129-90-8,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
58549,Terephthalic acid,202-830-0,100-21-0,Not Classified,REACH registration C&L,1158,Not classified:942;H315:215;H319:212;H335:188;H361:1;H302:2
58553,Trichloromethyl chloroformate,207-965-9,503-38-8,Acute Tox. 2;Skin Corr. 1B;Acute Tox. 2,Notified C&L,45,H300:40;H330:45;H314:45
58555,"Fatty acids, tallow",263-129-3,61790-37-2,Not Classified,Notified C&L,137,Not classified:137
58556,"Trihydrogen bis[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonato(3-)]chromate(3-), compound with 2-(methylamino)ethanol",284-206-8,84812-63-5,Aquatic Chronic 4,Notified C&L,2,H413:2
58557,"ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate",443-870-0,163520-33-0,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0;H317:0
58559,p-cyanophenyl p-butylbenzoate,254-085-6,38690-77-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
58560,Vanadium diiodide,239-545-6,15513-84-5,Not Classified,Notified C&L,1,Not classified:1
58561,"Gases (petroleum), preflash tower off, crude distn.;Refinery gas;[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",272-881-1,68919-08-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
58562,Sodium dodecane-1-thiolate,248-141-9,26960-77-0,,Notified C&L,2,H314:2;H317:1;H318:1;H228:1
58565,Hexadecyl methacrylate,219-672-3,2495-27-4,Not Classified,REACH registration C&L,347,Not classified:107;H315:240;H319:240;H335:240;H317:61;H302:1;H332:1
58567,"1-(2,4-xylyl)piperazine",213-797-7,1013-76-9,Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H314:2;H302:1;H312:1
58569,"2,2-dimethylpropane-1,3-diyl 2-ethylhexanoate",249-060-1,28510-23-8,Not Classified,REACH registration C&L,23,Not classified:23
58573,Phenobarbital,200-007-0,50-06-6,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 2,REACH registration C&L,191,H317:187;H301:190;H311:3;H331:3;H351:161;H360:183;H362:2;H361:1;H336:1;H400:1
58574,4-ethoxyaniline;p-phenetidine,205-855-5,156-43-4,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Muta. 2,Harmonised C&L,0,H341:0;H312:0;H317:0;H302:0;H319:0;H332:0
58575,Sodium naphthalene-1-sulphonate,204-976-0,130-14-3,Eye Irrit. 2,REACH registration C&L,52,H319:50;H315:45;H335:44;Not classified:2
58576,4-chloroanisole,210-772-2,623-12-1,Not Classified,REACH registration C&L,8,Not classified:4;H332:3;H302:3;H312:3;H315:1;H319:1;H335:1
58579,"2-Propenamide, homopolymer",618-350-3,9003-05-8,Not Classified,Notified C&L,508,Not classified:444;H302:63;H319:2
58585,"4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2-chlorophenol] S,S-dioxide",224-619-2,4430-20-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,204,H315:204;H319:204;H335:203
58587,"(6aR-cis)-2,3,6a,9a-tetrahydro-9a-hydroxy-4-methoxycyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-1,11-dione",229-865-4,6795-23-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 1B,Notified C&L,4,H310:4;H300:4;H350:4;H330:4
58588,3-bromobenzonitrile,230-127-9,6952-59-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:47;H312:45;H302:45;H335:46;H319:47;H332:45;H412:4;H301:2;H311:1;H331:1
58589,α-chloro-o-xylene,209-013-8,552-45-4,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,132,H318:88;H290:88;H302:92;H314:131;H315:1;H319:1;H335:1;H227:1
58592,Bis(triphenyltin) oxide,215-025-4,1262-21-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H400:43;H301:43;H311:43;H331:38;H410:43;H330:4
58593,"2,4-diethyl-9H-thioxanthen-9-one",280-041-0,82799-44-8,Not Classified,REACH registration C&L,58,Not classified:58
58596,"2,4,6-trimethyl-2,4,6-trivinylcyclotrisilazane",226-848-3,5505-72-6,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
58597,"1,3-Isobenzofurandione, 5-fluoro-",923-092-2,319-03-9,,Notified C&L,4,H319:4;H315:4;H302:4;H335:4
58599,Isotridecyl stearate,250-703-3,31565-37-4,Not Classified,Notified C&L,305,Not classified:295;H303:10
58600,(2-ethoxy-2-oxoethyl)dimethylsulphonium bromide,225-968-3,5187-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:43
58601,tert-butyl 4-hydroxybenzoate,247-272-9,25804-49-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H302:45;H335:47
58602,"3,6-dihydroxyphthalonitrile",225-241-0,4733-50-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:41;H312:2;H302:2;H332:2;H301:2;H311:2;H331:2
58603,N-phenylglycine,203-070-2,103-01-5,Not Classified,Notified C&L,3,Not classified:1;H315:2;H319:2;H335:2;H302:1
58606,"Benzenesulfonic acid, 4-C10-14-alkyl derivs., compds. with ethylenediamine (1:1)",290-638-8,90194-29-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
58607,Butylmagnesium chloride,211-739-5,693-04-9,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,163,H225:36;H260:159;H318:84;H314:163;H250:122;H224:4;H361:4;H261:1
58608,2'-hydroxy-4'-methoxyacetophenone,209-012-2,552-41-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,50,H315:49;H312:44;H302:50;H335:48;H319:49;H332:44
58610,2-amino-2-deoxy-D-mannose hydrochloride,226-847-8,5505-63-5,Not Classified,Notified C&L,8,Not classified:6;H319:2;H315:2;H302:2;H317:1;H335:1
58618,Sodium p-cumenesulphonate,239-854-6,15763-76-5,Eye Irrit. 2,REACH registration C&L,142,H319:142;H315:1
58620,"Dibromopyranthrene-8,16-dione",215-374-2,1324-35-2,Not Classified,REACH registration C&L,22,Not classified:22
58624,"1,8-dinitronaphthalene",210-016-1,602-38-0,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38;H228:38;H341:1
58626,"1,5-Dichloropentan-3-one",609-194-7,3592-25-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H332:1
58627,dibutyltin dilaurate;dibutyl[bis(dodecanoyloxy)]stannane,201-039-8,77-58-7,Muta. 2;STOT RE 1;Repr. 1B,Harmonised C&L,0,H341:0;H372:0;H360:0
58628,2-(4-methylthiazol-5-yl)ethyl hexanoate,303-210-3,94159-32-7,Not Classified,Notified C&L,90,Not classified:88;H315:2;H319:2;H335:1
58629,Cyclohexylacetic acid,226-132-0,5292-21-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
58632,Iron triperchlorate,236-908-0,13537-24-1,Not Classified,Notified C&L,3,Not classified:2;H271:1;H314:1
58638,Morphine,200-320-2,57-27-2,Acute Tox. 4;STOT SE 3,REACH registration C&L,71,H336:27;H302:70;H334:2;H341:1;H330:1;H362:1;H317:2;H301:1;H361:2;H315:1;H335:1;H319:1
58641,strontium 5-[(4-chloro-5-ethyl-2-sulfonatophenyl)diazenyl]-6-hydroxynaphthalene-2-sulfonate,428-180-1,197566-90-8,Aquatic Chronic 3,Notified C&L,84,H412:84
58644,Ethyl ethyl(phenyl)carbamate,213-796-1,1013-75-8,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,3,H315:3;H412:3
58645,"9,10-bis(phenylvinyl)anthracene",233-210-8,10075-85-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:47;H319:47;H335:46
58646,9H-fluoren-2-ol,219-478-9,2443-58-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
58647,"Benzamide, 3-amino-N-[4-(aminocarbonyl)phenyl]-4-methoxy-, hydrochloride",618-990-3,939961-06-5,Not Classified,Notified C&L,34,Not classified:34
58648,Mercury sulphate,231-992-5,7783-35-9,Acute Tox. 2;Acute Tox. 3;Aquatic Chronic 1,REACH registration C&L,82,H300:79;H311:2;H410:80;H310:77;H330:78;H400:75;H373:78;Not classified:2;H362:1;H312:1;H314:1;H301:1
58649,Doublecure 1172,485-150-9,,Aquatic Chronic 1,Notified C&L,1,H410:1
58650,"2H-Pyran-2-one, 6-[2-(β-D-glucopyranosyloxy)-4-hydroxy-6-methylphenyl]-4-methoxy-",609-550-1,38412-46-3,,Notified C&L,39,Not classified:39
58652,Tricyclopentylphosphine,423-150-2,7650-88-6,Pyr. Liq. 1,Notified C&L,1,H250:1
58654,"Pyrimidine, 5-butyl-2-(4'-fluoro[1,1'-biphenyl]-4-yl)-",619-134-1,95495-17-3,Not Classified,Notified C&L,1,Not classified:1
58656,Dodec-2-enoic acid,224-569-1,4412-16-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H335:1;H318:1
58661,Calcium chlorate,233-378-2,10137-74-3,Not Classified,Notified C&L,28,Not classified:25;H272:3
58663,"Fatty acids, tallow, hydrogenated, esters with pentaerythritol",283-083-8,84539-95-7,Not Classified,Notified C&L,1,Not classified:1
58669,1-β-D-arabinofuranosylcytosine hydrochloride,200-713-9,69-74-9,Skin Sens. 1;Eye Irrit. 2;Repr. 2,REACH registration C&L,40,H319:40;H361:40;H317:40;H341:38
58671,"Resin acids and Rosin acids, aluminum salts",263-075-0,61789-65-9,Self-heat. 1,REACH registration C&L,239,H251:2;Not classified:135;H315:101;H319:101;H316:1;H317:1;H228:1;H320:1;H332:1
58673,Dipotassium malate,209-549-2,585-09-1,Not Classified,Notified C&L,2,Not classified:2
58679,(S)-α-(trifluoromethyl)anthracene-9-methanol,262-348-1,60646-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
58680,"Hydrocarbons, C14",300-241-4,93924-47-1,Not Classified,Notified C&L,1,Not classified:1
58681,Amantadine,212-201-2,768-94-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Repr. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,133,H312:1;H314:2;H412:85;H302:133;H361:2;H226:84;H402:2;H318:2;H332:1;H319:48;H315:48;H335:47
58682,1H-tetrazol-5-acetic acid,244-563-2,21743-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39;H228:1
58686,Mercaptopropanol,264-572-5,63947-56-8,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,8,H315:8;H301:8;H311:8;H226:8;H319:8;H336:8
58687,"3-(3-chloropropyl)-1,1,1,5,5,5-hexamethyl-3-[(trimethylsilyl)oxy]trisiloxane",241-985-9,18077-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
58688,4-(trans-4-Ethylcyclohexylcarbonyloxy)-benzoic acid-(4-propylphenylester),926-600-0,,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
58692,"2,3-dimethoxy-p-benzoquinone",221-489-9,3117-02-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
58694,"chlordimeform hydrochloride;N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;N",243-269-1,19750-95-9,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H351:0;H302:0;H400:0
58697,p-nitrobenzohydrazide,211-271-1,636-97-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42;H312:1;H302:1;H332:1
58699,"4,11-diamino-2-[3-(2-methoxyethoxy)propyl]-1H-naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone",265-334-3,65059-45-2,Not Classified,REACH registration C&L,52,Not classified:51;H302:1
58700,2-chloro-6-methoxypyridin-3-amine,251-989-2,34392-85-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H302:38;H335:38;H318:38
58710,Ethyl (Z)-hept-4-enoate,254-702-9,39924-27-1,Not Classified,Notified C&L,89,Not classified:89
58711,"Bis(1,2-diphenylphosphino)ethane",216-769-2,1663-45-2,,Notified C&L,10,H315:10;H319:10;H335:10;H400:3;H410:4;H302:1;H332:1
58712,"1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile",411-990-2,68612-94-2,Skin Sens. 1,Harmonised C&L,0,H317:0
58713,3-Bromo-6-chloro-2-methylpyridine,603-643-0,132606-40-7,,Notified C&L,3,H315:3;H319:3;H335:2
58715,"tert-Butyl 2-[(4R,6R)-6-(2-Aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate",603-112-3,125995-13-3,Not Classified,Notified C&L,2,Not classified:1;H315:1;H319:1
58716,"3,3'-[(4-formylphenyl)imino]bispropiononitrile",241-382-0,17354-79-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H312:38;H302:38;H335:38;H319:38;H332:38
58717,"Alkanes, C7-10-iso-",292-458-5,90622-56-3,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,214,H411:153;H315:200;H225:180;H336:208;H304:214;H400:48;H224:33;H410:47
58718,"Benzoic acid, 3,5-dimethyl-4-(phenylmethoxy)-",925-930-2,97888-80-7,,Notified C&L,4,H315:4;H319:4;H335:4
58721,Zircon,239-019-6,14940-68-2,Not Classified,Notified C&L,174,Not classified:170;H350:4;H320:4;H315:4;H319:4
58723,nickel(II) propionate,222-102-6,3349-08-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H341:0;H400:0;H317:0;H372:0;H350:0;H410:0;H360:0
58724,"Glycine, N, N' - (1,9-nonandeiyl) bis-, monopotasium salt",470-270-6,,Not Classified,REACH registration C&L,1,Not classified:1
58728,"1-propyl-4-[(trans,trans)-4'-propyl[1,1'-bicyclohexyl]-4-yl]-benzene",617-607-7,84656-77-9,Not Classified,REACH registration C&L,1,Not classified:1
58732,2-tert-butylaminoethyl methacrylate,223-228-4,3775-90-4,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H315:0;H319:0;H317:0
58735,Pentafluoroethane,206-557-8,354-33-6,Press. Gas (Comp.),REACH registration C&L,207,H280:207
58738,Thiamethoxam,604-921-4,153719-23-4,Flam. Sol. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,229,H410:229;H302:229;H400:229;H228:189;H332:38
58739,"Sodium O,O'-diisopentyl dithiophosphate",261-176-4,58237-07-3,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,14,H318:14;H412:14;H302:14;H314:14
58741,"Fatty acids, C14-18 and C16-18-unsatd., Me esters, sulfated, ammonium salts",292-828-6,91001-57-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,29,H315:29;H318:29
58742,"2-ethylhexanoic acid, bismuth salt",276-958-0,72877-97-5,Skin Irrit. 2,Notified C&L,55,H315:55
58744,2-(hexylthio)ethanol,246-282-0,24475-56-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
58750,2-methyl-6-(4-methylcyclohex-3-en-1-ylidene)hept-2-ene,207-805-8,495-62-5,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1,Notified C&L,1714,H317:1711;H315:1711;H304:1711;H411:36;H332:36;Not classified:3;H319:2
58755,3-Methoxy-4-methylbenzaldehyde,607-471-7,24973-22-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H315:3;H302:2;H335:3
58759,Decyltrimethylammonium chloride,233-299-3,10108-87-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
58766,"3,5-di-tert-butyl-o-benzoquinone",222-189-0,3383-21-9,,Notified C&L,4,H315:4;H319:4;H335:4
58767,"Salt of (8a,9R)-cinchonan-9-ol and [(R)-{[(1S)-2-methyl-1-(propanoyloxy)propyl]oxy}(4-phenylbutyl)phosphoryl]acetic acid (1:1) / Salt of (8a,9R)-cinchonan-9-ol and [(R)-{[(1S)-2-methyl-1-(propanoyloxy)propyl]oxy}(4-phenylbutyl)phosphoryl]acetic acid",700-177-0,467430-13-3,Not Classified,Notified C&L,2,Not classified:2
58768,"Aluminium, 9,10-dihydro-1,4-dihydroxy-9,10-dioxo-2-anthracenesulfonic acid complex",215-512-1,1328-04-7,Not Classified,Notified C&L,5,Not classified:5
58769,Isotridecyl acetate,273-872-5,69103-23-7,Not Classified,Notified C&L,265,Not classified:265
58772,2-{[(4-Chloro-3-methoxypyridin-2-yl)methyl]sulfanyl)-6-(difluoromethoxy)-1H-benzimidazole,609-304-3,368890-20-4,Not Classified,Notified C&L,3,Not classified:2;H315:1;H312:1;H302:1;H335:1;H319:1;H332:1
58775,Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate,201-899-4,89-33-8,Acute Tox. 4,Notified C&L,74,H302:40;H317:32;Not classified:2;H319:1;H315:1;H335:1
58777,disodium metasilicate,229-912-9,6834-92-0,Skin Corr. 1B;STOT SE 3,Harmonised C&L,0,H335:0;H314:0
58778,"Benzyl[3-[[9,10-dihydro-4-[isopropylamino]-9,10-dioxo-1-anthryl]amino]propyl]dimethylammonium chloride",252-547-1,35402-38-1,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H318:1;H317:1
58780,Tris(2-butoxyethyl) phosphate,201-122-9,78-51-3,Not Classified,Notified C&L,527,Not classified:414;H335:111;H315:54;H312:52;H302:31;H319:56;H332:52;H412:1;H303:1;H413:1
58781,"zinc salts, fatty acids, C",446-470-4,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
58786,3-nitrobenzamidinium hydrochloride,260-159-9,56406-50-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H312:38;H302:38;H335:38;H319:38;H332:38
58792,2-[(2-hydroxy-1-naphthyl)azo]naphthalenesulphonic acid,249-459-0,29128-55-0,Not Classified,Notified C&L,2,Not classified:2
58793,"Di(tridecyl) 3,3'-thiodipropionate",234-206-9,10595-72-9,Aquatic Chronic 3,Notified C&L,294,H412:139;Not classified:95;H413:46;H410:14
58795,"Tetrahydrodifuro[3,4-b:3',4'-d]furantetrone",247-112-8,25574-69-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
58798,"Dimethyl, (Aminoethylaminopropyl)methyl Siloxane, Trimethylsiloxy-terminated",615-336-9,71750-79-3,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2,Notified C&L,741,H315:573;H319:624;H330:572;H318:113;H400:61;H314:49;H410:61;H371:47;H412:45;H413:13;H361:3;Not classified:2
58799,"5-(trifluoromethyl)benzene-1,3-diamine",206-708-8,368-53-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,46,H302:45;H318:43;H315:8;H311:5;H335:7;H332:6;H301:1;H331:1;H319:3;H312:1
58802,1-(1-bromoethyl)-4-chlorobenzene,238-870-0,14804-61-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:2
58808,6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene,264-408-2,63675-74-1,Acute Tox. 4,REACH registration C&L,11,H302:8;H315:3;H312:3;H373:2;H335:3;H319:3;H332:3;Not classified:1
58809,"Diallyl 2,2'-oxydiethyl dicarbonate",205-528-7,142-22-3,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1,REACH registration C&L,63,H315:63;H302:63;H400:62;H410:40;H319:1
58812,"D-gluconic acid, compound with N,N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1)",242-354-0,18472-51-0,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,206,H410:174;H400:197;H318:151;H302:49;H319:9;H335:8;Not classified:3;H315:2
58813,dimethylsulfamoylchloride,236-412-4,13360-57-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2;Carc. 1B,Harmonised C&L,0,H330:0;H312:0;H314:0;H302:0;H350:0
58814,benzo[k]fluoranthene,205-916-6,207-08-9,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H350:0;H410:0;H400:0
58818,coumafuryl (ISO);fumarin;(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin,204-195-5,117-52-2,Acute Tox. 3;STOT RE 1;Aquatic Chronic 3,Harmonised C&L,0,H301:0;H372:0;H412:0
58819,"Benzeneacetyl chloride, 4-methoxy-",922-515-8,4693-91-8,,Notified C&L,4,H314:4
58830,"Estra-1,3,5(10)-triene-3,17α-diol 3-benzoate",227-938-5,6045-53-0,,Notified C&L,1,H341:1;H302:1
58831,Iodoethylene,209-801-1,593-66-8,,Notified C&L,5,H350:5;H302:4;H301:1;H311:1;H330:1
58832,Calcium strontium bis[3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azo]-2-naphthoate],259-673-6,55491-44-6,Not Classified,Notified C&L,69,Not classified:69
58840,Diterbium trioxide,234-849-5,12036-41-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:42;H319:42;H335:42;Not classified:1
58848,"N,N-bis(2-methylpropyl)formamide",219-983-4,2591-76-6,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,84,H302:84;H318:84
58849,"Hexanoic acid, 3-mercaptohexyl ester",603-989-2,136954-22-8,Not Classified,Notified C&L,89,Not classified:89
58850,2-chloroethyl acrylate,218-619-1,2206-89-5,Flam. Liq. 3;Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1,Notified C&L,39,H301:39;H226:38;H400:38;H318:38;H315:1;H319:1;H335:1
58852,"1-benzyl-3,4-dimethylpyridinium chloride",244-824-0,22185-44-0,Acute Tox. 4,REACH registration C&L,1,H302:1
58854,"2,6-dimethyl-1H-pyrimidin-4-one",229-577-9,6622-92-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:43;H319:43;H335:42;Not classified:1
58856,"3-methoxy-N,N-dimethylpropionamide",258-420-7,53185-52-7,Eye Irrit. 2;STOT RE 2,REACH registration C&L,39,H373:37;H319:37;H361:35;Not classified:2;H371:1
58858,4-chloro-3-nitrobenzoyl chloride,254-133-6,38818-50-7,Skin Corr. 1B,Notified C&L,49,H314:49;H312:10
58859,"2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)-1,4-naphthoquinone",279-833-9,81818-54-4,Aquatic Chronic 4,Notified C&L,1,H413:1
58863,Allyl (cyclohexyloxy)acetate,272-657-3,68901-15-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1653,H410:30;H302:1649;H400:30;H315:1619;H412:1619;Not classified:4;H317:1
58868,"(±)-[1S*(S*)]-6-Fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran",618-039-2,876514-31-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1;H319:1;H335:1
58869,"1,3,5-triazine-2,4,6(1H,3H,5H)-trione, compound with hydrazine (1:1)",242-618-5,18836-29-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H331:38;H301:38;H311:38
58873,p-fluoro-β-nitrostyrene,211-891-2,706-08-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:39;H318:38;H332:1;H312:1;H314:1
58874,"(S)-7-AMINO-5,6,7,8-TETRAHYDRO-2-NAPHTHOL",617-783-5,85951-60-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
58877,5-methyl-2-(1-methylethyl)cyclohexyl lactate,241-218-8,17162-29-7,Aquatic Chronic 3,Notified C&L,1045,H412:965;Not classified:80
58879,"(2,6-difluorophenyl)acetonitrile",211-504-7,654-01-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:45;H312:45;H302:45;H335:44;H226:42;H319:45;H332:45;H301:2;H311:2;H331:1;H330:1
58883,"1-methyl-1-((3S,8S)-1,2,3,4,5,6,7,8-octahydro-3,8-dimethylazulen-5-yl)ethyl acetate",205-135-0,134-28-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1592,H315:1592;H319:1544;H410:48;H400:48;H317:48
58887,2-ethyl-2-methylbutyric acid,243-402-3,19889-37-3,Not Classified,Notified C&L,57,Not classified:55;H319:2;H315:2;H302:1;H335:2
58888,Pentafluorobenzaldehyde,211-502-6,653-37-2,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H332:39;H315:47;H319:47;H335:46;H301:2;H311:2;H331:2;H330:1;H312:1;H302:1
58894,Dichlorodiethylgermane,236-344-5,13314-52-8,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H312:43;H302:43;H335:39;H319:39;H332:43;H314:4
58895,3-bromo-5-methylaniline,277-932-1,74586-53-1,,Notified C&L,22,H315:21;H312:19;H302:21;H335:20;H319:21;H332:20
58896,Heptafluoro-1-iodopropane,212-045-5,754-34-7,,Notified C&L,6,H315:6;H319:6;H335:5
58902,"Oxidase, alcohol",232-971-3,9073-63-6,Resp. Sens. 1,Notified C&L,1,H334:1
58903,Rubidium dibromoiodate,237-034-2,13595-97-6,Not Classified,Notified C&L,25,Not classified:25
58906,2-(2-chloroethoxy)acetamide,609-321-6,36961-64-5,Acute Tox. 4;Eye Irrit. 2;Muta. 2,Notified C&L,2,H319:2;H341:1;H302:2
58913,"12'-hydroxy-5'α-isobutyl-2'-isopropylergotaman-3',6',18-trione phosphate",227-939-0,6045-63-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2;Lact.,REACH registration C&L,1,H362:1;H312:1;H302:1;H361:1;H332:1
58916,"3-Amino-6-chloro-4-(2-chlorophenyl)-2-methyl-3,4-dihydro-4-quinazolinol",611-168-5,54567-12-3,Not Classified,REACH registration C&L,1,Not classified:1
58921,"Hydrocarbons, C4-10-unsatd.",271-040-6,68514-38-5,Flam. Liq. 2;Asp. Tox. 1;Aquatic Chronic 1,REACH registration C&L,1,H225:1;H410:1;H400:1;H304:1
58923,2-octyldodecyl acetate,277-684-4,74051-84-6,Not Classified,Notified C&L,2,Not classified:2
58925,"(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate",430-790-6,,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0;H302:0;H318:0
58927,"9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthylium, salt with 4,5-dihydro-5-oxo-1-(4-sulphophenyl)-4-[(4-sulphophenyl)azo]-1H-pyrazole-3-carboxylic acid (3:1)",265-499-1,65138-66-1,Not Classified,REACH registration C&L,46,Not classified:39;H302:7
58928,C.I. Direct Blue 200,601-891-4,12217-57-1,Not Classified,Notified C&L,1,Not classified:1
58929,"[hexane-1,6-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid, potassium salt",254-135-7,38820-59-6,Not Classified,Notified C&L,31,Not classified:31
58930,phosphine,232-260-8,7803-51-2,Press. Gas;Flam. Gas 1;Skin Corr. 1B;Acute Tox. 1;Aquatic Acute 1,Harmonised C&L,0,H330:0;H400:0;H220:0;H314:0;Not classified:0
58931,BRUGGOLITE® FF6,432-070-7,,Not Classified,REACH registration C&L,2,Not classified:2
58933,"Sodium 4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluene-3-sulphonate",224-618-7,4430-18-6,Not Classified,REACH registration C&L,426,Not classified:321;H318:63;H412:63;H315:2;H319:3;H335:2;H332:1;H302:1;H312:1;H317:1
58935,Neburon,209-096-0,555-37-3,Acute Tox. 4,Notified C&L,41,H302:41
58936,"Reaction mixture of phosphorous trichloride and 4,4'-thiobis(2-(1,1-dimethylethyl)-5-methylphenol)",439-690-7,310903-37-8,Skin Sens. 1,Notified C&L,33,H317:33
58938,"3,3-dimethylbutyne",213-035-3,917-92-0,Flam. Liq. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,55,H225:14;H402:2;H412:5;H319:43;H315:44;H224:41;H335:43;H304:4;H341:1;H312:1;H302:1;H332:1;H318:1
58940,"4-(chloromethyl)-5-methyl-1,3-dioxol-2-one",617-178-6,80841-78-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H315:48;H319:48;H335:47;H302:44;Not classified:1
58941,"2,2'-(nitrosoimino)bisethanol",214-237-4,1116-54-7,Carc. 1B,Harmonised C&L,0,H350:0
58942,Oxyphencyclimine hydrochloride,204-742-8,125-52-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
58943,Dibenzothiophene,205-072-9,132-65-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,65,H410:52;H302:60;H400:60;H315:8;H311:8;H331:8;Not classified:13;H332:8
58944,Chlorofluoromethane,209-803-2,593-70-4,,Notified C&L,1,H332:1;H280:1
58951,Isodecyl stearate,250-704-9,31565-38-5,Not Classified,Notified C&L,3,Not classified:3
58952,hydroxydisulfito platinum(II) acid,423-310-1,61420-92-6,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Resp. Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H334:0;H317:0;H373:0;H314:0;H412:0;H302:0
58954,"Disodium 9,10-dihydro-9,10-dioxoanthracene-2,6-disulphonate",212-719-9,853-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
58959,"reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid;disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid",424-500-7,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
58960,"iso butyl 2,2-dimethylpropanoate",930-935-8,,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;STOT SE 3,REACH registration C&L,4,H315:4;H312:4;H302:4;H335:4;H226:4;H318:4;H332:4;H336:4
58961,"2,3-dihydroxypropyl laurate",205-526-6,142-18-7,Not Classified,REACH registration C&L,220,Not classified:132;H319:88
58963,"Alkanes, chloro",263-004-3,61788-76-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,965,H410:543;H400:543;Not classified:386;H413:75;H362:39
58964,3-ethylpent-2-ene,212-438-1,816-79-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H225:39;H315:38;H319:38;H335:38;H304:1
58966,3-((C,427-370-1,164288-56-6,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H318:0
58968,1-chloro-1H-benzotriazole,244-171-1,21050-95-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
58969,3-chlorobenzoyl chloride,210-552-6,618-46-2,Skin Corr. 1B;STOT SE 3,Notified C&L,80,H335:39;H314:47;H302:33;H318:2;H290:1
58974,"Fir, Abies balsamea, ext.",285-364-0,85085-34-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,1422,H315:1297;H317:1394;H413:7;H226:1334;H304:1335;H411:1385;Not classified:25;H410:3;H400:1;H319:1
58975,"N,N'-Diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine",613-752-5,65181-78-4,Aquatic Chronic 2,Notified C&L,38,H411:38
58978,4-m-tolylazo-m-toluidine,222-262-7,3398-09-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H302:38
58982,4-fluoroanisole,207-295-7,459-60-9,Flam. Liq. 3,Notified C&L,52,H226:52
58992,"11-(1-Piperazinyl)-dibenzo[b,f][1,4]thiazepine",611-547-5,5747-48-8,Acute Tox. 4;Skin Sens. 1;Repr. 2;STOT RE 2;STOT RE 2,Notified C&L,3,H373:3;H302:3;H361:3;H317:3
58997,"1,4-bis(5-phenyloxazol-2-yl)benzene",217-304-6,1806-34-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:39;H302:39;Not classified:1
59004,"Tar acids, brown-coal gasification;Crude Phenols;[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C",295-536-7,92062-22-1,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
59008,"Fatty acids, sunflower-oil, polymers with adipic acid, caprolactam, diethylenetriamine and triethylenetetramine",614-439-6,68390-20-5,Not Classified,Notified C&L,22,Not classified:22
59012,5-amino-4-cyano-1-phenyl-1H-pyrazole-3-acetonitrile,230-496-6,7152-40-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,42,H331:38;H301:38;H311:38;H315:4;H312:4;H302:4;H335:4;H319:4;H332:4
59015,m-toluidine;3-aminotoluene,203-583-1,108-44-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H400:0;H373:0;H301:0;H311:0;H331:0
59016,Sodium hydrogen -S-(2-aminoethyl)thiophosphate,223-079-5,3724-89-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
59018,"Ammonia-lyase, phenylalanine",232-778-4,9024-28-6,Resp. Sens. 1,Notified C&L,2,H334:2
59020,"N,N,N',N'-tetramethyl-p-phenylenediamine",202-831-6,100-22-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0;H312:0
59022,N-formyl-DL-methionine,224-322-8,4309-82-4,Eye Irrit. 2,Notified C&L,38,H319:38
59024,3-methyl-2-[(1-methyl-2-phenyl-1H-indol-3-yl)azo]thiazolium acetate,284-128-4,84787-87-1,Eye Irrit. 2,Notified C&L,3,H319:3
59025,"Fatty acids, tall-oil, compds. with ethanolamine",268-640-5,68132-47-8,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,76,H411:23;H319:19;Not classified:42;H318:15;H315:25;H317:15
59027,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with butyl 2-propenoate and methyl 2-methyl-2-propenoate",607-698-1,25322-99-0,Not Classified,Notified C&L,1,Not classified:1
59028,5-mesylbenzoxazol-2(3H)-one,237-688-9,13920-98-4,Not Classified,REACH registration C&L,1,Not classified:1
59030,(chloromethyl)vinylbenzene,250-005-9,30030-25-2,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,133,H315:37;H317:132;H400:132;H311:76;H302:132;H331:36;H410:92;H319:37;H312:56;H314:40;H335:1
59039,"(Z,Z)-hexadeca-7,11-dienyl acetate",257-737-8,52207-99-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
59041,"Octahydro-5,5-dimethylnaphthalene-2-carbaldehyde",272-120-3,68738-96-5,Not Classified,Notified C&L,233,Not classified:233
59042,"Fatty acids, C12-20 and C14-22-unsatd., sulfated-sulfonated, sodium salts",309-682-7,100684-11-5,Not Classified,Notified C&L,1,Not classified:1
59043,3-phenylpropan-1-ol,204-587-6,122-97-4,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,1917,H318:96;H314:96;H315:1818;H319:1761;H335:43;H411:1;H302:1;Not classified:1
59048,Praziquantel,259-559-6,55268-74-1,Aquatic Chronic 3,Notified C&L,85,H412:75;H332:6;H351:6;H302:10;H312:6;Not classified:3;H317:2;H335:2;H319:2;H373:1
59049,"6-heptyl-5,6-dihydro-2H-pyran-2-one",240-453-3,16400-72-9,Not Classified,Notified C&L,88,Not classified:88
59052,"1-bromo-2,3-epoxypropane",221-525-3,3132-64-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,43,H315:42;H302:42;H335:42;H226:41;H319:42;H351:42;H341:1;H314:1;H301:1;H311:1;H225:1;H331:1;H318:1
59054,"α,2,2,6-tetramethylcyclohexanepropanol",224-445-7,4361-23-3,Not Classified,Notified C&L,89,Not classified:89
59055,"Gases (petroleum), platformer stabilizer off, light ends fractionation;Refinery gas;[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]",272-880-6,68919-07-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
59056,"Sulfuric acid, mono-C12-14-alkyl esters, magnesium salts",292-222-1,90583-23-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,4,H412:4;H315:4;H302:4;H318:4;H335:2;H228:2;H226:2;H332:2
59060,"1,2,3,4-tetrahydronaphthalene-1-carbonitrile",611-399-1,56536-96-0,Not Classified,REACH registration C&L,6,Not classified:1;H315:4;H312:3;H302:4;H335:3;H319:4;H332:3
59061,Cortisone 21-acetate,200-006-5,50-04-4,Repr. 2;STOT RE 2,REACH registration C&L,21,H373:2;H361:19;H332:16;H312:16;H400:1;H341:1;H302:1
59064,Ethyl pyrazinecarboxylate,230-045-3,6924-68-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
59066,"1-Decanaminium, N-decyl-N,N-dimethyl-, carbonate (2:1)",604-650-1,148788-55-0,Not Classified,Notified C&L,24,Not classified:24
59067,Methyl p-tolyl sulphide,210-773-8,623-13-2,Acute Tox. 4,Notified C&L,40,H302:39;H315:1;H319:1;H335:1
59070,"(2R)-3-chloropropane-1,2-diol",611-463-9,57090-45-6,Acute Tox. 3;Eye Dam. 1,REACH registration C&L,46,H301:45;H318:45;H341:4;H330:4;H315:5;H312:4;H335:4;H360:4;H311:1;H361:1;H332:1;H300:1
59071,"1,4-naphthoquinone",204-977-6,130-15-4,Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,507,H330:479;H317:438;H314:78;H301:502;H400:478;H335:497;H410:121;H318:66;H315:424;H319:424;H334:105;H310:20;H311:35;Not classified:7;H341:1
59072,"ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate",435-210-5,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
59079,2-bromoethyl acetate,213-159-8,927-68-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H319:39;H335:38;H302:1
59082,"Pentanoic acid, 2-hydroxy-3-methyl-, ethyl ester",607-357-7,24323-38-4,Not Classified,Notified C&L,88,Not classified:88
59083,"2-Propenoic acid, homopolymer, potassium salt",607-755-0,25608-12-2,Not Classified,Notified C&L,20,Not classified:20
59085,Gold monochloride,233-655-8,10294-29-8,Skin Corr. 1B;Skin Sens. 1,Notified C&L,43,H317:39;H314:43;H290:1;H318:1
59086,Acetaldehyde oxime,203-479-6,107-29-9,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2;Carc. 2;Aquatic Chronic 3,REACH registration C&L,107,H412:4;H302:73;H351:4;H319:72;H226:106;H332:63;H312:4;H315:1;H331:2;H413:2
59088,Tetraethylsilane,211-155-0,631-36-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H226:44;H319:39;H335:39;H315:39
59091,Polyoxyethylene Sorbitol Hexaoleate,611-475-4,57171-56-9,Not Classified,Notified C&L,95,Not classified:94;H315:1;H319:1
59093,Potassium heptanoate,240-820-8,16761-12-9,Not Classified,Notified C&L,3,Not classified:3
59096,Tolazamide,214-588-3,1156-19-0,Not Classified,Notified C&L,2,Not classified:1;H370:1
59099,Dimethyl (methoxymethyl)succinate,246-806-8,25306-99-4,Eye Irrit. 2,Notified C&L,38,H319:38
59102,Diethyl [[(6-methyl-2-pyridyl)amino]methylene]malonate,236-233-1,13250-95-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
59107,Bisguanidinium phosphate,226-552-4,5423-23-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,61,H319:44;H302:61;H412:11;H332:44;H315:43;H312:1
59108,Dialuminium chloride pentahydroxide,234-933-1,12042-91-0,Met. Corr. 1,REACH registration C&L,385,H290:25;Not classified:259;H315:99;H319:101;H335:80
59110,"Amides, tallow, hydrogenated, N,N'-[[(2-hydroxyethyl)imino]di-2,1-ethanediyl]bis-, ethoxylated",614-486-2,68439-64-5,Not Classified,Notified C&L,5,Not classified:5
59115,"reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;3-(3-ethylphenyl)-2,2-dimethylpropanenitrile",412-660-0,134123-93-6,Aquatic Chronic 2,Harmonised C&L,0,H411:0
59116,"(±)-13-ethyl-3-methoxygona-2,5(10)-dien-17β-ol",213-860-9,1038-28-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H400:1
59118,p-cyanophenyl p-heptylbenzoate,254-084-0,38690-76-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
59120,Methanedisulphonic acid,207-966-4,503-40-2,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,19,H318:3;H413:3;H314:6;H315:11;H319:11;H335:11;H221:2
59121,"Furan-2,5-dicarbaldehyde",212-520-7,823-82-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
59123,Benzyl acrylate,219-673-9,2495-35-4,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,166,H410:7;H315:166;H400:8;H317:15;H411:146;H319:158;H335:156;H302:1
59124,"Tall oil, sulfurized",263-128-8,61790-36-1,Skin Sens. 1;Eye Dam. 1,Notified C&L,27,H318:26;H317:26;Not classified:1
59128,"Fatty acids, tallow, hydrogenated, reaction products with ethanolamine",283-084-3,84539-96-8,Not Classified,Notified C&L,6,Not classified:6
59132,3-chloro-2-nitroaniline,261-782-9,59483-54-4,Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H301:1;H311:1;H315:1;H319:1;H335:1
59133,Fosfornan sodny,600-090-7,10039-56-2,Not Classified,Notified C&L,342,Not classified:342
59134,"2,2-diphenylpropionic acid",226-924-6,5558-66-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
59137,"2-Propenoic acid, homopolymer, sodium",618-349-8,9003-04-7,Not Classified,Notified C&L,499,Not classified:284;H319:212;H315:68;H412:2;H373:1;H302:1
59139,3-pyrroline,203-723-1,109-96-6,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Notified C&L,46,H225:45;H332:44;H302:44;H314:45;H312:4;H318:1;H315:1;H319:1;H335:1
59140,"Octahydro-4,7-methano-1H-indenedimethanol",247-488-3,26160-83-8,Eye Irrit. 2,Notified C&L,1457,H319:1457
59144,"1-aza-4,6-dioxabicyclo[3.3.0]octane",227-305-3,5780-34-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
59146,Zinc bis[O-(2-ethylhexyl)] bis[O-(isobutyl)] bis(dithiophosphate),247-810-2,26566-95-0,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,32,H411:7;H318:7;H319:25
59153,"Octahydro-2,5,5-trimethyl-2-naphthol",276-054-6,71832-76-3,Not Classified,Notified C&L,25,Not classified:25
59156,Cyclohexyldimethylammonium dihydrogen phosphate,285-480-1,85099-25-8,Acute Tox. 4;Acute Tox. 3,REACH registration C&L,219,H311:1;H302:1;H315:218;H318:218
59157,"Glycerides, C16-18 di-",293-202-5,91052-41-4,Not Classified,Notified C&L,8,Not classified:8
59162,Sodium methanethiolate,225-969-9,5188-07-8,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,65,H301:52;H318:13;H226:12;H314:65;H302:2;H228:42;H312:1;H332:1
59165,Ditetradecyl ether,226-499-7,5412-98-6,Not Classified,Notified C&L,2,Not classified:2
59166,"4,4',4''-(1-methylpropanyl-3-ylidene)tris[6-tert-butyl-m-cresol]",217-420-7,1843-03-4,Skin Sens. 1B,REACH registration C&L,196,H317:48;H413:83;Not classified:65
59174,trans-Zeatin,605-343-5,1637-39-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
59181,Lithium salicylate,209-011-7,552-38-5,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,97,H318:5;H302:67;H314:3;H319:71;H315:71;Not classified:23;H335:4
59182,2-amino-4-(methylsulphinyl)butyric acid,207-225-5,454-41-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
59183,Calcium bis[dithioxolanthanate(1-)],235-689-9,12525-03-0,,Notified C&L,4,H315:4;H319:4;H335:4
59186,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1,2,3-propanetriol (9Z)-9-octadecenoate",611-469-1,57107-97-8,Not Classified,Notified C&L,28,Not classified:28
59188,Amikacin bis(sulphate),254-648-6,39831-55-5,Skin Sens. 1;Eye Dam. 1;STOT RE 1,REACH registration C&L,86,H318:53;H372:53;H317:78;Not classified:4;H315:4;H319:4;H335:3;H361:1
59189,Pentadecan-15-olide,203-354-6,106-02-5,Aquatic Chronic 2,REACH registration C&L,1812,H411:1498;H317:237;Not classified:269;H315:4;H410:2;H400:1
59190,"Fatty acids, coco, Me esters, distn. residues, bisulfited, sodium salts",309-437-4,100298-85-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,29,H315:29;H318:29
59193,Thiocolchicoside,210-017-7,602-41-5,Acute Tox. 3;Acute Tox. 3,Notified C&L,8,H301:7;H331:4;H372:3;H362:3;H361:3;H334:1;H302:1;H317:1
59194,Europium(3+) perchlorate,236-907-5,13537-22-9,,Notified C&L,4,H319:4;H315:4;H272:4;H335:4
59195,p-chlorophenethylamine,205-853-4,156-41-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:41;H319:40;H335:40;H301:1;H318:2;H314:1
59199,"N,N'-1,2-ethanediylbis-L-aspartic acid",439-840-1,20846-91-7,Not Classified,Notified C&L,1,Not classified:1
59201,"4,4'-oxybis(benzenesulfonylazide)",431-850-4,7456-68-0,Expl. 1.1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H201:0;H410:0;H400:0
59202,1-phenylcyclohexanecarbonitrile,201-038-2,77-57-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,4,H315:4;H312:4;H302:4;H335:3;H319:4;H332:4
59203,"(1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid",611-302-2,55701-03-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:53;H315:53;H302:52;H335:53
59205,Nalorphine hydrochloride,200-321-8,57-29-4,Acute Tox. 4,Notified C&L,39,H302:39;H334:1
59209,"(Z)-N-methyl-N-(1-oxo-9-octadecenyl)glycine, compound with 2-aminoethanol (1:1)",240-219-0,16070-29-4,Not Classified,Notified C&L,34,Not classified:33;H315:1;H318:1
59210,Benzyl methacrylate,219-674-4,2495-37-6,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3,REACH registration C&L,210,H315:200;H319:200;H335:199;H317:83;H318:1
59212,"1-(2,5-xylyl)piperazine",213-795-6,1013-25-8,,Notified C&L,6,H314:6;H318:1
59213,Tetrasodium 5-[[1-hydroxy-6-(phenylamino)-3-sulphonato-2-naphthyl]azo]-8-[[6-sulphonato-4-[(3-sulphonatophenyl)azo]naphthyl]azo]naphthalene-2-sulphonate,229-211-8,6428-60-0,Not Classified,Notified C&L,2,Not classified:2
59214,"(R)-(β-,3-dihydroxyphenethyl)methylammonium hydrogen [R-(R*,R*)]-tartrate",241-219-3,17162-39-9,Acute Tox. 4,Notified C&L,78,H302:78;H371:1
59216,sodium ethanolate;sodium ethoxide,205-487-5,141-52-6,Self-heat. 1;Skin Corr. 1B,Harmonised C&L,0,H314:0;H251:0
59217,"1,3-Dibromo-5-fluoro-2-iodobenzene",613-076-0,62720-29-0,,Notified C&L,7,H315:5;H319:5;H335:4;H332:2;H302:2;H312:2
59219,"1-Hexanol, 2-ethyl-, ethers with 2-butoxyethanol, 2-(2-butoxyethoxy)ethanol, 2-[2-(2-butoxyethoxy)ethoxy]ethanol and 2,2'-thiobis[ethanol]",296-149-6,92332-22-4,Aquatic Chronic 3,Notified C&L,33,H412:33
59224,2-(aminooxy)-2-methylpropionic acid hydrochloride,289-523-5,89766-91-6,,REACH registration C&L,6,H315:5;H319:5;H335:5;Not classified:1
59226,"Oxygenase, monophenol mono-",232-653-4,9002-10-2,,Notified C&L,2,H334:2
59228,"Hexanoic acid, 2-ethyl-, C16-18-alkyl esters",291-445-1,90411-68-0,Not Classified,REACH registration C&L,96,Not classified:96
59238,2H-tetrazol-2-acetic acid,244-562-7,21743-64-6,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1;H228:1
59239,salicylic acid,200-712-3,69-72-7,Acute Tox. 4;Eye Dam. 1;Repr. 2,Harmonised C&L,0,H302:0;H361:0;H318:0
59242,1-benzyl-3-pyrrolidone,226-131-5,5291-77-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42
59243,"Oak, Quercus petraea, ext.",290-100-2,90082-12-5,Not Classified,Notified C&L,2,Not classified:2
59244,6-sec-butylquinoline,265-777-2,65442-31-1,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,805,H411:37;H316:2;H315:39;H317:2;H302:767
59251,3-nitrophenylhydrazinium(1+) chloride,211-270-6,636-95-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H315:43;H312:43;H302:43;H335:42;H319:43;H332:43;H228:1
59256,Isodecyl acetate,273-873-0,69103-24-8,Not Classified,Notified C&L,89,Not classified:89
59259,"Amides, C18-unsatd., dimers, hydrogenated, N,N'-bis[2-(2-oxo-1-imidazolidinyl)ethyl]",600-754-6,1065642-53-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H302:1
59260,"1,3-Propanediol, 2,2-bis(hydroxymethyl)-, allyl ether",293-883-9,91648-24-7,Aquatic Chronic 3,REACH registration C&L,454,H412:454;H315:453;H319:453;H335:7
59261,"2,4,6-tris(trifluoromethyl)-1,3,5-triazine",206-709-3,368-66-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H312:38;H302:38;H335:42;H319:42;H332:42;H331:4;H315:4
59262,"Propionic acid, 2,2' ,2'' - [(vinylsilylidyne) trioxy] tri-, triethyl ester",927-659-5,,Not Classified,REACH registration C&L,2,Not classified:2
59266,Cyclohexanepropionaldehyde,224-446-2,4361-28-8,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H227:1;H318:1
59267,"4-amino-3,5-dinitrobenzamide",259-092-8,54321-79-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
59274,Dibutoxydibutylstannane,222-103-1,3349-36-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Chronic 2,Notified C&L,30,H411:29;H315:16;H312:16;H372:30;H302:16;H319:16;H341:14;H317:14;H314:14;H360:14;H370:1;H226:1;H410:1;H318:1;H332:1
59275,"(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone",613-265-8,63590-64-7,Acute Tox. 4,REACH registration C&L,42,H302:41;Not classified:1
59279,Triiron bis(orthophosphate),239-018-0,14940-41-1,Not Classified,Notified C&L,43,Not classified:43
59283,REACTIVE BLUE 221,618-904-4,93051-41-3,Not Classified,Notified C&L,7,Not classified:6;H317:1
59285,Acenaphthylene,205-917-1,208-96-8,Acute Tox. 1;Acute Tox. 1,Notified C&L,6,H310:2;H330:2;H319:3;H315:3;H302:3;H335:2;Not classified:1
59288,Trifluoroacetyl chloride,206-556-2,354-32-5,Press. Gas (Liq.);Skin Corr. 1B;Eye Dam. 1;Acute Tox. 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,196,H330:158;H314:196;H412:158;H372:2;H280:2;H318:2;H312:156;H335:38
59292,1-benzoylimidazole,233-805-2,10364-94-0,,Notified C&L,5,H315:5;H319:5;H335:1
59293,"1,4-Dicyano-2,3,5,6-tetra-chloro-benzene",401-550-8,1897-41-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H317:0
59294,"2-hydroxy-3-methyl-1,4-naphthoquinone",207-594-2,483-55-6,Aquatic Acute 1,REACH registration C&L,1,H400:1
59296,2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate,402-440-2,2094-99-7,Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H334:0;H330:0;H317:0;H373:0;H314:0;H400:0;H410:0
59297,Mycophenolic acid,246-119-3,24280-93-1,Acute Tox. 4;Muta. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,149,H341:144;H400:143;H372:143;H302:149;H410:143;H360:145;H361:1
59299,"Tricyclo[3.3.1.13,7]decan-1-ol",212-202-8,768-95-6,,Notified C&L,3,H332:1;H302:1;H312:1;H315:1;H319:1;H335:1;H228:1
59300,"Disodium 2(or 5)-[[1-benzoyl-2,7-dihydro-2,7-dioxo-6-[(sulphonatophenyl)amino]-3H-dibenz[f,ij]isoquinolin-4-yl]oxy]-5(or 2)-(tert-pentyl)benzenesulphonate",276-445-1,72187-19-0,Not Classified,Notified C&L,38,Not classified:37;H319:1
59302,3-tert-butyl-4-methoxyphenol,201-820-3,88-32-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:39;H302:39;Not classified:1;H315:1;H335:1
59317,Trioctylphosphine oxide,201-121-3,78-50-2,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,50,H315:45;H317:2;H318:43;H335:4;H410:2;H400:2;H314:3;H411:3;Not classified:2;H319:2;H302:1
59320,"4,4'-ethylenedipiperidine dihydrochloride",282-939-8,84473-84-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H318:38
59326,"N,N'-bis(1,3-dimethylbutylidene)-2,2'-iminobis(ethylamine)",234-205-3,10595-60-5,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,213,H318:95;H226:91;H302:117;H314:117;H335:8;H332:8;Not classified:96;H317:1
59328,"4-bromo-3,5-dimethyl-1H-pyrazole",222-263-2,3398-16-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
59336,"permethrin (ISO);m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",258-067-9,52645-53-1,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H302:0;H410:0;H332:0
59341,"chrysoidine-p-dodecylbenzenesulfonate;dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1)",264-409-8,63681-54-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H341:0;H315:0;H400:0;H302:0;H410:0;H318:0
59343,"Phosphonic acid, di-C12-20-alkyl esters",296-401-5,92623-69-3,Not Classified,Notified C&L,567,Not classified:567
59344,Chlorbromuron,236-411-9,13360-45-7,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,41,H332:38;H315:38;H319:38;Not classified:3
59346,Allyl heptanoate,205-527-1,142-19-8,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2470,H412:298;H400:1411;H301:254;H311:1947;H410:1741;H315:1623;H373:1400;H302:2215;H319:1944;H312:521;H331:208;H332:2
59348,"Formaldehyde, polymer with N1-(2-aminoethyl)-1,2-ethanediamine, benzylated",615-152-9,70750-07-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,59,H315:59;H312:59;H302:59;H319:59;H332:59
59351,"(E)-2-(3,3-dimethylbicyclo[2.2.1]hept-2-ylidene)ethyl acetate",261-250-6,58437-69-7,Acute Tox. 4,Notified C&L,247,H302:247
59354,"3,4,5,6-tetrachloro-2-(1,4,5,8-tetrabromo-6-hydroxy-3-oxoxanthen-9-yl)benzoic acid",242-355-6,18472-87-2,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,124,H411:9;H319:24;H373:74;H412:88;Not classified:15;H400:10;H315:1;H335:1
59356,Diphenyl azidophosphate,247-644-0,26386-88-9,Acute Tox. 3;Acute Tox. 2;Acute Tox. 2,REACH registration C&L,77,H310:14;H301:76;H330:16;H315:61;H311:63;H335:60;H331:61;H319:65;H300:1;H411:1;H400:1
59362,Hippuric acid,207-806-3,495-69-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,55,H315:52;H302:51;H335:51;H318:51;Not classified:3;H319:1
59366,"Amines, N-tallow alkyltrimethylenedi-, ethoxylated, di-Et sulfate- quaternized",614-885-1,68990-25-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H302:1;H318:1
59368,POLY(ETHYLENE-PROPYLENE) GLYCOL,611-024-1,53637-25-5,Not Classified,Notified C&L,208,Not classified:163;H302:25;H315:20;H319:20
59370,"3,4-dichloroisothiazole-5-carbonyl chloride",619-529-9,56914-82-0,Not Classified,Notified C&L,1,Not classified:1
59372,"O,O-dimethyl phosphorochloridothioate",219-754-9,2524-03-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,95,H330:57;H315:56;H312:56;H412:56;H302:57;H335:56;H318:57;H331:38;H301:38;H311:39;H314:39;H341:1;H290:1
59374,"2-Butyl-3-(4-chlorobenzyl)-1,3-diazaspiro[4.4]non-1-en-4-one and (7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl)-methanesulfonic acid",700-176-5,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
59375,Tocopherols,604-195-9,1406-66-2,Not Classified,REACH registration C&L,109,Not classified:109
59377,2-methylhex-2-enoic acid,249-294-4,28897-58-7,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,64,H318:64;H290:64;H314:64
59379,Solanidine,201-309-5,80-78-4,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,41,H413:38;H302:38;H331:3;H301:3;H311:3
59384,"Beta-cyclodextrin sulfobutyl ether, sodium salt",417-710-5,182410-00-0,Skin Sens. 1,Notified C&L,3,H317:3
59390,"4-isothiocyanato-N,N-dimethylnaphthalen-1-amine",249-800-3,29711-79-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,40,H334:39;H315:40;H317:38;H335:40;H319:40;H332:40;H302:1
59392,2-methyl-1-(3-sulphonatopropyl)pyridinium,260-158-3,56405-61-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H318:38
59394,"Butanoic acid, 3-mercaptohexyl ester",603-988-7,136954-21-7,Not Classified,Notified C&L,91,Not classified:89;H319:2;H315:2;H224:2;H335:2
59398,4-methoxyisophthalic acid,218-618-6,2206-43-1,Not Classified,REACH registration C&L,3,Not classified:3
59399,Hexyl chloroformate,228-036-4,6092-54-2,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;Aquatic Chronic 3,REACH registration C&L,162,H412:86;H315:86;H330:120;H318:87;H331:42;H301:42;H311:42;H314:76;H411:33;H310:1;H300:1;H290:1;H227:1
59402,"3,3',4',5,7-pentahydroxyflavylium chloride",208-438-6,528-58-5,Not Classified,Notified C&L,1,Not classified:1
59404,"4-[(2,5-dichlorophenyl)azo]-3-hydroxy-2-naphthoic acid",257-484-3,51867-77-7,Not Classified,REACH registration C&L,32,Not classified:32
59405,Beryllium di(acetate),208-850-6,543-81-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B;STOT RE 1;Aquatic Chronic 2,Notified C&L,40,H411:40;H315:40;H330:40;H317:40;H301:40;H372:40;H335:39;H350:40;H319:40;H370:1;H410:1
59406,"Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, hydrate (1:1), (2S,3S)-",615-311-2,71607-31-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:1;H319:1;H335:1;Not classified:1
59407,"Amines, C18-22-tert-alkyl, compds. with molybdic acid (H2MoO4)",295-607-2,92113-03-6,,Notified C&L,1,Not classified:1
59409,2'-deoxyadenosine 5'-(dihydrogen phosphate),211-503-1,653-63-4,Not Classified,Notified C&L,1,Not classified:1
59410,Decan-4-olide,211-892-8,706-14-9,Not Classified,REACH registration C&L,1817,Not classified:1669;H332:52;H315:145;H319:145;H335:108;H412:3
59411,N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]benzamide,245-201-6,22753-88-4,Not Classified,REACH registration C&L,2,Not classified:2
59422,"Glycerol, propoxylated, esters with acrylic acid, reaction products with diethylamine",500-744-0,162492-10-6,Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,77,H318:2;H412:2;H317:2;H319:73;Not classified:2;H315:1
59423,"D-Glucopyranoside, methyl, octadecanoate (2:3)",273-049-0,68936-95-8,Not Classified,Notified C&L,172,Not classified:172
59429,N-methylpentylamine,246-966-9,25419-06-1,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1B,Notified C&L,43,H225:43;H301:38;H314:43;H318:1
59430,"Fatty acids, vegetable-oil, polymd., unreacted fraction",273-100-7,68937-92-8,Not Classified,REACH registration C&L,5,Not classified:5
59431,"Sodium O,O-diisobutyl dithiophosphate",258-508-5,53378-51-1,Skin Corr. 1C,REACH registration C&L,75,H314:75;H318:14
59432,"2,5- diethyl-3-methyl pyrazine",607-310-0,24050-16-6,,Notified C&L,6,H226:6;H319:5;H335:5;H315:5
59442,Guanidine monohydrobromide,242-909-7,19244-98-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H332:1;H302:1
59443,Calcium dioleate,205-525-0,142-17-6,Not Classified,REACH registration C&L,24,Not classified:23;H302:1
59445,"2-benzofuran-1,3-dione, addition product with (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol and 2-(2-hydroxyethoxy)ethanol, propoxylated",601-238-3,113163-37-4,Not Classified,REACH registration C&L,1,Not classified:1
59446,"Starch, hydrogen 2-(octen-1-yl)butanedioate",610-914-7,52906-93-1,Not Classified,Notified C&L,113,Not classified:113
59447,Flutamide,236-341-9,13311-84-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,155,H332:137;H361:140;H302:144;H312:133;H373:12;H413:10;H360:13;H315:3;H370:2;H319:6;H411:4;H351:4;H336:1;H335:1;H412:1
59448,Tin diphosphate,242-357-7,18472-93-0,Not Classified,Notified C&L,2,Not classified:2
59450,"Glycerides, mixed decanoyl and octanoyl",277-452-2,73398-61-5,Not Classified,REACH registration C&L,709,Not classified:582;H319:89;H400:38
59454,"2-chloro-6,7-dimethoxyquinazolin-4-amine",245-821-7,23680-84-4,Acute Tox. 4,REACH registration C&L,142,H302:52;H319:63;H315:63;H335:59;H373:30;H332:1;H312:1
59458,1-ethoxy-4-[2-methyl-1-[(3-phenoxyphenyl)methoxy]propan-2-yl]benzene,617-179-1,80844-07-1,Lact.;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,168,H410:164;H362:162;H400:164;H373:6;H411:4
59464,"Piperazine-1,4-diethanol",204-586-0,122-96-3,Eye Dam. 1,REACH registration C&L,89,H318:2;Not classified:83;H226:2;H335:3;H314:2;H315:2;H319:2
59465,2-(trichloromethyl)quinazolin-4(1H)-one,226-927-2,5558-95-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
59469,3-methylrhodanine,225-367-6,4807-55-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H312:38;H302:38;H335:38;H319:38;H332:38
59470,"tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate",432-770-2,139189-30-3,Skin Sens. 1,Harmonised C&L,0,H317:0
59471,Chloroiodomethane,209-804-8,593-71-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H315:49;H319:49;H335:48;H312:4;H302:4;H332:4
59472,(±)-2-(6-methoxy-2-naphthyl)propionic acid,247-485-7,26159-31-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
59476,"3-hydroxy-2,4,6-triiodobenzoic acid",258-457-9,53279-72-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H315:46;H302:40;H335:46;H318:39;H319:7;H332:1
59480,C.I. Disperse Red 311,616-562-0,77907-28-9,Not Classified,Notified C&L,3,Not classified:3
59481,"1-Hydroxy-4-(3-morpholin-4-yl-propylamino)-anthracene-9,10-dione",609-594-1,38866-14-7,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H302:1;H317:1
59482,"sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex",412-730-0,150522-10-4,Skin Corr. 1B,Harmonised C&L,0,H314:0
59484,"Hydrocarbons, C9-C11, n-alkanes, <2% aromatics",927-807-9,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H315:55;H335:55;H226:55;H319:55;H336:55;H304:55
59486,Tetrakis(2-hydroxyethyl)ammonium hydroxide,211-158-7,631-41-4,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,40,H318:2;H314:40
59487,"Disodium 4-amino-3-[[4-[[[4-[(2-amino-4-hydroxyphenyl)azo]phenyl]amino]carbonyl]phenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",256-119-5,43151-71-9,Not Classified,Notified C&L,11,Not classified:11
59488,"(S)-1-(hydroxymethyl)ethane-1,2-diyl dipalmitate",250-131-4,30334-71-5,Not Classified,Notified C&L,1,Not classified:1
59491,"N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide",204-029-1,113-48-4,Skin Sens. 1B;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,47,H332:4;H411:4;H317:2;H311:39;Not classified:2;H312:2
59492,Pyridine-2-methanethiol,218-061-9,2044-73-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,89,H315:89;H319:88;H335:89;H312:1;H302:1;H227:1;H318:1;H332:1
59494,Triisobutylamine,214-236-9,1116-40-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3,Notified C&L,39,H315:38;H311:38;H302:38;H331:38;H226:39;H318:39;H314:1
59496,cadmium chloride,233-296-7,10108-64-2,Acute Tox. 3;Acute Tox. 2;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H330:0;H400:0;H301:0;H372:0;H350:0;H410:0;H340:0;H360:0
59498,Dibenzofuran,205-071-3,132-64-9,Aquatic Chronic 2,Notified C&L,23,H411:19;Not classified:3;H332:1;H302:2;H312:1
59499,Strontium iodide,233-972-1,10476-86-5,Skin Corr. 1B,Notified C&L,68,H314:64;H302:26;H315:4;H319:4
59500,"Rose, Rosa damascena, ext.",290-260-3,90106-38-0,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1714,H318:1668;H412:1444;H315:1674;H317:1670;H341:1652;H226:1357;H351:1653;Not classified:37;H411:11;H401:2;H319:7;H313:2;H302:1;H312:1;H400:1;H225:1
59501,Propyl-2-thiourea,213-158-2,927-67-3,Acute Tox. 4,Notified C&L,44,H302:38;H301:5;H315:1;H319:1;H335:1
59503,Sodium hydrogen N-(1-oxotetradecyl)-L-glutamate,253-981-4,38517-37-2,Eye Irrit. 2,REACH registration C&L,4,H319:3;Not classified:1
59506,Strontium zirconium trioxide,234-847-4,12036-39-4,Eye Irrit. 2,REACH registration C&L,2,H319:2
59511,Cyclohexyl chloroformate,236-230-5,13248-54-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 3,Notified C&L,2,H314:2;H301:2;H311:2;H331:2;H300:2
59515,"2-Propenoic acid, 2-methyl-, C11-14-isoalkyl esters, C13-rich",288-509-6,85736-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,12,H315:10;H319:10;H335:10;Not classified:2
59522,"8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione",279-990-3,82537-67-5,Not Classified,Notified C&L,5,Not classified:5
59523,"Hydrocarbons, C3;Petroleum gas",271-735-4,68606-26-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
59524,"2,4,5-trichlorotoluene",229-644-2,6639-30-1,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,74,H413:38;H318:38;Not classified:36
59525,"3,4-dimethyl-1H-pyrazole",429-130-1,2820-37-3,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H318:0
59527,Calcium zirconium oxide,234-373-8,11129-15-0,Not Classified,REACH registration C&L,9,Not classified:9
59528,"2,2'-ethylenebisisothiouronium dibromide",230-101-7,6943-65-3,,Notified C&L,4,H302:4
59532,m-bis(1-methylvinyl)benzene,223-146-9,3748-13-8,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,140,H411:98;H317:98;H315:38;H319:39;H335:38;H400:38;Not classified:3;H300:1
59533,2-chloronicotinamide,233-808-9,10366-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,199,H315:199;H319:199;H335:198
59541,"Disodium 5,5'-[(1-methylethylidene)bis(4,1-phenyleneoxysulphonyl-2,1-phenyleneazo)]bis[6-amino-4-hydroxynaphthalene-2-sulphonate]",257-854-4,52333-30-9,Skin Sens. 1,REACH registration C&L,58,H317:22;Not classified:33;H412:3
59542,"1,8-diamino-2-bromo-4,5-dihydroxyanthraquinone",265-650-1,65235-63-4,Not Classified,Notified C&L,5,Not classified:5
59543,Ethyl glycinate,207-298-3,459-73-4,Not Classified,Notified C&L,1,Not classified:1
59544,Didecyl succinate,234-209-5,10595-82-1,,Notified C&L,33,Not classified:33
59546,"N-octadecyl-1,3,5-triazine-2,4,6-triamine",244-611-2,21840-04-0,Not Classified,Notified C&L,2,Not classified:2
59547,Titanylphtalocyanine,419-970-5,26201-32-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
59548,"2-Propenoic acid, homopolymer, ammonium salt",618-348-2,9003-03-6,Not Classified,Notified C&L,169,Not classified:124;H412:23;H315:22;H319:22;H335:22;H318:22
59555,"1-benzyl-5-ethoxyimidazolidine-2,4-dione",417-340-4,65855-02-9,Acute Tox. 4,Harmonised C&L,0,H302:0
59556,Lanthanum(3+) acetate,213-034-8,917-70-4,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,93,H410:88;H400:88;H318:89;H315:4;H319:4;H411:1
59558,"1,4-dibutoxy-2-chloro-5-nitrobenzene",201-896-8,89-30-5,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H413:38;H319:38
59559,"Diisopropyl [S-(R*,R*)]-tartrate",263-771-4,62961-64-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,14,H315:12;H319:12;H335:12;Not classified:2
59562,Octadecyl docosanoate,246-115-1,24271-12-3,Not Classified,REACH registration C&L,4,Not classified:4
59563,Bis(trichloromethyl)mercury,229-867-5,6795-81-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H310:38;H330:38;H400:38;H373:38;H410:38;H300:38
59566,"Disodium 9,10-dihydro-9,10-dioxoanthracene-2,7-disulphonate",212-718-3,853-67-8,Eye Irrit. 2,REACH registration C&L,7,H319:6;Not classified:1;H315:2;H335:1
59568,Piperidine-1-valeronitrile,225-243-1,4734-49-0,Acute Tox. 3,Notified C&L,38,H301:38
59570,N-isopropylphthalimide,206-150-5,304-17-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,54,H319:39;H302:41;Not classified:12;H412:1
59572,O-phenylhydroxylamine hydrochloride,228-039-0,6092-80-4,Acute Tox. 3,Notified C&L,40,H301:40;H315:2;H319:2;H335:1
59577,"Ethanone, 1-(2-methylphenyl)-, 2-(4,6-dimethyl-2-pyrimidinyl)hydrazone, (1Z)-",618-259-9,89269-64-7,Acute Tox. 4;Eye Irrit. 2;STOT SE 2,Notified C&L,38,H319:38;H371:38;H302:38
59582,Dialuminium tricalcium hexaoxide,234-932-6,12042-78-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,21,H315:20;H318:20;H319:1
59583,"DL-2,4-diaminobutyric acid dihydrochloride",265-774-6,65427-54-5,Skin Corr. 1B,Notified C&L,40,H314:38;H315:2;H319:2;H335:1
59584,Guanidinium phosphate (1:1),226-551-9,5423-22-3,Acute Tox. 4,REACH registration C&L,94,H302:61;H319:45;H332:45;H315:45;Not classified:33
59585,(2-ethoxy-1-methyl-2-oxoethyl)triphenylphosphonium bromide,250-002-2,30018-16-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,46,H334:4;H315:46;H317:4;H301:4;H335:46;H319:46
59586,5-amino-2-hydroxybenzenesulphonic acid,220-607-6,2835-04-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38;H317:38
59587,Fenpyroximate,601-123-8,111812-58-9,Acute Tox. 4;Aquatic Acute 1,Notified C&L,39,H332:39;H400:39;H319:1
59590,1-(trimethylsilyl)prop-1-yne,228-314-5,6224-91-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H225:48;H315:43;H319:43;H335:42
59591,"quinalphos (ISO);O,O-diethyl-O-quinoxalin-2-yl phosphorothioate",237-031-6,13593-03-8,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H410:0;H312:0;H400:0
59592,"7,11-dimethyldodeca-4,6,10-trien-3-one",247-878-3,26651-96-7,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,344,H315:344;H319:344;H317:344;H411:83
59593,"Oils, shark-liver",273-616-2,68990-63-6,Not Classified,Notified C&L,2,Not classified:2
59596,"Fatty acids, tall-oil, ammonium salts",268-643-1,68132-50-3,Not Classified,Notified C&L,3,Not classified:3
59598,Butyl carbamate,209-751-0,592-35-8,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,117,H302:112;H318:111;H341:58;H351:58;H317:53;Not classified:5;H319:1;H315:1;H335:1
59599,"2-DICYCLOHEXYLPHOSPHINO-2',6'-DIISOPROPOXYBIPHENYL",616-653-5,787618-22-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,48,H332:43;H413:42;H302:43;H312:43;H315:5;H319:5;H335:4
59607,"reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane",425-340-0,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
59610,Silane,232-263-4,7803-62-5,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,148,H220:144;H280:144;Not classified:4;H315:1;H335:1;H319:1;H332:1
59612,Cremophor™ A6,617-781-4,85941-44-2,Skin Irrit. 2,Notified C&L,38,H315:38
59613,Pyrrole,203-724-7,109-97-7,Flam. Liq. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,1468,H301:88;H226:181;H332:83;H318:94;H302:1288;H300:10;H331:12;H311:2
59615,"Blood plasma, citrated, lyophilized",280-593-2,83732-46-1,Not Classified,Notified C&L,1,Not classified:1
59618,"N,N,N',N'-tetramethyl-p-phenylenediamine dihydrochloride",211-274-8,637-01-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:47;H319:47;H335:46;H312:6;H302:6;H332:6;Not classified:1
59619,2-hydroxy-2-methylpropionitrile;2-cyanopropan-2-ol;acetone cyanohydrin,200-909-4,75-86-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H310:0;H330:0;H400:0;H410:0;H300:0
59621,3-[4-[(5-nitrothiazol-2-yl)azo](2-phenylethyl)amino]propiononitrile,243-266-5,19745-44-9,Skin Sens. 1,Notified C&L,6,H317:4;Not classified:2
59622,Dimethyl 2-fluoroterephthalate,226-135-7,5292-47-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:2
59628,"2,2'-(octadec-9-enylimino)bisethanol",246-807-3,25307-17-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,763,H400:738;H314:763;H302:763;H410:188;H318:567;H317:47
59629,Pitch,263-072-4,61789-60-4,Carc. 1B,Harmonised C&L,0,H350:0
59632,"Fatty acids, C14-18-branched, Me esters",292-898-8,91002-21-0,Not Classified,Notified C&L,6,Not classified:6
59633,trimethylenediaminetetraacetic acid,400-400-9,1939-36-2,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H302:0;H318:0
59638,"6-bromo-α,α,α-trifluoro-m-toluidine",207-227-6,454-79-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H318:39;H314:39;H315:7;H311:4;H302:7;H319:7;H332:7;H312:3;H335:1
59645,Bis(dimethylamino)methylsilane,245-163-0,22705-33-5,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,62,H225:62;H314:62;H260:22;H318:1
59646,"2-heptadecyl-4,5-dihydro-1-(2-hydroxyethyl)-1-methyl-1-H-imidazolium methyl sulphate",302-407-1,94108-68-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H317:1
59651,Azetidine,207-963-8,503-29-7,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,41,H225:41;H314:41;H318:1
59657,"Methyl(propyl-9,10-ethano-9(10H)-anthryl)ammonium methanesulphonate",261-488-0,58902-67-3,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H410:1;H302:1;H400:1
59658,2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate,427-020-6,141772-37-4,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H400:0;H317:0
59662,3-isopropylhydroxybenzene,210-551-0,618-45-1,Acute Tox. 4,Notified C&L,132,H302:118;H314:42;Not classified:13;H318:1
59663,Quinidine gluconate,230-333-9,7054-25-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,64,H332:63;H302:40;H312:39;H301:24;H412:24;H317:26
59664,C.I. Fluorescent Brightener 113,603-225-8,12768-92-2,Not Classified,Notified C&L,4,Not classified:4
59665,Ethyl N-pyridin-2-yl-beta-alaninate,600-382-4,103041-38-9,Not Classified,REACH registration C&L,3,Not classified:3
59669,Methyl 3-oxo-2-(pent-2-enyl)cyclopentaneacetate,254-705-5,39924-52-2,Not Classified,Notified C&L,210,Not classified:170;H319:40;H302:40
59670,di-tert-(C,406-052-4,125078-60-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0;H302:0;H226:0;H318:0
59674,C.I. Acid Black 173,612-818-0,61967-86-0,,Notified C&L,34,Not classified:34
59677,"Benzaldehyde, 2-hydroxy-5-nonyl-, oxime, branched",605-717-8,174333-80-3,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,87,H315:86;H317:86;H373:3;H410:86;H318:86;H360:86;Not classified:1
59681,Dilactide,202-468-3,95-96-5,Eye Irrit. 2,REACH registration C&L,52,H319:52;H335:5;H315:2
59686,Vanadium triiodide,239-547-7,15513-94-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
59687,"Tall oil, sulfated, sodium salt",263-127-2,61790-35-0,Not Classified,Notified C&L,2,Not classified:2
59688,"2-{3-[4,6-bis(difluoromethoxy)-pyrimidin-2-yl]-ureidosulfonyl}-benzoic acid methylester",617-814-2,86209-51-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,157,H410:156;H400:157
59689,Cloxiquine,204-978-1,130-16-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,260,H315:258;H400:2;H335:257;H410:2;H319:258;Not classified:1;H302:1
59690,"(E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one",246-430-4,24720-09-0,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1683,H411:1359;H302:1679;H317:1681;H315:3;Not classified:1;H318:1
59691,"Sodium 8-[(4-halo-6-{ethyl[3-(2-hydroxyethyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]-2-[(E)-polycyclic-2-yl-diazenyl]polycycle-1-ol, polysulfonate",451-490-1,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1,H318:1;H412:1;H317:1
59693,cadmium sulphide,215-147-8,1306-23-6,Acute Tox. 4;Muta. 2;Carc. 1B;STOT RE 1;Aquatic Chronic 4;Repr. 2,Harmonised C&L,0,H341:0;H372:0;H302:0;H361:0;H350:0;H413:0
59695,4-decylaniline,253-546-9,37529-30-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,39,H315:39;H319:39;H335:38;H400:39;H410:1
59697,methacrifos (ISO);methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate;methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate,250-366-2,30864-28-9,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0;H317:0
59699,4-(2-furyl)but-3-en-2-one,210-774-3,623-15-4,Acute Tox. 4,Notified C&L,1421,H302:1326;Not classified:89;H315:6;H319:7;H335:6;H332:1;H312:1
59701,Sodium butyrate,205-857-6,156-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2,Notified C&L,12,H341:6;H315:12;H319:12;H335:12;H302:1
59707,"Fatty acids, C18-unsatd., dimers, di-Me esters",614-851-6,68956-10-5,Not Classified,Notified C&L,17,Not classified:17
59708,Ethylmercury chloride,203-478-0,107-27-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H310:42;H330:42;H400:42;H373:42;H410:42;H300:42
59709,Isooctyl acetate,250-701-2,31565-19-2,Not Classified,REACH registration C&L,91,Not classified:90;H411:1
59710,Gold tribromide,233-654-2,10294-28-7,Skin Corr. 1B,Notified C&L,43,H314:43
59711,"Trisodium 5-[[4-chloro-6-(ethylphenylamino)-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methyl-2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",277-616-3,73816-74-7,Not Classified,REACH registration C&L,8,Not classified:8
59717,4-(phenylazo)naphthalen-1-amine monohydrochloride,280-987-4,83833-14-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
59719,"  (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid",918-246-0,104239-97-6,Acute Tox. 4;Repr. 2,Notified C&L,1,H302:1;H361:1
59724,"2,4-dimethylbenzaldehyde",239-856-7,15764-16-6,Acute Tox. 4,Notified C&L,1437,H302:1286;Not classified:88;H315:63;H335:63;H318:63
59728,7-methylindan-4-ol,240-450-7,16400-13-8,,Notified C&L,4,H315:4;H319:4;H335:4
59734,"chrysoidine;4-(phenylazo)benzene-1,3-diamine",207-803-7,495-54-5,Acute Tox. 4;Skin Irrit. 2;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H341:0;H315:0;H400:0;H302:0;H410:0
59738,"4-[[5-[[[4-(aminocarbonyl)phenyl]amino]carbonyl]-2-methoxyphenyl]azo]-N-(5-chloro-2,4-dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide",261-785-5,59487-23-9,Skin Sens. 1,REACH registration C&L,59,H317:1;Not classified:47;H336:11;H335:11
59739,"Bile, hydrolyzates",273-997-5,69430-20-2,Not Classified,REACH registration C&L,2,Not classified:2
59740,Sodium anthranilate,209-010-1,552-37-4,Not Classified,Notified C&L,2,Not classified:1;H315:1;H319:1;H335:1;H317:1
59743,"3,5-dimethyl-p-anisic acid",244-441-9,21553-46-8,Acute Tox. 3;Eye Irrit. 2,Notified C&L,39,H301:38;H319:39;H315:1
59744,3-methyl-2-butenyl salicylate,271-434-8,68555-58-8,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,238,H411:3;H410:2;H400:2;Not classified:235
59749,"3-(2,6,6-trimethyl-2-cyclohexen-1-yl)propen-1-yl acetate",257-738-3,52210-18-1,Not Classified,Notified C&L,113,Not classified:113
59750,2-(4-aminophenyl)-6-methylbenzothiazole-7-sulphonic acid,204-979-7,130-17-6,Aquatic Chronic 3,Notified C&L,130,H412:90;H302:39;Not classified:1
59751,"11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-methanesulphonate",252-549-2,35410-28-7,Repr. 1B,REACH registration C&L,21,H360:3;H332:17;H361:18;H302:17;H312:17;H373:1
59756,"2-Butenedioic acid (Z)-, ester with 1,2-propanediol, compd. with 2-(dibutylamino)ethanol",286-304-6,85204-10-0,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,461,H318:461;H412:2;H302:2;H317:2;H226:441;H335:441;H315:441
59759,"1-(2,3-xylyl)piperazine",213-794-0,1013-22-5,,Notified C&L,7,H315:7;H319:7;H335:7
59768,Dipotassium tetraiodomercurate,231-990-4,7783-33-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45,H310:45;H330:45;H400:43;H373:45;H410:44;H300:45
59770,"2,4,5-trichlorophenol",202-467-8,95-95-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H302:0;H410:0;H319:0
59778,"1,4,7,10-Tetraazacyclododecane",608-365-3,294-90-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47,H312:46;H400:46;H314:46;H302:46;H410:46;H315:1;H319:1;H318:1
59785,"N,N,1,1-tetramethylsilylamine",245-162-5,22705-32-4,,Notified C&L,1,H225:1;H315:1;H319:1;H335:1
59786,"[R-(R*,R*)]-3,3'-dithiobis[2-amino-N-2-naphthylpropionamide]",215-022-8,1259-69-4,Carc. 1A,Notified C&L,1,H350:1
59791,2-bromo-1-chloro-4-(trifluoromethyl)benzene,207-226-0,454-78-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
59794,D-mannitol,200-711-8,69-65-8,Not Classified,Notified C&L,1445,Not classified:1445
59795,(3-methylbutoxy)acetic acid,269-553-5,68298-29-3,Skin Corr. 1B,Notified C&L,10,H314:10
59798,"2,3-dimethylhexane",209-547-1,584-94-1,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H400:0;H225:0;H410:0;H336:0;H304:0
59800,Diazine Black,610-186-0,4443-99-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
59801,trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-),235-688-3,12519-85-6,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H400:0;H317:0;H372:0;H350:0;H410:0
59803,S-(acetamidomethyl)-N-(tert-butoxycarbonyl)-L-cysteine,243-267-0,19746-37-3,Not Classified,Notified C&L,1,Not classified:1
59804,methyl 3-(2-bromopropanoylamino)-4-methyl-thiophene-2-carboxylate,918-697-3,,Not Classified,Notified C&L,1,Not classified:1
59806,(4-nitrophenyl)hydrazine monohydrochloride,211-273-2,636-99-7,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H312:44;H317:39;H302:45;H335:45;H228:38;H319:46;H332:6;H301:1;H311:1;H331:1
59808,"11-α-hydroxypregn-4-ene-3,20-dione",201-306-9,80-75-1,Not Classified,Notified C&L,2,Not classified:1;H302:1
59809,"6-methoxy-1,2,3,4-tetrahydronaphthalen-1-one",214-078-0,1078-19-9,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2B;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,54,H412:3;H317:3;H302:54;H320:2;H402:2
59811,Oxydiethylene dinonanoate,203-353-0,106-01-4,Not Classified,Notified C&L,1,Not classified:1
59812,"Sodium [sulphamoyl-29H,31H-phthalocyaninesulphonato(3-)-N29,N30,N31,N32]cuprate(1-)",264-574-6,63950-02-7,Not Classified,Notified C&L,14,Not classified:13;H315:1;H319:1
59814,Tripotassium hexa(cyano-C)chromate(3-),237-079-8,13601-11-1,,Notified C&L,38,Not classified:38
59816,"6,7-dihydro-5H-cyclopenta(b)pyridine",208-564-1,533-37-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
59818,"6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-",609-175-3,357-70-0,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,164,H315:164;H317:164;H373:163;H301:164;H400:163;H331:164;H410:163;H319:163
59822,Butyl benzoate,205-252-7,136-60-7,Not Classified,REACH registration C&L,452,Not classified:62;H315:390;H319:389;H302:147;H335:47;H334:2;H317:2
59823,5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole,619-308-7,97963-62-7,Aquatic Chronic 4,REACH registration C&L,50,H413:2;H315:45;H319:45;H335:44;H373:2;H411:2;H302:3
59824,"(S)-4,5-dihydro-2-(6-hydroxybenzothiazol-2-yl)thiazole-4-carboxylic acid",219-981-3,2591-17-5,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1;H335:1
59827,"(±)-(1α,2β,5α)-5-methyl-2-(1-methylvinyl)cyclohexan-1-ol",256-557-7,50373-36-9,Flam. Liq. 3;Eye Dam. 1,Notified C&L,10,H226:10;H318:10
59829,nickel dichlorate,267-897-0,67952-43-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H341:0;H400:0;H317:0;H372:0;H350:0;H410:0;H360:0
59831,"Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-, C12-18-alkyl ethers, ammonium salts",614-662-9,68610-22-0,,Notified C&L,2,Not classified:1;H315:1;H319:1
59840,"(3S)-3,5,5-trimethylcyclohexane-1,2-dione",610-435-3,4883-60-7,Not Classified,Notified C&L,92,Not classified:90;H315:2;H319:2;H335:1
59842,DL-α-phenylglycine,220-608-1,2835-06-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
59843,2-Fluoro-4-nitrobenzoic Acid,609-823-5,403-24-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H302:41;H335:47;H312:1;H332:1
59844,1-methoxy-1-methyl-3-phenylurea,216-406-8,1576-17-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38;H317:38
59846,Chlorobis(dimethylamino)phosphine,222-100-5,3348-44-5,Skin Corr. 1B,Notified C&L,42,H314:42
59849,N-(carboxymethyl)-N-(1-oxododecyl)glycine,223-226-3,3775-51-7,Not Classified,Notified C&L,1,Not classified:1
59850,"Dipotassium 9,10-dihydro-9,10-dioxoanthracene-1,8-disulphonate",239-017-5,14938-42-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
59861,Pyridine-2-methanol 1-oxide,233-580-0,10242-36-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
59863,2'-(3-methylbenzoyl)-2-naphthohydrazide,280-917-2,83803-96-7,,Notified C&L,4,H315:4;H319:4;H335:4
59864,(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane,405-020-7,105024-66-6,Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H400:0
59867,"Heptadecanol, branched and linear",291-378-8,90388-00-4,Not Classified,REACH registration C&L,120,Not classified:120
59868,"2,6-dimethylpyridine",203-587-3,108-48-5,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,425,H319:64;H226:425;H302:425;H315:75;H335:47;H318:23;H312:13;H314:13;H311:11;Not classified:2;H332:2
59871,"S,S,S-tributylphosphorotrithioate",201-120-8,78-48-8,Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,132,H310:127;H301:131;H410:128;H400:128;H311:3;H411:1;H312:2;H372:1;H302:1;H332:2;H370:1
59879,"2,2-dimethyl-3-(3-methylpenta-2,4-dienyl)oxirane",273-870-4,69103-20-4,Skin Sens. 1B,REACH registration C&L,266,H317:53;Not classified:213
59883,"2-phenyl-1,3-propanediol",411-810-2,1570-95-2,Eye Dam. 1,Harmonised C&L,0,H318:0
59884,"1,4-Dioxane-2,5-dione, 3,6-dimethyl-, (3R,6R)-, polymer with rel-(3R,6S)-3,6-dimethyl-1,4-dioxane-2,5-dione and (3S,6S)-3,6-dimethyl-1,4-dioxane-2,5-dione",618-575-7,9051-89-2,Not Classified,Notified C&L,36,Not classified:36
59886,1-(p-tolyl)piperazine dihydrochloride,235-975-3,13078-14-3,,Notified C&L,4,H315:4;H319:4;H335:4
59888,Diisobutyl fumarate,230-706-6,7283-69-4,Skin Irrit. 2,Notified C&L,38,H315:38
59891,"Wheat, ext., hydrolyzed",309-358-5,100209-50-5,Not Classified,Notified C&L,2,Not classified:2
59893,Octodrine,208-851-1,543-82-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:38;H302:43;H335:38;H226:43;H319:38;H314:5;H318:1
59907,4-[(3-hydroxypropyl)amino]-3-nitrophenol,406-305-9,92952-81-3,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
59908,N-(tert-Butyl)hydroxylamine acetate,607-710-5,253605-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
59911,Dibutylcarbamoyl chloride,236-410-3,13358-73-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
59913,Glycollaldehyde,205-484-9,141-46-8,,Notified C&L,2,H317:1;Not classified:1
59915,"Chromate(1-), [4-[4,5-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonamidato(2-)][2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]-, sodium",300-438-5,93940-42-2,Not Classified,Notified C&L,1,Not classified:1
59926,"2,5-bis(1,1-dimethylbutyl)hydroquinone",400-220-0,57246-09-0,Aquatic Chronic 2,Harmonised C&L,0,H411:0
59928,"6-(2-fluorophenyl)-2,8,10-trimethyl -2,5,9,10-tetrazabicyclo[5.3.0]deca-5,8,11-trien-3-one",608-606-2,31352-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
59930,2-fluoro-6-nitrotoluene,212-203-3,769-10-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H315:46;H312:45;H302:45;H335:45;H319:46;H332:45
59932,"2',5'-dichloroacetoacetanilide",218-060-3,2044-72-6,,Notified C&L,4,H315:4;H319:4;H335:4
59933,Picene,205-918-7,213-46-7,STOT SE 2,Notified C&L,15,H371:12;Not classified:3
59934,Benzyl succinimido carbonate,236-075-3,13139-17-8,Not Classified,Notified C&L,11,Not classified:8;H315:2;H319:2;H335:2;H317:2
59937,"1,3-Dioxolan-2-one, polymer with 1,6-hexanediol",612-184-5,61630-98-6,Not Classified,Notified C&L,1,Not classified:1
59938,"Methyl 2,2,3,3-tetrafluoro-3-methoxypropionate",212-048-1,755-73-7,Not Classified,Notified C&L,3,Not classified:2;H226:1
59942,2-[1-[2-(oxiran-2-ylmethoxy)propoxy]propan-2-yloxymethyl]oxirane,609-948-5,41638-13-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,755,H315:750;H412:749;H317:753;H335:496;H319:754;Not classified:1;H411:1
59950,"O,O-diethyl phosphorochloridothioate",219-755-4,2524-04-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;Aquatic Chronic 2,REACH registration C&L,136,H411:1;H330:98;H314:136;H412:90;H311:128;H302:98;H331:38;H301:38;H312:7;H310:1;H318:1;H290:1
59951,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers, reaction products with pentaerythritol triacrylate",500-769-7,162811-70-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,60,H411:26;H315:35;H317:34;H302:26;H318:26;Not classified:25;H319:9
59955,Benzimidazol-2-ylamine,213-280-6,934-32-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,104,H315:71;H317:61;H302:104;H335:70;H319:71;H361:7;H312:2;H332:2
59960,"2,2,3,3-tetrafluoropropyl methacrylate",256-189-7,45102-52-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H315:45;H302:38;H335:44;H226:45;H318:38;H319:7
59965,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[(4-nitrophenyl)azo]-3-oxobutyramide",258-221-5,52846-56-7,Not Classified,REACH registration C&L,126,Not classified:126
59967,Methyl 2-methylcrotonate,229-575-8,6622-76-0,Flam. Liq. 3,Notified C&L,132,H226:132
59969,"Myrica cerifera, ext.",284-518-4,84929-34-0,Not Classified,Notified C&L,3,Not classified:3
59971,1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthol,229-214-4,6434-57-7,Not Classified,REACH registration C&L,2039,Not classified:2039
59973,"N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine",401-280-0,91273-04-0,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0;H314:0
59974,"5-amino-α,α,α-trifluorotoluene-2,4-disulphonamide",211-506-8,654-62-6,Not Classified,REACH registration C&L,46,Not classified:1;H315:44;H319:44;H335:44;H302:1
59975,Reaction product of lactic acid and diethylene glycol,918-030-6,,Not Classified,Notified C&L,6,Not classified:6
59983,Magnesium ditantalum hexaoxide,235-562-8,12293-61-7,Not Classified,Notified C&L,1,Not classified:1
59986,"[3-(2,3-epoxypropoxy)propyl]dimethoxymethylsilane",265-929-8,65799-47-5,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,47,H318:2;H412:2;H317:16;H319:25;Not classified:6;H315:3;H335:1;H341:1
59987,Dirhodium trioxide,234-846-9,12036-35-0,Ox. Sol. 1,REACH registration C&L,135,H271:86;Not classified:38;H315:11;H312:11;H302:11;H335:9;H319:11;H332:11
59988,"5-methyl-1,10-phenanthroline",221-099-9,3002-78-6,Acute Tox. 4,Notified C&L,43,H302:43;H319:5;H315:5;H335:4
59991,"Paraffin waxes and Hydrocarbon waxes, microcryst.",264-038-1,63231-60-7,Not Classified,REACH registration C&L,1203,Not classified:1200;H319:3
59995,Sodium hydrogen N-(1-oxooctadecyl)-L-glutamate,253-980-9,38517-23-6,Eye Irrit. 2,Notified C&L,99,H319:97;H412:13;Not classified:2
59999,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, disodium salt, [6R-[6α,7β(Z)]]-",277-930-0,74578-69-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,3,H334:3;H317:3
60000,"2,6-di-tert-butyl-4-nonylphenol",224-320-7,4306-88-1,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,46,H410:3;H400:3;H317:3;H315:43;H319:28;H335:28;H412:42;H402:1
60002,Perfluorohex-1-ene,212-047-6,755-25-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
60004,"1-Butanone, 1-(trans-4-phenylcyclohexyl)-",604-293-1,142497-20-9,Not Classified,Notified C&L,1,Not classified:1
60007,"[S-(Z,E)]-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid",244-319-5,21293-29-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,159,H315:157;H319:157;H335:157;Not classified:2
60010,3-[[[5-(dimethylamino)-1-naphthyl]sulphonyl]aminopropyl]trimethylammonium iodide,249-899-3,29866-12-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
60012,"5,11-dichlorotricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaene",233-807-3,10366-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
60013,Tricosan-1-ol,221-527-4,3133-01-5,Not Classified,Notified C&L,2,Not classified:2
60018,"2-[4-(1,2-diphenylvinyl)phenoxy]ethyl(diethyl)ammonium chloride",277-686-5,74056-26-1,Repr. 1B,Notified C&L,1,H360:1
60024,4-fluorothiobenzamide,244-820-9,22179-72-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,45,H302:39;H317:38;H301:4;Not classified:1;H315:2;H319:2;H335:2
60027,"Pyrrolo[3,4-c]pyrrole-1,4-dione, 3,6-bis(4-chlorophenyl)-2,5-dihydro-",602-733-7,122390-98-1,,Notified C&L,39,Not classified:39
60037,"N-(p-arsenosophenyl)-1,3,5-triazine-2,4,6-triamine",244-612-8,21840-08-4,Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1,Notified C&L,1,H301:1;H410:1;H330:1;H400:1
60038,Decafluorobenzophenone,212-717-8,853-39-4,Not Classified,Notified C&L,5,Not classified:3;H315:2;H319:2;H335:2
60041,"2,2,2-trifluoroacetamide",206-559-9,354-38-1,Acute Tox. 3;Eye Irrit. 2,REACH registration C&L,114,H301:4;H319:114;H315:110;H302:3;H335:108
60043,Tetrapropylammonium iodide,211-157-1,631-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
60048,"Cyclohexanemethanol, α-methyl-4-(1-methylethyl)-",613-374-0,63767-86-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,40,H411:40;H315:40;H319:40
60049,Piracetam,231-312-7,7491-74-9,Not Classified,Notified C&L,62,Not classified:58;H302:3;H315:2;H319:2;H335:2;H332:1;H312:2;H317:1
60050,Strontium chloride,233-971-6,10476-85-4,Eye Dam. 1,REACH registration C&L,106,H318:88;H315:51;H335:51;Not classified:7;H302:7;H319:4
60051,3-(dimethylamino)acrylaldehyde,213-157-7,927-63-9,Skin Corr. 1B,Notified C&L,40,H314:39;H318:1;H315:1;H319:1;H335:1
60052,Cerium trinitrate,233-297-2,10108-73-3,Ox. Sol. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,188,H410:145;H272:150;H400:145;H318:110;H319:77;H271:31;H315:8;H412:5;H335:3;Not classified:1
60053,"1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene",415-580-4,130841-23-5,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0;H317:0
60054,Methyl 7-hydroxy-1-naphthylcarbamate,205-070-8,132-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,157,H315:157;H319:157;H335:157
60055,dimethylmercury,209-805-3,593-74-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H310:0;H330:0;H400:0;H373:0;H410:0;H300:0
60056,"pyrimethanil (ISO);N-(4,6-dimethylpyrimidin-2-yl)aniline",414-220-3,53112-28-0,Aquatic Chronic 2,Harmonised C&L,0,H411:0
60058,Fenpiverinium bromide,204-744-9,125-60-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:3;H315:3;H302:4;H335:3
60060,"Oxirane, 2-phenyl-, polymer with oxirane, mono(dihydrogen phosphate), decyl ether",620-301-6,308336-53-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,5,H412:5;H315:3;H318:3
60062,Dialuminium calcium tetraoxide,234-931-0,12042-68-1,Not Classified,Notified C&L,209,Not classified:104;H315:104;H318:104;H332:1;H319:1
60064,"[R(R*,R*)]-2-amino-1-[p-(methylthio)phenyl]propane-1,3-diol",245-460-5,23150-35-8,Acute Tox. 4,Notified C&L,1,H302:1
60065,"Amines, C12-14-tert-alkyl, C8-20-alkyl phosphates",296-404-1,92623-72-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,991,H411:991;H315:522;H318:523;H317:446
60069,"[1,7,7(or 2,2,3)-trimethylbicyclo[2.2.1]heptyl]cyclohexan-1-ol",292-384-3,90604-88-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
60070,"2,3-Di Chloro-4-Hydroxy Aniline (DCHA)",620-111-3,39183-17-0,STOT SE 3;Aquatic Chronic 2,Notified C&L,17,H411:16;H335:16;H410:1;H302:1;H317:1
60073,Bis(2-ethylhexyl) maleate,205-524-5,142-16-5,STOT RE 2;Aquatic Chronic 1,REACH registration C&L,906,H373:428;H410:478;H315:195;H319:192;Not classified:173;H413:60;H400:38;H317:3;H412:1;H318:1
60077,"Tar, coal, high-temp., high-solids;Coal Tar Solids Residue;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]",273-615-7,68990-61-4,Carc. 1B,Harmonised C&L,0,H350:0
60078,"3,7-dimethyloct-1-en-3-ol",242-358-2,18479-49-7,Eye Dam. 1,REACH registration C&L,129,H318:13;H332:114;H319:116;H412:23;H331:2
60080,trans-1-Fluor-4-(4-pentylcyclohexyl)-benzene,616-389-0,76802-61-4,Skin Corr. 1B;Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1;H314:1
60084,1H-indole-1-propionic acid,229-643-7,6639-06-1,Eye Dam. 1,Notified C&L,39,H318:39;H315:1;H302:1;H335:1
60089,Ethyl fluoroacetate,207-297-8,459-72-3,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,99,H310:59;H300:99;H226:99;H330:59;H400:40;H314:1;H318:1
60092,"2-chloro-4,6-diamino-1,3,5-triazine",222-260-6,3397-62-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,94,H315:94;H319:94;H335:93;H312:1;H302:1;H332:1
60094,2-(chloromethyl)quinoline hydrochloride,223-145-3,3747-74-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,43,H318:43;H315:43;H302:38;H317:43;H335:4
60098,"2-Methyl-1,3-thiazolidine-2,4-dicarboxylic acid",605-463-8,16708-09-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
60100,1-(methylsulphonyl)-1H-imidazole,255-058-1,40736-26-3,,Notified C&L,5,H315:5;H319:5;H335:5
60101,Dilanthanum tricarbonate,611-146-5,54451-24-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:44;H319:44;H335:44;Not classified:3
60102,"Propanedioic acid, compd. with 2-(dimethylamino)ethanol (1:2)",606-252-3,191848-61-0,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2,Notified C&L,25,H319:25;H302:25;H312:25
60105,2-methyl-4-oxo-4H-pyran-3-yl acetate,249-223-7,28787-36-2,Not Classified,Notified C&L,1,Not classified:1
60106,"2,5-dimethylbenzaldehyde",227-303-2,5779-94-2,Not Classified,Notified C&L,4,Not classified:3;H319:1;H315:1;H302:1;H335:1
60107,"4,5-dihydro-1H-pyrazole",203-725-2,109-98-8,Flam. Liq. 3,Notified C&L,1,H226:1
60109,p-octylphenol,217-302-5,1806-26-4,Skin Corr. 1C;Eye Dam. 1,Notified C&L,556,H318:446;H314:451;Not classified:62;H315:43;H319:43;H302:5;H361:5
60111,1-(2-methoxyphenyl)piperazinium chloride,226-762-6,5464-78-8,Acute Tox. 3,REACH registration C&L,66,H301:26;H315:54;H319:54;H335:54;Not classified:1;H302:1
60113,"Alkyl, C 16-18, aminopolyoxyethyleneethylammoniumethylsulfate",614-259-8,68071-95-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,504,H315:490;H319:502;H411:2;H302:2;H318:2
60114,"2,3,6a,8,9,9a-hexahydro-9a-hydroxy-4-methoxycyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-1,11-dione",229-989-9,6885-57-0,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 1B,Notified C&L,40,H310:39;H300:40;H350:40;H330:40;H360:1
60120,"resorcinol;1,3-benzenediol",203-585-2,108-46-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Harmonised C&L,0,H319:0;H315:0;H302:0;H400:0
60123,Hydralazine hydrochloride,206-151-0,304-20-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,112,H301:112;H315:105;H319:105;H335:92;H334:14;H341:12;H371:12;H351:4;H361:6;H362:1;H412:2;H317:2;H373:1
60126,"Fatty acids, C6-19-branched, lead salts",292-897-2,91002-20-9,Not Classified,Notified C&L,1,Not classified:1
60130,"5-ethyl-1,3-dioxane-5-methanol",225-967-8,5187-23-5,Eye Irrit. 2,REACH registration C&L,90,H319:86;Not classified:4
60137,"2,2-dimethyl-4,7-dihydro-1,3-dioxepine",445-850-7,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
60139,(2-hydroxy-5-nitrobenzyl)dimethylsulphonium bromide,249-105-5,28611-73-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
60143,2-methylpent-4-en-1-oic acid,216-404-7,1575-74-2,Not Classified,Notified C&L,157,Not classified:64;H302:64;H314:93;H318:25;H290:1;H335:1
60144,"Sulfuric acid, mono-C6-12-alkyl esters, sodium salts",292-224-2,90583-25-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,45,H315:45;H318:45;H302:8
60147,"2,2-dimethylthiazolidine",242-980-4,19351-18-9,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,63,H318:3;H226:52;H302:15;H314:4;H311:11;H290:11;H315:21;H319:10
60150,Dibismuth trimolybdenum dodecaoxide,237-032-1,13595-85-2,Not Classified,Notified C&L,38,Not classified:34;H373:4;H315:4;H319:4;H335:4
60152,"3′-chloro-4,4′-dimethyl-1,2,3-thiadiazole-5-carboxanilide",606-997-4,223580-51-6,Acute Tox. 4,Notified C&L,128,H332:127;H410:1
60157,Tetrabutylphosphonium hydrogen difluoride,471-140-1,,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H302:2;H314:2
60159,m-(p-toluidino)phenol,262-832-2,61537-49-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
60162,Reaction product of 2-Propyn-1-ol with methyloxirane,609-530-2,38172-91-7,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,86,H302:86;H318:86
60163,2'-Iodoacetanilide,606-341-7,19591-17-4,Acute Tox. 4,Notified C&L,38,H302:38
60164,Phenylmethyl chloroacetate,205-400-0,140-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,41,H315:41;H319:40;H335:40;H302:1;H318:1
60165,"Hydrocarbons, C2-4;Petroleum gas",271-734-9,68606-25-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
60167,"2,4-dibromo-1,3,5-trimethylbenzene",230-100-1,6942-99-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
60168,(E)-non-3-ene,243-495-0,20063-92-7,Flam. Liq. 3,Notified C&L,42,H226:42
60169,Cobalt bis(2-ethylhexanoate),205-250-6,136-52-7,Skin Sens. 1A;Eye Irrit. 2;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1031,H412:199;H400:481;H317:1022;H319:486;H360:114;H411:458;H315:380;H302:635;H226:180;H334:111;H314:95;H372:109;H361:282;H370:95;H351:96;H410:361;H318:95;H341:14;H350:27;Not classified:4;H330:2;H312:2;H336:1
60171,Sulphuric diamide,232-262-9,7803-58-9,Not Classified,REACH registration C&L,49,Not classified:2;H315:47;H319:47;H335:46
60176,Dimethyl 2-nitroterephthalate,226-134-1,5292-45-5,Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,35,H411:32;H401:32;H315:2;H319:2;H335:2;Not classified:1
60179,"1-Butyloxy-2,3-difluor-4-(4-trans-propylcyclohexyl)-benzene",606-661-7,208709-55-1,Not Classified,REACH registration C&L,1,Not classified:1
60181,Mitomycin,200-008-6,50-07-7,Acute Tox. 2;Carc. 2,Notified C&L,54,H300:50;H351:50;H400:1;H301:2;H361:2;H314:1;H372:2;H340:2;H318:1;H360:3;H373:1;H350:2;H302:1;H341:2;H362:1
60186,"(6R-trans)-7-amino-8-oxo-3-[(1H-1,2,3-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",253-547-4,37539-03-0,Skin Sens. 1B;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
60187,Phenelzine hydrogen sulphate,205-856-0,156-51-4,Acute Tox. 3,Notified C&L,39,H301:39
60192,"Pitch, coal tar-petroleum;Pitch Residues;[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 °C to 180 °C (140 °F to 356 °F). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]",269-109-0,68187-57-5,Carc. 1B,Harmonised C&L,0,H350:0
60195,"6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(p-hydroxyphenyl)-1H-3-benzazepinium methanesulphonate",266-612-7,67227-57-0,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H319:39;H302:39;H317:39
60200,Disilver(1+) sulphate,233-653-7,10294-26-5,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,107,H410:87;H400:86;H318:103;Not classified:4;H411:2;H315:1;H319:1;H335:1
60201,Methyl N-[3-(acetylamino)-4-[(2-chloro-4-nitrophenyl)azo]phenyl]-N-(3-methoxy-3-oxopropyl)-β-alaninate,215-024-9,1260-35-1,Not Classified,Notified C&L,1,Not classified:1
60203,"(NZ)-N-[1-(2,4-dichlorophenyl)-2-imidazol-1-ylethylidene]hydroxylamine",917-661-4,,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H400:2
60206,"Hydrogen [4-[[4-(dimethylamino)phenyl][2-ethoxy-5-sulphonato-4-(sulphonato-p-toluidino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium, monosodium salt",215-376-3,1324-50-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
60208,"Sodium (Z)-3-[2-[2-(heptadec-8-enyl)-4,5-dihydro-1H-imidazol-1-yl]ethoxy]propionate",302-408-7,94108-69-7,Not Classified,Notified C&L,1,Not classified:1
60210,"Stearic acid, compound with morpholine (1:1)",245-164-6,22707-25-1,Not Classified,Notified C&L,6,Not classified:6
60211,"α,α,α-trifluoro-3-tolualdehyde",207-228-1,454-89-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,50,H315:50;H319:50;H335:49;H400:41;H302:4;H411:1
60216,"1,3-propylene oxide",207-964-3,503-30-0,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H225:0;H332:0;H302:0;H312:0
60219,butyl chloroformate;chloroformic acid butyl ester,209-750-5,592-34-7,Flam. Liq. 3;Skin Corr. 1B;Acute Tox. 3,Harmonised C&L,0,H331:0;H226:0;H314:0
60220,"Sodium 3-[[2,4-dihydroxy-3-[(4-nitrophenyl)azo]phenyl]azo]-4-hydroxybenzenesulphonate",300-388-4,93939-97-0,Not Classified,Notified C&L,1,Not classified:1
60221,"N,N'-dicyclohexyl-N-methylcarbodiimidium iodide",252-846-7,36049-77-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H315:38;H312:38;H302:38;H335:38;H319:38;H332:38
60224,Zinc bis[bis(dodecylphenyl)] bis(dithiophosphate),259-048-8,54261-67-5,Repr. 1B;Repr. 1B;Aquatic Chronic 3,Notified C&L,475,H360:454;H412:463;H411:12;H361:9
60230,Methyl 1-piperidyl ketone,210-550-5,618-42-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,75,H315:39;H319:39;H335:38;Not classified:36;H302:1;H400:1
60232,"N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine",401-990-0,106990-43-6,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
60233,"2,2-diphenylbutyronitrile",226-926-7,5558-68-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H400:38;H302:38;H335:38;H318:38
60234,"Oxidase, urate",232-655-5,9002-12-4,,Notified C&L,2,H334:1;Not classified:1
60237,"Galium odoratum, ext.",289-877-0,90028-83-4,Flam. Liq. 3,Notified C&L,1,H226:1
60241,"[1α,3β(Z)]-(±)-3-[2-chloro-2-(4-chlorophenyl)vinyl]-2,2-dimethylcyclopropanecarboxylic acid",278-917-2,78479-03-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,25,H410:25;H302:25;H400:25
60244,"4,7-diphenyl-1,10-phenanthroline",216-767-1,1662-01-7,Not Classified,Notified C&L,2,Not classified:2
60249,"Glycerides, castor-oil mono-, di- and tri-",294-589-3,91744-27-3,Not Classified,REACH registration C&L,89,Not classified:89
60252,Ammonium cobalt phosphate,238-633-1,14590-13-7,,Notified C&L,7,H302:5;H317:5;Not classified:2
60255,"1,1,5,5-tetramethyl-3,3-diphenyltrisiloxane",241-828-4,17875-55-7,Aquatic Chronic 4,Notified C&L,37,H413:36;H315:1;H319:1
60256,[No public or meaningful name is available],615-695-1,71926-19-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H315:38;H319:38
60258,"Fatty acids, vegetable-oil, esters with trimethylolpropane",283-086-4,84539-98-0,Not Classified,Notified C&L,35,Not classified:35
60260,Sodium (-)-2-(6-methoxy-2-naphthyl)propionate,247-486-2,26159-34-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134,H315:83;H319:83;H335:83;H302:81;H360:39;H361:7;H372:3;Not classified:1;H373:1;H371:1
60261,1-phenyl-3-(p-toluenesulfonyl)urea,424-620-1,13909-63-2,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H373:0;H302:0;H412:0
60263,Dihydrogen bis(didodecyl phosphito-O'')tetrakis(propan-2-olato)titanate(2-),264-710-4,64157-15-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H335:1
60266,Cadmium selenide,215-148-3,1306-24-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,214,H410:213;H400:213;H373:211;H301:211;H331:207;H372:52;H312:44;H350:39;H330:4;H332:1;H224:1
60268,"(3Z)-5-amino-4-oxo-6-[4-(2-sufooxyethylsulfonyl)phenyl]diazenyl-3-[[4-(2-sulfooxyethylsulfonyl)phenyl]hydrazinylidene]naphthalene-2,7-disulfonic acid",918-176-0,,Not Classified,Notified C&L,1,Not classified:1
60269,"2-[[4-chloro-6-[[8-hydroxy-3,6-disulpho-7-[(1-sulpho-2-naphthyl)azo]-1-naphthyl]amino]-1,3,5-triazin-2-yl]amino]-5-sulphobenzoic acid, sodium salt",285-413-6,85098-62-0,Skin Sens. 1B,REACH registration C&L,17,H317:7;Not classified:10
60271,"2(1H)-Quinolinone, 7-(4-chlorobutoxy)-3,4-dihydro-",601-645-6,120004-79-7,Not Classified,Notified C&L,1,Not classified:1
60273,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-diisocyanatomethylbenzene and 2,2'-oxybis[ethanol], 4-methyl-2-pentanone oxime-blocked",604-609-8,147853-37-0,Not Classified,Notified C&L,1,Not classified:1
60276,"5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone",405-090-9,67485-29-4,Acute Tox. 4;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H372:0;H302:0;H410:0;H319:0
60278,"(+)-7-Ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin, monohydrochloride, trihydrate",603-967-2,136572-09-3,Acute Tox. 4;Repr. 1B,Notified C&L,15,H302:15;H360:14;H315:1;H312:1;H335:1;H351:1;H319:1;H340:1;H332:1;H341:4
60280,PC2001,469-930-6,,Not Classified,Notified C&L,1,Not classified:1
60281,(phenylmethoxy)acetaldehyde,262-349-7,60656-87-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40
60282,"Poly(oxy-1,2-ethanediyl), a,a',a''-1,2,3-propanetriyltris[w-hydroxy-, dodecanoate",611-468-6,57107-95-6,Eye Irrit. 2,Notified C&L,2,H319:2
60283,Ethyl N-(2-ethoxy-2-oxoethyl)-N-methylglycinate,226-496-0,5412-66-8,Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38
60286,1-bromopent-2-yne,240-451-2,16400-32-1,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2,REACH registration C&L,46,H301:2;H226:46;H315:46;H319:44;H335:44
60287,reaction mass of: tetradecanoic acid (42.5-47.5 %);poly(1-7)lactate esters of tetradecanoic acid (52.5-57.5 %),412-580-6,174591-51-6,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H317:0;H400:0;H410:0;H318:0
60288,Benzo[b]chrysene,205-919-2,214-17-5,STOT SE 2,Notified C&L,12,H371:12
60292,Manganese sulfate tetrahydrate,600-150-2,10101-68-5,STOT RE 2;Aquatic Chronic 2,Notified C&L,158,H373:158;H411:158
60293,Methyl hydrogen 2-nitroterephthalate,252-360-5,35092-89-8,Eye Irrit. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,78,H402:33;H319:78;H412:34;H315:43;H335:43;Not classified:1
60295,tert-butyl methacrylate,209-548-7,585-07-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,255,H226:147;H319:124;H335:123;H315:183;Not classified:71;H312:1;H302:1;H332:1;H317:1
60298,Tetrasodium [3-[[2-amino-5-hydroxy-6-[(2-hydroxy-5-nitro-3-sulphophenyl)azo]-7-sulpho-1-naphthyl]azo]-2-hydroxy-5-sulphobenzoato(6-)]ferrate(4-),276-443-0,72187-17-8,Not Classified,Notified C&L,2039,Not classified:2039
60299,4-amino-3-phenylbutyric acid,214-079-6,1078-21-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H315:3;H319:3;H335:3
60301,9-phenylanthracene,210-019-8,602-55-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
60304,(3R-cis)-1-(6-methoxy-4-quinolyl)-3-(3-vinyl-4-piperidyl)propan-1-one monohydrochloride,257-739-9,52211-63-9,,Notified C&L,1,H332:1;H302:1;H312:1
60308,"1,3,6,8-tetrabromopyrene",204-900-6,128-63-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40
60310,"(1-hydroxyethylidene)bisphosphonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)",300-994-9,93966-43-9,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
60314,Ammonium (N-hydroxynaphthylamino)oxoamide,213-793-5,1013-20-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38;H312:1;H302:1;H332:1
60315,Sodium prop-2-enesulphonate,219-676-5,2495-39-8,Not Classified,REACH registration C&L,190,Not classified:151;H410:38;H400:38;H318:38;H315:1;H319:1
60316,"1H-Pyrrole-2,5-dione, 1,1'-(methylenedi-4,1-phenylene)bis-, polymer with 4,4'-(1-methylethylidene)bis[2-(2-propen-1-yl)phenol]",613-023-1,62386-33-8,Not Classified,Notified C&L,9,Not classified:9
60317,"1,2,4,5-tetrachlorobenzene",202-466-2,95-94-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H315:47;H400:51;H302:88;H335:38;H410:51;H319:47;H411:1;Not classified:1
60318,"Galium verum, ext.",289-878-6,90028-84-5,Flam. Liq. 3,Notified C&L,1,H226:1
60323,"Alkanes, C9-12-iso-",292-459-0,90622-57-4,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,1691,H413:903;H226:1156;H304:1691;H411:77;H412:67;H332:55;H331:33;H225:1
60327,"difethialone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one",600-594-7,104653-34-1,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H310:0;H330:0;H400:0;H372:0;H410:0;H300:0;H360:0
60335,"Nasturtium officinale, ext.",283-899-4,84775-70-2,Not Classified,Notified C&L,3,Not classified:3
60336,3-((1R)-2-chloro-1-hydroxyethyl)phenol,618-855-9,925430-39-3,Eye Irrit. 2,REACH registration C&L,1,H319:1
60337,Bis(2-ethylhexanoato-O)-μ-oxodizinc,259-049-3,54262-78-1,Aquatic Chronic 2,Notified C&L,59,H411:57;H400:2
60343,"Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-hydroxy-, ester with boric acid (H3BO3), methyl ether",615-261-1,71243-41-9,Not Classified,Notified C&L,19,Not classified:18;H315:1
60345,Furfuryl acetate,210-775-9,623-17-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1403,H332:1314;H302:1314;H312:1314;Not classified:64;H301:24;H331:24;H226:24;H315:1;H319:1;H335:1
60346,5-ethylnon-3-en-2-one,233-379-8,10137-90-3,,Notified C&L,2,H315:2;H319:2;H335:2
60349,"Sodium [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",200-710-2,69-57-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,66,H334:51;H317:53;H225:10;H301:10;H314:10;H332:2;H302:2;H312:2;Not classified:1
60350,"1-propyl-1H-pyrrole-2,5-dione",244-564-8,21746-40-7,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1,Notified C&L,42,H226:38;H302:38;H317:38;H301:4;H315:4;H335:4;H318:4
60351,"Chromate(3-), bis[2-[[[5-[(2-chloro-5-sulfophenyl)azo]-2-hydroxyphenyl]methylene]amino]benzoato(3-)]-, potassium sodium",285-233-8,85049-62-3,Not Classified,Notified C&L,3,Not classified:3
60353,"(4R-cis)-4,4a,5,6,7,8-hexahydro-4,4a-dimethyl-6-(1-methylethylidene)naphthalen-2(3H)-one",239-855-1,15764-04-2,Not Classified,Notified C&L,88,Not classified:64;H317:24
60355,Carminic acid,215-023-3,1260-17-9,Not Classified,Notified C&L,90,Not classified:89;H314:1
60359,N6-benzyloxycarbonyl-L-lysine,214-585-7,1155-64-2,Not Classified,Notified C&L,1,Not classified:1
60361,Chlormezanone,201-307-4,80-77-3,Acute Tox. 4,Notified C&L,158,H302:158
60367,"2,6-dichlorobenzaldehyde oxime",246-720-0,25185-95-9,Acute Tox. 4,Notified C&L,40,H302:40;H315:1;H312:1;H335:1;H319:1;H332:1
60368,"Hexanoic acid, 2-ethyl-, C12-15-alkyl esters",291-443-0,90411-66-8,Not Classified,REACH registration C&L,15,Not classified:15
60369,1-iodo-4-nitrobenzene,211-272-7,636-98-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:44;H312:44;H302:44;H335:43;H319:44;H332:44
60372,Clomethiazole,208-565-7,533-45-9,Acute Tox. 4;Eye Irrit. 2;STOT SE 3;STOT SE 3;Aquatic Chronic 3,Notified C&L,6,H319:5;H302:6;H335:6;H412:6;H315:2
60373,"2,2,4(or 2,4,4)-trimethylhexanedinitrile",283-810-9,84713-17-7,Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,1,H373:1;H301:1;H412:1
60375,1-(m-tolyl)piperazine dihydrochloride,235-974-8,13078-13-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
60376,"2,2,2-trifluoro-1-(trifluoromethyl)ethyl acrylate",218-479-1,2160-89-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,45,H411:41;H315:45;H335:44;H225:45;H319:45
60380,tert-butyl bromoacetate,226-133-6,5292-43-3,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,75,H226:75;H319:68;H335:68;H315:68;H302:6;H314:7;H312:1;H332:1;H318:2
60383,Zinc bis(2-ethylhexanoate),205-251-1,136-53-8,Eye Irrit. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,769,H412:154;H319:429;H361:324;H400:170;H411:394;H317:177;H302:177;H226:180;H410:98;H315:243;Not classified:40;H335:39;H350:22;H360:17;H304:4
60384,"Slags, silicochromium-manufg.",286-096-7,85187-09-3,Not Classified,Notified C&L,1,Not classified:1
60385,"Phosphorous acid, (1-methylethylidene)di-4,1-phenylene tetra-C12-15-alkyl esters",306-120-2,96152-48-6,Skin Sens. 1B,Notified C&L,105,H317:75;Not classified:30;H319:1;H361:1
60388,Ammonium N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate,276-052-5,71832-73-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,2,H315:2;H400:1;H318:2
60389,p-hydroxyphenyl benzoate,219-479-4,2444-19-1,Skin Sens. 1,Notified C&L,43,H317:38;H315:5;H319:5;H335:5
60391,"4-hydroxy-6-(3-sulphoanilino)naphthalene-2-sulphonic acid, sodium salt",280-594-8,83732-47-2,Not Classified,REACH registration C&L,10,Not classified:10
60392,(+)-2-ethylhexyl acetate,256-556-1,50373-28-9,Not Classified,Notified C&L,5,Not classified:5
60394,"Methyl 2,2-dimethoxypropionate",233-211-3,10076-48-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
60395,"Octadecanoic acid, reaction products with acetic acid and triethylenetetramine",291-699-3,90459-55-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
60398,PUMICE,603-719-3,1332-09-8,Not Classified,Notified C&L,503,Not classified:413;H319:90;H335:90
60401,Hydrazinium chloride,220-154-4,2644-70-4,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,66,H317:66;H400:66;H301:66;H311:51;H350:65;H331:51;H410:66;H310:14;H341:14;H330:14;H314:15;H351:1;H318:1
60403,"4,6-dimethyl-2-thioxo-(1H)-pyrimidinediylium sulphate",272-656-8,68901-13-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
60406,"Sulfuric acid, mono-C8-14-alkyl esters, sodium salts",292-225-8,90583-26-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H315:8;H318:8
60409,"3,7-diamino-2-methoxyphenoxazin-5-ium chloride",267-230-3,67827-66-1,Not Classified,Notified C&L,1,Not classified:1
60410,"Pyrimidine, 2-(4'-fluoro[1,1'-biphenyl]-4-yl)-5-pentyl-",619-135-7,95495-18-4,Not Classified,Notified C&L,1,Not classified:1
60414,nickel diformate,222-101-0,3349-06-2,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H341:0;H400:0;H317:0;H372:0;H350:0;H410:0;H360:0
60415,2-Chloro-5-(chloromethyl)pyridine,454-800-3,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,3,H411:3;H317:3;H373:3;H301:3;H311:3;H314:3
60419,"Benzoic acid, 3,5-dibromo-2-hydroxy-, methyl ester",606-824-2,21702-79-4,,Notified C&L,4,H315:4;H319:4;H335:4
60423,2-chloro-6-nitroaniline,212-204-9,769-11-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
60425,"Benzenesulfonic acid, 4-C10-14-alkyl derivs., compds. with ethylenediamine (2:1)",290-639-3,90194-30-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
60429,2'-(4-methylbenzoyl)-2-naphthohydrazide,280-916-7,83803-95-6,Aquatic Acute 1,Notified C&L,42,H400:38;H315:4;H319:4;H335:4
60431,"2,4-dimethylpyridine",203-586-8,108-47-4,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1445,H301:71;H226:159;H319:72;H315:72;H332:1400;H302:1374;H312:1404;H311:39;H335:69;H331:43
60432,Crotamiton,207-596-3,483-63-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,51,H319:51;H315:51;H302:51;H317:51
60435,Ruthenium disulphide,235-318-0,12166-20-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H315:42;H319:42;H335:42;H228:4
60436,"Nonanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",233-581-6,10246-68-1,Aquatic Chronic 3,Notified C&L,566,H412:566;H332:125
60437,"4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-",612-950-9,6217-54-5,Not Classified,Notified C&L,3,Not classified:3
60440,"4,8-diamino-1,5-dihydroxy-2-(4-methoxyphenyl)anthraquinone",225-181-5,4702-64-1,Not Classified,Notified C&L,5,Not classified:5
60443,1-methoxy-2-propylamine,422-550-4,37143-54-7,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H225:0;H412:0;H302:0;H314:0
60445,diammonium nickel bis(sulfate),239-793-5,15699-18-0,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H341:0;H317:0;H400:0;H372:0;H302:0;H350:0;H410:0;H332:0;H360:0
60447,"10-methoxy-5H-dibenz[b,f]azepine-5-carboxamide",249-189-3,28721-09-7,Acute Tox. 4,Notified C&L,39,H302:39;H332:1;H312:1
60449,"benzene-1,2:4,5-tetracarboxylic dianhydride;pyromellitic dianhydride",201-898-9,89-32-7,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H334:0;H317:0;H318:0
60450,"Fats, animal, stearins",297-158-8,93348-18-6,Not Classified,Notified C&L,1,Not classified:1
60451,Dioctadecyl fumarate,230-705-0,7283-68-3,Not Classified,Notified C&L,126,Not classified:126
60455,Benzothiazol-2(3H)-one,213-281-1,934-34-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,79,H332:42;H302:42;H312:42;Not classified:33;H315:5;H319:5;H335:5
60456,Non-2-enenitrile,249-458-5,29127-83-1,Acute Tox. 4,Notified C&L,160,H302:160
60459,N-methoxymethylamine hydrochloride,229-642-1,6638-79-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,173,H315:173;H319:173;H335:110;H302:2
60460,"1,1'-(isopropylidene)bis[3,5-dibromo-4-(2,3-dibromo-2-methylpropoxy)benzene]",306-832-3,97416-84-7,Not Classified,REACH registration C&L,8,Not classified:8
60462,"Disodium 5-[[2,4-dihydroxy-3-[(4-sulphonatophenyl)azo]phenyl]azo]-2-(phenylamino)benzenesulphonate",229-130-8,6416-67-7,Not Classified,Notified C&L,1,Not classified:1
60463,C.I. Direct Brown 115,602-745-2,12239-29-1,,Notified C&L,1,H319:1
60469,"2,4-dichloro-1-(dichloromethyl)benzene",205-134-5,134-25-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,3,H411:3;H315:3;H302:3;H335:3;H319:3
60473,Polyester Resin product,608-203-1,28407-73-0,,Notified C&L,34,Not classified:33;H317:1
60474,"1-(3,4-dimethoxybenzyl)-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinolinium chloride",229-213-9,6429-04-5,Acute Tox. 4,REACH registration C&L,42,H302:42
60479,"2-methylenepropane-1,3-diyl diacetate",223-225-8,3775-29-9,Acute Tox. 4,REACH registration C&L,2,H302:2
60480,Lead bis(dimethyldithiocarbamate),242-748-2,19010-66-3,Not Classified,Notified C&L,35,Not classified:35
60483,"Fatty acids, lanolin, sodium salts",287-531-3,85536-48-7,Not Classified,Notified C&L,1,Not classified:1
60484,"Decanoic acid, mixed esters with heptanoic acid, isovaleric acid, octanoic acid and pentaerythritol",268-594-6,68130-51-8,Not Classified,REACH registration C&L,25,Not classified:25
60487,Diallyl carbonate,239-106-9,15022-08-9,Flam. Liq. 3;Acute Tox. 3;Aquatic Acute 1,REACH registration C&L,39,H301:1;H226:39;H400:1;H319:38;H335:38;H315:38
60489,"[S-(R*,S*)]-5-(1,5-dimethylhexen-4-yl)-2-methyl-1,3-cyclohexa-1,3-diene",207-804-2,495-60-3,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:1;H315:1;H317:2;H319:1;H304:2
60495,Isopropyltriphenylphosphonium iodide,246-281-5,24470-78-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
60496,"Hemlock (Tsuga), T. canadensis, ext.",289-926-6,90045-63-9,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,6,H317:6;H410:5;H226:6;H304:5;H315:1;H319:2
60497,"Gum arabic, ext.",291-377-2,90387-99-8,Not Classified,Notified C&L,1,Not classified:1
60498,N-(tert-butoxycarbonyl)-L-isoleucine,236-074-8,13139-16-7,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1;H335:1
60501,"Pyridine, 2-(chloromethyl)-4-methoxy-3,5-dimethyl-, hydrochloride (1:1)",434-680-9,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,4,H411:3;H315:4;H302:3;H318:3;H400:1;H410:1;H319:1;H335:1;H317:1
60503,"sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate",418-410-7,139122-78-4,Eye Irrit. 2,Harmonised C&L,0,H319:0
60504,p-(2-nitropropenyl)anisole,241-381-5,17354-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
60519,Isopentyl nitrate,208-852-7,543-87-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
60521,D-cellobiose,208-436-5,528-50-7,Not Classified,Notified C&L,6,Not classified:6
60523,C.I. Acid Black 107,602-498-0,12234-55-8,,Notified C&L,1,H411:1
60526,"D-(-)-N-(2,4-diamino-6-pteridinyl(dimethylamino)benzoyl)glutamic acid",257-482-2,51865-79-3,,Notified C&L,2,H341:2;H315:1;H373:1;H301:2;H360:2;H351:1;H319:1
60530,4-carboxymethylpyridinium chloride,229-576-3,6622-91-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
60532,Bistrifluron,606-446-8,201593-84-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
60534,2-(methylthio)benzimidazole,230-494-5,7152-24-1,Not Classified,Notified C&L,23,Not classified:22;H315:1;H319:1;H335:1
60536,4'-bromo-3-chloropropiophenone,250-784-5,31736-73-9,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,45,H315:45;H400:2;H317:2;H335:45;H410:2;H318:2;H319:43
60541,2-(p-aminophenyl)-2-phenylacetonitrile monohydrochloride,274-137-1,69833-17-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H315:38;H335:38;H318:38
60543,1-Naphthaleneboronic Acid (contains varying amounts of Anhydride),604-119-4,13922-41-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H315:49;H319:49;H335:48;H332:2;H302:2;H312:2
60546,"2,6-dimethylhydroquinone",211-505-2,654-42-2,Acute Tox. 3,Notified C&L,2,H301:1;H315:1;H302:1;H360:1;H318:1
60547,3-(benzylamino)propionitrile,211-890-7,706-03-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H315:38;H312:42;H302:42;H335:38;H319:38;H332:42
60549,C.I. Reactive Red 222,618-908-6,93051-45-7,Not Classified,Notified C&L,4,Not classified:4
60550,"2-benzyl-4,4,6-trimethyl-1,3-dioxane",266-795-3,67633-94-7,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1545,H411:3;H315:3;Not classified:1542
60552,"Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides, compds. with attapulgite",273-218-9,68953-57-1,Not Classified,Notified C&L,62,Not classified:62
60553,"Methyl (S)-2,5-dioxooxazolidine-4-propionate",216-770-8,1663-47-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H335:1;H318:1
60554,4-Bromo-3-nitroaniline,610-987-5,53324-38-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:1;H312:1;H302:1;H332:1
60561,C.I. Direct Black 112,601-886-7,12217-52-6,Not Classified,Notified C&L,2,Not classified:2
60565,Vanadium carbide nitride,601-732-9,12069-91-9,Not Classified,REACH registration C&L,2,Not classified:2
60566,"Alcohols, C12-16, ethoxylated, sulfates, sodium salts",500-512-9,161074-78-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:2;H318:2
60567,Magnesium fluoride,231-995-1,7783-40-6,STOT SE 3,REACH registration C&L,466,H335:269;H315:310;H319:310;Not classified:145;H302:1;H332:1
60568,Clindamycin hydrochloride,244-398-6,21462-39-5,Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 1B,REACH registration C&L,112,H317:91;H335:10;H319:109;H332:3;H360:3;H315:18;H302:5;Not classified:2;H361:2;H362:1
60569,"4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride",432-470-1,189012-93-9,Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0;H318:0
60572,"Barium, carbonate 4-nonylphenol complexes",270-484-8,68442-67-1,Not Classified,Notified C&L,1,Not classified:1
60574,"6-diazo-5,6-dihydro-5-oxonaphthalene-2-sulphonyl chloride",223-211-1,3770-97-6,Flam. Sol. 1;Self-react. B;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H317:1;H412:1;H302:1;H228:1;H241:2;H319:1;H318:1;H314:1
60575,"Ethyl 2-hydroxy-5-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate",260-850-5,57615-05-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
60579,Alkali salt of substituted aryl sulfonyl triazinyl amino substituted alkyl sulfonato alkyl pyridin azo aryl sulfonate,443-090-0,,Not Classified,REACH registration C&L,2,Not classified:2
60581,"2,4-dichloro-6-methoxy-1,3,5-triazine",222-863-4,3638-04-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
60582,"Acetic acid, cadmium salt dihydrate",611-525-5,5743-04-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H312:44;H400:44;H302:44;H410:44;H332:44;H350:1
60583,chloridazon (ISO);5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;pyrazon,216-920-2,1698-60-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H317:0
60584,"1,3,5-Triazine-2,4,6-triamine, polymer with formaldehyde, methylated",614-203-2,68002-20-0,Aquatic Chronic 3,Notified C&L,888,H412:783;Not classified:56;H332:38;H351:38;H317:48;H302:2;H318:2;H226:2;H371:1
60589,Tris(2-hydroxyethyl)ammonium decyl sulphate,254-710-2,39943-70-9,Not Classified,Notified C&L,442,Not classified:441;H315:1;H318:1
60590,Proxymetacaine hydrochloride,227-541-7,5875-06-9,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,42,H312:40;H317:40;H302:41;H319:40;H332:40;H301:1
60592,"Isotridecanol, ethoxylated",500-027-2,9043-30-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,1679,H302:1237;H318:1254;H412:232;H319:247;H315:297;Not classified:134;H226:33;H400:36;H411:86;H320:8;H227:7;H401:7;H335:5
60596,"Sulfonic acids, C10-21-alkane, Ph esters",293-728-5,91082-17-6,Not Classified,Notified C&L,101,Not classified:101
60598,(4-nonylphenoxy)acetic acid,221-486-2,3115-49-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,134,H317:134;H400:89;H314:134;H302:134;H410:89;H318:89;H411:45
60601,[No public or meaningful name is available],447-710-0,165261-13-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,24,H302:24;H317:24
60602,Triethylgallium,214-232-7,1115-99-7,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,135,H250:135;H260:41;H318:54;H314:135;H300:56;H330:56;H261:38;H225:38
60604,"Alkenes, C>10 α-, polymd.",614-571-4,68527-08-2,Not Classified,Notified C&L,40,Not classified:40
60610,"Ferrate(1-), bis[4-[2-[5-chloro-2-(hydroxy-κO)phenyl]diazenyl-κN1]-3-(hydroxy-κO)-N-phenyl-2-naphthalenecarboxamidato(2-)]-, hydrogen (1:1)",601-580-3,119029-85-5,Not Classified,Notified C&L,5,Not classified:5
60611,"1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane",420-190-2,771478-66-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H317:0;H373:0;H314:0;H400:0;H302:0;H410:0
60612,Molybdenum sesquioxide,215-205-2,1313-29-7,Not Classified,Notified C&L,32,Not classified:32
60615,2-aminoethanol;ethanolamine,205-483-3,141-43-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0;H312:0;H314:0
60617,Pheniramine,201-656-2,86-21-5,Acute Tox. 2,Notified C&L,39,H300:38;H302:1
60618,"Rubber, synthetic",613-658-4,64706-29-2,Not Classified,Notified C&L,1,Not classified:1
60619,Prasterone,200-175-5,53-43-0,Repr. 1B;Lact.;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,208,H410:152;H362:152;H360:168;H400:151;H315:39;H319:39;H335:39;H312:16;H302:17;H351:16;H332:16
60621,"2,4,5-trichlorothiophenol",223-223-7,3773-14-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,43,H413:38;H315:43;H335:42;H318:38;H319:5
60623,"Esterification products of 4,4'-isopropylidenediphenol, ethoxylated and prop-2-enoic acid",613-584-2,64401-02-1,Aquatic Chronic 2,Notified C&L,321,H411:159;H315:111;H319:126;H335:41;H317:41;Not classified:36;H360:1
60626,"Butane, 1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxy-",605-339-3,163702-07-6,Not Classified,Notified C&L,205,Not classified:146;H332:51;H413:5;H315:3;H319:3;H335:3
60628,"3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione",413-330-9,134724-55-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
60633,"Benzene, 1,2-dimethyl-, reaction products with styrene",270-121-3,68411-40-5,Not Classified,Notified C&L,11,Not classified:11
60634,"L-Ornithine, fermentation products",924-152-0,,Not Classified,Notified C&L,1,Not classified:1
60638,"1,2,3,4-tetrahydroisoquinoline",202-050-0,91-21-4,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;STOT SE 2;Aquatic Chronic 3,REACH registration C&L,131,H310:85;H314:85;H412:85;H301:85;H318:85;H332:85;H371:85;H315:46;H319:46;H335:44;H302:5;H312:1
60640,"Siloxane und Silikone, methoxyvinyl",603-472-1,131298-48-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,13,H315:13;H335:13;H318:13
60647,1-acetylpiperidine-4-carboxylic acid,247-049-6,25503-90-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H317:39;H302:39;H335:44;H319:45
60649,"Chromium, chloro hydroxy stearate complexes",290-956-7,90294-69-2,Not Classified,Notified C&L,2,Not classified:2
60650,"(E)-3,4,5,6,6-pentamethylhept-3-en-2-one",279-823-4,81786-74-5,Aquatic Chronic 3,Notified C&L,135,H412:75;H411:60;H317:44
60651,1-(4-cyanophenyl)guanidine,611-382-9,5637-42-3,Aquatic Chronic 3,REACH registration C&L,2,H412:1;H315:1;H312:1;H302:1;H319:1;H332:1
60653,1-(4-Ethoxyphenylethinyl)-4-propylbenzol,609-762-4,39969-29-4,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
60655,"Distillates (petroleum), hydrotreated full-range",295-307-1,91995-46-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,14,H302:14;H312:14
60656,"5-Bromo-2,3-difluorophenol",606-090-3,186590-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:45;H319:45;H335:44;H302:5;H301:1;H311:1;H332:2;H312:1
60658,"2,3-dinitrotoluene",210-013-5,602-01-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H341:0;H400:0;H373:0;H301:0;H311:0;H361:0;H350:0;H331:0;H410:0
60659,Ethyl 3-aminobenzoate,209-482-9,582-33-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
60665,"6,7-dimethoxy-3,4-dihydroisoquinolinium chloride",606-469-3,20232-39-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,6,H315:6;H319:6;H335:5
60666,6-methoxy-m-toluidine;p-cresidine,204-419-1,120-71-8,Acute Tox. 4;Carc. 1B,Harmonised C&L,0,H350:0;H302:0
60667,"2,2-bis[[(1-oxooctyl)oxy]methyl]-1,3-propanediyl dioctanoate",221-123-8,3008-50-2,Not Classified,Notified C&L,43,Not classified:43
60671,1-Benzylhydantoin,614-130-6,6777-05-5,Acute Tox. 4,Notified C&L,1,H302:1
60674,Alkophen mesyl lactone,470-280-0,,Skin Sens. 1;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H373:1;H361:1;H336:1
60681,Chlorodicyclohexylborane,609-212-3,36140-19-9,Flam. Liq. 2;Pyr. Liq. 1;Skin Corr. 1B,Notified C&L,38,H225:38;H250:38;H314:38
60683,"(9Z,12Z)-octadeca-9,12-dienoyl chloride",231-233-8,7459-33-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H290:1
60686,1-[3-(trifluoromethyl)phenyl]piperazinium chloride,240-153-2,16015-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:45;H330:1;H301:1;H311:1
60687,"Sulfuric acid, mono-C10-14-alkyl esters, sodium salts",292-227-9,90583-28-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,44,H315:44;H318:44
60691,"2-(dimethylamino)-2-phenylbutyl (-)-3,4,5-trimethoxybenzoate",261-546-5,58997-88-9,Not Classified,Notified C&L,1,Not classified:1
60694,"3,3-dimethylfuran-2,4(3H,5H)-dione",226-604-6,5436-15-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
60697,Calcium didocosanoate,222-700-7,3578-72-1,Not Classified,REACH registration C&L,6,Not classified:6
60698,"1-Propene, homopolymer, maleated",601-608-4,119415-04-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,56,H315:56;H412:56;H317:31;H302:56;H318:56
60701,Superphosphates,232-379-5,8011-76-5,Eye Dam. 1,REACH registration C&L,70,H318:70
60705,"Glycine, N,N'-[(1S)-1-methyl-1,2-ethanediyl]bis[N-(carboxymethyl)-",604-860-3,15250-41-6,Not Classified,Notified C&L,1,Not classified:1
60711,"Phosphoric acid, C6-12-alkyl esters, potassium salts",291-900-4,90506-39-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
60713,"Extracts (petroleum), heavy paraffinic distillate solvent",265-103-7,64742-04-7,Carc. 1B,Harmonised C&L,0,H350:0
60714,"Ethanethioic acid, S-[1-[2-(acetyloxy)ethyl]butyl] ester",603-990-8,136954-25-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,89,H319:78;H315:78;H302:78;H335:78;Not classified:11
60715,"[3S-[3α,6α(R*)]-tetrahydro-2,2,6-trimethyl-6-(4-methyl-3-cyclohexen-1-yl)-2H-pyran-3-ol",245-086-2,22567-36-8,Aquatic Chronic 2,Notified C&L,40,H411:38;Not classified:2
60717,5-bromo-2-furanecarboxylic acid,209-559-7,585-70-6,Eye Irrit. 2,Notified C&L,44,H319:44;H315:5;H335:5
60723,5-(2-aminoethyl)pyrogallol hydrochloride,227-223-8,5720-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
60724,Sodium 3-(trimethylsilyl)propionate,253-308-4,37013-20-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
60725,4-Chloro-2-fluorocinnamic Acid,606-508-4,202982-65-8,,Notified C&L,7,H315:7;H319:7;H335:6
60726,Non-2-en-1-ol,244-783-9,22104-79-6,Not Classified,Notified C&L,88,Not classified:88
60735,9-methyl-9H-fluorene,219-750-7,2523-37-7,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H411:38;H302:38
60736,"glyphosine (ISO);N,N-bis(phosphonomethyl)glycine",219-468-4,2439-99-8,Eye Dam. 1,Harmonised C&L,0,H318:0
60739,Dierbium trisulphate,236-779-0,13478-49-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H319:39;H335:39;Not classified:1
60740,Trioxysalen,223-459-0,3902-71-4,Skin Corr. 1B;Carc. 2,Notified C&L,40,H351:39;H314:40;H318:2
60741,2-(4-amino-N-ethyl-m-toluidino)ethanol sulphate,248-780-3,28020-34-0,Not Classified,Notified C&L,2,Not classified:2
60742,[8-[(p-aminophenyl)azo]-7-hydroxy-2-naphthyl]trimethylammonium chloride,247-640-9,26381-41-9,Skin Sens. 1,REACH registration C&L,71,H317:70;H319:37;Not classified:1
60746,1-cyclohexylethyl 2-butenoate,268-276-7,68039-69-0,Not Classified,Notified C&L,292,Not classified:238;H317:54
60747,"1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithiumsalt",419-520-8,172890-93-6,Skin Sens. 1,Harmonised C&L,0,H317:0
60748,4-methyl-γ-methylenecyclohex-3-ene-1-propan-1-ol,239-857-2,15766-66-2,Not Classified,Notified C&L,88,Not classified:88
60749,4-nitrobenzenesulphonamide,228-691-6,6325-93-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
60754,Potassium hydrogen phthalate,212-889-4,877-24-7,Not Classified,REACH registration C&L,122,Not classified:111;H315:9;H319:9;H335:7;H341:1;H361:1;H318:1
60756,4-acetylbenzenesulphonamide,216-363-5,1565-17-9,,Notified C&L,7,H315:7;H319:7;H335:6;H302:1
60758,4'-chloro-5-fluoro-2-hydroxybenzophenone,263-539-2,62433-26-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
60761,Dibenzyl succinate,203-110-9,103-43-5,,Notified C&L,33,Not classified:33
60766,9-(chloromethyl)anthracene,246-274-7,24463-19-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:39;H319:40;H335:40;H314:8;H318:1;H290:1
60774,Diethyl mesoxalate,210-176-2,609-09-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:2
60775,Levomepromazine,200-495-5,60-99-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:39;H302:39;H312:39;H411:1
60781,"Quaternary ammonium compounds, benzyldimethyltallow alkyl, chlorides",263-085-5,61789-75-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,36,H330:20;H314:20;H400:20;H311:20;H302:36;H335:20;H410:20;H318:21;H315:1
60782,Chromium nitride,246-016-3,24094-93-7,Not Classified,Notified C&L,3,Not classified:3
60783,"4-(3-Butenyl)-benzoic acid-(4-cyano-3,5-difluorphenylester)",606-655-4,208528-35-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
60785,"3-amino-2,4-dichlorophenol",262-909-0,61693-42-3,Not Classified,Notified C&L,1,Not classified:1
60786,2-phenoxyethyl methacrylate,234-201-1,10595-06-9,Skin Sens. 1A;Repr. 2;Aquatic Chronic 2,REACH registration C&L,192,H411:24;H361:6;H317:19;H315:172;H319:172;H335:38;Not classified:1
60788,2-[2-(methacryloyloxy)ethoxycarbonyl]benzoic acid,248-616-0,27697-00-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,82,H315:74;H319:72;Not classified:8;H318:2;H317:2
60792,"Hexadecanoic acid, ester with 1,2,3-propanetriol",234-400-3,11140-06-0,Not Classified,Notified C&L,4,Not classified:4
60793,Cinnamylidenemalonic acid,224-746-3,4472-92-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:42;H302:38;H315:4;H335:4
60795,Methyl (2E)-2-[2-({[2-isopropoxy-6-(trifluoromethyl)-4-pyrimidinyl]oxy}methyl)phenyl]-3-methoxyacrylate,607-186-8,229977-93-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H410:194;H400:194
60798,CBC-53F,441-140-6,106349-49-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
60800,2-ethylpyridine 1-oxide,225-413-5,4833-24-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
60801,Tricobalt bis(orthophosphate),236-655-6,13455-36-2,Acute Tox. 4,Notified C&L,49,H302:30;Not classified:18;H319:4;H315:4;H335:4;H334:2;H400:2;H317:3;H350:2;H410:2;H341:1
60803,4-[(E)-2-(1-methyl-5-nitro-1H-imidazol-2-yl)ethenyl]pyrimidin-2-amine bisulfate,924-375-3,,Not Classified,Notified C&L,1,Not classified:1
60808,Butyltrimethoxysilane,213-936-1,1067-57-8,,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
60813,Diammonium 2-ethylhexyl phosphate,288-863-1,85909-58-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
60814,Bis(4-chlorobutyl) ether,228-713-4,6334-96-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H302:44;H335:39
60820,4'-methylvalerophenone,216-804-1,1671-77-8,Acute Tox. 4,Notified C&L,38,H302:38
60824,"1-Hexadecanol, phosphate, potassium salt",284-374-2,84861-79-0,Eye Dam. 1,Notified C&L,17,H318:16;Not classified:1
60827,Bis(2-ethylhexyl) glutarate,244-326-3,21302-20-5,Not Classified,Notified C&L,5,Not classified:5
60828,2-[1-[3-[2-[(dimethylamino)sulphonyl]-10H-phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl palmitate,253-536-4,37517-26-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,1,H315:1;H302:1;H317:1
60829,"N,N'-(iminodiethylene)distearamide monoacetate",268-344-6,68072-50-4,Not Classified,Notified C&L,2,Not classified:2
60833,Di-2-propynylamine,230-036-4,6921-28-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H226:39;H314:39;H318:1
60838,"(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylic acid",225-067-5,4638-92-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42,H315:41;H319:41;H302:3;H335:3;Not classified:1
60840,"trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate",402-170-5,106359-91-5,Skin Sens. 1,Harmonised C&L,0,H317:0
60842,"2,4-di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol",223-383-8,3864-99-1,STOT RE 2;Aquatic Chronic 3,Notified C&L,602,H373:521;H412:517;H371:46;H315:50;H319:50;H335:48;Not classified:21;H413:11;H410:5;H400:5;H302:1;H331:1
60843,sec-butyl isothiocyanate,224-609-8,4426-79-3,Skin Corr. 1B,Notified C&L,3,H314:2;H315:1;H301:2;H335:2;H331:2;H226:2;H319:1
60846,Zinc abietate,229-875-9,6798-76-1,Not Classified,Notified C&L,1,Not classified:1
60854,"2,3-dibromobutyric acid",209-992-1,600-30-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H315:38;H302:38;H335:38;H314:4
60855,Dierbium trioxalate,212-764-4,867-63-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H312:1
60856,"4-chloro-2',4'-dimethoxybutyrophenone",279-432-9,80269-97-2,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H319:38;H302:38;H400:38;H317:38
60861,"4-(1-naphthylazo)benzene-1,3-diamine",229-127-1,6416-57-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
60862,(E)-N-(pentan-2-ylidene)hydroxylamine,484-470-6,623-40-5,Acute Tox. 4;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,43,H373:17;H319:42;H302:43;H412:20;H413:22;H312:1;H317:1;H351:1;H227:1;H318:1;H332:1
60866,"Bis(3-amino-4,5,6,7-tetrachloro-1H-isoindol-1-one oximato-N2,O1)nickel",274-916-6,70833-37-3,Not Classified,Notified C&L,39,Not classified:39
60867,L-Sorbose,201-771-8,87-79-6,Not Classified,Notified C&L,3,Not classified:3
60870,"4,5,5-trimethylhexanoic acid, compound with 2-aminoethanol (1:1)",306-040-8,95873-51-1,Aquatic Chronic 3,Notified C&L,13,H412:13
60874,4-(1-pyrrolidinyl)benzaldehyde,257-570-0,51980-54-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
60876,"Hydrogen [4-[4-(diethylamino)-3',4'-bis(sulphonatomethyl)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium, potassium salt",300-596-5,93942-43-9,Skin Irrit. 2,Notified C&L,1,H315:1
60880,"2-amino-4,6-dinitrophenol;picramic acid;[≥ 20 % water]",202-544-6,96-91-3,,,0,H201:0;H312:0;H412:0;H302:0;H332:0
60883,"2-hydroxy-1H-benz[de]isoquinoline-1,3(2H)-dione",232-251-9,7797-81-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
60889,Chlorotriphenylmethane,200-986-4,76-83-5,Skin Corr. 1B;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,95,H410:19;H400:17;H335:15;H314:63;H315:31;H413:2;H319:2;H318:1;H290:1;Not classified:1
60891,Diethyl tetrafluorosuccinate,206-821-2,377-71-9,,Notified C&L,4,H315:4;H319:4;H335:4
60892,"2,5-dichloroterephthalic acid",237-454-6,13799-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
60895,Ethyl 2-cyano-3-ethoxyacrylate,202-299-5,94-05-3,Acute Tox. 4,REACH registration C&L,48,H302:5;H315:46;H319:45;H335:45;H334:7;H317:7;H301:5;H318:1
60897,Phenyl 3-pyridyl ketone,226-561-3,5424-19-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
60900,"Sodium 2-[[(3α,5β,12α)-3,12-dihydroxy-24-oxocholan-24-yl]amino]ethane-1-sulphonate",214-652-0,1180-95-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6,H315:5;H319:5;H335:6
60906,"Oils, lard",232-405-5,8016-28-2,Not Classified,Notified C&L,172,Not classified:172
60907,Disodium N-[2-(carboxylatomethoxy)ethyl]-N-[2-[(1-oxododecyl)amino]ethyl]glycinate,269-546-7,68298-20-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT SE 2,Notified C&L,24,H332:13;H371:13;H302:13;H312:13;Not classified:11
60913,"Iron, complexes with diazotized 2-amino-4,6-dinitrophenol coupled with diazotized 4-nitrobenzenamine and 4-[(2,4-dihydroxyphenyl)azo]-5-hydroxy-2,7-naphthalenedisulfonic acid, sodium salts",289-124-6,86014-76-8,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,112,H411:6;H319:8;H412:93;Not classified:11
60915,"Phosphoric acid, butyl ester, sodium salt",258-380-0,53126-67-3,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,41,H315:3;H318:1;Not classified:38
60916,"2,5-Cyclohexadien-1-one, 2,6-bis(1,1-dimethylethyl)-4-(phenylmethylene)-",615-169-1,7078-98-0,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,15,H413:15;H317:15
60918,"2-Propenoic acid, 2-methyl-, C6-12-alkyl esters",292-081-6,90530-40-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,17,H315:15;H319:15;H335:15;H410:2;H400:2;H317:2
60919,Trisodium trioxalatoferrate,209-092-9,555-34-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,2043,H302:2043;H312:2043
60926,Barium di(acetate),208-849-0,543-80-6,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,244,H332:243;H302:243;Not classified:2
60927,Sodium 3-nitrosulphanilate,225-735-6,5042-33-1,Not Classified,REACH registration C&L,2,Not classified:1;H315:1;H319:1;H335:1
60928,Melapur M 200,606-855-1,218768-84-4,Not Classified,Notified C&L,121,Not classified:121
60929,"2,2'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis[5-tert-butylbenzenesulphonic] acid, sodium salt",306-674-5,97375-18-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,9,H315:9;H319:9;H412:9
60930,"pentanol isomers, with the exception fo those specified elsewhere in this Annex",250-378-8,30899-19-5,Flam. Liq. 3;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H332:0;H226:0;H335:0
60933,"Cryptomeria japonica, ext.",294-953-1,91771-60-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1;H317:1;H226:1;H304:1
60936,"Fuel oil, residual;Heavy Fuel oil;[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]",270-675-6,68476-33-5,Carc. 1B,Harmonised C&L,0,H350:0
60941,3β-hydroxyurs-12-en-28-oic acid,201-034-0,77-52-1,Not Classified,Notified C&L,92,Not classified:91;H319:1
60945,"1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea",278-928-2,78491-02-8,Eye Irrit. 2,REACH registration C&L,1100,H319:398;H317:543;H412:146;Not classified:42;H315:32;H318:23;H411:13;H332:5;H341:1
60951,"Fatty acids, C12-18, mixed esters with citric acid, pentaerythritol and stearyl alc.",603-405-6,130328-22-2,Not Classified,Notified C&L,62,Not classified:62
60954,"Hexahydro-4,7-methano-1H-indenyl acrylate",235-697-2,12542-30-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,86,H411:86;H315:86;H317:85;H335:85;H319:85
60955,Hydrocodone,204-733-9,125-29-1,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1,Notified C&L,41,H334:41;H302:40;H400:40;H317:41;H301:1;H331:1
60956,3-Fluoro-4-methoxybenzoic Acid,609-820-9,403-20-3,,Notified C&L,9,H315:9;H319:9;H335:8
60962,Tetracosanoic acid,209-180-7,557-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H319:39;H335:38;Not classified:1
60964,"1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",201-489-5,83-62-5,Eye Irrit. 2,Notified C&L,38,H319:38
60965,"Tetrasodium 5-[[4-chloro-6-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",245-603-1,23354-52-1,Not Classified,Notified C&L,41,Not classified:40;H318:1
60966,3-phenylpiperidine,223-602-7,3973-62-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,4,H332:2;H302:3;H312:2;H315:2;H319:2;H335:1
60968,C.I. Basic blue 75,602-133-5,12221-43-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,13,H302:13;H318:13
60969,Calcium hydrogen (2R-cis)-(3-methyloxiranyl)phosphonate,247-408-7,26016-98-8,Not Classified,Notified C&L,2,Not classified:2
60971,"α,α,α-trifluoro-m-toluoyl chloride",218-844-5,2251-65-2,Skin Corr. 1B,Notified C&L,45,H314:45;H319:1;H335:1;H318:1;H290:1
60972,4-nonylphenyl ditridecyl phosphite,284-119-5,84787-77-9,Skin Irrit. 2,Notified C&L,1,H315:1
60973,"Propanamide, 2-[4-[(6-chloro-2-benzoxazolyl)oxy]phenoxy]-N-(2-fluorophenyl)-N-methyl-",607-768-1,256412-89-2,Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,127,H332:127;H410:127;H400:127;H317:127
60985,"estra-1,3,5(10)-triene-3,17β-diol 3-benzoate 17-butyrate",263-807-9,63042-18-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H332:38;H351:38;H302:38;H312:38
60986,"Distillates (petroleum), hydrocracked solvent-refined, dewaxed;Baseoil - unspecified;[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]",295-306-6,91995-45-8,Carc. 1B,Harmonised C&L,0,H350:0
60992,Iron diarsenide,234-485-7,12006-21-2,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H331:38;H410:38;H400:38
60993,"Sodium [3-[[5-[(3-amino-4-nitrophenyl)azo]-2,4-dihydroxyphenyl]azo]-2-hydroxybenzenesulphonato(3-)]cuprate(1-)",281-095-8,83863-34-7,Not Classified,Notified C&L,2,Not classified:2
60994,p-phenylene di(acetate),214-887-9,1205-91-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:38
60995,Zinc dilaurate,219-518-5,2452-01-9,Not Classified,REACH registration C&L,65,Not classified:64;H412:1
60996,Isonicotinthioamide,218-592-6,2196-13-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H315:50;H302:49;H335:49;H312:1;H332:1
60997,2-aminobenzophenone,220-613-9,2835-77-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45;H302:1
60998,"α,α,α-trifluoro-p-cresol",206-945-7,402-45-9,Flam. Sol. 1;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,78,H315:44;H301:43;H335:43;H228:43;H318:44;Not classified:33;H302:1
60999,N-ethylnicotinamide,224-331-7,4314-66-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H315:1
61003,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7-pentadecafluoro-7-iodoheptane",206-393-7,335-58-0,,Notified C&L,6,H315:6;H319:6;H335:5;H312:1;H302:1;H332:1
61006,"1,8-dichloroanthraquinone",201-420-9,82-43-9,Not Classified,REACH registration C&L,10,Not classified:3;H319:7;H315:1;H335:1
61009,Glucosyle monolinoleate,462-890-0,,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1
61010,N-cyclohexylcyclohexanammonium 2-(3-benzoylphenyl)propanoate,607-305-3,24021-57-6,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H301:2;H410:2;H400:2
61013,calcium chloride,233-140-8,10043-52-4,Eye Irrit. 2,Harmonised C&L,0,H319:0
61014,"Alkenes, polymd., chlorinated",614-454-8,68410-99-1,Not Classified,Notified C&L,18,Not classified:12;H362:6;H413:6;H319:6
61019,"5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one",414-470-3,95885-13-5,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
61020,"Hydrocarbons, C5-8",295-762-6,92128-65-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 1B;Carc. 1B;Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,339,H315:339;H400:211;H373:104;H361:239;H225:227;H350:339;H410:211;H340:339;H336:331;H304:339;H224:112;H411:120;H372:171;H319:155;H412:4
61021,But-2-yne,207-962-2,503-17-3,Flam. Liq. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H319:69;H315:68;H224:73;H335:67
61022,5-bromoindole,233-208-7,10075-50-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,58,H315:50;H319:50;H335:49;Not classified:8
61023,"N-(2,4-dimethoxyphenyl)acetamide",245-394-7,23042-75-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
61030,Octyl hexanoate,225-499-4,4887-30-3,Not Classified,Notified C&L,88,Not classified:88
61032,(E)-hept-3-enyl acetate,216-411-5,1576-77-8,Not Classified,Notified C&L,88,Not classified:88
61033,Bis(2-propylheptyl) phthalate,258-469-4,53306-54-0,Not Classified,REACH registration C&L,131,Not classified:131
61036,Acepromazine hydrogen maleate,222-748-9,3598-37-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:41;H302:42;H312:40;H315:1;H335:1;H319:1;H411:1;H318:1;H317:1
61041,Rubidium iodide,232-198-1,7790-29-6,Not Classified,Notified C&L,3,Not classified:3
61045,"Alpha,alpha-dibromotoluene",210-543-7,618-31-5,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,38,H331:38;H301:38;H311:38;H314:38
61046,Naphthalen-2-ethanol,216-061-3,1485-07-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
61051,"Sodium 2-[(2,6-dichloro-3-methylphenyl)amino]benzoate",228-983-3,6385-02-0,Acute Tox. 4,Notified C&L,2,H302:1;H332:1;H312:1
61053,"Fatty acids, C16-18 and C18-unsatd., iso-Bu esters",284-868-8,84988-79-4,Not Classified,REACH registration C&L,21,Not classified:20;H315:1;H319:1;H335:1
61054,"7α-chloro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate)",266-464-3,66734-13-2,Repr. 1B;STOT RE 2,Notified C&L,13,H373:11;H360:11;H315:2;H312:2;H301:1;H319:2;Not classified:1;H302:1;H335:1;H361:1;H332:1
61056,"2,2'-(octylimino)bisethanol",239-555-0,15520-05-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,127,H412:91;H315:127;H302:125;H318:127
61064,"pentasodium bis{}{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato}} chromate (III)",419-210-2,178452-71-6,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
61065,tris(isopropyl/tert-butylphenyl) phosphate,405-010-2,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
61070,Chromium oxide,234-361-2,11118-57-3,Pyr. Sol. 1,REACH registration C&L,6,H250:6
61071,Ethyl 3-chloro-3-oxopropionate,252-934-5,36239-09-5,Skin Corr. 1B,REACH registration C&L,52,H314:52;H318:3;H290:1
61073,"(2S,3R,4R,5R)-2,4-bis(acetyloxy)-5-methyloxolan-3-yl acetate",612-957-7,62211-93-2,Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:3;H335:2;H371:1
61079,Sodium nitrate,231-554-3,7631-99-4,Ox. Sol. 3;Eye Irrit. 2,REACH registration C&L,1710,H319:1449;H272:958;Not classified:62;H271:99;H302:303;H315:26;H335:26;H300:10;H373:1
61083,"1, 2-Benzisoxazole-3-methanesulfonamide",614-395-8,68291-97-4,Acute Tox. 4;Repr. 2,Notified C&L,96,H302:96;H361:56;H336:1;H332:2;H312:1;H370:1;H372:1
61088,"Methyl 2-[[[2,4(or 3,5)-dimethyl-3-cyclohexen-1-yl]methylene]amino]benzoate",272-124-5,68738-99-8,Not Classified,Notified C&L,1553,Not classified:1541;H317:12;H412:1;H315:1;H319:1
61092,"Methyl (16β,17α)-17-hydroxyyohimban-16-carboxylate",207-590-0,483-10-3,Acute Tox. 3,Notified C&L,1,H301:1
61093,2-fluorophenol,206-681-2,367-12-4,,Notified C&L,15,H226:14;H302:11;H312:11;H314:5;H319:5;H335:3;H315:5;H332:6;Not classified:1
61096,"N'-(ethylcarbonimidoyl)-N,N-dimethylpropane-1,3-diamine",217-579-2,1892-57-5,Skin Corr. 1B,Notified C&L,48,H314:48;H334:6;H317:6;H302:7;H335:2;H318:4
61097,"Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-(1-methylethyl)-, ethyl ester, (1R,2R,3R,4S)-rel-",639-062-4,116126-82-0,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,159,H411:159;H317:159
61100,Arecoline hydrobromide,206-087-3,300-08-3,Acute Tox. 3,Notified C&L,132,H301:129;H302:3;H331:2;H311:2
61101,Linalyl acetate,204-116-4,115-95-7,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,2337,H315:2025;H319:2023;H317:291;Not classified:288;H335:44;H411:26;H412:5
61104,"2,5-Pyrrolidinedione, 3-C18-24-alkenyl derivs.",295-099-2,91783-21-0,Not Classified,Notified C&L,32,Not classified:32
61107,(2S)-1-(tert-butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid,617-556-0,84348-37-8,Not Classified,REACH registration C&L,46,Not classified:2;H319:44;H302:44
61109,"Rubber, synthetic, acrylic",614-044-9,67254-76-6,Not Classified,Notified C&L,33,Not classified:33
61115,Hydrofluor Ether,605-340-9,163702-08-7,Not Classified,Notified C&L,151,Not classified:96;H332:51;H413:4
61116,"Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, salts with bentonite",273-219-4,68953-58-2,Not Classified,Notified C&L,3127,Not classified:3101;H319:20;H373:4;H335:2
61118,"Zanthoxylum piperitum, ext.",306-820-8,97404-53-0,Aquatic Chronic 2,Notified C&L,53,H411:53
61119,1-hydroxydecan-3-one,266-796-9,67633-95-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1168,H315:1158;H319:1168;H317:10;H314:10
61122,"2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:4)",604-452-5,145017-98-7,Not Classified,Notified C&L,13,Not classified:13
61124,Dirhodium trisulphite,279-381-2,80048-77-7,Acute Tox. 4;Skin Corr. 1A;Aquatic Chronic 3,Notified C&L,5,H412:5;H302:5;H314:5
61125,Benzoyl bromide,210-544-2,618-32-6,Skin Corr. 1B;STOT SE 3,Notified C&L,41,H335:39;H314:41;H318:2;H290:1
61128,"Alcohols, C12-13, branched and linear, ethoxylated, sulfates, sodium salts",500-513-4,161074-79-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,58,H412:48;H315:58;H318:58
61129,"Trimethylsilyl 2,2,2-trifluoro-N-(trimethylsilyl)acetimidate",247-103-9,25561-30-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,58,H225:37;H315:44;H319:44;H226:21;H335:8;H314:11;H302:3;H318:1
61130,Acepromazine,200-496-0,61-00-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H315:38;H317:38;H301:38;H311:38;H335:38;H331:38;H319:38
61132,"(S)-1-(4-Ethoxybenzyl)-3-azapentane-1,5-diaminedihydrochlorid",606-947-1,221640-21-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2;H318:2
61135,3-methyloct-1-en-3-ol,246-015-8,24089-00-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,233,H319:233;H315:233;H302:233
61136,Isopropyl S-(-)-lactate,264-417-1,63697-00-7,Flam. Liq. 3,Notified C&L,41,H226:41;H318:1
61138,"7-(4-bromobutoxy)-3,4-dihydro-2(1H)-quinolinone",603-356-0,129722-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 2;Repr. 2,Notified C&L,4,H341:2;H315:2;H335:2;H361:2;H351:2;H319:2;H413:1;Not classified:1
61144,"3-methoxy-O,α-dimethyl-L-tyrosine",254-711-8,39948-18-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
61145,Dioctyl hydrogen phosphate,221-485-7,3115-39-7,Skin Corr. 1B,Notified C&L,27,H314:26;Not classified:1
61152,Trisodium 12-molybdophosphate,215-206-8,1313-30-0,,Notified C&L,4,H315:4;H319:4;H335:4
61157,Tridecylbenzenesulphonic acid,247-036-5,25496-01-9,Skin Corr. 1B,Notified C&L,2,H314:2
61159,"2,5-DICHLORO-3-NITROPYRIDINE",606-762-6,21427-62-3,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H301:39;H315:43;H335:42;H318:39;H319:4;H302:3
61162,Methanthelinium bromide,200-176-0,53-46-3,,Notified C&L,1,H332:1;H302:1
61165,"Benzene, 1-iodo-2,4-dimethoxy-",606-562-9,20469-63-0,,Notified C&L,5,H315:5;H319:5;H335:1
61166,2-ethylhexyl 3-octyloxiran-2-octanoate,205-482-8,141-38-8,Not Classified,Notified C&L,89,Not classified:89
61169,"Glycerides, C16-18 and C18-unsatd. mono- and di-, citrates, potassium salts",293-178-6,91052-20-9,Not Classified,Notified C&L,6,Not classified:6
61170,9-ethyl-3-nitro-9H-carbazole,201-655-7,86-20-4,,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
61171,"3-[[4-[(2-chloro-4,6-dinitrophenyl)azo]naphthyl]amino]propane-1,2-diol",274-136-6,69828-87-1,Not Classified,Notified C&L,3,Not classified:3
61173,5-nitrosoquinolin-8-ol,222-650-6,3565-26-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H301:39;H315:39;H319:39;H335:39;H332:1;H242:1;H302:1;H312:1
61177,Oxygen difluoride,231-996-7,7783-41-7,Ox. Gas 1;Skin Corr. 1B;Acute Tox. 1,Notified C&L,22,H330:22;H270:22;H314:22
61179,"Poly(oxy-1,2-ethanediyl), α-(2-chloroethyl)-ω-(decyloxy)-",612-195-5,61702-77-0,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,30,H411:28;H302:29;H318:29;Not classified:1
61180,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(1-methylethoxy)propyl]amino]sulfonyl derivs.",279-767-0,81457-65-0,Not Classified,REACH registration C&L,162,Not classified:162
61185,"1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexane",206-391-6,335-56-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
61186,Fluorene-9-carboxylic acid,217-866-2,1989-33-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
61187,"2,4-dioxo-1,3-diazetidine-1,3-bis(hexamethylene) diisocyanate",245-699-5,23501-81-7,Not Classified,Notified C&L,176,Not classified:176
61189,"2-Propenoic acid, 2-methyl-, ammonium salt (1:1), homopolymer",608-549-3,30875-88-8,Not Classified,Notified C&L,46,Not classified:32;H315:14;H319:14
61190,Bis(2-hydroxypropyl) methylenesuccinate,237-518-3,13824-30-1,,Notified C&L,1,Not classified:1
61191,2-chloro-5-nitrobenzaldehyde,228-830-0,6361-21-3,,Notified C&L,6,H315:6;H319:6;H335:5
61192,Levamfetamine,205-850-8,156-34-3,Acute Tox. 3;Acute Tox. 3,REACH registration C&L,40,H301:40;H311:40
61200,"2-Propenoic acid, 4-[(chlorocarbonyl)oxy]butyl ester",606-061-5,185756-32-5,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,83,H318:83;H315:83;H317:83
61201,"Rosin, ext., potassium salt",293-652-2,91081-47-9,,Notified C&L,45,Not classified:45
61202,cis-vinylenebis[diphenylphosphine],213-569-7,983-80-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:43
61205,"α,α'-trimethylenedinitrilodi-o-cresol",204-418-6,120-70-7,Skin Sens. 1,Notified C&L,4,H317:3;H315:1;H319:1
61206,2-(benzylthio)aniline,228-690-0,6325-92-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
61207,"Prunus africana, ext.",304-841-7,94279-95-5,Not Classified,Notified C&L,1,Not classified:1
61208,"Hydrocarbons, C10-14, n-alkanes, isoalkanes, <2% aromatic",920-274-3,,Asp. Tox. 1,REACH registration C&L,3,H304:3
61214,"Dinitroviolanthrene-5,10-dione",249-215-3,28780-10-1,Not Classified,Notified C&L,1,Not classified:1
61217,2-ethylhexyl vinyl ether,203-111-4,103-44-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,122,H411:83;H315:83;H373:83;H302:122;H226:122;H319:83
61220,"Boric acid, compd. with 2-aminoethanol",270-367-1,68425-67-2,Not Classified,Notified C&L,489,Not classified:487;H315:2;H319:2
61223,4-bromobiphenyl,202-176-6,92-66-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,46,H315:45;H400:41;H302:44;H335:44;H318:42;H319:3;H332:2;H312:2;H314:1;Not classified:1;H410:2
61224,Bicyclo[2.2.1]heptane-2-carbaldehyde,243-025-4,19396-83-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H315:2;H302:2;H335:2
61225,"Tetrahydro-4,6,6-trimethyl-2H-pyran-2-one",243-927-8,20628-36-8,Acute Tox. 4,Notified C&L,10,H302:10
61226,2-butylisouronium chloride,263-538-7,62432-76-2,Not Classified,Notified C&L,1,Not classified:1
61227,"N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine",406-610-7,62478-82-4,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H314:0;H373:0;H412:0;H302:0;H226:0;H332:0
61229,3-hydroxy-4-[(4-methyl-2-sulphophenyl)azo]-2-naphthoic acid,240-152-7,16014-23-6,Muta. 2;Aquatic Chronic 3,Notified C&L,1,H341:1;H412:1
61231,Methyl 5-methyl-4-[(oxomethylene)sulfamoyl]thiophene-3-carboxylate,618-297-6,897671-34-0,Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;Aquatic Chronic 3,REACH registration C&L,37,H334:37;H412:36;H317:36;H331:37;H319:36
61233,"POLYOXYETHYLENE(4) C16-18 ALKYLETHER,MONO-DI-TRIPHOSPHATE",601-610-5,119415-05-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,69,H315:69;H318:38
61236,"Extracts (petroleum), light paraffinic distillate solvent",265-104-2,64742-05-8,Carc. 1B,Harmonised C&L,0,H350:0
61238,Sodium 5-[(2-hydroxynaphthyl)azo]naphthalenesulphonate,227-460-7,5850-93-1,Not Classified,Notified C&L,4,Not classified:4
61247,"N,N-di[2H3]methyl[2H]formamide",224-745-8,4472-41-7,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Repr. 1B,Notified C&L,50,H312:49;H226:48;H319:49;H332:48;H360:50;H331:1;Not classified:1;H341:1;H372:1;H370:1;H318:1;H371:1
61248,Thallium(III) trifluoroacetate,245-761-1,23586-53-0,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,44,H373:43;H300:44;H411:44;H330:44;H310:1
61249,Isonicotinaldehyde,212-832-3,872-85-5,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,51,H318:3;H315:48;H317:9;H319:46;H335:45;H332:3;H314:3;H226:1
61259,"(5-tert-butyl-4-neopentyl-3H-1,2-dithiol-3-ylidene]methylsulphonium chloride",272-284-6,68784-93-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
61264,"3-amino-1,2,4-triazole-5-thiol",240-735-6,16691-43-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,101,H319:101;H315:101;H302:58;H335:100;H312:1;H332:1
61266,"2,4,6-trimethyl-2,4,6-trivinylcyclotrisiloxane",223-458-5,3901-77-7,Aquatic Chronic 4,Notified C&L,27,H413:22;Not classified:5
61267,3-methoxysalicylic acid,212-888-9,877-22-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:43;H319:43;H335:42;Not classified:2
61269,N-(2-chloroethyl)benzamide,247-641-4,26385-07-9,,Notified C&L,4,H315:4;H319:4;H335:4
61270,2-Amino-6-bromophenol,608-169-8,28165-50-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:39;H302:39;H400:39;H315:1;H319:1;H335:1
61271,5-hydroxynaphthalene-1-sulphonic acid,204-199-7,117-59-9,,Notified C&L,34,Not classified:33;H319:1
61272,1-(4-methoxyphenyl)pentan-1-one,216-803-6,1671-76-7,Acute Tox. 4,Notified C&L,38,H302:38
61274,"Carbonic acid, cerium(3+) salt (3:2), pentadecahydrate",611-694-5,5853-16-7,Not Classified,Notified C&L,3,Not classified:3
61276,2-Iodobenzamide,609-642-1,3930-83-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H302:1;H335:1
61280,Heptyl isobutyrate,219-076-3,2349-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:38;H319:38;H335:38;Not classified:1
61284,"Sulfuric acid, mono-C8-16-alkyl esters, sodium salts",292-226-3,90583-27-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,37,H315:36;H319:28;H318:8;Not classified:1
61285,"Fatty acids, C16-18 (even numbered) and C18-unsatd., adipic acid esters with pentaerythritol",921-836-0,,Not Classified,REACH registration C&L,1,Not classified:1
61287,Methyl (R)-aminophenylacetate,246-273-1,24461-61-8,Not Classified,REACH registration C&L,1,Not classified:1
61288,Triphenylmethanol,200-988-5,76-84-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,REACH registration C&L,112,H315:55;H319:13;H335:11;Not classified:56;H302:1
61289,"Carboxylic acids, C5-9",271-676-4,68603-84-9,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,16,H318:10;H412:10;H314:16;H317:2;H335:2
61291,"3,5,5-trimethylhexanal",226-603-0,5435-64-3,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,1730,H317:1523;H412:84;H226:1730;H315:1729;H411:1;H319:1
61298,Diethyl methylmalonate,210-175-7,609-08-5,Not Classified,REACH registration C&L,6,Not classified:6
61299,"3,5-dihydroxybenzaldehyde",247-479-4,26153-38-8,,Notified C&L,4,H315:4;H319:4;H335:4
61303,"3,3'-thiodipropan-1-ol",234-202-7,10595-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
61304,Calcium bis[3-nitro-4-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]benzenesulphonate],235-557-0,12286-65-6,Not Classified,REACH registration C&L,111,Not classified:111
61309,"N-cyclohexyl-N-nitrosohydroxylamine, potassium salt",248-617-6,27697-50-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,466,H301:441;H315:466;H319:466;H302:25
61311,Isobutyl 2-methylcrotonate,262-908-5,61692-84-0,Not Classified,Notified C&L,89,Not classified:89
61313,Olive oil,617-519-9,84012-27-1,Not Classified,Notified C&L,26,Not classified:26
61314,"pyrazophos (ISO);O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate",236-656-1,13457-18-6,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H332:0;H410:0;H302:0;H400:0
61318,Cyclooctanemethanol,222-862-9,3637-63-6,,Notified C&L,5,H315:5;H319:5;H335:5
61323,"7,8-dihydroxy-4-methyl-2-benzopyrone",218-290-4,2107-77-9,Eye Irrit. 2;Resp. Sens. 1,Notified C&L,39,H334:38;H319:39;H315:1
61324,"Methyl 3,3-dimethoxy-2-oxa-7,10-diaza-3-silatridecan-13-oate",213-937-7,1067-66-9,Not Classified,Notified C&L,26,Not classified:26
61325,Sodium m-[[[4-(benzothiazol-2-ylazo)-m-tolyl]ethylamino]methyl]benzenesulphonate,277-150-0,72968-74-2,Aquatic Chronic 2,Notified C&L,9,H411:9
61326,Copper(II) isooctanoate,282-034-8,84082-87-1,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1;H400:1
61327,4-(dimethylamino)-3-methylbutan-2-one,244-782-3,22104-62-7,,Notified C&L,3,H226:3;H302:2;H312:2;H314:2;H411:2;H335:2
61330,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl)",500-028-8,9048-57-1,Not Classified,Notified C&L,411,Not classified:233;H334:177;H315:159;H317:178;H302:96;H335:159;H319:160;H373:63;H332:46;H351:56
61331,Trisodium tetraoxovanadate,237-287-9,13721-39-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,55,H332:54;H302:54;H312:50;H315:4;H335:4;H319:4;Not classified:1
61335,N-(5-chloro-2-methylphenyl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]naphthalene-2-carboxamide,269-389-4,68227-78-1,Not Classified,Notified C&L,57,Not classified:55;H341:1;H351:1;H312:1;H412:1;H317:1
61337,"fosthiazate (ISO);(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate",619-377-3,98886-44-3,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H400:0;H317:0;H301:0;H331:0;H410:0
61344,"9,19-dichloro-5,15-diethyl-5,15-dihydrocarbazolo[3',4':5,6][1,4]oxazino[2,3-b]indolo[3,2-h]phenoxazine",606-790-9,215247-95-3,Not Classified,REACH registration C&L,171,Not classified:171
61345,"Sodium 1,4-diisodecyl sulphonatosuccinate",249-894-6,29857-13-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,197,H315:196;H400:165;H318:175;H319:21;H411:7;H302:1;H312:1
61346,"1-chloro-1,1,2-trifluoro-2-iodoethane",206-553-6,354-26-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:2
61347,"Resin acids and Rosin acids, hydrogenated, potassium salts",273-572-4,68990-01-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,11,H319:11;H317:11
61348,Triangulo-dodecacarbonyltriosmium,239-789-3,15696-40-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H315:39;H302:39;H335:39;H301:4;H330:4
61357,Dimethylbis(oleoyloxy)stannane,223-384-3,3865-34-7,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1A;Acute Tox. 2;Repr. 2;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,9,H330:4;H317:4;H412:4;H301:4;H311:4;H372:9;H361:9;H413:5
61358,Didysprosium trioxalate,212-763-9,867-62-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H312:1
61361,Piperidine-2-methylamine,245-371-1,22990-77-8,Acute Tox. 4;Skin Corr. 1A,REACH registration C&L,63,H302:6;H314:63;H318:39;H319:1
61365,"Dodecylbenzenesulphonic acid, compound with 2-(dimethylamino)-2-methylpropan-1-ol (1:1)",272-408-9,68833-66-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:39;H302:39;H335:39;H314:39;Not classified:1
61368,"4-[[3-(acetylamino)phenyl]amino]-1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",266-465-9,66736-54-7,Not Classified,Notified C&L,6,Not classified:6
61374,"Oils, vanilla",617-022-7,8024-06-4,Not Classified,Notified C&L,144,Not classified:102;H317:38;H335:2;H302:1;H315:1;H319:2
61375,"Quaternary ammonium compounds, benzyldimethylsoya alkyl, chlorides",263-083-4,61789-74-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,18,H315:18;H302:18;H318:18
61376,Isononylcyclohexan-1-ol,285-405-2,85085-86-5,Not Classified,Notified C&L,2,Not classified:2
61382,4-bromo-3-nitrobiphenyl,248-618-1,27701-66-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
61383,Mannitol,201-770-2,87-78-5,Not Classified,Notified C&L,31,Not classified:31
61386,Diammonium tetrahydrogen [nitrilotris(methylene)]trisphosphonate,224-869-2,4532-21-2,Not Classified,Notified C&L,1,Not classified:1
61387,"Fuels, diesel, No 2;Gasoil - unspecified;[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 °C (100 °F).]",270-676-1,68476-34-6,Carc. 2,Harmonised C&L,0,H351:0
61389,Ethyl 2-Iodobenzoate,605-985-6,1829-28-3,,Notified C&L,8,H315:6;H319:6;H335:1;H332:1;H302:1;H312:1;Not classified:1
61392,"Cymbopogon winterianus, ext.",294-954-7,91771-61-8,Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,272,H411:270;H317:272;H302:71;H318:272;H304:103;H315:201;H412:1
61394,"4'-methyl[1,1'-biphenyl]-4-carbonitrile",256-701-9,50670-50-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H315:1;H312:1;H302:1;H319:1;H332:1
61398,"4α,5-epoxy-5α-androst-2-eno[2,3-d]isoxazol-17β-ol",243-485-6,20051-76-7,Skin Irrit. 2;Eye Irrit. 2;Repr. 2,Notified C&L,1,H315:1;H319:1;H361:1
61400,Trichlorotrimethyldialuminium,235-698-8,12542-85-7,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,REACH registration C&L,2,H250:2;H260:2;H314:2
61402,"Benzo-1,3-dioxole-4-carboxaldehyde",232-252-4,7797-83-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3;H335:1
61404,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-[4-[[[4-[2-(2,4-diaminophenyl)diazenyl]phenyl]amino]sulfonyl]phenyl]diazenyl]-5-hydroxy-3-[2-(4-nitrophenyl)diazenyl]-, potassium salt (1:2)",619-444-7,99576-15-5,Not Classified,Notified C&L,4,Not classified:3;H319:1
61405,Tetrafluorosuccinic acid,206-820-7,377-38-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:39;H319:39;H335:38;H314:6
61408,"N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide",202-543-0,96-88-8,Acute Tox. 3,Notified C&L,1,H301:1
61410,"12-Hydroxystearic acid, oligomers, reaction products with stearic acid",500-140-7,58128-22-6,Skin Irrit. 2,Notified C&L,584,H315:544;Not classified:40;H319:32
61411,"1,2-difluoro-3-nitrobenzene",230-035-9,6921-22-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:2
61412,Tetramethylammonium hydrogen sulfate monohydrate,600-490-1,103812-00-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
61414,2-(4-aminopiperazin-1-yl)ethanol,223-603-2,3973-70-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
61417,"β-D-glucose pentakis[3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoate]",226-562-9,5424-20-4,Not Classified,Notified C&L,6,Not classified:6
61422,Benactyzine hydrochloride,200-324-4,57-37-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H331:38;H301:39;H311:38
61423,"Tris(ethyl acetoacetato-O1',O3)aluminium",239-343-8,15306-17-9,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,11,H319:8;H317:8;Not classified:3
61427,"L-Proline, 5-oxo-, manganese salt",608-327-6,29193-02-0,Not Classified,Notified C&L,1,Not classified:1
61430,"2,3-dihydro-1,4-benzodioxin-5-carboxylic acid",224-670-0,4442-53-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39;H312:1;H302:1;H332:1
61440,"Propane, 1,1,1,2,3,3-hexafluoro-3-methoxy-",609-536-5,382-34-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H225:1;H315:1;H319:1
61442,Dihydrogen [2-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),277-214-8,73003-98-2,Aquatic Chronic 2,Notified C&L,3,H411:3
61444,Aluminium tribenzoate,209-091-3,555-32-8,Not Classified,REACH registration C&L,162,Not classified:79;H319:83
61445,"2,4-dimethylpentan-3-ol",209-993-7,600-36-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H315:39;H302:38;H335:38;H226:46;H318:38;H319:1
61452,"reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%);2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%);2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%);2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%);2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%);2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%);2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20%)",442-800-6,,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
61464,3-(4-methoxyphenyl)-2-phenylpropionic acid,224-332-2,4314-68-5,,Notified C&L,4,H315:4;H319:4;H335:4
61466,"Hydrochloric acid, reaction products with calcined bastnaesite lanthanum oxide fraction",283-228-5,84583-76-6,Met. Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H318:1;H290:1;H317:1
61467,"2,3-dihydro-N-methyl-2-oxobenzoxazole-5-sulphonamide",269-312-4,68214-73-3,Not Classified,Notified C&L,2039,Not classified:2039
61468,"2-Propenenitrile, homopolymer, oxidized",614-761-7,68908-35-0,Not Classified,Notified C&L,1,Not classified:1
61470,"Phosphoric acid, 2-ethylhexyl ester, compd. with 2-aminoethanol",270-368-7,68425-72-9,Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,45,H332:20;H318:28;H335:20;H314:20;Not classified:15;H315:10;H319:2
61472,"[3R-(3α,3aβ,6α,7β,8aα)]-octahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-6-ol",201-035-6,77-53-2,Aquatic Chronic 2,REACH registration C&L,1814,H411:1811;Not classified:2;H315:1;H319:1
61476,cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline,416-040-0,120807-02-5,Aquatic Chronic 3,Harmonised C&L,0,H412:0
61479,3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonyl chloride,273-987-0,69399-79-7,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,9,H318:3;H314:8;H311:1;H317:1
61482,4'-(tert-butyl)propiophenone,275-265-0,71209-71-7,Flam. Liq. 3,Notified C&L,1,H226:1
61488,"p-[(4-amino-2,5-xylyl)azo]benzenesulphonic acid",258-468-9,53305-44-5,Not Classified,REACH registration C&L,2,Not classified:2
61489,1-(chloroacetyl)pyrrolidine,243-658-6,20266-00-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:2;H335:2;H302:1;H318:1
61491,1-benzyl-4-piperidone oxime,213-443-1,949-69-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
61493,Octacosan-1-ol,209-181-2,557-61-9,Not Classified,Notified C&L,5,Not classified:4;H315:1;H319:1;H335:1
61495,Cyflufenamid,605-896-2,180409-60-3,Aquatic Chronic 2,Notified C&L,212,H411:173;H332:55;H410:39;H400:39
61497,"Disodium (1R,2S)-(1,2-epoxypropyl)phosphonate",247-409-2,26016-99-9,Not Classified,Notified C&L,5,Not classified:3;H334:1;H302:1;H317:1;H362:1
61500,"1-Ethoxy-2,3-difluor-4-[4-(trans-4-butylcyclohexyl)-1-cyclohexen-1-yl]-benzene",923-035-1,,Not Classified,REACH registration C&L,2,Not classified:2
61503,5-bromoisophthalic acid,245-602-6,23351-91-9,Acute Tox. 3,Notified C&L,45,H301:39;H315:6;H319:6;H335:5
61512,valinamide,402-840-7,20108-78-5,Eye Irrit. 2;Skin Sens. 1;Repr. 2,Harmonised C&L,0,H319:0;H361:0;H317:0
61518,Diisopropylcarbamoyl chloride,242-743-5,19009-39-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,40,H318:40;H314:40;H290:1
61520,"Phthalic acid, compound with aniline (1:1)",256-856-2,50930-79-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
61521,Trizinc diarsenide,234-486-2,12006-40-5,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,234,H301:234;H331:234;H410:234;H400:230;H350:22;H373:4
61522,p-nitrocinnamic acid,210-617-9,619-89-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
61523,BLEU REACTIF VOH 72,410-300-7,,Not Classified,Notified C&L,1,Not classified:1
61524,Sodium N-dodecyl-N-methylglycinate,231-553-8,7631-98-3,Eye Irrit. 2,Notified C&L,1,H319:1
61527,2-Bromo-4-methoxyphenol,605-671-9,17332-11-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H315:3;H319:3;H335:1
61528,Perfluoroheptane,206-392-1,335-57-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
61529,"Benzene, 1-bromo-4-iodo-2-methoxy-",616-227-9,755027-18-0,,Notified C&L,1,H315:1;H319:1;H335:1
61530,4-hydroxy-1-(hydroxymethyl)-5-methoxy-3-(methoxymethyl)imidazolidin-2-one,242-081-7,18190-79-9,Not Classified,Notified C&L,1,Not classified:1
61531,3-aminobenzophenone,220-614-4,2835-78-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,44,H315:44;H319:44;H335:5
61532,"Plankton, marine, ext.",293-445-7,91079-57-1,Not Classified,Notified C&L,37,Not classified:37
61533,"1,1'-Biphenyl, mixt. with 1,1'-oxybis[benzene]",616-827-0,8004-13-5,,Notified C&L,4,H315:4;H400:4;H335:4;H410:4;H319:4
61535,"Cyclohexanol, 4-propyl-, trans-",616-534-8,77866-58-1,Not Classified,Notified C&L,1,Not classified:1
61538,Dihydrocodeine,204-732-3,125-28-0,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1,REACH registration C&L,41,H334:41;H317:41;H301:41;H311:41;H331:41;H361:1
61539,Epoxypropionic acid,207-961-7,503-11-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
61540,"1,4-dimethoxynaphthalene",233-209-2,10075-62-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
61541,Dichloromethoxymethane,225-498-9,4885-02-3,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;STOT SE 3,Notified C&L,209,H314:207;H302:206;H335:160;H225:204;H332:205;H312:6;H350:6;H318:7;H315:2;H301:2;H311:2;H331:2;H226:5;H319:2;H351:2;Not classified:2
61543,"(E)-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O-methyloxime",456-110-8,,Not Classified,REACH registration C&L,2,Not classified:2
61544,N-[3-(dimethylamino)propyl]myristamide N-oxide,267-191-2,67806-10-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2,Notified C&L,3,H373:2;H315:2;H302:2;H318:3;H411:1;H410:1;H400:1
61545,"Butanoic acid, 2-amino-4-(ethylseleno)-, (+-)-",607-809-3,2578-27-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H400:38;H373:38;H301:38;H311:38;H335:38;H331:38;H410:38;H319:38
61548,"O-butyl hydrogen dithiocarbonate , sodium salt",205-481-2,141-33-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
61550,Bromomethylcyclopropane,230-331-8,7051-34-5,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,REACH registration C&L,74,H315:20;H302:24;H335:19;H226:73;H319:19;Not classified:1;H312:2;H332:2;H411:1
61551,"4-Penten-1-one, 1-phenyl-",608-738-0,3240-29-7,Not Classified,Notified C&L,1,Not classified:1
61558,4-(3-chloropropyl)morpholinium chloride,260-851-0,57616-74-7,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,51,H301:48;H317:48;H312:48;H314:48;H315:2;H319:2;H335:2;H302:1;H334:1;H318:1
61559,5-iodo-o-toluidine,281-094-2,83863-33-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,43,H315:43;H317:38;H301:39;H335:42;H318:38;H312:4;H302:4;H319:5;H332:4
61564,Disodium hydrogen bis[3-hydroxy-4-[(2-hydroxyphenyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(3-),310-117-1,102506-12-7,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H319:2;H317:2
61566,Sodium periodate,232-197-6,7790-28-5,Ox. Sol. 1;Skin Corr. 1C;Eye Dam. 1;STOT RE 1;STOT RE 1;Aquatic Acute 1,REACH registration C&L,351,H400:194;H314:194;H372:193;H318:154;H271:205;H335:237;H315:147;H302:90;H319:148;H272:145;H301:56;H312:20;H332:19;H311:10;H331:10;Not classified:1;H373:1
61571,"1,2,5,8-tetrahydroxyanthraquinone",201-366-6,81-61-8,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H302:38;H400:38
61572,"Sodium (±)-2,3-dihydroxypropanesulphonate",252-542-4,35396-47-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
61582,Cesium bicarbonate,239-554-5,15519-28-5,Eye Dam. 1;Repr. 2,REACH registration C&L,27,H361:2;H318:1;H319:26
61588,"Reaction products of hexane-1,6-diol with 2-(chloromethyl)oxirane (1:2)",618-939-5,933999-84-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,194,H412:194;H315:194;H319:194;H317:194
61592,2-pentylcyclopent-2-en-1-one,247-104-4,25564-22-1,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,115,H320:1;H316:1;H317:115
61595,3-chloro-4-fluoroaniline,206-682-8,367-21-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,79,H331:44;H301:44;H311:48;H373:48;H302:35;H318:30;H315:5;H319:5;H332:4
61596,"α,α,α,4-tetrafluorotoluene",206-944-1,402-44-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H225:46;H315:46;H319:46;H335:45
61598,"Betaines, C14-18-alkyldimethyl",308-641-0,98171-34-7,Not Classified,Notified C&L,1,Not classified:1
61599,3-chloropentane,210-467-4,616-20-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H225:0;H332:0;H302:0;H312:0
61600,2-(4-chlorophenoxy)ethanol,217-578-7,1892-43-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H315:43;H302:38;H335:42;H318:43;H312:4;H311:1
61603,"(E)-1,1-dimethoxyhex-2-ene",242-204-4,18318-83-7,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1,Notified C&L,233,H226:233;H302:233;H317:233
61606,"6-bromo-5-methyl-1H-imidazo[4,5-b]pyridine",248-936-0,28279-41-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
61607,bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate,406-770-8,149057-64-7,Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H373:0;H400:0;H410:0;H318:0
61610,Cyclohexylammonium chloride,225-661-4,4998-76-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:32;H315:45;H302:46;H335:44;H318:14;H361:4;H311:1;H314:1
61611,"Ocimum basilicum, ext.",283-900-8,84775-71-3,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1651,H315:1376;H317:1648;H412:148;H319:1366;H304:8;H341:1576;H411:1291;H351:1577;H302:273;H318:2;H332:1;H312:1;H316:1;H226:1;H334:1;H335:1;H227:1;Not classified:1
61612,4-hydroxyphenyl-alpha-D-glucopyranoside,440-470-8,84380-01-8,Acute Tox. 4,Notified C&L,4,H302:4
61615,"Fatty acids, C12-16",306-791-1,97404-27-8,Eye Irrit. 2,Notified C&L,2,H319:1;Not classified:1
61618,"3,5-dimethylbenzonitrile",245-001-9,22445-42-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
61623,Silver tert-dodecanethiolate,256-108-5,43126-83-6,Flam. Sol. 1,Notified C&L,1,H228:1
61627,"4,6-diphenylthieno[3,4-d]-1,3-dioxol-2-one 5,5-dioxide",259-301-2,54714-11-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
61628,"Gas oils (petroleum), vacuum, hydrocracked, hydroisomerized, hydrogenated, C10-25, branched and cyclic",610-193-9,445411-73-4,Asp. Tox. 1,Notified C&L,80,H304:80
61637,Chromium boride,234-487-8,12006-79-0,Not Classified,Notified C&L,3,Not classified:3
61638,"5-(diethoxymethyl)-3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene",266-793-2,67633-92-5,Not Classified,Notified C&L,88,Not classified:88
61640,(S)-3-Methyl-1-(2-piperidine-1-phenyl)butylamine compound with N-Acetyl-L-glutamic acid,606-883-4,219921-94-5,Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,2,H301:1;H411:1;H302:2;H318:1
61643,"Extracts (petroleum), middle distillate solvent",265-105-8,64742-06-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Notified C&L,199,H350:83;H340:83;H304:193;H302:63;Not classified:5
61647,"1-Hexanol, 3,5,5-trimethyl-, ethoxylated, propoxylated",606-555-0,204336-40-3,Aquatic Chronic 3,Notified C&L,179,H412:174;Not classified:5
61651,3-Methyl-2-buten-1-thiol,610-907-9,5287-45-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,156,H226:156;H319:117;H335:117;H315:117;H302:40;H312:2;H332:2
61655,Ethylene di(acetate),203-881-1,111-55-7,Not Classified,REACH registration C&L,336,Not classified:215;H319:120;H315:58;H335:42;H373:16;H302:1
61656,"2-(3,4-dimethoxyphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine",279-382-8,80050-87-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:2;H400:2
61657,2-chloro-6-nitrobenzaldehyde,228-831-6,6361-22-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
61658,"Hydrocarbons, C10-C13, n-alkanes, isoalkanes, cyclics, < 2% aromatics",918-481-9,,Asp. Tox. 1,REACH registration C&L,530,H304:530;H226:441
61662,"1,3-dimethyl-1,3-bis(trimethylsilyl)urea",414-180-7,10218-17-4,Acute Tox. 4;Skin Irrit. 2,Harmonised C&L,0,H315:0;H302:0
61664,"(3R,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diyl bis(4-hydroxybenzoate)",606-059-4,185756-31-4,Not Classified,REACH registration C&L,85,Not classified:85
61667,"Phosphoric acid, decyl ester, potassium salt",281-954-7,84070-00-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:1;H318:1
61671,Chloramphenicol sodium succinate,213-568-1,982-57-0,Carc. 2,Notified C&L,40,H351:38;H319:1;H312:1;H350:1
61672,"2,4-dichlorophenol",204-429-6,120-83-2,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H411:0;H302:0;H314:0
61674,Trizinc dinitride,215-207-3,1313-49-1,,Notified C&L,4,H315:4;H319:4
61675,"4,4a,5,9b-tetrahydroindeno[1,2-d]-1,3-dioxin",241-997-4,18096-62-3,Repr. 2,REACH registration C&L,1556,H361:14;Not classified:1542
61677,"[1R-(1α,2β,5α)]-1-(isopropyl)-2-methoxy-4-methylcyclohexane",216-365-6,1565-76-0,Aquatic Chronic 2,REACH registration C&L,91,H411:13;H315:78;H319:78;H317:78;H302:1
61678,1-(bromomethyl)-4-(trifluoromethyl)benzene,206-947-8,402-49-3,Skin Corr. 1B,Notified C&L,48,H314:48;H319:2;H335:2;H318:2;H290:1;H332:1;H302:1
61683,Reaction product of 4-aminophenol with 2-ethyl-6-methylbenzenamine and sodium polysulfide,600-519-8,1040873-93-5,Not Classified,REACH registration C&L,1,Not classified:1
61684,"Slack wax (petroleum), clay-treated;[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C",292-660-3,90669-78-6,Carc. 1B,Harmonised C&L,0,H350:0
61686,Dihexadecyl hydrogen phosphate,218-594-7,2197-63-9,Not Classified,Notified C&L,70,Not classified:36;H315:34;H318:34
61688,Diethyl 2-cyclopenten-1-ylmalonate,258-661-8,53608-93-8,Eye Irrit. 2,Notified C&L,38,H319:38
61689,"(lactato-O1,O2)silver",239-859-3,15768-18-0,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,1,H410:1;H315:1;H302:1;H400:1
61691,(2S)-2-(3-benzoylphenyl)propanoic acid,606-944-5,22161-81-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,REACH registration C&L,42,H315:41;H301:41;H311:3;H335:41;H331:3;H319:41;H400:38;Not classified:1
61693,p-phenylbenzyl alcohol,222-745-2,3597-91-9,Repr. 2,Notified C&L,1,H361:1
61694,Dihydrogen [orthoborato(3-)-O]phenylmercurate(2-),203-068-1,102-98-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H310:39;H330:39;H400:38;H373:39;H410:38;H300:39;Not classified:3;H362:1
61696,Dodecyl chloroformate,246-272-6,24460-74-0,Skin Corr. 1B,Notified C&L,91,H314:91;H318:39;H310:1;H330:1;H300:1;H290:1
61700,(S)-2-((R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide,801-184-2,357336-20-0,Acute Tox. 4,Notified C&L,2,H302:2
61702,16F,605-583-0,17068-78-9,,Notified C&L,23,Not classified:23
61703,"Cyclohexanecarboxamide, 1-(2-ethylbutyl)-N-(2-mercaptophenyl)-",606-714-4,211513-21-2,Aquatic Chronic 2,Notified C&L,1,H411:1
61705,"O-6-deoxy-α-L-mannopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl (2α,3β,4α,6β)-2,3,6,23-tetrahydroxyurs-12-en-28-oate",252-076-1,34540-22-2,Not Classified,Notified C&L,4,Not classified:4
61709,N-[2-(diethylamino)ethyl]acrylamide,234-203-2,10595-45-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
61713,3-methylcyclohex-2-en-1-one,214-769-7,1193-18-6,Not Classified,Notified C&L,279,Not classified:235;H302:44;H319:1;H332:1;H312:1
61715,2-[tert-butyl(phenylmethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl] hydrochloride,246-014-2,24085-08-3,Skin Sens. 1A;Aquatic Chronic 3,REACH registration C&L,5,H412:4;H317:4;H301:1;H360:1;H334:1;H302:1
61716,1-chloro-8-nitronaphthalene,210-015-6,602-37-9,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,38,H412:38;H318:38
61717,p-phenylbenzonitrile,220-860-2,2920-38-9,Aquatic Chronic 2,REACH registration C&L,130,H411:85;H332:45;H302:44;H312:45;H315:2;H301:1;H319:2;H335:1
61719,"Phosphorodithioic acid, mixed O,O-bis(2-ethylhexyl and iso-Pr) esters",272-722-6,68909-92-2,Skin Corr. 1C;Eye Dam. 1,Notified C&L,442,H318:441;H314:442;H225:1
61723,α-butylcinnamaldehyde,231-320-0,7492-44-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1565,H315:1565;H319:1565;H317:65
61724,"Fatty acids, C16-18, compds. with triethanolamine",288-308-3,85711-48-4,Not Classified,Notified C&L,128,Not classified:128
61726,"Distillates (coal tar), naphthalene oils, acid exts.;Methylnaphthalene Oil Extract Residue;[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230°C to 255°C (446°F to 491°F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]",295-309-2,91995-48-1,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
61727,"1,1'-(isopropylidene)bis[3,5-dibromo-4-(2,3-dibromopropoxy)benzene]",244-617-5,21850-44-2,Not Classified,REACH registration C&L,47,Not classified:47
61728,Dialuminium tritungsten dodecaoxide,239-184-4,15123-82-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,8,H319:8;H302:8;H315:1;H335:1
61733,"Coconut oil, stearins",296-892-6,93165-08-3,Not Classified,Notified C&L,1,Not classified:1
61738,"1-hexadecyl hydrogen 2-sulphosuccinate, compound with 2-aminoethanol (1:2)",300-085-7,93920-01-5,Not Classified,Notified C&L,1,Not classified:1
61743,4-chloro-3-fluoroaniline,206-683-3,367-22-6,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,51,H315:48;H311:49;H302:49;H335:43;H331:45;H319:48;H373:5;H332:6;H412:3;H318:3;H312:2;H301:2
61744,Zinc bis[O-(6-methylheptyl)] bis[O-(sec-butyl)] bis(dithiophosphate),298-577-9,93819-94-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,491,H411:491;H315:491;H318:491
61745,"α,2,2-trimethyl-6-methylenecyclohexanepropanol",237-284-2,13720-13-3,Not Classified,Notified C&L,88,Not classified:88
61746,"2,6-dimethylpyridin-4-ol",237-089-2,13603-44-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3;H312:1;H302:1;H335:2;H332:1
61748,4-acetilammino-N-((1-etil-2pirrolidinil)metil) -5 etilsulfonil-2-metossi benzamide,925-003-2,,Not Classified,REACH registration C&L,2,Not classified:2
61749,Polihexanide,640-037-5,133029-32-0,,Notified C&L,2,H351:1;H400:1;H302:1
61751,"7,16-dichloro-6,15-dihydroanthrazine-5,9,14,18-tetrone",204-980-2,130-20-1,Not Classified,REACH registration C&L,31,Not classified:31
61754,"Sulfuric acid, mono-C8-18-alkyl esters, magnesium salts, compds. with triethanolamine",287-840-3,85586-38-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,128,H412:105;H315:128;H302:105;H318:105;H319:23
61756,"SULFUROUS ACID, SODIUM SALT (1:1), POLYMER WITH FORMALDEHYDE AND 1,3,5-TRIAZINE-2,4,6-TRIAMINE",613-691-4,64787-97-9,,Notified C&L,38,Not classified:35;H317:3
61757,m-pentylphenol,243-487-7,20056-66-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1;H314:1
61759,C.I. Reactive Red 223,618-906-5,93051-43-5,Not Classified,Notified C&L,2,Not classified:2
61763,"sodium 3,4-dihydroxy-2,6,6-trimethylcyclohex-2-en-1-one",925-045-1,,Not Classified,REACH registration C&L,1,Not classified:1
61764,"1,4:3,6-dianhydro-D-glucitol 2-nitrate",240-271-4,16106-20-0,Self-react. E;Acute Tox. 4,Notified C&L,5,H242:3;H302:4;Not classified:1
61765,"Oils, walnut",617-023-2,8024-09-7,Flam. Liq. 3,Notified C&L,88,H226:87;Not classified:1
61767,"L-threonine, fermentation products byproduct",923-725-2,,Not Classified,Notified C&L,1,Not classified:1
61770,"Benzene, mono-C10-14-alkyl derivs.",270-486-9,68442-69-3,Not Classified,Notified C&L,51,Not classified:45;H315:6;H400:6;H304:6
61773,Dimercury sulphate,231-993-0,7783-36-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H310:39;H330:39;H400:39;H373:39;H410:39;H300:39
61777,Amikacin,253-538-5,37517-28-5,Skin Sens. 1;Eye Dam. 1;STOT RE 1,REACH registration C&L,3,H318:1;H372:1;H317:2;H332:1;H360:1
61778,"Alcohols, tallow",308-980-4,99561-04-3,Not Classified,Notified C&L,1,Not classified:1
61782,"2-[2-[(4-methoxyphenyl)amino]vinyl]-1,3,3-trimethyl-3H-indolium chloride",601-885-1,12217-50-4,Aquatic Chronic 3,Notified C&L,8,H412:8
61790,1-(bromomethyl)-3-phenoxybenzene,257-327-9,51632-16-7,,Notified C&L,1,H331:1;H301:1;H311:1;H314:1
61791,"2-ethylhexanoic acid, nickel salt",231-480-1,7580-31-6,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H341:0;H400:0;H317:0;H372:0;H350:0;H410:0;H360:0
61793,C.I. Pigment Blue 29,611-533-9,57455-37-5,Not Classified,Notified C&L,330,Not classified:330
61794,Cyclopentanemethanol,222-861-3,3637-61-4,,Notified C&L,6,H315:6;H319:6;H335:6;H227:1
61797,1-(4-dodecylphenyl)-2-hydroxy-2-methylpropan-1-one,274-071-3,69673-80-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,21,H315:13;H319:13;Not classified:8
61798,2-anilino-5-bromoterephthalic acid,275-140-0,71033-00-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H400:38;H302:38;H335:38;H410:38;H319:38
61800,"2,6-dimethyl-4-morpholinepropiononitrile",282-302-4,84145-73-3,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38,H301:38;H319:38
61804,"2,6-di-tert-butylpyridine",209-557-6,585-48-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:40;H302:1
61807,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with methyl 2-propenoate",618-476-9,9011-87-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,135,H315:96;H319:96;H335:96;H334:39;H372:39;H361:39;H317:39
61808,Hept-1-en-3-ol,225-579-9,4938-52-7,Flam. Liq. 3,Notified C&L,1416,H226:1416;H319:38;H335:38;H315:38
61813,Metformin hydrochloride,214-230-6,1115-70-4,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,259,H319:163;H302:258;H315:160;H412:41;H335:31;H361:3;H371:2;H362:3;H312:6;H332:3;H413:1;H372:1
61814,"bis(2,4-dicumylphenyl) neopentyl diphosphite;3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane",421-920-2,154862-43-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
61815,"(2,4-diaminopteridin-6-yl)methanol hydrobromide",430-620-0,76145-91-0,Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H373:0;H412:0;H317:0
61816,"3,5-dithia-4-thioxo-1,7-heptanedioic acid",228-693-7,6326-83-6,,Notified C&L,5,H315:5;H319:5;H335:4
61819,5-chloro-1-methyl-1H-imidazolium nitrate,224-868-7,4531-53-7,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2;H318:2
61820,6-nitro-o-toluidine,209-329-6,570-24-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,45,H411:44;H373:44;H301:45;H311:45;H331:41;H330:4;H315:1;H412:1;H319:1
61821,"2,3,5,6-tetrachloro-p-xylene",212-887-3,877-10-1,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
61823,2-(4-((2-Aminoethyl)amino)-3-nitrophenoxy)ethanol,416-410-1,85765-48-6,Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H317:1
61824,Aquafil,601-216-3,112945-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2456,H315:1404;H319:1406;H335:1406;Not classified:832;H350:184;H373:34;H302:3;H332:2
61829,"1-Methylethyl 3,4-diethoxyphenylcarbamate",617-968-0,87130-20-9,Eye Irrit. 2,Notified C&L,38,H319:38
61832,"2,4,4'-trichlorobiphenyl",230-293-2,7012-37-5,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,53,H373:53;H410:50;H400:50;H332:3;H302:3;H312:3
61834,Cellulose 2-hydroxyethyl 2-[2-hydroxy-3-,617-262-2,81859-24-7,Aquatic Chronic 2,Notified C&L,429,H411:429
61836,"Glycerides, tallow mono-, hydrogenated, citrates, sodium salts",273-575-0,68990-05-6,Not Classified,Notified C&L,22,Not classified:22
61837,Dichlorofluoromethane,200-869-8,75-43-4,Press. Gas (Liq.),Notified C&L,113,H280:112;H420:38;Not classified:1
61838,Vinyl 2-ethylhexanoate,202-297-4,94-04-2,Skin Sens. 1B;Repr. 2;Aquatic Acute 1,REACH registration C&L,495,H410:489;H400:489;H361:489;H317:10;H315:6;H319:6;H335:5
61839,"O-(2-ethylhexyl) O,O-tert-pentyl peroxycarbonate",274-919-2,70833-40-8,Org. Perox. D;Skin Sens. 1,REACH registration C&L,14,H242:9;H317:8;Not classified:5;H319:2
61842,2-nitroanisole,202-052-1,91-23-6,Acute Tox. 4;Carc. 1B,Harmonised C&L,0,H350:0;H302:0
61844,Ethyl 2-bromo-3-methylbutyrate,210-178-3,609-12-1,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,48,H302:42;H314:45;H318:1;H290:1;H315:2;H319:1;H335:1
61849,"Kinase (phosphorylating), acetate",232-818-0,9027-42-3,Resp. Sens. 1,Notified C&L,35,H334:35
61850,"[3R-(3α,3aβ,6α,7β,8aα)]-octahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl acetate",201-036-1,77-54-3,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1766,H410:54;H400:54;H317:54;H411:1674;H315:38
61851,Methyl diethylphosphonoacetate,213-938-2,1067-74-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:44;H319:45;H335:43
61852,N-(aminoiminomethyl)formamide,224-744-2,4471-51-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
61855,"Butan-2-one O,O'-(diethoxysilanediyl)dioxime",299-854-7,93917-75-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,23,H315:22;H319:23;H317:23;H412:1;H372:1;H332:1
61861,p-hydroxyphenylacetic acid,205-851-3,156-38-7,Eye Dam. 1,REACH registration C&L,266,H318:37;Not classified:2;H315:226;H319:226;H335:225;H302:1
61864,2-hydroxy-1-phenylethan-1-one,209-480-8,582-24-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
61868,Sodium 3-hydroxy-4-[(2-hydroxynaphthyl)azo]-7-nitronaphthalene-1-sulphonate,222-807-9,3618-58-4,,Notified C&L,38,Not classified:37;H315:1;H319:1
61872,3-hydroxy-2-methylquinoline-4-carboxylic acid,204-198-1,117-57-7,Acute Tox. 4,REACH registration C&L,48,H302:9;H315:39;H319:39;H335:39
61876,"Adesmia boronioides, ext.",920-374-7,1088668-26-1,Skin Sens. 1,Notified C&L,1,H317:1
61880,"2,5-Pyrrolidinedione, 3-(acetyloxy)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-, (3R)-",618-622-1,906802-36-6,,Notified C&L,33,Not classified:33
61881,Copper(2+) neodecanoate,268-439-2,68084-48-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,110,H411:1;H302:2;H400:3;Not classified:107;H410:2
61884,7-acetamido-4-hydroxynaphthalene-2-sulphonic acid,228-715-5,6334-97-0,Not Classified,REACH registration C&L,5,Not classified:5
61890,"Hydrocarbon waxes (petroleum), oxidized, compds. with triethanolamine",269-779-4,68333-24-4,Not Classified,Notified C&L,441,Not classified:441
61892,"3,4-difluoroaniline",223-381-7,3863-11-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H302:47;H335:41;H373:5;H311:6;H332:7;H312:1;H301:1;H331:1;H227:1
61893,5-dimethylaminonaphthalene-1-sulphonohydrazide,251-337-7,33008-06-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:39;H319:39;H335:38;H260:4;H228:4
61897,1-phenylpyrrolidin-2-one,225-069-6,4641-57-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,72,H315:72;H319:72;H335:71
61904,8-chlorooctan-1-ol,245-451-6,23144-52-7,,Notified C&L,7,H315:6;H319:5;Not classified:1
61906,Tribromoacetic acid,200-919-9,75-96-7,Skin Corr. 1A,Notified C&L,46,H314:46;H318:1;H290:1
61907,Dodecyl bis(4-nonylphenyl) phosphite,284-117-4,84787-76-8,Skin Irrit. 2,Notified C&L,1,H315:1
61908,Hexaammineruthenium dichloride,239-342-2,15305-72-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H315:42;H312:42;H302:42;H335:42;H319:42;H332:42
61910,"Benzene, 1-chloro-2-fluoro-4-iodo-",606-510-5,202982-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
61914,"Disodium 3-[(5-chloro-2-phenoxyphenyl)azo]-4-hydroxy-5-[[(p-tolyl)sulphonyl]amino]naphthalene-2,7-disulphonate",229-129-2,6416-66-6,Not Classified,REACH registration C&L,2174,Not classified:83;H411:2052;H315:39;H319:39;H335:38;H332:1;H302:1
61915,"1,2-dichloro-3-nitrobenzene",221-717-7,3209-22-1,Acute Tox. 3,Notified C&L,47,H301:38;H373:6;H411:9;H302:9;H315:2;H311:2;H370:2;Not classified:1;H317:1
61917,"Dinonylnaphthalenesulphonic acid, compound with 2-amino-2-methylpropan-1-ol (1:1)",272-409-4,68833-67-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
61924,pyridaben (ISO);2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one,405-700-3,96489-71-3,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H331:0;H410:0;H400:0
61925,Sodium (S)-lactate,212-762-3,867-56-1,Not Classified,REACH registration C&L,50,Not classified:50
61927,9-borabicyclo[3.3.1]nonane,206-000-9,280-64-8,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,125,H250:86;H260:125;H314:86;H302:1;H335:1;H225:1;H319:1
61933,"1H-Inden-1-amine, 2,3-dihydro-2,6-dimethyl-, (1R,2S)-",620-065-4,752984-24-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,84,H318:83;H412:84;H302:84;H314:84
61939,1-phenylpiperidine,223-848-5,4096-20-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
61940,Ethyl 2-methylacetoacetate,210-179-9,609-14-3,Eye Irrit. 2,Notified C&L,3,H319:3;H315:2;H335:2
61946,"Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, chlorides",263-082-9,61789-73-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,44,H315:23;H318:25;H317:18;H410:6;H400:3;H314:3;H335:1
61959,5-ethyl-5-(1-methylbutyl)-2-thiobarbituric acid,200-984-3,76-75-5,Acute Tox. 4,REACH registration C&L,43,H302:43
61960,"Sorbitan, dioctadecanoate",253-084-8,36521-89-8,Not Classified,Notified C&L,12,Not classified:12
61963,Barium bromate,237-750-5,13967-90-3,Ox. Sol. 2;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:43;H272:43;H302:43
61964,3-amino-4-hydroxy-5-nitrobenzenesulphonic acid,202-546-7,96-93-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,268,H315:93;H319:94;H317:92;H314:132;Not classified:42;H335:1
61972,"4,4,5,5-tetramethyl-1,3,2$l^{2}-dioxaborolane",607-485-3,25015-63-8,Flam. Liq. 2;Water-react. 1;Skin Irrit. 2;Repr. 1B,REACH registration C&L,172,H225:171;H260:91;H315:92;H360:6;H318:118;H261:47;H220:33;H335:2;H319:1
61973,Stiripentol,256-480-9,49763-96-4,Acute Tox. 4,Notified C&L,40,H302:39;Not classified:1
61978,"Sodium [2S-[2α,5α,6β(S*)]]-6-[[amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",252-124-1,34642-77-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,8,H334:7;H317:7;H315:1;H319:1
61979,Pentobarbital sodium,200-323-9,57-33-0,Acute Tox. 3,Notified C&L,41,H301:41;H361:2;H332:2;H312:2
61981,Butyl hydrogen tetrachlorophthalate,246-112-5,24261-19-6,Not Classified,Notified C&L,16,Not classified:16
61988,aluminium-tri-isopropoxide,209-090-8,555-31-7,Flam. Sol. 1,Harmonised C&L,0,H228:0
61991,Cesium formate,222-492-8,3495-36-1,Acute Tox. 4;Eye Irrit. 2;Repr. 2;STOT RE 2;STOT RE 2,REACH registration C&L,126,H373:41;H319:126;H302:120;H361:1;H371:39;H315:6;H335:2;Not classified:1
61993,Bis(4-tert-butylcyclohexyl) peroxydicarbonate,239-557-1,15520-11-3,Org. Perox. C;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,150,H412:17;H242:117;H317:17;Not classified:33
61994,4-(4-Methylphenyl)-4-oxobutyric Acid,610-285-9,4619-20-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
61995,"Dibenz[a,c]anthracene",205-920-8,215-58-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1,Notified C&L,53,H331:38;H301:41;H311:41;H400:38;H341:12;H350:3;H330:3
61996,"3-(phosphonooxy)-N-(2,4-xylyl)naphthalene-2-carboxamide",216-480-1,1596-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
61998,3-methylaminopropionitrile,211-740-0,693-05-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H315:41;H312:40;H335:40;H319:41;H332:40
61999,"2-Propenoic acid, 2-propylheptyl ester",604-669-5,149021-58-9,Not Classified,REACH registration C&L,88,Not classified:4;H411:83;H315:84;H317:84;H335:83;H319:83;H412:1
62001,Niobium pentabutanolate,256-923-6,51030-47-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:39
62006,"Phenol, 4-[[2-(1-methylethoxy)ethoxy]methyl]-",605-793-2,177034-57-0,,Notified C&L,1,H302:1
62007,SDC 1-0487,423-540-2,,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,31,H315:31;H317:31;H413:31;H226:31;H318:31
62008,"Ethyl 3-(2,2-dichlorovinyl)-2,2-dimethyl-1-cyclopropanecarboxylate",261-826-7,59609-49-3,Aquatic Chronic 2,Notified C&L,38,H411:38
62009,"Silicic acid, lead salt",234-363-3,11120-22-2,Acute Tox. 3;Acute Tox. 3;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,101,H400:101;H373:84;H301:83;H331:83;H410:101;H360:101;H302:18;H332:18
62016,"Cyperus scariosus, ext.",294-955-2,91771-62-9,Eye Irrit. 2,REACH registration C&L,1451,H319:2;H315:2;H402:1;H411:1299;H317:1303;H412:83;H304:147;Not classified:2
62018,Propanethioic acid,217-577-1,1892-31-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:38;H301:1;H226:1;H317:1
62020,"perboric acid (HBO(O2)), sodium salt, monohydrate;sodium peroxoborate;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm];[containing = 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm];perboric acid (HBO(O2)), sodium salt, tetrahydrate;perboric acid (HBO(O2)), sodium salt, tetrahydrate sodium peroxoborate hexahydrate;sodium peroxometaborate",231-556-4,7632-04-4,,,0,H302:0;H335:0;H272:0;H318:0;H360:0
62021,"Distillates (petroleum), oxidized light, Bu esters",266-856-4,67674-18-4,Not Classified,Notified C&L,1,Not classified:1
62022,"2,5-Furandione, homopolymer, sodium salt",615-090-2,70247-90-4,Not Classified,Notified C&L,21,Not classified:20;H302:1
62023,"(3β,5β,12β)-3,12,14-trihydroxycard-20(22)-enolide",216-806-2,1672-46-4,Acute Tox. 1;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H310:38;H300:38;H330:38
62024,"1-(3,4-xylyl)piperazine",213-798-2,1014-05-7,,Notified C&L,6,H314:6;H332:1;H302:1
62025,(±)-N-ethyl-α-methylphenethylamine hydrochloride,240-270-9,16105-78-5,Acute Tox. 4,Notified C&L,39,H302:38;H301:1
62026,"Tetrasodium 5,5'-[carbonylbis[imino(2-sulphonato-4,1-phenylene)azo]]bis(6-amino-4-hydroxynaphthalene-2-sulphonate)",220-593-1,2829-43-8,,Notified C&L,43,Not classified:43
62027,Terphenyl,247-477-3,26140-60-3,,Notified C&L,627,H410:626;H400:572;H302:1
62039,reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate,415-350-3,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
62043,"silver zinc zeolite (Zeolite, LTA framework type, surface-modified with silver and zinc ions) [This entry covers LTA (Linde Type A) framework type zeolite which has been surface-modified with both silver and zinc ions at contents Ag+ 0,5 %-6 %, Zn2 + 5 %-16 %, and potentially with phosphorus, NH4+, Mg2+ and/or Ca2+ each at level < 3 %]",603-404-0,130328-20-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H315:0;H400:0;H361:0;H410:0;H318:0
62044,"1,4-bis[(2,6-dibromo-4-methylphenyl)amino]anthraquinone",269-469-9,68239-76-9,Eye Irrit. 2,Notified C&L,30,H319:21;Not classified:9
62047,Tetrapropylenebenzenesulphonic acid,234-288-6,11067-81-5,Not Classified,Notified C&L,1,Not classified:1
62055,Pentafluorobenzoyl chloride,218-842-4,2251-50-5,Skin Corr. 1B,Notified C&L,56,H314:56;H318:2;H290:2
62056,Tris(propyn-2-yl)amine,230-038-5,6921-29-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H226:43;H319:43;H335:42;H315:43
62060,"1-octadecyl hydrogen 2-sulphosuccinate, compound with 2-aminoethanol (1:2)",300-084-1,93919-99-4,Not Classified,Notified C&L,1,Not classified:1
62064,3-Methylquinoline-8-sulphonyl chloride,616-150-0,74863-82-4,Skin Corr. 1C;Eye Dam. 1,Notified C&L,4,H318:2;H314:2;Not classified:1;H319:1
62065,"Naphthalene-1,5-diol",201-487-4,83-56-7,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,262,H411:45;H319:64;H317:35;H302:237;H315:11;H335:11;Not classified:3
62073,N-phenyl-m-toluidine,214-885-8,1205-64-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:38;H302:4;H312:4
62074,"3,7-dimethylocta-1,5,7-trien-3-ol",249-975-6,29957-43-5,Not Classified,Notified C&L,88,Not classified:88
62076,"1,1,1,3,3,3-hexafluoro[2-2H]propan-2-[2H]ol",254-091-9,38701-74-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,47,H332:45;H302:45;H312:44;H314:46;H315:1;H319:1;H335:1;H318:1;Not classified:1
62083,"Calcium dihexa-2,4-dienoate",231-321-6,7492-55-9,Not Classified,Notified C&L,59,Not classified:58;H319:1
62088,"2-{2-[2-chloro-3-[1,3,3-trimethylbenz(e)indolin-2-ylidene-ethylidene)-1-cyclohexen-1-yl]-ethenyl]-1,3,3-trimethyl-3H-benz(e)indolio}-4-methylphenylsulfonate",420-680-6,,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 4,REACH registration C&L,4,H373:4;H413:4;H302:2;H317:2
62090,5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile,421-300-1,138564-59-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
62092,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-heptadecafluorooctane",206-395-8,335-65-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
62093,"2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethane-1-sulfonyl chloride",610-161-4,4403-36-5,Skin Sens. 1,REACH registration C&L,50,H317:3;H314:47;H318:2;H290:1
62095,"N-(tert-butoxycarbonyl)-1-(p-tosyl)-L-histidine, compound with dicyclohexylamine (1:1)",265-328-0,65057-34-3,Not Classified,Notified C&L,1,Not classified:1
62096,"Glycerides, C16-18 and C18-unsatd. mono-, di- and tri-, citrates, potassium salts",294-585-1,91744-23-9,Not Classified,REACH registration C&L,2,Not classified:2
62105,1-chloro-3-(propan-2-yloxy)propan-2-ol,610-079-9,4288-84-0,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1;H227:1;H335:1
62107,5-(acetylamino)-2-aminobenzoic acid,256-702-4,50670-83-2,Acute Tox. 4,Notified C&L,44,H302:39;H315:5;H319:6;H335:5
62110,"1,2-epoxy-3-fluoropropane",207-960-1,503-09-3,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,41,H314:41;H301:41;H311:40;H225:41;H331:41
62111,Lofepramine,245-396-8,23047-25-8,STOT SE 3;STOT SE 1;STOT RE 2,REACH registration C&L,2,H373:2;H370:2;H336:2
62116,"3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid",407-670-7,115099-58-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
62118,DL-histidine,225-660-9,4998-57-6,Not Classified,Notified C&L,2,Not classified:2
62121,"Honey, desaccharided",295-760-5,92128-63-7,Not Classified,Notified C&L,50,Not classified:25;H224:25
62123,Ammonium sodium 2-[4-[[1-[[(2-methoxy-5-methyl-4-sulphonatophenyl)amino]carbonyl]-2-oxopropyl]azo]phenyl]-6-methylbenzothiazole-7-sulphonate,276-770-9,72705-24-9,Not Classified,REACH registration C&L,127,Not classified:127
62125,2-[(4-chloro-2-nitrophenyl)azo]-N-(4-chloro-o-tolyl)-3-oxobutyramide,251-038-1,32432-45-4,Not Classified,Notified C&L,8,Not classified:8
62126,Australian magnesite,604-004-9,13717-00-5,Not Classified,Notified C&L,20,Not classified:20
62129,"Methyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate",228-985-4,6386-38-5,Aquatic Chronic 2,REACH registration C&L,310,H411:276;H302:54;Not classified:33;H315:1;H319:1;H335:1
62132,Poloxalene,618-355-0,9003-11-6,Not Classified,Notified C&L,1243,Not classified:898;H412:158;H319:97;H226:59;H315:38;H332:2;H413:1
62133,4-bromo-3-methyl-1H-pyrazole,237-456-7,13808-64-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
62134,Ethyl 1-naphthoate,221-120-1,3007-97-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
62136,"(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal",426-330-9,177964-68-0,Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H319:0;H317:0
62138,4-methylazobenzene,213-444-7,949-87-1,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
62140,"Siloxanes and Silicones, di-Me, Me hydrogen, reaction products with polypropylene glycol monoallyl ether",614-852-1,68957-00-6,Eye Irrit. 2,Notified C&L,28,H319:22;Not classified:6
62143,Sodium phenoxyacetate hemihydrate,222-746-8,3598-16-1,Not Classified,REACH registration C&L,94,Not classified:54;H315:40;H319:40;H335:39
62146,Pent-4-ene-1-yl acetate,216-413-6,1576-85-8,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H226:39;H302:38;H400:1;H315:1
62150,(trans(trans))-4'-but-3-enyl-4-(4-methylphenyl)-bicyclohexyl,429-580-7,,Not Classified,REACH registration C&L,1,Not classified:1
62151,1-naphthylamine,205-138-7,134-32-7,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
62154,[[2-(hydroxymethyl)-5-furyl]methyl]ammonium chloride,279-686-0,81074-81-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:42;H319:42;H335:42;H302:1
62155,"3-bromo-1,1-dimethoxypropane",252-936-6,36255-44-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H226:45;H319:45;H335:44;H315:45;H302:1
62156,"Oils, cognac",232-403-4,8016-21-5,Flam. Liq. 3,Notified C&L,1547,H226:1290;Not classified:218;H315:39;H319:39
62159,2-[(2-chloro-4-nitrophenoxy)methyl]pyridine,605-865-3,179687-79-7,Not Classified,Notified C&L,3,Not classified:3
62160,"Hexadeca-7,11-dienyl acetate",256-857-8,50933-33-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H413:38;H315:38;H319:38
62163,Methyl 4-(aminocarbonyl)-2-nitrobenzoate,243-537-8,20132-75-6,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,33,H319:33;H412:33
62164,2-Hydroxypropyl starch,618-565-2,9049-76-7,Not Classified,Notified C&L,141,Not classified:141
62167,Dibutyltin oxide,212-449-1,818-08-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Muta. 2;Repr. 1B;STOT SE 1;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,611,H341:492;H411:278;H315:256;H317:245;H372:319;H302:133;H370:259;H318:496;H360:496;H373:178;H301:468;H410:308;H400:198;H332:38;H312:9;H412:9;H319:17;H311:7;Not classified:5;H300:5;H361:2;H314:1
62169,"Ethanone, 2-[(3-hydroxyphenyl)thio]-1-(4-methoxyphenyl)-",610-105-9,431047-59-5,,Notified C&L,33,Not classified:33
62170,1-chloro-2-methylbutane,210-466-9,616-13-7,Flam. Liq. 2,Notified C&L,39,H225:39
62173,"Dandelion, ext.",273-624-6,68990-74-9,Not Classified,Notified C&L,93,Not classified:90;H226:3;H319:1
62178,"Benzenesulfonic acid, 4-chloro-2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(3-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]-5-methyl-, calcium salt (1:1)",603-331-4,129423-54-7,Not Classified,Notified C&L,63,Not classified:62;H412:1
62181,Reactive Blue FC 15353,401-270-6,,Not Classified,REACH registration C&L,1,Not classified:1
62184,n-butyl acrylate,205-480-7,141-32-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3,Harmonised C&L,0,H315:0;H317:0;H335:0;H226:0;H319:0
62185,"5-chloro-1,3-dimethoxybenzene",230-330-2,7051-16-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
62186,"fensulfothion (ISO);O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate",204-114-3,115-90-2,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H310:0;H300:0;H410:0;H400:0
62187,"4-(2,5-diethoxy-4-nitrophenyl)morpholine",201-653-6,86-16-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62192,bis (8-hydroxyquinolinium) sulphate,205-137-1,134-31-6,Acute Tox. 4,Harmonised C&L,0,H302:0
62198,"2H-Pyran-4-carboxylic acid, tetrahydro-, methyl ester",422-770-0,110238-91-0,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H412:83;H318:83
62202,Dichromium boride,234-488-3,12006-80-3,Not Classified,Notified C&L,1,Not classified:1
62205,N-(3-methoxyphenyl)piperazine,240-154-8,16015-71-7,Skin Corr. 1B,Notified C&L,41,H314:40;H315:1;H312:1;H302:1;H335:1;H319:1;H332:1;H318:1
62206,2-methyldecan-1-al,242-745-6,19009-56-4,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1600,H411:57;H315:55;H317:55;Not classified:1543
62213,quinoline,202-051-6,91-22-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H341:0;H411:0;H315:0;H312:0;H302:0;H350:0;H319:0
62217,Cinchocaine hydrochloride,200-498-1,61-12-1,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,127,H411:86;H318:125;H302:123;H317:85;H301:4;H410:1;H400:1;H315:1;H330:1;H311:1;H335:1
62218,"Reaction products of amines, dicoco alkyl and glycollic acid",471-920-1,,Skin Sens. 1B,REACH registration C&L,443,H317:443
62221,Ethyl ethoxyacetate,212-447-0,817-95-8,Flam. Liq. 3,Notified C&L,40,H226:40
62222,"(2,3,5,6-tetrafluorophenyl)methanol",609-872-2,4084-38-2,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,57,H319:57;H302:56;H317:56;H315:1;H335:1
62223,"1,4-dithioterephthalic acid",214-069-1,1076-98-8,Resp. Sens. 1,Notified C&L,38,H334:38
62224,"N,N,N',N'-tetramethylbut-2-ynylenediamine",203-880-6,111-53-5,Acute Tox. 4,Notified C&L,38,H302:38
62228,"α-[(benzyl-tert-butylamino)methyl]-m-xylene-4,α,α'-triol",246-013-7,24085-03-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,4,H302:4;H412:2
62230,"3-[3-(methylamino)-4-nitrophenoxy]propane-1,2-diol",279-383-3,80062-31-3,Acute Tox. 4,Notified C&L,7,H302:7
62231,Tetrabutylphosphonium bromide,221-487-8,3115-68-2,Met. Corr. 1;Acute Tox. 4;Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;Repr. 2;Aquatic Chronic 2,REACH registration C&L,57,H411:6;H317:4;H311:44;H302:56;H361:4;H318:50;H290:5;H315:53;H335:44;H310:11;H319:7;H332:5;H413:1;H312:2
62232,"reaction mass of: trisodium 5-{}{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{}{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{}{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{}{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate",414-620-8,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
62234,"disodium 7-{[4-chloro-6-(dodecylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[{4-[(4-sulfonatophenyl)diazen-1-yl]phenyl}diazen-1-yl]naphthalene-2-sulfonate",415-510-2,145703-76-0,Not Classified,REACH registration C&L,49,Not classified:2;H412:47
62236,"Fatty acids, coco, esters with oxybis(propanediol)",288-309-9,85711-49-5,Skin Sens. 1,REACH registration C&L,10,H317:2;Not classified:8
62238,"1,4-bis[(2-hydroxyethyl)amino]anthraquinone",224-743-7,4471-41-4,Aquatic Chronic 2,Notified C&L,7,H411:7
62240,Piperidine-1-carboxamide,218-476-5,2158-03-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
62241,Disodium 3-[[4-[[4-[ethyl[[3(or 4)-sulphonatophenyl]methyl]amino]phenyl]azo]-1-naphthyl]azo]benzenesulphonate,281-953-1,84067-17-4,Not Classified,Notified C&L,4,Not classified:4
62245,"Spruce, Picea glauca, ext.",294-419-8,91722-18-8,Not Classified,Notified C&L,1,Not classified:1
62246,"Coconut oil, oleins",296-891-0,93165-07-2,Not Classified,Notified C&L,1,Not classified:1
62247,Disodium oxide,215-208-9,1313-59-3,Skin Corr. 1B,REACH registration C&L,732,H314:650;H318:184;Not classified:70;H290:20;H301:17;H271:6;H335:5;H370:4
62252,"imazapyr (ISO);2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate",617-219-8,81334-34-1,Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H412:0
62256,"7H-benzimidazo[2,1-a]benzo[3,4][2]benzothiopyrano[7,8,1-def]isoquinolin-7-one",258-465-2,53304-32-8,Not Classified,Notified C&L,1,Not classified:1
62260,[4-chloro-2-(hydroxymethyl)phenoxy]acetic acid,228-987-5,6386-63-6,Carc. 2;Aquatic Acute 1,Notified C&L,38,H351:38;H400:38
62261,"3-methylcyclohexane-1,2-dione",221-122-2,3008-43-3,Not Classified,Notified C&L,114,Not classified:113;H315:1;H319:1;H335:1
62262,4-nitro-3-phenyl-L-alanine,213-446-8,949-99-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,44,H301:38;H315:39;H319:39;H317:4;H302:2;H335:1
62263,"Oleic acid, monoester with glycerol",247-038-6,25496-72-4,Not Classified,Notified C&L,522,Not classified:508;H319:13;H302:2;H332:1;H312:1
62271,"N-(2-benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide",251-452-2,33311-76-1,,Notified C&L,1,H302:1
62273,N-isopropylbenzylamine,203-067-6,102-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H315:48;H319:48;H335:47;Not classified:3
62279,"2,3-dihydro-1,4,5,8-tetrahydroxyanthraquinone",201-364-5,81-59-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62282,Nadide phosphate,200-178-1,53-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
62286,Non-3-enoic acid,223-932-1,4124-88-3,Skin Corr. 1B,Notified C&L,89,H314:89;H318:37;H290:1
62287,Methyl trimethyl-3-[(1-oxododecyl)amino]propylammonium sulphate,234-204-8,10595-49-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H315:1;H400:1;H318:1
62291,Pentamethylbenzenesulphonyl chloride,257-968-4,52499-94-2,Skin Corr. 1B,Notified C&L,43,H314:43
62295,N-ethyl-p-methoxy-α-methylphenethylamine hydrochloride,300-765-3,93963-24-7,,Notified C&L,1,H302:1
62296,"5'-O-(p,p'-dimethoxytrityl)thymidine 3'-(hydrogen succinate)",277-851-1,74405-40-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,38,H315:38;H312:38;H302:38;H335:38;H351:38;H319:38;H332:38
62298,Mercury difluoride,231-994-6,7783-39-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H310:43;H330:43;H400:43;H373:43;H410:42;H300:43
62299,"Cuprate(3-), [3-[2-[5-(hydroxy-κO)-4-[2-[1-(hydroxy-κO)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-κN1]-2-methylphenyl]diazenyl]-1,5-naphthalenedisulfonato(5-)]-, sodium (1:3)",616-328-8,76359-37-0,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,39,H412:39;H318:39
62300,Acid Orange 142,612-631-4,61901-39-1,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,3,H411:3;H319:3
62304,"2,5-dichlorobenzaldehyde",228-832-1,6361-23-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:38;H319:38;H335:38;H314:7;H318:1
62306,"1,1'-binaphthyl-2,2'-diol",210-014-0,602-09-5,Eye Irrit. 2,REACH registration C&L,52,H319:51;H301:50;H315:7;H335:6;H341:1;H331:1;H311:1
62307,"Phosphorodithioic acid, mixed O,O-bis(2-ethylhexyl and iso-Pr) esters, zinc salts",272-723-1,68909-93-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,445,H411:445;H315:445;H319:445
62309,O-ethyl O-(4-methylthiophenyl) S-propyl dithiophosphate,252-545-0,35400-43-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,104,H330:101;H400:101;H301:104;H311:101;H410:101;H312:3
62310,"Hexadecan-1-ol, propoxylated",500-026-7,9035-85-2,Not Classified,Notified C&L,98,Not classified:98
62315,"1,3,5-Triazine-2,4,6-triamine, polymer with formaldehyde, isobutylated",614-204-8,68002-21-1,Aquatic Chronic 4,Notified C&L,309,H413:195;H411:71;H226:38;Not classified:5
62319,"(Z)-3,4,5,6,6-pentamethylhept-3-en-2-one",279-822-9,81786-73-4,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1551,H411:1421;H317:1410;H412:95;Not classified:36
62322,"Fatty acids, animal, C2-12-alkyl esters, mixed with C8-20 alkenes and vegetable-oil fatty acid C2-12-alkyl esters, sulfurized",307-323-9,97593-21-0,Not Classified,Notified C&L,1,Not classified:1
62323,"1,2,4-trifluorobenzene",206-684-9,367-23-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H225:45;H315:43;H319:44;H335:44;H314:1
62325,"(2S,3S,6R)-3-[[(3S)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2H-pyran-2-carboxylic acid;hydrochloride",609-067-6,3513-03-9,Acute Tox. 2,Notified C&L,5,H300:5;H312:1;H311:1;H332:1
62327,Reaction product of Castor oil and Methylenediphenyl diisocyanate,925-165-4,,Not Classified,Notified C&L,46,Not classified:46
62332,"2-chloro-2,2-difluoroacetamide",206-555-7,354-28-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H315:42;H312:38;H302:38;H335:42;H319:42;H332:38
62333,4-(4-aminoanilino)-6-[3-(dibutylamino)propylamino]-heteromonocyclic-2-ol,427-670-0,,Aquatic Chronic 2,Notified C&L,1,H411:1
62334,"2-(2,4-dichlorophenoxy)ethanol",204-416-5,120-67-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H315:40;H302:39;H335:40;H318:39;H319:1
62335,Chloromethylene dimethylammonium chloride,609-368-2,3724-43-4,Acute Tox. 4;Skin Corr. 1A;Repr. 2,Notified C&L,46,H302:42;H361:40;H314:46;H301:4;H360:6
62337,S-methylmethioninium chloride,214-231-1,1115-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,115,H315:114;H319:114;H335:114;Not classified:1
62340,3-benzylpiperidine,237-088-7,13603-25-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H302:1;H318:1
62341,"3,5-Dichloro-2,4-difluoroaniline",617-438-9,83121-15-7,Acute Tox. 4,Notified C&L,6,H302:5;H315:2;H312:1;H335:1;H319:2;H332:1
62343,Tetraammineplatinum dinitrate,243-929-9,20634-12-2,Self-react. A;Aquatic Chronic 3,REACH registration C&L,135,H240:3;H412:3;H400:83;H317:127;H410:83;H318:83;H271:83;H315:45;H335:44;H319:45;H272:44;H314:4;H200:4
62345,1-chloro-3-fluorobenzene,210-919-0,625-98-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H225:49;H315:45;H319:45;H335:43;H332:8;H302:1;H312:1
62347,C.I. Reactive Blue 222,618-907-0,93051-44-6,Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,24,H334:18;H319:17;H335:17;Not classified:6;H317:1
62348,Epoxy-amine adduct,922-961-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
62349,3-(N-(2-hydroxyethyl)anilino)propiononitrile,202-174-5,92-64-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
62354,[[2-[2-[2-(3-chloro-2-hydroxy-propoxy)propoxymethyl]-3-(2-prop-2-enoyloxypropoxy)-2-(2-prop-2-enoyloxypropoxymethyl)propoxy]-1-methyl-ethyl] prop-2-enoate,611-591-5,57903-73-8,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,2203,H411:2203;H317:2203
62355,"2,5-dichlorothiophene",221-638-8,3172-52-9,Flam. Liq. 3,Notified C&L,44,H226:44;H300:6;H341:5;H311:4;H310:2;H330:1
62356,"1,3-diaminoguanidine hydrochloride",252-854-0,36062-19-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,99,H315:99;H319:99;H335:98
62357,"Benzenamine, N-phenyl-, styrenated",270-485-3,68442-68-2,Aquatic Chronic 4,REACH registration C&L,571,H413:501;H410:1;H400:1;H412:69
62358,"Douglas fir, Pseudotsuga menziesii, ext.",294-957-3,91771-64-1,Not Classified,Notified C&L,190,Not classified:184;H341:3;H315:6;H317:6;H412:3;H351:3;H319:3;H400:3;H226:3;H410:3;H304:3
62359,Methyl acetopyruvate,243-891-3,20577-61-1,Eye Irrit. 2,Notified C&L,41,H319:41;H315:2;H335:2;H312:1;H302:1;H332:1
62361,Trimethylsilyl isothiocyanate,218-929-7,2290-65-5,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H334:38;H315:42;H301:42;H311:38;H335:43;H331:42;H226:43;H319:43;H330:1
62362,(1-chloro-1-methylethyl)benzene,213-284-8,934-53-2,Flam. Liq. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,3,H227:2;H335:2;H314:3
62373,"[1R-(1α,2α,5β,8β)]-4,4,8-trimethyltricyclo[6.3.1.02,5]dodecan-1-yl acetate",260-555-1,57082-24-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1586,H410:14;H400:14;H317:1582;H315:36;Not classified:1
62374,"Chromate(2-), [2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-5-sulfobenzoato(3-)]-, lithium sodium",288-678-6,85865-79-8,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,43,H411:35;H317:35;Not classified:8
62376,4-cyanopentylmorpholine,282-301-9,84145-72-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
62378,"Glycerol dihydrogen phosphate, sodium salt",254-713-9,39951-36-5,,Notified C&L,1,Not classified:1
62381,Dichloro(phenyl)phosphine sulphide,222-494-9,3497-00-5,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,39,H312:38;H314:39;H302:38;H332:38;H290:39;H318:1
62382,2-ethylthiophene,212-830-2,872-55-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,138,H332:90;H226:132;H302:90;H312:90;H225:6;H315:6;H319:6;H335:6;H224:1
62383,Prednisolone 21-(hydrogen succinate),220-861-8,2920-86-7,Repr. 1A;STOT RE 2,Notified C&L,28,H373:27;H360:25;H332:1;H351:1;H302:1;H361:1;Not classified:1
62384,"2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2-methoxyphenyl)-3-oxobutyramide]",224-867-1,4531-49-1,Not Classified,REACH registration C&L,239,Not classified:239
62385,2-(4-chlorophenyl)-3-methylbutyric acid,217-934-1,2012-74-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
62386,DAODA,453-870-2,,Not Classified,Notified C&L,1,Not classified:1
62390,4-FLUOROANILINE HYDROCHLORIDE,606-772-0,2146-07-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62391,"2,4,5,6-tetrachloro-m-xylene",212-886-8,877-09-8,Not Classified,Notified C&L,4,Not classified:3;H319:1;H315:1;H302:1;H335:1
62394,"Barium 3,3-diethoxy-2-hydroxypropyl phosphate",300-986-5,93965-35-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38
62401,(Z)-dodec-7-enol,243-488-2,20056-92-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62402,"1,3,5-Trioxane, polymer with 1,3-dioxolane",607-470-1,24969-26-4,Not Classified,Notified C&L,37,Not classified:37
62403,2-methanesulfonylethan-1-amine,610-479-3,49773-20-8,Skin Corr. 1B,Notified C&L,1,H314:1
62404,"Hydrocarbons, C7",300-230-4,93924-37-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,18,H411:18;H315:18;H225:18;H336:18;H304:18
62406,"Carboxylic acids, di-, C4-6",271-678-5,68603-87-2,Eye Dam. 1,REACH registration C&L,147,H318:144;H335:8;Not classified:3
62407,3-Iodobenzamide,600-498-5,10388-19-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
62408,"5-sulphoisophthalic acid, sodium salt",232-255-0,7800-91-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H412:83;H315:83;H318:83
62410,3-Amino-7-diethylamino-5-phenylphenazinium chloride,610-268-6,4569-86-2,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,2,H318:2;H410:2;H317:2
62416,N-[(benzyloxy)carbonyl]-L-threonine,243-258-1,19728-63-3,Not Classified,Notified C&L,1,Not classified:1
62419,"4,5,6,7,8,9,10,11,12,13-decahydrocyclododecaoxazole",253-869-5,38303-23-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,261,H315:261;H319:261
62420,"Benzenesulfonic acid, C10-14-alkyl derivs., sodium salts",274-070-8,69669-44-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:26;H315:39;H302:38;H318:14;H317:1;H335:1
62422,"Ethyl 2,3-dibromobutyrate",210-177-8,609-11-0,Acute Tox. 4;Skin Corr. 1B,Notified C&L,40,H302:39;H314:40;H318:1;H332:1;H312:1
62423,"2,6-dimethoxybenzoyl chloride",217-868-3,1989-53-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H318:39;H314:43;H312:1;H302:1;H332:1
62426,"4,4-dimethoxybutanone",226-605-1,5436-21-5,Flam. Liq. 3,REACH registration C&L,1574,H226:1485;Not classified:88;H225:1;H315:2;H319:2;H335:2
62429,Potassium benzoate,209-481-3,582-25-2,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,616,H315:530;H318:6;H319:76;H302:37;Not classified:10
62431,(2R)-(+)-2-[Hydroxy(diphenyl)methyl]pyrrolidine,606-992-7,22348-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:47;H319:47;H335:46;H312:1;H302:1;H332:1
62432,4-hydroxyphenylpyruvic acid,205-852-9,156-39-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
62436,1-phenylcyclopentanecarboxylic acid,201-037-7,77-55-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
62437,Dimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl](3-sulphopropyl)ammonium hydroxide,222-860-8,3637-26-1,Not Classified,REACH registration C&L,46,Not classified:7;H302:39;H312:39
62440,1-(4-trans-Propylcyclohexyl)-4-[(4-propyloxyphenyl)ethinyl]- benzol,601-459-5,116903-49-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
62441,"3-oxyde-2,4-pyrimidinediamine monohydrate",419-140-2,,Not Classified,Notified C&L,2,Not classified:2
62447,Niobium pentabromide,236-778-5,13478-45-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,38,H312:38;H314:38;H302:38;H318:38;H332:38
62448,2-phenylbutan-2-ol,216-364-0,1565-75-9,Acute Tox. 4,Notified C&L,38,H302:38
62451,Diethyl formamidomalonate,228-692-1,6326-44-9,Not Classified,Notified C&L,1,Not classified:1
62455,4-methoxy-2-nitrobenzenesulphonyl chloride,241-996-9,18092-54-1,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H290:1;H314:2;H335:1
62457,"Poly[oxy(methyl-1,2-ethanediyl)], alpha-hydro-omega-hydroxy-, 2-propyn-1-yl ether",614-169-9,67922-60-5,Acute Tox. 4,Notified C&L,1,H302:1
62458,"2-amino-2',5-dichlorobenzophenone",220-985-2,2958-36-3,Not Classified,REACH registration C&L,54,Not classified:8;H315:45;H319:45;H335:43;H302:6
62461,1-phenylpyrrolidine,223-849-0,4096-21-3,,Notified C&L,4,H302:4;H312:4
62467,"5-chloro-1,3-dihydro-1-(4-piperidinyl)-2H-benzimidazol-2-one",258-771-6,53786-28-0,Acute Tox. 4;Eye Dam. 1;Repr. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,49,H412:2;H373:2;H302:3;H361:2;H318:2;H315:46;H319:46;H335:45
62468,"Cuprate(4-), [2-(amino-kN)ethanol][7-[[3-(hydroxy-kO)-4-[[1-(hydroxy-kO)-3-sulfo-7-[(2-sulfoethyl)amino]-2-naphthalenyl]azo]-kN1]phenyl]azo]-1,3-naphthalenedisulfonato(6-)]-,tetrasodium",450-270-2,,Not Classified,Notified C&L,2037,Not classified:2037
62470,"3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one",255-207-0,41078-70-0,Acute Tox. 4;Skin Sens. 1B;Muta. 2;Aquatic Chronic 3,REACH registration C&L,2,H341:1;H412:1;H302:1;H317:1;H315:1;H319:1
62471,(E)-pent-2-en-1-al,216-414-1,1576-87-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H225:46;H315:45;H319:46;H335:44;H226:1;H411:1;H317:1;H311:1;H302:1
62474,"2-ethyl-2-[(3-mercapto-1-oxopropoxy)methyl]propane-1,3-diyl bis[3-mercaptopropionate]",251-336-1,33007-83-9,Acute Tox. 4;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,65,H410:3;H302:3;H400:3;H317:3;H315:49;H319:49;H335:48;Not classified:13
62477,Pentabromoethane,200-918-3,75-95-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H315:1;H301:1;H311:1;H331:1;H319:1
62479,"Resin acids and Rosin acids, hydrogenated, sodium salts",273-574-5,68990-02-3,Eye Irrit. 2,REACH registration C&L,9,H319:2;Not classified:7
62488,"Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, chlorides",263-081-3,61789-72-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,45,H315:41;H318:42;H302:22;H400:21;H314:3;Not classified:1
62489,Lithium lactate,212-761-8,867-55-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
62493,4-phenyl-1-(p-tolylsulphonyl)piperidine-4-carboxylic acid,282-549-8,84255-02-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:38;H302:39;H332:1;H312:1
62496,2-hexylcyclopentan-1-one,235-970-6,13074-65-2,Not Classified,REACH registration C&L,1601,Not classified:1297;H319:304;H315:1;H412:1
62497,Ammonium wolframate,234-364-9,11120-25-5,Not Classified,REACH registration C&L,72,Not classified:59;H302:8;H315:5;H319:5;H335:5
62498,dimethyl (2S)-2-hydroxysuccinate,432-310-0,617-55-0,Flam. Liq. 3;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H226:0;H318:0
62499,"1-(4'-Fluorophenyl)-1,3-DihydroIsobenzofuran-5-Carbonitrile",613-489-6,64169-67-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,3,H315:3;H312:1;H302:3;H319:2;H332:2;H335:1
62502,"potassium [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",204-038-0,113-98-4,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,65,H334:23;H317:64;H360:1
62511,(±)-2-aminobutyric acid,220-616-5,2835-81-6,Eye Irrit. 2,Notified C&L,56,H319:55;Not classified:1
62515,esfenvalerate (ISO);(S)-a-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate,613-911-9,66230-04-4,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H301:0;H331:0;H410:0
62520,3-(2-methylaminoethyl)indol-5-ol oxalate,239-611-4,15558-50-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H312:38
62521,2-amino-4-imino-2-thiazoline hydrochloride,253-083-2,36518-76-0,,Notified C&L,4,H302:4
62526,3-O-ethylmorphine hydrochloride,204-734-4,125-30-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,5,H331:2;H301:1;H311:2;H302:4;H332:1;H315:1;H318:1;H334:1;H317:1;H361:1
62528,"Triethyl ethane-1,1,2-tricarboxylate",231-235-9,7459-46-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
62531,Tricopper bis(orthophosphate),232-254-5,7798-23-4,,Notified C&L,12,H302:4;H412:4;H315:3;H319:3;H335:3;H301:1;H410:1
62533,"Tris(N-hydroxy-N-nitrosophenylaminato-O,O')aluminium",239-341-7,15305-07-4,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 1,REACH registration C&L,129,H410:10;H302:23;H317:23;H350:87;Not classified:12;H341:17;H351:1;H319:1;H318:1
62534,Phenobarbital sodium,200-322-3,57-30-7,Acute Tox. 3;Skin Sens. 1;Carc. 2,Notified C&L,44,H301:44;H351:41;H317:42;H362:1;H361:1;H336:1;H360:3
62536,"7-tert-butoxybicyclo[2.2.1]hepta-2,5-diene",212-885-2,877-06-5,Flam. Liq. 3,Notified C&L,38,H226:38
62541,"6-(dimethylamino)-4,4-diphenylheptan-3-one hydrobromide",245-450-0,23142-53-2,Acute Tox. 3,Notified C&L,1,H301:1
62544,Thallium iodide,232-199-7,7790-30-9,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,83,H373:83;H300:83;H411:83;H330:83
62545,"5-amino-1,3,4-thiadiazole-2-thiol",219-078-4,2349-67-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H302:38;H335:42
62546,3-ethyl-2-propylquinoline,221-948-3,3290-24-2,Not Classified,Notified C&L,45,Not classified:44;H302:1
62547,"(2R,3R,4S,5R)-2-(acetoxymethyl)-6-oxotetrahydro-2H-pyran-3,4,5-triyl triacetate",612-107-5,61259-48-1,Not Classified,Notified C&L,1,Not classified:1
62549,"2(5H)-Furanone, 5-hydroxy-4-methyl-",609-869-6,40834-42-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,86,H225:1;H319:86;H315:86;H302:86;H335:1
62552,Methyl 5-Iodosalicylate,609-859-1,4068-75-1,Acute Tox. 3,Notified C&L,43,H301:38;H315:5;H319:5;H335:4
62557,Diethyl isopropylidenemalonate,229-876-4,6802-75-1,Not Classified,Notified C&L,1,Not classified:1
62558,"2-methylpentane-1,5-diamine",239-556-6,15520-10-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,465,H312:166;H314:464;H302:464;H335:143;H318:328;H332:266;H331:123;H372:32;H412:23
62566,"2,3-dihydro-2-thioxoquinazolin-4(1H)-one",237-676-3,13906-09-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62567,5-thiazolylmethanol,414-780-9,38585-74-9,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
62568,"Benzoic acid, 2,4-difluoro-, ethyl ester",600-886-4,108928-00-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
62569,"Sodium 2(or 5)-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy]-5(or 2)-(tert-pentyl)benzenesulphonate",273-450-0,68966-83-6,Aquatic Chronic 3,Notified C&L,27,H412:24;Not classified:3
62575,"Sodium N,N-dimethylglycinate",242-206-5,18319-88-5,Skin Corr. 1C;Eye Dam. 1,Notified C&L,56,H318:55;H314:55;H315:1;H312:1;H302:1;H335:1;H319:1;H332:1
62576,Dipotassium platinate,235-554-4,12285-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:39;H302:1;H290:1
62577,"2,2'-dithiobisethanol",217-576-6,1892-29-1,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1B;Eye Irrit. 2A;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,173,H411:2;H317:2;H301:142;H311:2;H401:2;H319:33;H318:45;H302:31
62578,Cyclohexyl isocyanate,221-639-3,3173-53-3,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,89,H334:85;H315:56;H330:88;H301:6;H311:6;H335:56;H226:89;H319:56;H312:76;H317:83;H302:83;H314:33;H331:1;H413:1
62584,Sodio(2-hydroxyethyl)[2-hydroxy-3-sulphonatopropyl](methyl)[2-[(1-oxooctadec-9-enyl)amino]ethyl]ammonium methyl sulphate,277-607-4,73791-62-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,40,H315:40;H319:3;H317:2
62585,"Benzene-1,3-di(sulphonyl chloride)",209-556-0,585-47-7,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,46,H334:40;H317:40;H314:46;H318:2;H290:2
62586,3-(chlorosulphonyl)benzoyl chloride,223-759-1,4052-92-0,Acute Tox. 4;Skin Corr. 1B;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H314:1;H302:1;H335:1;H319:1
62587,3-chloro-5-(trifluoromethyl)aniline,273-989-1,69411-05-8,,Notified C&L,7,H315:7;H312:6;H302:6;H319:7;H332:6;H335:3
62589,"Fatty acids, tall-oil, low-boiling, reaction products with 1-piperazineethanamine",276-042-0,71820-35-4,Not Classified,Notified C&L,2,Not classified:1;H317:1;H314:1;H302:1;H410:1;H318:1
62592,"3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride",403-440-5,93633-79-5,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
62593,[No public or meaningful name is available],479-660-0,,Self-heat. 1,REACH registration C&L,6,H251:6
62594,"(3aS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo[de,g]chromene-1,5,11-trione",200-985-9,76-78-8,Not Classified,Notified C&L,11,Not classified:10;H319:1;H332:1;H302:1;H312:1
62595,"Phenol, nonyl-, branched",291-844-0,90481-04-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H315:41;H400:41;H302:41;H410:41;H318:41
62597,Isododecylphenol,234-287-0,11067-80-4,Eye Irrit. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H315:1;H400:1;H361:1;H410:1;H319:1
62601,"Formaldehyde, polymer with ethenylbenzene and phenol",608-168-2,28135-23-1,Not Classified,REACH registration C&L,2,Not classified:2
62602,cis-4-hydroxy-L-proline,210-542-1,618-27-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H315:2;H319:2;H335:2;Not classified:2;H332:1;H302:1;H312:1
62603,5-methylfuran-2-propionaldehyde,252-190-1,34756-16-6,Not Classified,Notified C&L,6,Not classified:6
62605,Disodium 7-amino-4-hydroxy-3-[[5-hydroxy-6-(phenylazo)-7-sulphonato-2-naphthyl]azo]naphthalene-2-sulphonate,228-323-4,6227-02-7,Not Classified,REACH registration C&L,4,Not classified:4
62607,"Magnesium 3-(2,4-dimethoxyphenyl)-2-butenoate",247-407-1,26011-83-6,Not Classified,Notified C&L,1,Not classified:1
62609,p-(1H-pyrrol-1-yl)phenol,245-600-5,23351-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62613,"O-(2,4-dichlorophenyl) O-ethyl S-propyl dithiophosphate",252-125-7,34643-46-4,Acute Tox. 4;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H410:38;H330:38;H302:41;H400:38;H332:3;H312:3
62614,(2S)-2-[[(2R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]azaniumyl]propanoate,617-383-0,82717-96-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,83,H315:47;H319:47;H335:47;Not classified:35;H361:1;H318:1
62617,2-[N-(o-methylphenyl)carbamoyl]-3-naphthyl acetate,208-439-1,528-66-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62620,N-2-hydroxyethylformamide,211-741-6,693-06-1,Eye Irrit. 2,Notified C&L,42,H319:42;H315:4;H335:4
62621,"reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate",405-670-1,,Acute Tox. 4;Skin Corr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H373:0;H314:0;H302:0;H410:0
62627,"3-(tridecyloxy)propylamine, branched and linear",272-724-7,68909-95-5,Acute Tox. 4;Skin Corr. 1A;Aquatic Chronic 2,Notified C&L,40,H411:40;H302:40;H314:40
62628,2-amino-N-(5-chloropyridin-2-yl)-5-methoxybenzamide,923-755-6,280773-17-3,STOT SE 2,REACH registration C&L,2,H371:2
62631,1-phenylcyclopropanemethanol,250-781-9,31729-66-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
62632,"1,5-bis[1,2-bis(ethoxycarbonyl)ethylamino]-2-methylpentane",433-260-2,,Aquatic Chronic 3,REACH registration C&L,2,H412:2
62639,"Oils, animal, mixed with animal oil Me esters, sulfurized",273-625-1,68990-80-7,Not Classified,Notified C&L,30,Not classified:30
62642,BENZOIC ACID C9-11 BRANCHED ALKYL ESTERS,603-470-0,131298-44-7,Acute Tox. 4,Notified C&L,153,H332:93;H315:41;H400:42;H410:42;H319:41;Not classified:57;H411:1;H302:1;H314:1
62643,2-carboxyethyl acrylate,246-359-9,24615-84-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,235,H315:126;H319:126;Not classified:55;H314:52;H411:49;H335:50;H317:44;H332:14;H318:15;H400:2;H302:2;H312:1
62645,α-[4-[2-(diethylamino)ethoxy]phenyl]-α-phenylphenethyl alcohol,277-461-1,73404-00-9,Not Classified,REACH registration C&L,2,Not classified:2
62648,sodium nitrite,231-555-9,7632-00-0,Ox. Sol. 3;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H301:0;H272:0;H400:0
62650,Pentadecafluorooctyl chloride,206-394-2,335-64-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H318:38;H314:46;Not classified:1;H335:2
62651,"4-(2,5-dibutoxy-4-nitrophenyl)morpholine",201-652-0,86-15-7,Eye Irrit. 2,Notified C&L,38,H319:38
62652,Disodium dihydrogen [[(2-hydroxyethyl)imino]bis(methylene)]bisphosphonate,282-460-4,84215-54-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,14,H315:14;H319:14
62657,1-(o-chlorobenzyl)-1H-pyrrole,245-830-6,23694-46-4,Acute Tox. 4;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H302:2
62661,Disodium 2-[4-[[1-[[(2-methoxy-5-methyl-4-sulphonatophenyl)amino]carbonyl]-2-oxopropyl]azo]phenyl]-6-methylbenzothiazole-7-sulphonate,276-771-4,72705-26-1,Not Classified,REACH registration C&L,19,Not classified:19
62663,"3,5-diamino-2,4,6-trimethylbenzenesulphonic acid",251-039-7,32432-55-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
62664,2-(prop-2-ynyloxy)ethanol,223-601-1,3973-18-0,Eye Irrit. 2;Acute Tox. 4,Notified C&L,100,H332:63;H319:89;H302:28;Not classified:10;H315:2;H335:2;H334:1;H317:1
62668,"[cyclohexane-1,2-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid, sodium salt",310-115-0,102506-09-2,Not Classified,REACH registration C&L,3,Not classified:3
62669,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with oxydipropanol",500-142-8,59952-43-1,Resp. Sens. 1,Notified C&L,55,H334:55
62670,"Benzo-1,3-dioxole-5-ethylamine",216-060-8,1484-85-1,,Notified C&L,3,H315:2;H319:2;H335:2;H318:1
62675,"1,3-divinylimidazolidin-2-one",237-457-2,13811-50-2,Eye Irrit. 2A;Repr. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,86,H373:85;H319:85;H361:85;H412:85;Not classified:1
62679,"α,α,α-trifluoro-4-nitro-m-cresol",201-818-2,88-30-2,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,51,H315:50;H312:41;H301:10;H335:49;H319:50;H332:41;H302:41
62681,"1,4-bis(butylamino)anthraquinone",241-379-4,17354-14-2,Not Classified,REACH registration C&L,4252,Not classified:2827;H302:1286;H413:138;H341:1;H317:1
62683,N-Methyl-3-sulfanylpropanamide,610-826-9,52334-99-3,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,57,H302:2;H318:2;H301:55;H332:55;H312:55
62684,Disodium 8-hydroxy-7-[(4-sulphonato-1-naphthyl)azo]quinoline-5-sulphonate,258-663-9,53611-17-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62685,"1,3-Propanediol, 2,2-dimethyl-, reaction products with epichlorohydrin",618-937-4,933999-82-7,Skin Irrit. 2;Skin Sens. 1,Notified C&L,55,H315:55;H317:55
62693,"Butane, 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluoro-",922-358-5,163702-05-4,Not Classified,Notified C&L,58,Not classified:36;H413:22
62696,"[μ-[[3,3'-[azoxybis[(2-hydroxy-p-phenylene)azo]]bis[4-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicopper, tetrasodium salt",278-093-4,75173-68-1,Aquatic Chronic 3,REACH registration C&L,133,H412:86;Not classified:130
62701,"1-Pentanone, 1-(4-phenylcyclohexyl)-, trans-",615-882-8,73011-78-6,Not Classified,Notified C&L,1,Not classified:1
62706,Cephaeline,207-591-6,483-17-0,Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H330:1
62707,(E)-3-methylpent-2-ene,210-465-3,616-12-6,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,64,H225:64;H304:61
62710,"Dodecanedioic acid, 1,12-bis(2-octyldodecyl) ester",603-333-5,129423-55-8,Not Classified,Notified C&L,1,Not classified:1
62711,"(2R)-2-[(18R)-3,6-Dimethoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-18-yl]-3,3-dimethyl-2-butanol",605-428-7,16614-59-8,Acute Tox. 4;Acute Tox. 4;Resp. Sens. 1;Repr. 2;Lact.,REACH registration C&L,106,H334:7;H362:7;H302:106;H361:7;H332:7;H412:16
62713,p-fluorobenzenesulphonamide,206-946-2,402-46-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,198,H315:198;H301:195;H311:195;H335:197;H331:194;H319:198;H312:1;H302:3;H332:1
62714,"2,4-dihydro-5-methyl-2-phenyl-4-(phenylazo)-3H-pyrazol-3-one",224-330-1,4314-14-1,Not Classified,Notified C&L,2388,Not classified:2360;H302:25;H412:2;H413:1
62716,3-ethyl-2-[(3-ethyl-3H-benzothiazol-2-ylidene)methyl]benzothiazolium iodide,218-593-1,2197-01-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H315:38;H301:38;H311:38;H335:38;H331:38;H319:38
62718,disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate,423-730-5,250688-43-8,Eye Dam. 1,Harmonised C&L,0,H318:0
62723,Isooctadecanoyl chloride,278-996-3,78851-23-7,Skin Irrit. 2;Skin Sens. 1B,Notified C&L,83,H315:83;H317:83
62724,"1-tert-Butyl 3-ethyl 4-oxo-1,3-piperidine-dicarboxylate",619-384-1,98977-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
62726,"O,O-dimethyl O-(4-sulphamoylphenyl) thiophosphate",204-115-9,115-93-5,Acute Tox. 3,Notified C&L,38,H301:38
62729,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-N-(2-methyl-1-oxopropyl)guanosine 3'-(hydrogen butanedioate),277-854-8,74405-46-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H315:38;H301:38;H311:38;H335:38;H331:38;H319:38
62730,"Fatty acids, C12-18, propoxylated",616-209-0,75300-89-9,Not Classified,Notified C&L,3,Not classified:3
62734,"Ferrate(1-), bis[3-[[3-[[4-[[3-[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]azo]-2,5-dimethylphenyl]azo]-2,4-dihydroxyphenyl]azo]-4-hydroxybenzenesulfonamidato(2-)]-, hydrogen, tris(2-hydroxypropanoate) (salt)",279-384-9,80063-37-2,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,37,H411:37;H319:37
62740,"1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one",216-133-4,1506-02-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1754,H410:1754;H302:1751;H400:1646
62743,2-(3-thienyl)pyridine,244-322-1,21298-55-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
62745,S195037,472-040-0,,Eye Dam. 1,Notified C&L,1,H318:1
62747,β-methylphenethyl isobutyrate,265-931-9,65813-53-8,Not Classified,Notified C&L,89,Not classified:89
62750,anthraquinone,201-549-0,84-65-1,Carc. 1B,Harmonised C&L,0,H350:0
62755,"Linseed oil, polymd., oxidized",613-886-4,66071-03-2,Not Classified,Notified C&L,6,Not classified:6
62758,1-iodopentane,211-030-0,628-17-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H226:47;H319:47;H335:46;H315:47;H302:1;H332:1
62762,"(α,α,α,α',α',α'-2H6)p-xylene",247-033-9,25493-13-4,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,38,H332:38;H226:38;H312:38;H315:38
62763,"Imidazole-4,5-dicarboxylic acid",209-327-5,570-22-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H315:44;H319:44;H335:43
62765,Reaction mass of 4-sec-butylaniline and 2-sec-butylaniline,700-229-2,,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H315:1;H301:1;H311:1;H320:1;H331:1;H319:1
62766,5-chloro-2-methyl-3-(3-sulphonatopropyl)benzoxazolium,257-574-2,51981-33-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,7,H302:7;H318:6;H312:1;H314:1
62767,Welan gum,619-250-2,96949-22-3,Not Classified,Notified C&L,59,Not classified:59
62772,sodium peroxide,215-209-4,1313-60-6,Ox. Sol. 1;Skin Corr. 1A,Harmonised C&L,0,H271:0;H314:0
62774,"1,1'-[iminobis(ethyleneiminoethylene)]bis[3-(octadecenyl)pyrrolidine-2,5-dione]",264-637-8,64051-50-9,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,25,H412:4;H317:4;Not classified:21
62784,"1,3(2H,4H)-Isoquinolinedione, 7-methoxy-2-methyl-",616-380-1,76746-95-7,Not Classified,Notified C&L,1,Not classified:1
62785,"1H-1,2,4-Triazole-3-carboxylic acid, 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-, methyl ester",609-754-0,39925-10-5,Not Classified,REACH registration C&L,2,Not classified:2
62788,N-(4-chlorophenyl)-2-hydroxy-9H-carbazole-3-carboxamide,205-068-7,132-61-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H302:38
62790,5-Chloro-2-methoxybenzeneboronic acid,618-292-9,89694-48-4,,Notified C&L,11,H315:10;H319:10;H335:9;H302:1
62792,"4,4'-bis(2-methoxystyryl)-1,1'-biphenyl",254-935-6,40470-68-6,Not Classified,REACH registration C&L,7,Not classified:7
62795,"Fuel gases, crude oil of distillates;Petroleum gas;[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]",270-670-9,68476-29-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
62797,2-(4-fluorophenyl)propionic acid,278-340-6,75908-73-5,Acute Tox. 3,Notified C&L,39,H301:38;H332:1;H302:1;H312:1
62798,"2,4-difluorobenzamide",285-654-7,85118-02-1,,Notified C&L,4,H315:4;H319:4;H335:4
62800,3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile,268-417-2,68084-04-8,Not Classified,Notified C&L,113,Not classified:113
62801,Tall-oil fatty acids oligomeric reaction products with triethylenetriamine and gylcidyl tolyl ether,919-898-9,,Acute Tox. 5;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 2,REACH registration C&L,10,H315:1;H400:1;H317:1;H401:1;H303:1;H318:1;Not classified:9
62804,"4-amino-5-hydroxynaphthalene-1,3-disulphonic acid",201-425-6,82-47-3,Skin Corr. 1B,Notified C&L,39,H314:38;Not classified:1
62806,Tris(2-chloroethyl)amine hydrochloride,212-442-3,817-09-4,Acute Tox. 2;Skin Corr. 1B;Carc. 2,Notified C&L,38,H300:38;H351:38;H314:38
62810,Phenyl 3-hydroxy-2-naphthoate,230-681-1,7260-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:39
62812,Secbutabarbital,204-738-6,125-40-6,Acute Tox. 3,Notified C&L,41,H301:41
62814,Promazine hydrochloride,200-179-7,53-60-1,Acute Tox. 4;Skin Sens. 1,Notified C&L,42,H302:42;H317:41;H411:2;H318:1
62821,"Tetrasodium 4-amino-6-[[2,5-dimethoxy-4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]-5-hydroxy-3-[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonate",282-468-8,84229-70-9,Skin Sens. 1B;Resp. Sens. 1B,REACH registration C&L,55,H334:35;H317:24;Not classified:18;H320:13;H335:13
62825,"2-ethylhexanoic acid, chromium salt",230-822-7,7329-33-1,Not Classified,Notified C&L,85,Not classified:71;H317:13;H315:1;H319:1
62829,"9,10α-dihydro-12'-hydroxy-5'α-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate",238-163-7,14271-05-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H315:1;H312:2;H335:1;H319:1;H332:3;H302:2
62832,m-(trifluoromethyl)benzamide,217-289-6,1801-10-1,,Notified C&L,5,H315:5;H319:5;H335:5
62834,5M (mineral,602-803-7,12269-78-2,Not Classified,Notified C&L,46,Not classified:25;H319:21
62837,5(or 6)-carboxy-4-hexylcyclohex-2-ene-1-octanoic acid,258-897-1,53980-88-4,Eye Irrit. 2,Notified C&L,558,H319:488;Not classified:50;H315:42;H318:20;H314:20;H413:1;H302:1;H335:1
62840,[2-(2-methoxymethylethoxy)methylethoxy]propanol,247-045-4,25498-49-1,Not Classified,REACH registration C&L,2588,Not classified:2566;H319:22
62842,Chlormethine hydrochloride,200-246-0,55-86-7,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1B;Muta. 1B;Carc. 1B;Repr. 1B,Notified C&L,39,H310:38;H314:38;H350:38;H340:38;H300:38;H360:38;H301:1;H361:1
62843,3-phenylbutyric acid,224-987-4,4593-90-2,,Notified C&L,94,H315:94;H319:94;H335:94;H302:1
62844,C.I. Acid Red 62,612-257-1,61724-30-9,Not Classified,Notified C&L,1,Not classified:1
62845,Potassium sulphamate,237-515-7,13823-50-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,77,H412:70;H315:76;H335:76;H318:56;H319:20;Not classified:1;H312:1;H332:1
62846,"1-methyl-2,8,9-trioxa-5-aza-1-silabicyclo[3.3.3]undecane",218-928-1,2288-13-3,,Notified C&L,13,H315:13;H319:13;H335:13
62847,"Fatty acids, C18-24, zinc salts",283-985-1,84776-57-8,Not Classified,REACH registration C&L,9,Not classified:9
62849,"Fatty acids, C14-18 and C16-18-unsatd., maleated",288-306-2,85711-46-2,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2B,REACH registration C&L,194,H315:191;H319:178;H317:190;H335:79;Not classified:3
62851,"2-heptyl-4,5-dihydro-1H-imidazole-1-ethanol",252-853-5,36060-61-4,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Repr. 1B;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,29,H362:2;H314:4;H400:3;H302:3;H410:2;H318:3;H360:3;H315:25;H319:25;H317:1
62855,(2-methylpropyl)lithium;isobutyllithium,440-620-2,920-36-5,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H314:0;H260:0;H410:0;H250:0;H336:0
62856,"O,O-dibutyl hydrogen dithiophosphate",218-848-7,2253-44-3,Skin Corr. 1A,Notified C&L,1,H314:1
62857,C.I. Reactive Yellow 145,618-901-8,93050-80-7,Not Classified,Notified C&L,7,Not classified:7
62860,"Phosphoric acid, C12-16-alkyl esters, potassium salts",291-904-6,90506-42-6,Not Classified,Notified C&L,1,Not classified:1
62864,3-phenoxybenzyl 2-dimethyl-3-(methylpropenyl)cyclopropanecarboxylate,247-404-5,26002-80-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,186,H312:172;H400:177;H302:172;H410:178;H332:171;Not classified:8
62866,Sodium (2-butoxyethoxy)acetate,268-040-3,67990-17-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,93,H315:1;H312:1;H302:1;H331:1;H319:1;H332:1;H318:1;Not classified:91
62867,4-nitrobenzamide,210-613-7,619-80-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H319:11;H315:11;H302:13;H335:11;H331:38;H301:38;H311:38;H332:1
62869,4-hexylresorcinol,205-257-4,136-77-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H319:54;H315:53;H302:56;H335:51;Not classified:3;H312:1;H314:1;H228:1;H318:1;H332:1;H411:1
62870,Diclofenac,239-348-5,15307-86-5,Acute Tox. 4;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,228,H411:134;H372:99;H302:137;H361:112;Not classified:52;H301:39;H362:9;H317:10;H410:9;H412:5;H373:1;H335:1
62871,"1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;TGIC",219-514-3,2451-62-9,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;Muta. 1B;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H373:0;H301:0;H412:0;H318:0;H331:0;H340:0
62874,"1-(5,5-dimethyl-1-cyclohexen-1-yl)pent-4-en-1-one",260-486-7,56973-85-4,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1626,H411:44;H317:1625;H315:1;H412:1
62876,"2,3-Dihydrobenzofuran-5-acetic Acid",615-045-7,69999-16-2,Skin Sens. 1;Eye Dam. 1,Notified C&L,36,H318:33;H317:33;H315:3;H312:1;H302:1;H335:2;H319:3;H332:1
62877,"Amides, tallow, N-[2-[(2-aminoethyl)amino]ethyl]",271-673-8,68603-78-1,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,7,H410:7;H400:7;H314:7
62879,7-hydroxy-6-methoxycoumarin,202-171-9,92-61-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,200,H315:200;H319:200;H335:199
62882,Ethyl 3-(1-pyrrolidinyl)crotonate,259-303-3,54716-02-8,Eye Irrit. 2,Notified C&L,43,H319:43;H315:5;H335:1
62885,Gossypin from Hibiscus vitifolius,613-767-7,652-78-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:41
62888,2-methyl-2-buten-1-ol,225-127-0,4675-87-0,Acute Tox. 4;STOT SE 3,Notified C&L,1374,H332:1374;H335:1374;H226:477
62889,4-methyl-salicylamide,444-900-5,49667-22-3,Aquatic Chronic 3,Notified C&L,2,H412:2;H315:1;H302:1;H335:1;H319:1
62892,"2,6-dibromo-4-[1-(3-bromo-4-hydroxyphenyl)-1-methylethyl]phenol",228-988-0,6386-73-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,14,H410:14;H400:14
62896,"N-(2,6-dimethylphenyl)acetamide",218-596-8,2198-53-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:42;H312:39;H302:44;H335:42;H319:42;H332:39
62897,2-amino-4-methylbenzophenone,225-577-8,4937-62-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
62898,"mephosfolan (ISO);diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate",213-447-3,950-10-7,Acute Tox. 2;Acute Tox. 1;Aquatic Chronic 2,Harmonised C&L,0,H310:0;H300:0;H411:0
62899,"(1-methylethylidene)bis[4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)] bismethacrylate",216-367-7,1565-94-2,,Notified C&L,176,H315:123;H319:124;H317:132;H318:40;Not classified:4;H412:1;H335:1;H341:1;H302:1;H314:1
62902,(E)-2-decenol,242-289-8,18409-18-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:40;H319:40;H335:40;Not classified:3
62907,"2,2-bis(hydroxymethyl)butyl (R)-12-hydroxyoleate",266-551-6,67025-99-4,Not Classified,Notified C&L,1,Not classified:1
62911,4-(fluorosulphonyl)benzoyl chloride,206-949-9,402-55-1,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,38,H302:38;H335:38;H314:38
62913,pentachlorobenzene,210-172-0,608-93-5,Flam. Sol. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0;H228:0
62914,"Fatty acids, C16-18 and C18-unsatd., Bu esters",284-863-0,84988-74-9,Not Classified,REACH registration C&L,71,Not classified:71
62917,methomyl (ISO);1-(methylthio)ethylideneamino N-methylcarbamate,240-815-0,16752-77-5,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H410:0;H400:0
62924,Triethyloxonium hexachloroantimonate(1-),221-874-1,3264-67-3,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H332:38;H411:38;H302:38
62925,Sodium dihydrogen 4-sulphonatophthalate,251-572-5,33562-89-9,Aquatic Chronic 3,Notified C&L,116,H412:83;H319:33
62927,Octadecyl octanoate,242-200-2,18312-31-7,Not Classified,Notified C&L,18,Not classified:18
62928,"Diammonium [N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]ferrate(2-)",289-064-0,85959-68-8,,REACH registration C&L,141,Not classified:141
62932,"Ethene, homopolymer, oxidized",614-498-8,68441-17-8,Not Classified,Notified C&L,804,Not classified:804
62933,Disodium 8-[[4-[[(4-methylphenyl)sulphonyl]oxy]phenyl]azo]-5-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]naphthalene-1-sulphonate,277-155-8,72968-81-1,Not Classified,REACH registration C&L,6,Not classified:6
62934,halogenated polyetherpolyol,615-120-4,70535-99-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,83,H319:83;H302:83
62937,Calcium zinc salts of oligomers of rosin,920-105-3,,Not Classified,REACH registration C&L,2,Not classified:2
62940,1-methyl-1-phenylhydrazine,210-547-9,618-40-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:44;H312:40;H302:44;H335:43;H319:44;H332:40
62941,(-)-bornan-2-one,207-354-7,464-48-2,Muta. 2,Notified C&L,135,H341:89;H315:46;H319:46;H335:41;H228:47;H302:2;H332:1
62948,Calcium dobesilate,243-531-5,20123-80-2,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
62950,"Poly(oxy-1,2-ethanediyl), alpha,alpha′-(Thiodi-2,1-ethanediyl)bis [omega-butoxy-],",614-862-6,68958-65-6,Acute Tox. 4,Notified C&L,34,H302:34
62957,Ethyl 1-methyl-5-propyl-1H-pyrazole-3-carboxylate,607-431-9,247583-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
62960,β-nitrostyrene,203-066-0,102-96-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H301:38;H315:40;H319:40;H335:40;Not classified:1
62962,"2,2'-[[]6-(4-methoxyphenyl)-1,3,5-triazine-2,4-diyl]bis[[]5-[[](2-ethylhexyl)oxy]phenol",425-950-7,187393-00-6,Not Classified,REACH registration C&L,111,Not classified:111
62968,"4-amino-5-hydroxynaphthalene-1,7-disulphonic acid",204-982-3,130-23-4,Not Classified,REACH registration C&L,36,Not classified:1;H302:34;H319:2;H315:2;H335:1
62969,"4-[(2,4-dimethoxyphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",262-838-5,61550-72-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H315:38;H400:38;H302:38;H335:38;H319:38
62970,6-O-α-D-glucopyranosyl-D-fructose,237-282-1,13718-94-0,Not Classified,Notified C&L,23,Not classified:23
62973,Nimetazepam,217-931-5,2011-67-8,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H302:38;H400:38
62974,"3-[2-chloro-4-[(2,6-dichloro-4-nitrophenyl)azo]anilino]propiononitrile",267-484-5,67874-57-1,Not Classified,Notified C&L,31,Not classified:31
62978,4-bromo-2-fluoroaniline,206-685-4,367-24-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:47;H319:47;H335:46;H312:7;H302:7;H332:7;H318:3;H331:1;H301:1;H311:1;H411:1
62986,"Reaction product of 1,5-naphthylene diisocyanate (3173-72-6) and Cyclohexylamine (108-91-8)",926-367-5,,Not Classified,Notified C&L,1,Not classified:1
62989,Isodecyl methacrylate,249-978-2,29964-84-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,634,H315:122;H319:122;H335:122;H410:154;Not classified:441;H400:52;H317:13
62991,"10,15-dihydroxyanthra[2,1,9-mna]naphth[2,3-h]acridin-5(16H)-one disodium bis(sulphate)",224-742-1,4471-37-8,Not Classified,Notified C&L,1,Not classified:1
62998,"Formaldehyde, reaction products with sulfonated sulfonylbis[phenol], ammonium salts",300-304-6,93925-05-4,Skin Corr. 1B,Notified C&L,1,H314:1
63001,Cobalt chromate,236-651-4,13455-25-9,,Notified C&L,4,H350:4;H410:4;H400:4;H317:4
63003,"Acetaldehyde, reaction products with formaldehyde, by-products from",270-480-6,68442-60-4,Flam. Liq. 1,Notified C&L,104,H224:83;Not classified:21
63005,"2,4,7,9-Tetramethyldec-5-yne-4,7-diol, ethoxylated",500-022-5,9014-85-1,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2272,H318:777;H412:838;H317:22;H319:1313;Not classified:182;H413:158;H315:255;H411:83;H335:99;H410:14;H332:2
63007,Lead(2+) acrylate,212-760-2,867-47-0,,Notified C&L,4,H400:4;H373:4;H302:4;H410:4;H332:4;H360:4
63011,"2-Hexene-1,4-diol, 4-ethyl-6-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, cyclized",291-450-9,90411-73-7,Not Classified,Notified C&L,88,Not classified:88
63012,6-nitro-p-toluic acid,221-481-5,3113-72-2,,Notified C&L,7,H315:7;H319:7;H335:6
63013,"Oils, Tolu balsam",617-021-1,8024-03-1,Not Classified,Notified C&L,1,Not classified:1
63014,Cetrimide,617-073-5,8044-71-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,40,H312:40;H314:40;H302:40;H318:39;H332:40
63020,2-cyclohexylethylamine,224-673-7,4442-85-7,,Notified C&L,6,H314:6;H318:1;H226:1
63021,Potassium hydrogen diiodate,236-650-9,13455-24-8,Ox. Sol. 2;Skin Corr. 1B,Notified C&L,47,H272:47;H314:45;H319:2;H315:1;H318:2;H302:2;H335:2;H317:1
63022,3-mercaptopentan-2-one,266-799-5,67633-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1444,H315:1371;H319:1405;H335:1394;H226:119;H302:39;H318:38;H225:1
63028,"Carbonic acid, potassium salt",241-378-9,17353-70-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,29,H315:29;H319:29;H335:28;H371:1;H302:1
63030,"1-(m,p-dichlorophenyl)-1,2-dihydro-5H-tetrazole-5-thione",264-414-5,63684-99-1,Flam. Sol. 2,Notified C&L,1,H228:1
63032,5-hydroxy-2-nitrobenzaldehyde,255-832-9,42454-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:45;H335:44;H412:1
63035,Oxazoline-functional copolymer,452-610-5,,Not Classified,Notified C&L,1,Not classified:1
63038,Tin difluoride,231-999-3,7783-47-3,Met. Corr. 1;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,153,H411:7;H315:50;H301:11;H318:50;H290:7;H412:61;H302:105;H314:67;Not classified:36;H332:1;H312:1
63039,Trichloro(vinyl)silane,200-917-8,75-94-5,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 3,REACH registration C&L,96,H314:94;H311:63;H302:94;H225:95;H331:66;H312:31;H332:4;H318:1;H290:1;H315:1;H335:2;H319:1;H411:1;Not classified:1
63041,"3,7-diaminobenzo[b]phenoxazinylium acetate",234-043-3,10510-54-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:2
63042,Secobarbital,200-982-2,76-73-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H301:40;H315:39;H319:39;H335:39;H361:1;H332:1;H312:1
63043,4-ethyloct-1-yn-3-ol,227-545-9,5877-42-9,Acute Tox. 3;Aquatic Acute 1,Notified C&L,62,H311:38;H400:38;H315:23;H319:24;H412:23;H310:1;H411:1;H302:1
63045,3-[(4-acetamidophenyl)azo]-4-hydroxy-7-[[[[5-hydroxy-6-(phenylazo)-7-sulpho-2-naphthyl]amino]carbonyl]amino]naphthalene-2-sulphonic acid,246-726-3,25188-34-5,Not Classified,Notified C&L,3,Not classified:3
63046,"5’,5’’’’-(1,1,1-trifluoropropane-2,2-diyl)bis(1,1’:3’,1’’-terphenyl-2’-ol)",610-104-3,43100-47-6,Not Classified,REACH registration C&L,1,Not classified:1
63048,"Chloro-6,15-dihydroanthrazine-5,9,14,18-tetrone",215-369-5,1324-27-2,Not Classified,Notified C&L,17,Not classified:10;H315:7;H319:7;H335:7
63054,"Soaps, stocks, sardine-oil, acidulated",297-501-1,93572-70-4,Not Classified,Notified C&L,1,Not classified:1
63056,2-aminoethanesulphonamide monohydrochloride,289-519-3,89756-60-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,3,H315:3;H319:3;H335:3
63063,"Oils, sage",616-985-0,8016-64-6,Not Classified,Notified C&L,29,Not classified:25;H341:4;H317:4;H400:4;H226:4;H410:4;H304:4
63065,"Sodium hydrogen 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[5-methyl-2-(1-methylethyl)phenolate] S,S-dioxide",263-650-6,62625-21-2,Not Classified,Notified C&L,2,Not classified:2
63069,"Formaldehyde, reaction products with ethanolamine",286-011-3,85186-27-2,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4,Notified C&L,7,H332:4;H318:5;H302:6;H317:6;H315:2;H319:2
63074,Alkane 6,438-390-3,,Not Classified,Notified C&L,2,Not classified:2
63075,"N-[2-[(2,6-dicyano-p-tolyl)azo]-5-(dipropylamino)phenyl]methanesulphonamide",277-156-3,72968-82-2,,Notified C&L,39,Not classified:39
63076,O-(4-nitrobenzyl)hydroxylammonium hydrochloride,218-228-6,2086-26-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,157,H315:157;H319:157;H335:157
63079,"Phosphoric acid, mono- and di-C10-14-alkyl esters",302-253-5,94095-45-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:2;H314:2
63081,"2,2'-[(2,4-dihydroxy-1,3-phenylene)bis(azo-4,1-phenyleneimino)]bis(5-nitrobenzenesulphonic) acid",278-876-0,78265-88-0,Not Classified,Notified C&L,5,Not classified:4;H319:1
63084,"Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides",263-080-8,61789-71-7,Acute Tox. 4;Skin Corr. 1B,Notified C&L,133,H302:129;H314:124;H400:70;H312:43;H311:20;H335:20;H410:20;H318:21;Not classified:4
63087,"1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrole",225-739-8,5044-23-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H315:39;H302:38;H335:38;H413:38;H318:38;H319:1
63088,"Sulfonic acids, C10-21-alkane, chloro, ammonium salts",286-672-8,85338-01-8,Not Classified,Notified C&L,1,Not classified:1
63091,Pyridinium hydrogen sulphate,208-845-9,543-54-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1;H314:1
63092,"Linseed oil, epoxidized",232-401-3,8016-11-3,Not Classified,REACH registration C&L,123,Not classified:123
63093,1-ethylpiperidin-3-ol,236-584-0,13444-24-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,40,H226:2;H319:2;H315:40;H302:38
63095,2-chloroethyl ethyl sulphide,211-742-1,693-07-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Carc. 1A,Notified C&L,43,H314:39;H301:39;H311:38;H350:38;H331:38;H226:39;H302:4;H315:1;H335:1;H351:1;H319:1;H318:1
63097,Hexyl nicotinate,245-767-4,23597-82-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,79,H315:42;H319:43;H335:38;Not classified:36;H334:2;H411:2;H317:2;H318:1
63102,"Paraformaldehyde, oligomeric reaction products with 4-tert-butylphenol, m-phenylenebis(methylamine) and trimethylhexane-1,6-diamine",922-419-6,,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,2,H317:1;H412:1;H314:1;H302:1;H332:1;Not classified:1
63107,Thrombin,232-648-7,9002-04-4,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H334:43;H315:43;H319:43;H335:41;Not classified:1;H310:1;H317:1
63110,Pethidine,200-329-1,57-42-1,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1,REACH registration C&L,3,H301:3;H334:3;H331:3;H317:3
63114,(±)-α-amino-1H-pyrazole-1-propionic acid,248-785-0,28024-60-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
63115,"2,6-dibromo-3-methyl-4-nitroanisole",263-479-7,62265-99-0,Not Classified,Notified C&L,88,Not classified:88
63116,4-mesyl-2-nitrotoluene,430-550-0,1671-49-4,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H412:0;H302:0;H361:0;H317:0
63118,"Diethyl [S-(R*,R*)]-tartrate",237-458-8,13811-71-7,Not Classified,REACH registration C&L,46,Not classified:45;H315:1;H319:1;H335:1
63119,"Alcohols, C14-22 and C16-22-unsatd.",268-107-7,68002-95-9,Not Classified,Notified C&L,1,Not classified:1
63123,(S)-2-amino-5-methoxytetralin hydrochloride,611-645-8,58349-17-0,Acute Tox. 3;Skin Sens. 1;STOT SE 1;Aquatic Chronic 4,REACH registration C&L,2,H301:2;H413:2;H370:2;H317:2
63125,"2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride",412-390-3,86386-75-6,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0;H318:0
63135,Methyl tetrahydrofurfuryl ether,242-986-7,19354-27-9,Flam. Liq. 3,Notified C&L,38,H226:38
63138,"1,3-dibromo-5,5-dimethylhydantoin",201-030-9,77-48-5,Ox. Sol. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Aquatic Acute 1,REACH registration C&L,119,H315:12;H400:81;H302:58;H319:45;H272:104;H301:61;H314:74;H317:16;H410:24;H318:11;H271:1;Not classified:1
63144,"tetrahydrofuran-2,5-diyldimethanol",203-239-0,104-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H315:0;H319:0;H335:0
63145,"1,4-benzodioxane-2-methanol",222-921-9,3663-82-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H315:2;H312:1;H302:1;H335:2;H319:2;H332:1
63147,Disodium 4-octadecyl 2-sulphonatosuccinate,246-358-3,24614-51-5,Not Classified,Notified C&L,2,Not classified:2
63152,"1,4-dibromo-2,5-difluorobenzene",206-317-2,327-51-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:47;H319:48;H335:46;H332:1;H302:1;H312:1
63154,2-hydroxypropyl salicylate,275-818-6,71672-82-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
63157,cis-2-methyl-5-(1-methylvinyl)cyclohex-2-en-1-yl acetate,214-883-7,1205-42-1,Not Classified,Notified C&L,113,Not classified:113
63159,"Glycerides, C16-18 and C18-unsatd. mono- and di-, citrates",293-173-9,91052-16-3,Not Classified,REACH registration C&L,75,Not classified:75
63162,"Acetic acid, anhydride, reaction products with triethylenetetramine",296-779-1,93062-28-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,60,H315:60;H319:60
63164,2-(3-phenylpropyl)tetrahydrofuran,221-715-6,3208-40-0,Acute Tox. 4,Notified C&L,1374,H302:1286;Not classified:88
63166,"Amides, tall-oil fatty, N-[3-(dimethylamino)propyl]",272-047-7,68650-79-3,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,12,H317:6;H400:4;H314:10;H410:1;H318:9;H315:2
63167,"4-[(2,5-dichlorophenyl)azo]-3-hydroxy-N-phenylnaphthalene-2-carboxamide",227-930-1,6041-94-7,Not Classified,REACH registration C&L,337,Not classified:314;H317:22;H341:1
63168,Zinc diethyl difumarate,263-368-3,62008-21-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
63170,"1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide",411-750-7,119126-15-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
63171,Lafutidine,601-513-8,118288-08-7,Acute Tox. 4,Notified C&L,1,H302:1
63174,N-(2-aminoethyl)piperidine,248-540-8,27578-60-5,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,44,H226:44;H314:44;H318:1
63175,"Terpineol, dihydro-",261-542-3,58985-02-7,Skin Irrit. 2,Notified C&L,91,H315:89;Not classified:2
63176,"Pregna-4,17(20)-diene-3,16-dione, (17E)-",609-606-5,39025-24-6,STOT SE 3,Notified C&L,40,H335:40
63177,"1,1,2,2-tetraethoxyethane",223-606-9,3975-14-2,Not Classified,Notified C&L,33,Not classified:33
63182,"5-Heptenoic acid, 7-[3,5-dihydroxy-2-[2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]-, [1R-[1α(Z),2β(E),3α,5α]]-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)",278-752-6,77698-96-5,Repr. 1B;STOT RE 1,Notified C&L,1,H372:1;H360:1
63183,2-(cyclohexylamino)ethanesulphonic acid,203-115-6,103-47-9,Not Classified,REACH registration C&L,56,Not classified:8;H319:48;H315:4;H335:4
63186,"4-[({(3R,3aR,6S,6aR)-6-[(4-{[4-({[4-(acryloyloxy)butoxy]carbonyl}oxy)benzoyl]oxy}benzoyl)oxy]hexahydrofuro[3,2-b]furan-3-yl}oxy)carbonyl]phenyl 4-({[4-(acryloyloxy)butoxy]carbonyl}oxy)benzoate",431-360-0,,Aquatic Chronic 3,Notified C&L,1,H412:1
63193,"1-Methyl-4-(4-trans-vinyl-[1,1'-bicyclohexyl]-4'-trans-yl)-b enzol",685-449-6,155041-85-3,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
63194,4-Ethoxy-4-methyl-diphenylacetylene,601-457-4,116903-46-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
63200,4-isocyanatobenzonitrile,254-934-0,40465-45-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H315:42;H312:41;H302:41;H335:42;H319:42;H332:41;H301:1;H311:1;H331:1
63207,"1,1-DICHLORO-1-FLUOROTHANE",605-613-2,1717-00-6,Aquatic Chronic 3,Notified C&L,88,H412:88;H059:22;H420:11
63209,N-{1-[1-(4-Fluoro-benzyl)-1H-benzoimidazol-2-yl]-piperidin-4-yl}-N-methyl-guanidinium chloride,919-944-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2
63210,4-hydroxyphthalic acid,210-221-6,610-35-5,,Notified C&L,8,H315:8;H319:8;H335:1
63213,Sodium hexadecane-1-sulphonate,239-100-6,15015-81-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:38;H319:38;H335:39;H314:1
63214,"2,5-difluorobenzamide",285-655-2,85118-03-2,,Notified C&L,5,H315:5;H319:5;H335:5
63215,"1,5-dichloroanthraquinone",201-424-0,82-46-2,,Notified C&L,7,H319:7
63216,Dodecahydro-1H-carbazole,228-695-8,6326-88-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H302:38;H400:38
63217,"Tar, pine",232-374-8,8011-48-1,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,180,H412:103;H317:162;H312:58;H302:58;H226:43;H332:55;Not classified:18;H315:12;H335:9;H319:12
63220,"3,5-dichloro-2-pyridone",226-609-3,5437-33-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
63221,"Morpholine, 4-[(triethoxysilyl)methyl]-",480-370-1,21743-27-1,Aquatic Chronic 3,Notified C&L,14,H412:14
63225,Chlorine pentafluoride,237-123-6,13637-63-3,Ox. Gas 1;Press. Gas (Liq.);Skin Corr. 1A;Acute Tox. 1,Notified C&L,111,H280:111;H330:111;H270:111;H314:111
63226,Triphenylene,205-922-9,217-59-4,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,64,H410:47;H400:38;H318:49;H371:12;H332:2;H302:2;H312:2;H315:1;H319:1;H335:1
63227,Potassium (hydroxymethyl)methyldithiocarbamate,256-921-5,51026-28-9,Acute Tox. 4,Notified C&L,38,H302:38
63228,"Boric acid, aluminum salt",234-365-4,11121-16-7,Repr. 2,REACH registration C&L,4,H361:3;Not classified:1
63232,Tris[2-(dimethylamino)ethanolato-O](propan-2-olato)titanium,270-542-2,68443-62-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H335:1
63235,2-ethylhexyl chloroformate,246-278-9,24468-13-1,Met. Corr. 1;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 1,REACH registration C&L,159,H317:152;H290:74;H330:158;H315:153;H332:18;H411:5;H319:4;H301:1;H311:1;H314:2;H310:1;H318:1;H300:1
63237,C.I. Acid Blue 154,600-995-7,11075-29-9,Not Classified,Notified C&L,1,Not classified:1
63238,Chlorphenamine hydrogen maleate,204-037-5,113-92-8,Acute Tox. 3,Notified C&L,240,H301:212;H311:79;H314:36;H373:37;H318:38;H336:38;H411:9;H302:26;H361:7;Not classified:2;H331:3;H330:2;H319:2;H315:2;H372:1;H317:1
63239,1-(4-methoxyphenyl)cyclohexanecarbonitrile,252-938-7,36263-51-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H315:1;H312:1;H302:1;H335:1;H319:1;H332:1
63242,"Extract oils (coal), acidic, tar-base free;Methylnaphthalene Oil Extract Residue;[The extract oil boiling in the range of approximately 220°C to 265°C (428°F to 509°F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]",284-901-6,84989-12-8,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
63244,L-ribose,246-110-4,24259-59-4,Not Classified,Notified C&L,2,Not classified:2
63246,Pentadecan-6-one,213-681-6,1001-45-2,Aquatic Chronic 4,Notified C&L,38,H413:38
63247,6-methylpyridine-2-carboxylic acid,213-287-4,934-60-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:47;H319:47;H335:46
63254,"3,5-di-tert-butyl-4-hydroxybenzyl alcohol",201-815-6,88-26-6,Aquatic Chronic 3,REACH registration C&L,44,H412:1;H315:43;H319:43;H335:42
63256,"N,N'-dibutylhexane-1,6-diamine",225-417-7,4835-11-4,Skin Corr. 1B;Acute Tox. 1,Notified C&L,38,H330:38;H314:38
63257,Triphenyl phosphate,204-112-2,115-86-6,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1410,H411:177;H400:1164;H410:1213;H413:23;Not classified:9;H319:3;H332:1
63260,"2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-[2-(2-ethylhexanoyloxy)ethoxy]phenol",476-130-0,,Aquatic Chronic 4,Notified C&L,1,H413:1
63262,"Tetrasodium N,N'-[3H-2,1-benzoxathiol-3-ylidenebis[(6-hydroxy-5-methylphen-3,1-ylene)methylene]]bis[N-(carboxylatomethyl)aminoacetate] S,S-dioxide",222-805-8,3618-43-7,Not Classified,Notified C&L,7,Not classified:7
63266,"reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)",435-450-0,17779-27-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
63267,"N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide",216-808-3,1672-58-8,Acute Tox. 4;Acute Tox. 1,Notified C&L,39,H330:38;H302:39
63268,chlorodinitrobenzene,247-109-1,25567-67-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H373:0;H301:0;H311:0;H331:0;H410:0
63270,"Petrolatum (petroleum), oxidized, Me ester",266-854-3,67674-15-1,Not Classified,Notified C&L,125,Not classified:125
63278,6-benzyl-2-thiouracil,228-717-6,6336-50-1,,Notified C&L,1,H315:1;H302:1;H335:1;H319:1;H332:1
63279,di-L-para-menthene,417-870-6,83648-84-4,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H400:0;H317:0
63281,Sodium 2-formylbenzenesulphonate dihydrate,202-053-7,91-25-8,Not Classified,Notified C&L,1,Not classified:1
63282,Potassium benzenesulphonate,213-286-9,934-55-4,Not Classified,Notified C&L,22,Not classified:22
63283,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-pentenyl]amino]-8-oxo-, [6R-[6.alpha.,7.beta.(Z)]]-, compd. with N-(1-methylethyl)-2-propanamine (1:1) (9CI)",604-880-2,153012-37-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
63284,Magnesium hydroxide sulphate trihydrate,483-390-9,12508-61-1,Eye Irrit. 2,REACH registration C&L,3,H319:3;H411:1
63286,"Adenosine 3',5'-phosphate monohydrate",200-492-9,60-92-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H315:3;H319:3;H335:3;Not classified:2;H318:1;H314:1
63287,"(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methylthiazol-4-yl)ethenyl]- 4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione",604-822-6,152044-54-7,Acute Tox. 1;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Muta. 2;Repr. 1B;STOT RE 1;Aquatic Chronic 1,Notified C&L,5,H310:3;H341:4;H315:4;H317:3;H372:2;H410:3;H300:4;H360:3;H301:1;H361:3;H400:1;H351:1;H335:1;H318:1
63289,methyl (2R)-2-amino-3-phenylpropanoate;hydrochloride,603-406-1,13033-84-6,Not Classified,REACH registration C&L,6,Not classified:2;H315:4;H319:4;H335:4
63294,"Ferrate(1-), bis[3-[[5-[[4-[[3-[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]azo]-2,5-dimethylphenyl]azo]-2,4-dihydroxyphenyl]azo]-4-hydroxybenzenesulfonamidato(2-)]-, hydrogen, tris(2-hydroxypropanoate) (salt)",279-385-4,80063-38-3,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,31,H411:31;H319:31
63299,"Oils, tunny",273-215-2,68953-53-7,Not Classified,Notified C&L,1,Not classified:1
63304,4-chlorobutyronitrile,211-031-6,628-20-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,99,H301:99;H315:61;H319:61;H335:60
63308,Reaction Mass of 6-(1-bromoethyl)-4-chloro-5-fluoropyrimidine and Toluene,927-248-0,,Flam. Liq. 2;Asp. Tox. 1;Skin Corr. 1B;Skin Sens. 1;STOT SE 3;Repr. 2;STOT RE 2,REACH registration C&L,1,H317:1;H314:1;H373:1;H361:1;H225:1;H336:1;H304:1
63310,3-(2-methyl-1H-imidazol-1-yl)propan-1-amine,607-116-6,2258-21-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,128,H302:127;H314:128
63314,3-aminosalicylic acid,209-328-0,570-23-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H315:46;H319:46;H335:45;H302:1
63315,Calcium phosphonate,247-032-3,25493-06-5,,Notified C&L,10,Not classified:6;H315:3;H319:3;H314:1
63316,"BENZENE,2-CHLORO-1-[(3-FLUOROPHENYL)METHOXY]-4-NITRO-",610-179-2,443882-99-3,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1
63318,"Trans-2-[4'-[Difluor(3,4,5-trifluorphenoxy)methyl]-3',5'-difluor[1,1'-biphenyl]-4-yl]-5-propyl-tetrahydro-2H-pyran",615-063-5,700863-48-5,Not Classified,REACH registration C&L,2,Not classified:2
63321,1-[[(3-nitrophenyl)methoxy]methyl]pyridinium chloride,221-128-5,3009-13-0,Acute Tox. 4,Notified C&L,38,H302:38
63325,N-(2-benzoyl-4-nitrophenyl)-2-bromoacetamide,217-932-0,2011-70-3,Not Classified,REACH registration C&L,2,Not classified:1;H314:1
63328,1-Methoxy-4-(4-propylphenylethinyl)-benzen,609-761-9,39969-26-1,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
63329,2-chloro-6-fluorobenzylamine,239-259-1,15205-15-9,Skin Corr. 1B,Notified C&L,45,H314:45
63335,3-bromo-2-methylthiophene,250-128-8,30319-05-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 3;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H315:1;H412:1;H301:1;H311:1;H335:1;H331:1;H226:1;H319:1
63336,2-Benzyloxyethyl mesylate,611-750-9,58841-52-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
63339,"4-(bromomethyl)-1,2-difluorobenzene",285-653-1,85118-01-0,Skin Corr. 1B;STOT SE 3,Notified C&L,47,H335:40;H314:47;H301:1;H311:1;H319:2;H318:1;H290:1
63340,p-menthan-8-yl acetate,261-543-9,58985-18-5,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1629,H411:1352;H319:1291;H317:1287;Not classified:273;H315:1
63343,"Fuel oil, No 2;Gasoil - unspecified;[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 °C (100 °F) to a maximum of 37,9 SUS at 37,7 °C (100 °F).]",270-671-4,68476-30-2,Carc. 2,Harmonised C&L,0,H351:0
63344,Acebutolol,253-539-0,37517-30-9,Lact.,Notified C&L,1,H362:1
63345,"Plum, ext.",290-179-3,90082-87-4,Not Classified,REACH registration C&L,76,Not classified:50;H226:25;H225:1
63351,(Z)-N-[2-[(2-aminoethyl)amino]ethyl]-9-octadecenamide,239-614-0,15566-80-0,Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H400:1;H314:1;H410:1;H318:1
63353,"Acetic acid, nickel(2+) salt, tetrahydrate",611-946-4,6018-89-9,Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,2106,H334:2106;H341:2106;H317:2106;H372:2106;H302:2106;H350:2106;H332:2106;H360:2106;H400:67;H410:67
63356,Biphenyl-2-yl methyl ether,201-659-9,86-26-0,Not Classified,Notified C&L,1374,Not classified:1374
63357,Heptasodium trihydrogen [[bis[2-[bis(phosphonatomethyl)amino]ethyl]amino]methyl]phosphonate,268-990-9,68155-78-2,Eye Irrit. 2,Notified C&L,115,H319:54;Not classified:56;H318:3;H320:1;H315:1;H411:1;H290:1
63358,"3,4,5-Trifluorobenzaldehyde",603-550-5,132123-54-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H301:38;H315:46;H319:46;H335:45
63359,Primidone,204-737-0,125-33-7,Acute Tox. 4;Carc. 2,Notified C&L,204,H351:203;H302:204;H362:4;H360:5;H317:1;H373:1;H336:2;H412:1
63360,Cobalt dihydroxide,244-166-4,21041-93-0,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 1;Resp. Sens. 1B;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,288,H334:258;H411:146;H330:143;H317:286;H400:271;H302:287;H350:174;H319:267;H360:90;H335:47;H410:128;H332:124;H341:8;H315:12;H312:9;Not classified:1
63364,"2,4-dichloro-3-ethyl-6-nitrophenol",420-740-1,99817-36-4,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H301:0;H410:0;H318:0
63365,"chlorsulfuron (ISO);2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide",265-268-5,64902-72-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
63368,"Tetrasodium N,N-bis(carboxylatomethyl)-L-glutamate",257-573-7,51981-21-6,Not Classified,REACH registration C&L,215,Not classified:190;H315:23;H319:23;H318:2;H314:2
63370,1-Butyl-3-methylimidazolium Bromide,617-674-2,85100-77-2,,Notified C&L,6,H315:5;H319:5;Not classified:1
63375,N-(2-hydroxyethyl)-2-phenoxyacetamide,228-694-2,6326-87-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H302:38;H335:38;H318:38
63386,"Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol, acetates (salts)",284-697-9,84962-04-9,Repr. 1B,Notified C&L,2,H360:1;H411:1;H315:1;H319:1
63387,Cyano (3-phenoxybenzyl)-2-(4-chlorophenyl)-3-methylbutyrate,257-326-3,51630-58-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,219,H315:194;H301:199;H335:194;H410:211;H319:194;H400:55;H332:12;H302:15;Not classified:5;H317:1;H372:1;H370:1
63388,Thorium tetranitrate,237-514-1,13823-29-5,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,66,H411:39;H315:43;H373:63;H302:43;H335:43;H319:63;H272:43;Not classified:2
63398,"Bis(pentane-2,4-dionato-O,O')nickel",221-875-7,3264-82-2,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Muta. 2,REACH registration C&L,54,H341:2;H312:2;H317:10;H302:49;H332:2;H334:39;H350:50;H319:1;H351:1;H335:1
63401,"Phosphoric acid, C12-14-alkyl esters, potassium salts",291-903-0,90506-41-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,33,H315:31;H318:31;Not classified:2
63404,"α,α-dibromo-4-nitrotoluene",210-612-1,619-75-0,Acute Tox. 3;Skin Corr. 1B,Notified C&L,38,H301:38;H314:38
63406,Enprofylline,255-201-8,41078-02-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
63408,Bis(3-methylbutyl) mercaptosuccinate,268-416-7,68084-03-7,Not Classified,Notified C&L,88,Not classified:88
63410,Prop-2-ynylamine,219-513-8,2450-71-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 2;Skin Corr. 1B,Notified C&L,61,H225:61;H310:58;H302:61;H314:49;H311:3;H318:3;H315:1;H332:1
63417,"1-(4-methoxyphenyl)butane-1,3-dione",223-689-1,4023-80-7,,Notified C&L,1,H315:1;H319:1;H335:1
63419,Proflavine,202-172-4,92-62-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
63426,2-ethyl-2-phenylbutyric acid,226-767-3,5465-28-1,Eye Irrit. 2,REACH registration C&L,1,H319:1
63427,6-amino-5-chlorotoluene-3-sulphonic acid,228-989-6,6387-14-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H317:38
63429,"1,1-dimethoxycyclododecane",213-448-9,950-33-4,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,252,H411:252;H317:2
63431,4-Aminothiobenzamide,610-329-7,4714-67-4,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,40,H319:38;H302:38;H317:38;H301:1;Not classified:1
63441,"Xylenols, ethoxylated",500-145-4,61723-82-8,Eye Dam. 1,Notified C&L,31,Not classified:31;H318:31
63447,"1-icosyl hydrogen 2-sulphosuccinate, compound with 2-aminoethanol (1:2)",300-086-2,93920-03-7,Not Classified,Notified C&L,1,Not classified:1
63448,"1-Tridecanamine, N-tridecyl, branched, reaction products with carbon disulfide 2-ethyl-N-(2-ethylhexyl)-1-hexanamine and molybdenum oxide (MoO3)",618-681-3,90901-24-9,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1
63451,Cyclopentylphenylacetic acid,223-454-3,3900-93-4,,Notified C&L,4,H315:4;H319:4;H335:4
63456,"Shale oils, heavy",930-690-7,,Acute Tox. 3;Asp. Tox. 1;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Muta. 1B;Carc. 1B;Repr. 1B;Aquatic Chronic 1,REACH registration C&L,3,H314:3;H317:3;H301:3;H311:3;H335:3;H340:3;H350:3;H410:3;H318:3;H332:3;H360:3;H304:3
63461,8-bromooctan-1-ol,256-785-7,50816-19-8,,Notified C&L,5,H315:4;H319:4;H302:1
63465,Methoxypyrazine,221-579-8,3149-28-8,Acute Tox. 4,Notified C&L,1426,H302:1410;H226:131;H315:45;H335:44;H318:38;H319:7
63467,Morpholine-4-carboxamide,218-474-4,2158-02-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H302:39;H335:39
63471,2-chlorobenzonitrile,212-836-5,873-32-5,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H319:0;H302:0;H312:0
63473,"Fatty acids, C14-18 and C16-18-unsatd., maleated, reaction products with oleylamine",288-307-8,85711-47-3,Skin Sens. 1,REACH registration C&L,1,H317:1
63476,"Tetrasodium 3-[(9,10-dihydroxy-1-anthryl)amino]-10,15-dihydroxyanthra[2,1,9-mna]naphth[2,3-h]acridin-5(16H)-one tetrakis(sulphate)",245-765-3,23594-58-3,Not Classified,Notified C&L,1,Not classified:1
63478,Tris(2-methylpropyl)phosphine,223-934-2,4125-25-1,Flam. Liq. 2;Pyr. Liq. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,39,H312:38;H314:38;H302:38;H225:38;H318:38;H250:39;H332:38;H315:1;H251:1;H335:1;H319:1
63479,"2-ethoxy-4-(4-methyl-1,3-dioxolan-2-yl)phenol",271-281-7,68527-76-4,Not Classified,Notified C&L,88,Not classified:88
63484,3-ethoxypropionaldehydediethylacetal,232-193-4,7789-92-6,Flam. Liq. 3;Acute Tox. 4,Notified C&L,130,H226:130;H302:130
63487,"2,2'-dithiobis(ethylammonium) sulphate",240-340-9,16214-16-7,Acute Tox. 4,REACH registration C&L,2,H302:2
63489,"3,4-dimethylbenzaldehyde",227-770-2,5973-71-7,Not Classified,REACH registration C&L,3,Not classified:3
63492,"(1S-endo)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol",207-353-1,464-45-9,Flam. Sol. 1;Skin Irrit. 2,REACH registration C&L,323,H315:139;H228:322;H317:38;Not classified:1
63498,"fenbuconazole (ISO);4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile",406-140-2,114369-43-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
63499,"1,2,3,4-tetrahydro-1,1,2,4,4,7-hexamethylnaphthalene",218-226-5,2084-69-7,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1
63502,"Fatty acids, C10-18, reaction products with 3-[[2-[(2-aminoethyl)amino]ethyl]amino]propanenitrile",308-885-8,98903-83-4,Not Classified,Notified C&L,1,Not classified:1
63507,Ethyl 4-chloro-2-methylthio-5-pyrimidinecarboxylate,227-619-0,5909-24-0,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,57,H318:7;H315:56;H335:54;H317:11;H319:49;Not classified:1
63508,"Amines, N-tallow alkyltrimethylenedi-, C4-18-alkyl phosphates",271-672-2,68603-74-7,,Notified C&L,2,H302:2;H400:2;H314:1;H315:1;H318:1
63509,3-chlorohexane,219-072-1,2346-81-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
63510,Pentyl 3-(methylthio)propionate,297-748-5,93762-35-7,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
63512,Cinnamoyl chloride,203-065-5,102-92-1,Skin Corr. 1B,Notified C&L,41,H314:41;H335:1;H318:1
63514,"1,4,5,8-tetrachloroanthraquinone",201-362-4,81-58-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
63517,(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoic acid,617-393-5,82834-12-6,Aquatic Chronic 3,REACH registration C&L,11,H412:8;Not classified:2;H315:1;H319:1;H335:1
63521,Pyridin-N-oxide-4-carboxylic acid,237-086-6,13602-12-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,64,H315:44;H319:44;H335:43;Not classified:20;H302:1
63525,"4-(2,2-dimethyl-6-methylenecyclohexyl)butan-2-one",237-283-7,13720-12-2,Skin Sens. 1,Notified C&L,89,H317:89
63527,(S)-2-methylbutan-1-ol,216-366-1,1565-80-6,Flam. Liq. 3;Acute Tox. 4;STOT SE 3,Notified C&L,133,H332:97;H226:108;H335:55;H315:25;H331:10;H302:3
63529,Non-4-ene,218-595-2,2198-23-4,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,39,H226:39;H304:38
63532,"4-nitro-α,α,α-trifluorotoluene",206-948-3,402-54-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,44,H315:44;H330:43;H302:44;H335:43;H319:44;H312:5;H332:1
63533,"Sodium 9,10-dihydro-3,4-dihydroxy-9,10-dioxoanthracene-2-sulphonate monohydrate",204-981-8,130-22-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:45;H319:45;H335:45;Not classified:1
63535,CYCLOHEXYLIDENE-O-TOLYL-ACETONITRILE,482-300-5,,Skin Sens. 1,Notified C&L,1286,H317:1286
63536,Tri-n-butyltin methanolate,213-933-5,1067-52-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H315:43;H312:42;H400:43;H301:43;H372:43;H410:42;H319:43
63537,Dodecaaluminium trimolybdenum dodecaoxide,239-183-9,15123-80-5,Not Classified,REACH registration C&L,6,Not classified:4;H319:2;H302:1
63538,2-(2-hydroxyphenyl)acetamide,245-005-0,22446-40-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
63539,"Fatty acids, C14-18 and C16-18-unsatd., esters with propylene glycol",284-864-6,84988-75-0,Not Classified,REACH registration C&L,39,Not classified:39
63544,"Yarrow, Achillea millefolium, ext.",282-030-6,84082-83-7,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,191,H411:161;H317:161;H304:161;H226:45;H315:25;Not classified:2
63546,Dimethoxymethylvinylsilane,240-816-6,16753-62-1,Flam. Liq. 2,REACH registration C&L,88,H225:88;H315:45;H319:45;H335:43
63548,Nitrosyl hexafluorophosphate(1-),240-980-9,16921-91-8,Skin Corr. 1B,Notified C&L,46,H314:46;H318:1;H332:1;H302:1;H312:1
63549,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-(phenylazo)naphthalene-2-sulphonic] acid",246-725-8,25188-23-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
63551,"Nonylphenol, ethoxylated",500-024-6,9016-45-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,4508,H319:3527;H411:3991;H315:3176;H302:2505;H318:969;H412:242;H335:195;H312:60;H400:79;H413:99;Not classified:23;H373:41;H361:42;H410:8;H304:1;H314:1
63552,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and methylenediphenol",500-269-9,87182-08-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,68,H411:68;H315:68;H319:68;H317:68
63553,"Phenol, 2,4-dinitro-, reaction products with sodium sulfide (Na2S) and sulfur",272-721-0,68909-89-7,Not Classified,Notified C&L,6,Not classified:6
63554,"Sulfonic acids, C15-18-alkane hydroxy and C15-18-alkene, sodium salts",293-724-3,91082-14-3,,Notified C&L,1,H301:1;H318:1
63557,"Dodecylphenol, ethoxylated",500-023-0,9014-92-0,Eye Irrit. 2,Notified C&L,227,H319:187;H411:42;H302:35;H318:35;H315:8;Not classified:5;H335:1
63559,Heptan-2-ol,208-844-3,543-49-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1752,H315:1611;H319:1709;H312:1749;H226:1720;Not classified:2;H302:1
63560,"5,6-dimethylbenzimidazole",209-488-1,582-60-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,4,H319:3;H315:3;H302:2;H412:2;Not classified:1;H335:1
63561,Pentachlorophenyl laurate,223-220-0,3772-94-9,Acute Tox. 3;Carc. 1B,Notified C&L,1,H301:1;H350:1
63562,N-phenylethylenediamine,216-773-4,1664-40-0,Skin Corr. 1B,Notified C&L,45,H314:44;H315:1;H319:1
63563,"2,2'-Dithienyl Disulfide",614-928-4,6911-51-9,Acute Tox. 4,Notified C&L,279,H302:279;H318:38;H319:5;H315:5;H335:4
63564,"N,N'-methanetetraylbis(1-methylethylamine)",211-743-7,693-13-0,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,197,H334:197;H330:192;H315:193;H317:197;H400:10;H335:192;H226:197;H410:11;H318:196;Not classified:2;H319:1
63565,5-bromo-2-chlorobenzoic acid,244-558-5,21739-92-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H315:48;H319:48;H335:47
63572,"Starch, acetate, oxidized",614-359-1,68187-08-6,Not Classified,Notified C&L,1,Not classified:1
63573,C.I. Reactive Yellow 164,600-742-0,106387-52-4,Not Classified,Notified C&L,1,Not classified:1
63574,"Pyrazine, 2,5-diethyl-",603-572-5,13238-84-1,Flam. Liq. 3,Notified C&L,1,H226:1
63577,Ethyl 5-amino-1-phenyl-1H-pyrazole-4-carboxylate,240-224-8,16078-71-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44;H302:1
63578,"9-fluoro-11β,21-dihydroxy-16α,17-(isopropylidenedioxy)pregna-1,4-diene-3,20-dione 21-acetate",223-388-5,3870-07-3,Repr. 2,Notified C&L,1,H361:1
63582,Naftazone,239-785-1,15687-37-3,Not Classified,Notified C&L,1,Not classified:1
63585,15803-02-8 4-BROMO-1-METHYLPYRAZOL,605-126-5,15803-02-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H315:43;H335:42;H318:42;Not classified:1;H319:1
63586,3-Carbamyl-1-methylpyridinium Chloride,463-670-7,1005-24-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
63592,Methyl hydrogen sulphate,200-916-2,75-93-4,Not Classified,Notified C&L,33,Not classified:31;H318:1;H314:2
63594,"2-Amino-4,5-dimethyl-thiophene-3-carbonitrile",610-309-8,4651-94-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 3,Notified C&L,2,H331:1;H301:1;H311:1;H412:1;H302:1;H318:1
63595,"1-Propanol, 2-methyl-3-[(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)oxy]-",603-258-8,128119-70-0,Skin Irrit. 2,Notified C&L,48,H315:25;H411:23;H319:23
63598,"(1R,4aS,8R,8aS)-2,2,6,8-tetramethyl-1,2,3,4,4a,5,8,8a-octahydronaphthalen-1-ol",434-960-0,103614-86-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H410:33;H315:33;H400:32
63599,"1-(2-hydroxyethyl)-4-hydroxy-2,2,6,6-tetramethyl piperidine-succinic acid, dimethyl ester, copolymer",613-797-0,65447-77-0,Aquatic Chronic 3,Notified C&L,545,H412:283;H413:106;H410:74;Not classified:82
63600,5-ethylphenazinium ethyl sulphate,234-044-9,10510-77-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
63602,"Chromium, 8-[(5-chloro-2-hydroxyphenyl)azo]-7-hydroxy-1,3-naphthalenedisulfonic acid complex",229-047-7,6407-99-4,Not Classified,Notified C&L,2,Not classified:2
63605,"Zirconium, C5-23-branched carboxylate octanoate complexes",281-951-0,84067-14-1,Aquatic Chronic 4,Notified C&L,2,H413:2
63606,2-ethylhexyl hexanoate,240-447-0,16397-75-4,Not Classified,Notified C&L,6,Not classified:6
63607,N-(tert-butoxycarbonyl)-3-methyl-L-valine,613-118-8,62965-35-9,Not Classified,Notified C&L,2,Not classified:1;H315:1;H319:1;H335:1
63608,3β-hydroxypregn-5-en-20-one 3-(hydrogen succinate),225-001-5,4598-67-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,16,H312:16;H302:16;H361:16;H351:16;H332:16
63612,"Pentasodium 3-[[4-[[4-[[4-chloro-6-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-5-sulphonato-1-naphthyl]azo]-6-sulphonato-1-naphthyl]azo]naphthalene-1,5-disulphonate",279-762-3,81430-40-2,Not Classified,Notified C&L,5,Not classified:5
63613,Aluminium tris(quinolin-8-olate),218-227-0,2085-33-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H319:39;H335:39;Not classified:1;H410:1;H400:1
63614,Mebrofenin,278-877-6,78266-06-5,,Notified C&L,4,H315:4;H319:4;H335:4
63617,"7-Oxa-3,20-diazadispiro[5.1.11.2]heneicosane-20-propanoic acid, 2,2,4,4-tetramethyl-21-oxo-, tetradecyl ester",617-672-1,85099-50-9,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,52,H411:52;H315:52
63619,"1-bromo-2,4,5-trifluorobenzene",206-318-8,327-52-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H226:44;H319:44;H335:43;H315:44
63621,"Glycerides, C16-18 and C18-unsatd. mono-, di and tri-",294-582-5,91744-20-6,Not Classified,REACH registration C&L,56,Not classified:56
63622,"potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate",411-640-9,153352-59-1,Acute Tox. 4,Harmonised C&L,0,H302:0
63625,"Reaction mass of 9-[(12-oxo-6a,12-dihydro-4H-isoindolo[2,1-a]heteropolycycl-10-yl)oxy]-12H-isoindolo[2,1-a]heteropolycycl-12-one, 10,10'-oxydi(12H-isoindolo[2,1-a]heteropolycycl-12-one) and 9,9'-oxydi(12H-isoindolo[2,1-a]heteropolycycl-12-one)",421-640-0,,Aquatic Chronic 4,REACH registration C&L,1,H413:1
63626,"Sodium [μ-[4-[[5-[(5-chloro-2-hydroxyphenyl)azo]-2,4-dihydroxyphenyl]azo]-3-hydroxy-7-nitronaphthalene-1-sulphonato(5-)]]dihydroxydichromate(1-)",307-694-7,97692-41-6,,Notified C&L,9,H411:8;Not classified:1
63634,"Kinase (enzyme-activating), strepto-",232-647-1,9002-01-1,Resp. Sens. 1,Notified C&L,131,H334:131
63636,"1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoate",604-465-6,145202-66-0,Eye Irrit. 2,Notified C&L,132,H319:91;H360:40;H372:35;H302:36;H361:36;H336:36;H312:1;H362:1;H412:1;H318:1
63639,"Oils, fish",232-402-9,8016-13-5,Not Classified,Notified C&L,19,Not classified:19
63645,Dibutylammonium trihydrogen diphosphorate,240-730-9,16687-06-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:38;H302:38;H312:38;Not classified:6
63646,"Alcohols, C16-18 and C18-unsatd.",268-106-1,68002-94-8,Not Classified,REACH registration C&L,889,Not classified:806;H315:83;H412:83
63648,"2-Butyloctan-1-ol, ethoxylated",500-144-9,60636-37-5,Not Classified,Notified C&L,9,Not classified:3;H318:6;H302:3
63651,"Sodium 5-chloro-2-[4-chloro-2-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]phenoxy]benzenesulphonate",222-654-8,3567-25-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H332:41;H302:41
63658,Phenytoin,200-328-6,57-41-0,Acute Tox. 4;Carc. 2;Repr. 1B,REACH registration C&L,198,H351:148;H302:198;H360:193;H350:44;H317:6;H319:2;H315:2;H335:2;H341:1;H372:2;H370:2;H340:2
63660,"Poly(oxy-1,2-ethanediyl), a,a'-[[methyl[3-(tridecyloxy)propyl]iminio]di-2, 1-ethanediyl]bis[w-hydrosy-, branched, chlorides",614-661-3,68610-19-5,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,53,H314:53;H302:53;H413:31;H226:31;H318:31;H411:22
63664,Benzylmagnesium chloride,230-039-0,6921-34-2,Flam. Liq. 2;Skin Corr. 1B;STOT SE 3;STOT SE 3;Carc. 2,REACH registration C&L,72,H314:72;H335:4;H225:29;H351:4;H336:3;H224:4;H361:4;H318:1
63667,"5-amino-2-chloro-N-(2,4-dimethylphenyl)benzenesulphonamide",275-269-2,71215-81-1,Aquatic Chronic 2,REACH registration C&L,40,H411:2;H302:38
63672,Ethyl(5-isocyanato-2-methylphenyl)carbamoyl chloride,276-048-3,71832-33-2,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1,Notified C&L,25,H334:25;H330:25;H317:25;H314:25;H318:25
63677,Isononyl acetate,254-898-6,40379-24-6,Not Classified,REACH registration C&L,180,Not classified:128;H411:52;H315:52
63678,"2-methyl-2-nitropropane-1,3-diol",201-031-4,77-49-6,,Notified C&L,4,H315:4;H319:4;H335:4
63693,tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II),403-210-4,108300-90-9,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0
63696,Butyl 2-ethylhexanoate,270-543-8,68443-63-0,Not Classified,Notified C&L,1,Not classified:1
63699,"Tricyclo[3.3.1.13,7]decane",206-001-4,281-23-2,Aquatic Acute 1,REACH registration C&L,51,H400:49;H319:5;H410:1;H302:1
63700,4-benzylideneaminophenol,209-620-8,588-53-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H315:38;H335:38;H318:38;H302:1
63705,Blue MOP 6314,440-780-3,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H319:2;H317:2
63706,"N,N,2,2-tetramethylpropane-1,3-diamine",258-501-7,53369-71-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H226:39;H314:39;H318:1
63707,4-chloro-5-sulphamoylbenzoic acid,214-882-1,1205-30-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,56,H315:53;H319:53;H335:52;Not classified:2;H302:1
63709,2-(4-methyl-3-pentenyl)anthraquinone,428-320-1,71308-16-2,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H413:0;H302:0;H317:0
63710,"Didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate",252-939-2,36265-41-5,Not Classified,REACH registration C&L,30,Not classified:30
63712,"2-[[4-chloro-6-[[8-hydroxy-3,6-disulpho-7-[(1-sulpho-2-naphthyl)azo]-1-naphthyl]amino]-1,3,5-triazin-2-yl]amino]-5-sulphobenzoic acid",300-001-9,93919-17-6,Not Classified,Notified C&L,9,Not classified:9
63714,"Hydrocarbons, C6, n-alkanes, isoalkanes, cyclics, n-hexane rich",917-485-8,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,6,H411:6;H315:6;H373:6;H361:6;H225:6;H336:6;H304:6
63715,"Zinc O,O'-diisopropyl bis[dithiocarbonate]",213-680-0,1000-90-4,,Notified C&L,36,Not classified:36
63716,"Distillates (coal tar), upper, fluorene-rich;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]",284-900-0,84989-11-7,Carc. 1B,Harmonised C&L,0,H350:0
63718,"Methyloxirane, polymer with oxirane ether with 1,2,3-propanetriol polymer with 1,1'-methylenebis[4-isocyanatobenzene]",611-860-7,59675-67-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;STOT RE 2,Notified C&L,44,H334:42;H315:42;H317:42;H373:42;H335:42;H319:42;H332:42;H351:17;Not classified:2
63719,Calcium diethyl difumarate,263-369-9,62008-22-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:40
63720,"4-Fluoro-1,3-dioxolan-2-one",601-313-0,114435-02-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,43,H319:39;H315:39;H302:39;H317:39;Not classified:3;H335:1
63723,"reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione",421-550-1,,Skin Sens. 1;Carc. 1B;Aquatic Chronic 3;Repr. 1B,Harmonised C&L,0,H350:0;H412:0;H360:0;H317:0
63726,α-hydroxypyridine-3-acetic acid,256-481-4,49769-60-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H335:1;H318:1
63734,Diisopropyl phosphorofluoridate,200-247-6,55-91-4,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,39,H310:39;H300:39;H330:39
63738,"Disodium hydrogen 5-[[4-[[4-[[4-[(4-amino-9,10-dihydro-9,10-dioxo-3-sulphonato-1-anthryl)amino]-2-sulphonatophenyl]amino]-6-morpholino-1,3,5-triazin-2-yl]amino]phenyl]azo]salicylate",277-039-7,72927-98-1,Not Classified,Notified C&L,1,Not classified:1
63739,"1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-acetic acid, compound with 6-amino-2-methylheptan-2-ol (1:1)",233-205-0,10075-18-0,Acute Tox. 4;STOT SE 2,Notified C&L,36,H371:35;H302:36
63741,17β-hydroxyandrost-4-en-3-one decanoate,227-226-4,5721-91-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,56,H332:56;H351:56;H302:55;H312:55;H360:17;H373:1
63744,"4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2,5-dimethylphenol] S,S-dioxide",204-736-5,125-31-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:45;H319:45;H335:44;Not classified:1
63745,"Potassium N-[(5-amino-1,3,3-trimethylcyclohexyl)methyl]-β-alaninate",283-118-7,84540-26-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H315:25;H319:25
63748,G2S78,472-670-6,,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H302:1
63751,"1H-Pyrido(4,3-b)indole, 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-",638-815-4,3613-73-8,Eye Irrit. 2,Notified C&L,67,H319:38;H413:29
63752,Phenethyl isobutyrate,203-116-1,103-48-0,Not Classified,REACH registration C&L,1657,Not classified:1656;H412:1
63756,C.I. Acid Green 68,612-624-6,61901-32-4,Not Classified,Notified C&L,1,Not classified:1
63760,"3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide",406-840-8,101664-25-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
63763,"Quaternary ammonium compounds, N,N,N'-tris(hydroxyethyl)-N,N'- dimethyl-N'-tallow alkyltrimethylenedi-, ethoxylated, sulfates (1:1) (salts)",614-883-0,68989-99-1,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,37,H319:37;H412:37
63767,1-ethyl-1H-pyrazol-5-amine,609-110-9,3528-58-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:51;H319:51;H335:51
63768,1-aminoanthraquinone,201-423-5,82-45-1,,Notified C&L,10,H315:5;H319:6;H335:5;H332:2;H312:2;Not classified:2;H410:1;H400:1
63769,"3,4-dinitrotoluene",210-222-1,610-39-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H341:0;H411:0;H373:0;H301:0;H311:0;H361:0;H350:0;H331:0
63776,3-methoxy-5-methylphenol,221-716-1,3209-13-0,Acute Tox. 4,Notified C&L,1450,H302:1406;H315:45;H319:45;H335:44
63781,"nickel diperchlorate;perchloric acid, nickel(II) salt",237-124-1,13637-71-3,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H341:0;H317:0;H314:0;H400:0;H372:0;H350:0;H410:0;H360:0
63782,"Apricot, ext.",272-046-1,68650-44-2,Flam. Liq. 3,Notified C&L,1459,H226:1310;Not classified:121;H224:24;H225:1;H302:3;H411:1;H315:1;H304:1;H373:1;H335:1;H319:1;H332:1
63786,2-nitro-N-phenylaniline,204-348-6,119-75-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H315:59;H319:59;H335:59
63787,Benzyl(cyclohexyl)dimethylammonium chloride,245-452-1,23145-46-2,Aquatic Chronic 3,Notified C&L,22,H412:22
63788,"disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate",432-980-4,243858-60-8,Eye Dam. 1,Harmonised C&L,0,H318:0
63790,"Amides, tallow, N-(hydroxyethyl)",292-546-3,90640-29-2,Not Classified,Notified C&L,1,Not classified:1
63795,"4-Methoxy-2,3,5-Trimethylpyridine HCl",600-915-0,109371-19-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H319:1;H335:1
63796,"Phosphoric acid, C12-14-branched and linear alkyl esters, compds. with diethanolamine",306-948-4,97467-99-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H315:8;H318:8
63797,"2,6-di-tert-butyl-α-dimethylamino-p-cresol",201-816-1,88-27-7,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,268,H400:41;H317:60;H302:262;H410:41;H319:121;Not classified:6;H413:6;H315:5;H335:4
63798,N-(2-benzylphenyl)-2-chloroacetamide,606-793-5,21535-43-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H315:2;H319:2;H317:1
63799,"7-[[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-3,5-dihydroxy-2-(4-hydroxyphenyl)-4H-benzopyran-4-one",241-377-3,17353-03-6,Acute Tox. 4,Notified C&L,1,H302:1
63803,"2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide",700-227-1,40722-73-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Carc. 2;Aquatic Chronic 4,Notified C&L,1,H315:1;H302:1;H413:1;H351:1;H319:1
63805,"Soaps, stocks, capelin-oil, acidulated, hydrogenated",297-500-6,93572-69-1,Not Classified,Notified C&L,1,Not classified:1
63806,"Gases (petroleum), depropanizer bottoms fractionation off;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]",271-742-2,68606-34-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;Not classified:0;H340:0
63809,"1,4-diiodobutane",211-032-1,628-21-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:44;H319:44;H335:39;H332:1;H302:1;H312:1
63810,Sodium tetrapropylenebenzenesulphonate,234-289-1,11067-82-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,76,H412:58;H315:75;H302:76;H318:75;H411:17
63811,Pentobarbital,200-983-8,76-74-4,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4;Repr. 2,REACH registration C&L,42,H301:42;H361:41;H332:2;H312:2
63815,"Hydrocarbons, C5, ethylene-manuf.-by-product, hydrogenated",295-765-2,92128-68-2,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 2;Carc. 1B;Aquatic Chronic 2,Notified C&L,83,H341:83;H411:83;H315:83;H302:83;H225:83;H350:83;H336:83;H304:83
63818,"2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane",408-200-3,63187-91-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H315:0;H318:0
63819,"2,5-dimercaptomethyl-1,4-dithiane",419-770-8,136122-15-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H314:0;H302:0;H410:0
63820,"1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione",421-080-7,161462-35-7,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H400:0
63821,"dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate",407-310-9,122630-55-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
63825,"Acetic acid, esters with turpentine-oil myrcene fraction terpene alcs.",273-868-3,69103-01-1,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1406,H412:15;H317:15;Not classified:1391
63829,"Reaction mass of 11a,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione and metarhizium anisopliae biomass",700-181-2,,Repr. 1B;STOT RE 2,Notified C&L,1,H373:1;H360:1
63831,Petrolatum;[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C,232-373-2,8009-03-8,Carc. 1B,Harmonised C&L,0,H350:0
63832,"5-mercapto-3-phenyl-1,3,4-thiadiazole-2(3H)-thione, potassium salt",228-718-1,6336-51-2,,Notified C&L,5,H315:4;H302:5;H335:4;H319:4;H332:4
63835,"2,4-Dimethoxytoluene",609-515-0,38064-90-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
63846,2'-methoxycinnamaldehyde,216-131-3,1504-74-1,Not Classified,Notified C&L,300,Not classified:262;H315:38;H319:38;H335:38
63847,"2,6-dimethylbenzenethiol",204-272-3,118-72-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1444,H315:1444;H319:1444;H335:1443;H312:4;H302:4;H331:4
63849,"[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)",421-940-1,28698-31-9,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H318:0
63850,(4-chloro-2-fluorophenyl)methanamine hydrochloride,606-507-9,202982-63-6,,Notified C&L,5,H315:5;H319:5;H335:5;H302:1
63856,"Sodium [2-[(2,6-dichlorophenyl)amino]phenyl]acetate",239-346-4,15307-79-6,Acute Tox. 4;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,290,H411:102;H372:110;H302:66;H361:133;H301:224;H315:38;H319:37;H362:9;H310:4;H331:7;H311:7;H412:17;H373:5;H413:1;H335:1;H330:3;H360:3;H332:1;H370:1
63859,"(3S,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diamine",818-745-2,125335-70-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H302:1;H335:1;H318:1
63863,"N,N'''-1,6-hexanediylbis[N'-cyanoguanidine]",240-032-4,15894-70-9,Not Classified,REACH registration C&L,86,Not classified:85;H411:1
63871,"Fatty acids, C6-19-branched, lead salts, basic",271-675-9,68603-83-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,16,H400:16;H302:16;H410:16;H332:16;H360:16
63875,Sodium dibutylnaphthalenesulphonate,246-960-6,25417-20-3,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,346,H332:299;H302:313;H335:157;H318:247;H315:126;H412:142;H319:36;Not classified:33
63880,1-benzyl-4-[(3-chlorophenyl)amino]piperidine-4-carbonitrile,282-546-1,84254-99-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H315:38;H400:38;H335:38;H410:38;H318:38
63883,"Pyridinium, 3,5-dimethyl-1-(phenylmethyl)-, chloride",416-110-0,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1
63884,(5-Carboxypentyl)triphenylphosphonium Bromide,610-581-8,50889-29-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:43;H319:43;H335:42;H332:2;H302:2;H312:2
63886,"N,N-diethylbenzene-p-diamine monohydrochloride",218-598-9,2198-58-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H315:38;H301:38;H311:38;H335:38;H331:38;H319:38
63888,"methidathion (ISO);2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate",213-449-4,950-37-8,Acute Tox. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H300:0;H410:0;H312:0;H400:0
63892,"1H-Perylo[3,4-cd]pyridine-1,3(2H)-dione",608-929-9,33955-44-1,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,84,H413:84;H319:84
63894,2-(diphosphonomethyl)succinic acid,403-070-4,51395-42-7,Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H317:0;H314:0
63898,Dirubidium oxide,241-993-2,18088-11-4,Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,41,H260:41;H318:41;H314:41
63899,TRANSLUZONE,424-860-5,,Acute Tox. 4;Skin Sens. 1B,Notified C&L,25,H302:25;H317:25
63900,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-diisocyanatomethylbenzene",923-227-5,9017-09-8,,Notified C&L,33,Not classified:33
63908,"Rosin, maleated, reaction products with bisphenol A, formaldehyde and pentaerythritol",293-655-9,91081-50-4,Not Classified,Notified C&L,8,Not classified:8
63916,"1,1,2,2-tetraphenylethane-1,2-diol",207-356-8,464-72-2,Not Classified,Notified C&L,67,Not classified:65;H410:2;H400:2
63917,"2,9-bis(4-ethoxyphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",246-018-4,24108-89-2,Not Classified,Notified C&L,20,Not classified:20
63918,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., calcium salts",284-903-7,84989-14-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,137,H412:108;H315:121;H318:137;H411:16;H302:17
63919,"(17β)-13-ethyl-3-methoxy-gona-1,3,5(10)-trien-17-yl acetate",604-939-2,154095-77-9,Skin Sens. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H373:2;H410:2;H400:2;H317:2
63920,Calcium bis[4-[[1-[[(2-methylphenyl)amino]carbonyl]-2-oxopropyl]azo]-3-nitrobenzenesulphonate],235-558-6,12286-66-7,Not Classified,REACH registration C&L,240,Not classified:239;H412:1
63922,"Cyclopentane, methoxy-",611-360-9,5614-37-9,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,109,H225:109;H319:104;H315:70;H302:109;H312:33;H412:3
63923,"Fatty acids, rape-oil, Me esters, sulfurized",287-062-4,85408-98-6,Not Classified,Notified C&L,441,Not classified:441
63924,"2-(bromomethyl)-1,3-difluorobenzene",285-652-6,85118-00-9,Skin Corr. 1B,REACH registration C&L,81,H314:81;H319:2;H335:2;H318:1;H290:1
63925,"(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-OL",605-076-4,156928-09-5,Acute Tox. 4;STOT RE 1,REACH registration C&L,2,H372:2;H302:2
63927,Quinine dihydrochloride,200-493-4,60-93-5,Acute Tox. 4;Skin Sens. 1A,REACH registration C&L,4,H302:4;H317:1
63929,Ethyl 4-phenylpiperidine-4-carboxylate hydrochloride,246-276-8,24465-45-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,1,H301:1;H311:1;H330:1
63930,diethanolamine perfluorooctane sulfonate,274-460-8,70225-14-8,Acute Tox. 4;Acute Tox. 4;Carc. 2;Lact.;STOT RE 1;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H411:0;H362:0;H372:0;H302:0;H351:0;H332:0;H360:0
63932,"Alcohols, C10-12, ethoxylated",614-040-7,67254-71-1,Eye Dam. 1,Notified C&L,138,H318:118;H302:30;H319:20;H315:1;H412:2;H400:1
63934,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[(4-aminophenyl)sulfonyl]amino]-, disodium salt, reaction products with 3,4-dichlorobenzenesulfonyl chloride",290-710-9,90218-36-3,Not Classified,Notified C&L,20,Not classified:20
63936,"2-(methylamino)ethanol, compound with sulphur dioxide",244-169-0,21049-70-7,Acute Tox. 5,REACH registration C&L,85,H303:2;Not classified:83
63938,Hexyl isobutyrate,219-075-8,2349-07-7,Not Classified,REACH registration C&L,1612,Not classified:1612
63939,"4-trans-Pentyl-4'-trans-propyl-[1,1'-bicyclohexyl]",618-832-3,92263-41-7,Not Classified,REACH registration C&L,1,Not classified:1
63941,1-(Ethoxy)nonafluorobutane,639-028-9,163702-05-4,Not Classified,Notified C&L,164,Not classified:52;H413:49;H315:38;H319:38;H335:38;H225:25
63943,2-hydroxy-5-octanoylbenzoic acid,417-790-1,,Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,2,H318:2;H412:2;H335:2;H317:2
63944,"2,7-Naphthalenedisulfonic acid, 5-(chloro-(2-(2-substitutedalkoxy)alkylamino)- heteromonocyclylamino)-3-(4-substitutedphenyl)azo)-4-hydroxy-, potassium sodium salt",401-420-0,,Not Classified,Notified C&L,1,Not classified:1
63945,"Copper complex of ({4-halo-6-[methyl(2-{[2-(sulfonatooxy)ethyl] sulfonyl}ethyl)amino]-1,3,5-triazin-2-yl}amino)-hydroxy-[{2-[(2-hydroxyl-5-sulfonatophenyl)diazenyl]-4,5-dimethoxyphenyl} diazenyl]polycycledisulfonic acid, tetrasodium salt",442-640-7,,Not Classified,REACH registration C&L,1,Not classified:1
63948,"1H-Indole-5-sulfonicacid, 2-phenyl-3-[2-[2-(phenylsulfonyl)phenyl]diazenyl]-, sodium salt (1:1)",618-621-6,90677-63-7,Aquatic Chronic 3,Notified C&L,3,H412:3
63950,Caesium chloride,231-600-2,7647-17-8,Repr. 2,REACH registration C&L,203,H361:120;Not classified:65;H373:32;H302:32;H341:15;H315:3;H319:3;H335:3
63953,1-Methyl-3-propylimidazolium Bromide,617-673-7,85100-76-1,Not Classified,Notified C&L,2,Not classified:1;H315:1;H319:1
63955,"2,4-difluoroaniline",206-687-5,367-25-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,53,H312:4;H400:2;H302:52;H331:49;H410:3;H311:49;H315:8;H373:4;H319:7;H332:2;H372:1;H318:1;H301:1
63958,"2-Butenoic acid, cyclohexyl ester, (2E)-",608-621-4,31416-78-1,Not Classified,Notified C&L,119,Not classified:119
63961,"3,3,4,4,5,5,6,6,6-nonafluorohexyl methacrylate",217-287-5,1799-84-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
63965,galanthaminone,610-608-3,510-77-0,Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H301:2;H331:2;H315:1;H317:1
63968,"3,3-diphenylpropiononitrile",218-926-0,2286-54-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,REACH registration C&L,5,H315:4;H319:4;H335:3;H312:1;H302:1;H332:1;Not classified:1
63971,"Disodium [μ-[[7,7'-iminobis[4-hydroxy-3-[[2-hydroxy-5-sulphamoylphenyl]azo]naphthalene-2-sulphonato]](6-)]]dicuprate(2-)",229-872-2,6798-03-4,Not Classified,REACH registration C&L,23,Not classified:7;H315:14;H319:15;H411:1
63972,"bromobenzylbromotoluene, reaction mass of isomers",402-210-1,99688-47-8,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H400:0;H317:0
63976,Disodium molybdate,231-551-7,7631-95-0,Not Classified,REACH registration C&L,707,Not classified:315;H332:238;H315:307;H319:308;H335:307;H412:85;H302:2;H361:1;H351:1;H341:1;H317:1
63978,Reaktiv-Orange DYPR 934,433-180-8,,Not Classified,REACH registration C&L,1,Not classified:1
63979,4-dimethylaminobenzoic acid,210-615-8,619-84-1,Not Classified,REACH registration C&L,44,Not classified:1;H315:43;H319:43;H335:42
63984,"Neodecanoic acid, 2,3-dihydroxypropyl ester",616-670-8,79245-77-5,Not Classified,Notified C&L,71,Not classified:71
63986,"Fatty acids, C10-18, reaction products with 3-[[2-[(2-aminoethyl)amino]ethyl]amino]propanenitrile, acetates",308-886-3,98903-84-5,Not Classified,Notified C&L,1,Not classified:1
63988,Thionyl difluoride,231-997-2,7783-42-8,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 2,Notified C&L,23,H310:23;H300:23;H330:23;H314:23;H318:1
63989,Manganese bis(phosphinate),233-143-4,10043-84-2,Not Classified,Notified C&L,2,Not classified:2
63993,1-(4'-fluorophenyl)piperazine,218-846-6,2252-63-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:39;H315:39;H302:40;H335:39;H301:5;H314:6;H318:1;H312:1
64002,"(E)-1-propene-1,2,3-tricarboxylic acid",223-688-6,4023-65-8,Not Classified,REACH registration C&L,14,Not classified:7;H315:7;H319:7;H335:6
64006,"(1S,2S)-(-)-1,2-Diphenylethane-1,2-diamine",608-420-1,29841-69-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H315:44;H319:43;H335:43;H314:4;H302:3;H312:2;H332:1;H318:1
64007,Malonyl dichloride,216-772-9,1663-67-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,65,H226:65;H314:65;H318:2
64011,Lithium hydride,231-484-3,7580-67-8,Water-react. 1;Skin Corr. 1B,REACH registration C&L,74,H260:74;H314:74;H301:42;H318:4;H371:4;H331:4
64013,Barium bis(4-anilinobenzenesulphonate),228-278-0,6211-24-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,80,H332:79;H302:79;Not classified:1;H301:1;H331:1
64015,Sodium β-alaninate,240-734-0,16690-93-0,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,85,H318:85;H314:85
64019,"Benzenesulfonic acid, 4,4'-[1,3-phenylenebis[azo(4,6-diamino-3,1-phenylene)azo]]bis-",607-602-8,25180-42-1,Not Classified,Notified C&L,1,Not classified:1
64021,1-(6-methoxy-2-naphthyl)ethan-1-one,223-453-8,3900-45-6,Skin Irrit. 2,REACH registration C&L,44,H315:43;H335:41;H319:3;H302:1
64022,"5,5'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[3-methylsalicylic] acid, potassium salt, compound with 2,2',2''-nitrilotriethanol",286-555-1,85269-31-4,,Notified C&L,33,Not classified:33
64026,"Fatty acids, C18-unsatd., dimers",500-148-0,61788-89-4,Not Classified,REACH registration C&L,1130,Not classified:1039;H315:60;H319:60;H412:59;H413:31
64030,oxydiethylene dinitrate;diethylene glycol dinitrate;digol dinitrate;[>25 % phlegmatiser],211-745-8,693-21-0,,,0,H310:0;H330:0;H412:0;H373:0;H200:0;H300:0
64031,Chlorek cobaltawy,616-574-6,7791-13-1,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,88,H334:87;H341:75;H317:87;H400:86;H302:88;H350:88;H410:86;H360:74;H411:1;H315:1
64034,"Fatty acids, C14-18 and C16-18-unsatd., esters with trimethylolpropane",284-865-1,84988-76-1,Not Classified,Notified C&L,1,Not classified:1
64035,Clotrimazole,245-764-8,23593-75-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,333,H315:265;H400:277;H302:327;H410:279;H319:300;H373:35;H311:35;H361:35;H335:2;Not classified:3;H301:1;H332:1;H312:1
64037,Ethyl 2-(Aminosulfonyl)benzoate,611-882-7,59777-72-9,Eye Irrit. 2,Notified C&L,21,H319:21;H315:2
64038,Methyl (2-hydroxyphenyl)acetate,245-004-5,22446-37-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:2;H335:2
64039,"3-methyltetrahydrothiophene 1,1-dioxide",212-833-9,872-93-5,Acute Tox. 3;Eye Irrit. 2;STOT RE 2;STOT RE 2,REACH registration C&L,2,H373:2;H301:2;H319:2
64041,Vetrabutine hydrochloride,227-771-8,5974-09-4,Not Classified,Notified C&L,1,Not classified:1
64042,L-(-)-xylose,210-174-1,609-06-3,Not Classified,Notified C&L,6,Not classified:5;H315:1;H319:1;H335:1
64043,Dl-α-methylbenzylamine,210-545-8,618-36-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H302:0;H312:0;H314:0
64044,"(3S,6E)- 3,7,11-trimethyldodeca-6,10-dien-1-ol",450-320-3,,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H315:2;H400:2;H317:2
64047,2-cyano-N-[(ethylamino)carbonyl]acetamide,255-202-3,41078-06-2,Not Classified,Notified C&L,13,Not classified:13
64051,"Arnica montana, ext.",273-579-2,68990-11-4,Not Classified,Notified C&L,209,Not classified:204;H302:2;H226:3;H319:1
64052,O-(4-hydroxy-3-iodophenyl)-3-iodo-L-tyrosine,225-005-7,4604-41-5,Acute Tox. 4,Notified C&L,38,H302:38
64056,"Sodium [3-[[3-[[4-[[[4-[(2-amino-4-hydroxyphenyl)azo]phenyl]amino]carbonyl]phenyl]azo]-2,4-dihydroxyphenyl]azo]-4-hydroxybenzenesulphonato(3-)]cuprate(1-)",289-066-1,85959-71-3,Not Classified,Notified C&L,1,Not classified:1
64059,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, (butylamino)sulfonyl [(2-ethylhexyl)amino]sulfonyl derivs.",279-766-5,81457-64-9,Not Classified,Notified C&L,5,Not classified:5
64061,Tribromoethylene,209-920-9,598-16-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H315:2;H312:1;H302:2;H335:1;H319:2;H332:2
64063,"(8R,9S,10R,13S,14S,17R)-17-ethynyl-10,13-dimethyl-1,2,4,7,8,9,10,11,12,13,14,15,16,17,-tetradecahydrospiro[cyclopenta[a]phenanthrene-3,2´-[1,3]dioxolan]-17-ol",610-527-3,50407-76-6,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H373:1;H410:1;H400:1
64067,2-Bromo-3-methylbenzoic Acid,611-027-8,53663-39-1,,Notified C&L,9,H315:9;H319:9;H335:8
64069,N-(2-aminoethyl)-N'-octadecylethylenediamine,230-683-2,7261-63-4,Skin Sens. 1,REACH registration C&L,2,H317:2
64070,"1,3-Pentadiene, polymer with 2-methyl-2-butene",608-001-3,26813-14-9,Not Classified,Notified C&L,6,Not classified:6
64072,(Z)-oct-3-en-1-ol,243-533-6,20125-84-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1399,H315:1287;H400:1286;H302:1286;H319:1287;H332:1286;Not classified:112;H335:1
64073,S195178,466-670-5,,Skin Sens. 1,Notified C&L,1,H317:1
64075,"Ylang-ylang, ext.",281-092-1,83863-30-3,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1705,H317:1703;H412:1699;H315:1694;H304:1702;H411:4;H319:1560;H361:6;Not classified:5;H331:1;H226:1;H413:1
64079,"Vetiveria zizanioides, ext., acetylated",282-031-1,84082-84-8,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1406,H411:1405;H317:1405;H304:1
64083,"3,4-(methylenedioxy)aniline",238-161-6,14268-66-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H315:47;H319:47;H335:42;H312:6;H302:7;H332:6;H331:2;H301:2;H311:2
64085,"2,2-diphenyltetrahydrofuran",212-957-3,887-15-0,Acute Tox. 4,Notified C&L,38,H302:38
64087,[No public or meaningful name is available],468-910-4,,Eye Dam. 1,Notified C&L,1,H318:1
64093,"7-chloro-1,3-dihydro-1-methyl-5-phenyl-2-oxo-2H-1,4-benzodiazepin-3-yl acetate",242-597-2,18818-64-9,Not Classified,REACH registration C&L,4,Not classified:4
64095,"tris(2-methoxyethoxy) vinylsilane; 6-(2-methoxyethoxy)- 6-vinyl-2,5,7,10-tetra­oxa-6-silaundecane",213-934-0,1067-53-4,Repr. 1B,Harmonised C&L,0,H360:0
64099,4-propoxyaniline,224-740-0,4469-80-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H319:38;H335:38
64101,9-decenyl acetate,256-784-1,50816-18-7,Not Classified,Notified C&L,267,Not classified:267
64103,Cerium molybdenum oxide,258-899-2,53986-44-0,Not Classified,Notified C&L,5,Not classified:5
64104,cis-hex-3-en-1-yl methyl carbonate,266-797-4,67633-96-9,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,1582,H315:8;H317:33;Not classified:1548;H411:1
64107,Dibenzyl adipate,219-516-4,2451-84-5,,Notified C&L,33,Not classified:33
64112,"1,1'-(hexamethylenedioxy)bis(3-chloropropan-2-ol)",243-778-9,20387-39-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H302:1;H317:1
64114,1-chloro-1-nitropropane,209-990-0,600-25-9,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0
64115,1-methyl-3-phenylindan,229-125-0,6416-39-3,Aquatic Acute 1,Notified C&L,38,H400:38
64117,"1-phenylicosane-1,3-dione, barium salt",280-501-0,83581-80-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
64119,"2,4,6-Tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediol phosphite",605-265-1,161717-32-4,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,120,H411:71;H317:120;H413:49
64123,"Cyclohexane-1,4-diamine",221-483-6,3114-70-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,51,H302:50;H312:33;H314:51;H318:18
64127,"Sorbitan monostearate, ethoxylated",500-020-4,9005-67-8,Not Classified,REACH registration C&L,431,Not classified:431
64128,"Ferrate(2-), pentakis(cyano-C)nitrosyl-, disodium, dihydrate, (OC-6-22)-",604-025-3,13755-38-9,Acute Tox. 3,Notified C&L,75,H301:75;H332:4;H312:4;H331:1;H311:1
64135,Propyl 3-(2-furyl)acrylate,210-780-6,623-22-3,Acute Tox. 4,Notified C&L,1374,H302:1287;Not classified:87
64136,tert-butyl hydroperoxide,200-915-7,75-91-2,Muta. 2,Harmonised C&L,0,H341:0
64139,Dimethylbis(palmitoyloxy)stannane,223-385-9,3865-35-8,Repr. 2;STOT RE 1;Aquatic Chronic 4,Notified C&L,55,H413:55;H372:55;H361:55
64140,"Aniba rosaeodora, ext.",281-093-7,83863-32-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1434,H412:1434;H315:1434;H319:1391;H317:1434
64141,Sodium N-[(2-hydroxy-5-nonylphenyl)methyl]-N-methylaminoacetate,260-483-0,56968-08-2,Eye Irrit. 2,Notified C&L,114,H319:114
64142,"disul (ISO);2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;2,4-DES",205-259-5,136-78-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Harmonised C&L,0,H315:0;H302:0;H318:0
64146,Bis(3-cyclopentadienyl)chlorohydrurozirconium,253-479-5,37342-97-5,Water-react. 2;Skin Corr. 1B,Notified C&L,46,H261:45;H314:45;H228:5;H312:1;H302:1;H318:2;H332:1;H315:1;H319:1;H335:1
64147,"Dihydrogen hexahydroxyplatinate, compound with 2-aminoethanol (1:2)",268-717-3,68133-90-4,Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,88,H318:87;H410:87;H400:87;H314:87;H319:1
64150,"4-(chloromethyl)-2,2-dimethyl-1,3-dioxolane",224-452-5,4362-40-7,Flam. Liq. 3;Acute Tox. 3,Notified C&L,38,H301:38;H226:38
64152,"Dihydro-3-(tetrapropenyl)furan-2,5-dione, compound with methyl-1H-benzotriazole",276-047-8,71829-80-6,Skin Corr. 1B,Notified C&L,6,H314:6
64155,"Balsams, Douglas-fir, Pseudotsuga menziesii",308-234-8,97926-19-7,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,4,H317:4;H400:3;H410:4;H226:4;H304:4;H315:1
64156,"4,4'-methylenebis[3-hydroxy-2-naphthoic] acid, compound with 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propylamine (1:2)",233-206-6,10075-24-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:1;H302:2;H400:1;H370:1
64158,Diethyl sec-butylethylmalonate,200-980-1,76-71-1,Acute Tox. 4,Notified C&L,38,H302:38
64160,"7-anilino-3-[[4-[(2,4-dimethyl-6-sulphophenyl)azo]-6-methoxy-m-tolyl]azo]-4-hydroxynaphthalene-2-sulphonic acid",246-728-4,25188-53-8,Not Classified,Notified C&L,1,Not classified:1
64161,"2,5-di-tert-butylphenol",227-543-8,5875-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,42,H413:42;H315:42;H319:42;H335:42
64168,"Sodium [4-hydroxy-5-[(2-hydroxy-1-naphthyl)azo]benzene-1,3-disulphonato(4-)]chromate(1-)",274-914-5,70833-33-9,Not Classified,Notified C&L,1,Not classified:1
64174,Farnesol,225-004-1,4602-84-0,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1950,H410:167;H315:1937;H400:166;H317:1622;H319:1752;H334:1;H318:1;Not classified:1;H412:1
64179,"1-chloro-3,4-dinitrobenzene",210-223-7,610-40-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H400:44;H373:43;H301:44;H311:43;H331:40;H410:43;H330:4;H317:1;H371:1
64181,Methyl 1-methylcyclopropyl ketone,216-369-8,1567-75-5,Flam. Liq. 3,Notified C&L,44,H226:44;H302:1
64183,"Siloxanes and Silicones, di-Me, Me vinyl, hydroxy-terminated",614-174-6,67923-19-7,Not Classified,Notified C&L,15,Not classified:14;H319:1
64184,"Purine-2(3H),6(1H)-dione",200-718-6,69-89-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,80,H319:46;H317:41;H332:33;H302:33;Not classified:1;H312:1;H315:1;H335:1
64186,"Phenol, 2,4-dibromo-6-fluoro-",611-567-4,576-86-3,,Notified C&L,5,H319:5;H315:5;H302:5;H335:5;H312:1;H332:1
64187,"9β,11β-epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione",213-563-4,981-34-0,Not Classified,REACH registration C&L,8,Not classified:8
64189,"3-hydroxy-2,2-bis(hydroxymethyl)propyl octanoate",262-288-6,60550-73-4,,Notified C&L,1,Not classified:1
64191,"Fatty acids, C14-18 and C16-18-unsatd., 2-ethylhexyl esters",284-866-7,84988-77-2,Not Classified,Notified C&L,13,Not classified:13
64196,1-methylheptylamine,211-744-2,693-16-3,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,40,H301:40;H226:40;H314:40;H318:1
64200,"Phosphoric acid, isononyl ester, compd. with 2,2'-iminobis[ethanol]",285-408-9,85098-58-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3
64202,2-bromo-5-chlorobenzoic acid,244-559-0,21739-93-5,Acute Tox. 3;Aquatic Acute 1,Notified C&L,46,H301:44;H400:39;H315:7;H319:7;H335:6
64208,2-nitroresorcinol,210-010-9,601-89-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H315:44;H312:42;H302:42;H335:43;H319:44;H332:42
64210,"Garcinia cambogia, ext.",289-882-8,90045-23-1,Not Classified,Notified C&L,55,Not classified:54;H319:1;H335:1
64211,"tris(mixed dodecyl and octyl)benzene-1,2,4-tricarboxylate",700-342-7,1163775-81-2,Not Classified,Notified C&L,2,Not classified:2
64215,o-(allyloxy)anisole,223-935-8,4125-43-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H302:38;H335:38;H318:38
64216,"2,4,6-trimethylcyclohex-3-ene-1-methanol",271-282-2,68527-77-5,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1592,H411:50;H318:50;H315:1592;H317:1592;H319:1542;H412:31
64217,Potassium periodate,232-196-0,7790-21-8,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:52;H315:52;H272:54;H335:52
64218,"Butanedioic acid, 2-methylene-, polymer with 1,3-butadiene, ethenylbenzene and 2-propenenitrile",608-354-3,29383-53-7,Not Classified,Notified C&L,1,Not classified:1
64219,CoCoat T,603-783-2,13397-24-5,Not Classified,Notified C&L,40,Not classified:40
64220,Sodium (6R-cis)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,251-574-6,33564-30-6,Skin Sens. 1B,Notified C&L,49,H317:49;H334:6;H315:5;H335:5;H319:5;H411:1
64231,"Dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo[1,1'-bianthracene]-4,4'-diyl)bis-",603-984-5,136897-58-0,Not Classified,Notified C&L,1,Not classified:1
64232,"lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate",429-730-1,193562-37-7,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
64233,nickel bis(benzenesulfonate),254-642-3,39819-65-3,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H334:0;H341:0;H400:0;H317:0;H372:0;H350:0;H410:0;H360:0
64234,trans-hex-2-enyl acetate,219-680-7,2497-18-9,Flam. Liq. 3,Notified C&L,1572,H226:1444;Not classified:127;H319:101;H335:100;H315:101
64235,"3,5,6,6-tetramethyl-4-methyleneheptan-2-one",279-825-5,81786-75-6,Aquatic Chronic 3,Notified C&L,124,H412:76;H411:48;H317:32
64239,"Propanol, 1(or 2)-(2-propenyloxy)-, benzoate",606-361-6,197178-94-2,Not Classified,Notified C&L,21,Not classified:21
64244,Propyl 4-hydroxybenzoate,202-307-7,94-13-3,Aquatic Chronic 3,REACH registration C&L,2767,H412:19;H315:1814;H319:1901;H335:1788;Not classified:804;H336:52;H318:36;H413:10;H317:27;H400:5;H334:3;H411:1;H373:1;H332:1;H302:1
64246,Barium selenite,237-280-0,13718-59-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,55,H315:2;H400:55;H373:55;H301:55;H331:55;H410:55;H319:2
64248,"1,2,4,5-tetrafluorobenzene",206-319-3,327-54-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,66,H225:66;H315:66;H319:66;H335:65
64249,"[hydroxyacetato(2-)-O1,O2](isooctadecanoato-O)[11-[3-(pent-2-en-1-yl)oxiranyl]undec-9-enoato-O1]titanium",272-126-6,68739-04-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H335:1
64250,Methyl 6-methylpyridine-2-carboxylate,237-085-0,13602-11-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
64251,dichromium tris(chromate);chromium III chromate;chromic chromate,246-356-2,24613-89-6,Ox. Sol. 1;Skin Corr. 1A;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H314:0;H350:0;H410:0;H271:0
64254,Clioquinol,204-984-4,130-26-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,130,H301:43;H315:84;H319:84;H317:7;H335:81;H400:81;H334:4;H361:5;H302:2
64256,"Fluorophosphoric acid, sodium salt",231-552-2,7631-97-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,7,H315:7;H312:7;H302:7;H335:7;H319:7;H332:7
64257,4-ethoxybenzoic acid,210-616-3,619-86-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,47,H315:47;H319:47;H412:2;H335:44
64263,"α-methyl-1,3-benzodioxole-5-propionaldehyde",214-881-6,1205-17-0,Skin Sens. 1B;Repr. 2;Aquatic Chronic 2,REACH registration C&L,1668,H411:1628;H361:66;H317:620;H315:40;H319:40;H335:39;Not classified:2;H373:1
64264,Phenyl 1-hydroxy-2-naphthoate,205-065-0,132-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H319:39;H335:38
64265,"Amines, C12-18-alkyl, ethoxylated",615-877-0,72968-37-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,40,H411:39;H302:40;H318:38;H315:1;H400:1;H314:2
64267,8-[3-(m-amidinophenyl)-2-triazeno]-3-amino-5-ethyl-6-phenylphenanthridinium chloride hydrochloride,229-873-8,6798-24-9,Acute Tox. 3,Notified C&L,36,H301:35;H341:1;H331:1
64269,"2,3-dihydro-1,4-benzodioxin-2-methylamine",224-671-6,4442-59-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H315:39;H335:39;H318:38;H314:1;H319:1
64274,Dimethyl methylphosphonate,212-052-3,756-79-6,Eye Irrit. 2A;Muta. 1B;Repr. 2,REACH registration C&L,230,H361:142;H340:184;H318:3;H319:224;H332:42;H226:36;H412:13;H302:8;H304:1
64287,3-tert-butylphenol,209-553-4,585-34-2,Skin Corr. 1B,Notified C&L,174,H314:174;H318:76;H411:1
64290,"2,3-dimethylbenzonitrile",227-229-0,5724-56-1,Eye Irrit. 2,Notified C&L,46,H319:46;H315:8;H335:3;H302:1;H332:1
64292,Phenethyl acetate,203-113-5,103-45-7,Eye Dam. 1,REACH registration C&L,1824,H318:1433;H319:360;H315:25;H335:25;Not classified:5;H411:1
64293,5-Fluoro-o-anisaldehyde,606-310-8,19415-51-1,,Notified C&L,7,H315:7;H319:7;H335:6
64294,1-(1-Adamantyl)ethylamine Hydrochloride,604-725-9,1501-84-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H302:44;H335:43
64298,Pyrrolidine-1-acetonitrile,249-463-2,29134-29-0,Acute Tox. 3,Notified C&L,43,H301:38;H315:5;H312:5;H302:5;H319:5;H332:5
64299,Butyl methyl ether,211-033-7,628-28-4,Flam. Liq. 2,Notified C&L,39,H225:39
64301,"Pregna-4,9(11)-diene-3,20-dione, 17,21-bis(acetyloxy)-",616-506-5,7780-63-4,Not Classified,REACH registration C&L,2,Not classified:2
64303,"8-chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one",700-018-5,50892-62-1,Acute Tox. 4,REACH registration C&L,12,H302:1;H301:10;H341:9;H361:1;Not classified:1
64307,"2,4,6-trimethoxybenzoic acid",209-325-4,570-02-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:42
64309,"Erythromycin, 9-oxime",603-467-4,13127-18-9,Aquatic Chronic 2,REACH registration C&L,3,H411:3
64310,"Oils, fish-liver",232-372-7,8009-00-5,Not Classified,Notified C&L,1,Not classified:1
64313,N-(5-chloropyridin-2-yl)-5-methoxy-2-nitrobenzamide,928-655-6,280773-16-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H302:1;H312:1
64321,"4,5-dihydro-2-undecyl-1H-imidazole-1-ethylamine monoacetate",301-646-9,94023-49-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H315:3;H302:3;H318:3
64327,Argipressin,204-035-4,113-79-1,Acute Tox. 4,Notified C&L,39,H332:39
64329,6-phenyl-2-pyridone,242-740-9,19006-82-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H315:1
64333,2-Cyanoethanethioamide,615-994-7,7357-70-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H315:46;H312:46;H302:46;H335:46;H319:46;H332:46;Not classified:1
64334,"Hydrocarbons, C8-25",300-233-0,93924-39-1,Asp. Tox. 1,Notified C&L,1,H304:1
64335,"Hexanoic acid, 2-ethyl-, tridecyl ester",603-090-5,125804-07-1,Not Classified,Notified C&L,1,Not classified:1
64336,Dimethylmethoxyphenyl siloxane,614-853-7,68957-04-0,Acute Tox. 4,Notified C&L,44,H302:43;H351:1;H315:1;H319:1;H317:1
64337,3-amino-5-chloro-2-hydroxybenzenesulphonic acid,201-813-5,88-23-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,89,H315:2;H319:2;Not classified:87;H301:1;H311:1;H331:1
64338,Chlorotriphenylethylene,241-992-7,18084-97-4,Skin Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H315:38;H335:38;H400:38
64342,zinc bis(diethyldithiocarbamate),238-270-9,14324-55-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H315:0;H317:0;H400:0;H302:0;H335:0;H410:0;H319:0
64344,Valerohydrazide,253-864-8,38291-82-6,Acute Tox. 4,Notified C&L,42,H302:38;H315:4;H319:4;H335:4
64346,2-Bromo-5-methylpyridine,609-062-9,3510-66-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44;H312:4;H302:4;H332:4
64347,trans-methyl-2-ethyl-but-2-enoate,443-150-6,101226-85-1,Flam. Liq. 3,Harmonised C&L,0,H226:0
64354,"3,4-dihydro-2H-pyran-2-methanol",223-150-0,3749-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H319:40;H335:39
64360,"Fatty acids, C8-9-branched, zirconium salts",293-051-5,91051-02-4,Not Classified,Notified C&L,1,Not classified:1
64361,Pentaerythritol tetrastearate,204-110-1,115-83-3,Not Classified,REACH registration C&L,418,Not classified:418
64363,"γ,.zeta.-dioxobenzeneheptanoic acid",228-719-7,6336-53-4,Eye Dam. 1,Notified C&L,39,H318:38;H315:1;H319:1;H335:1
64365,"[nitrilotri(methylene)]tris(phosphonic) acid, compound with 2-aminoethanol and 2,2',2''-nitrilotriethanol",270-248-4,68413-75-2,Not Classified,Notified C&L,1,Not classified:1
64366,"9-Octadecenoic acid (9Z)-, polymer with N-(2-aminoethyl)-1,2-ethanediamine and 2,5-furandione",609-328-4,37080-19-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,28,H315:28;H319:28
64368,"Stannate (Sn(OH)62-), zinc (1:1), (OC-6-11)-",404-410-4,12027-96-2,Not Classified,REACH registration C&L,5,Not classified:5
64375,"Decahydro-2-hydroxy-2,5,5,8a-tetramethylnaphthalene-1-ethanol",259-880-1,55881-96-4,Not Classified,REACH registration C&L,2,Not classified:2
64376,"2,2',2'',2'''-[ethane-1,2-diylidenetetrakis(p-phenyleneoxymethylene)]tetraoxirane",230-820-6,7328-97-4,Not Classified,Notified C&L,132,Not classified:96;H341:36
64381,"Meat extracts, beef",273-578-7,68990-09-0,Not Classified,Notified C&L,29,Not classified:29
64382,"Butanedioic acid, 2-(phenylmethyl)-, (2S)-",609-742-5,3972-36-9,Not Classified,Notified C&L,1,Not classified:1
64385,3-hydroxy-2-methyl-4-pyrone,204-271-8,118-71-8,Acute Tox. 4,REACH registration C&L,1936,H302:1608;Not classified:327;H319:105;H315:116;H335:101;H312:1;H303:1;H316:1
64387,3-(p-tolyl)propionic acid,216-132-9,1505-50-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H315:45;H319:45;H335:44
64388,2-bromo-3-methoxypyridine,246-017-9,24100-18-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H315:40;H302:39;H335:39;H318:39;H319:1
64393,Silicon oxide,234-368-0,11126-22-0,Not Classified,Notified C&L,3,Not classified:3
64401,3-(dimethoxymethylsilyl)-N-methylpropylamine,250-434-1,31024-35-8,,Notified C&L,1,H315:1;H335:1;H318:1
64403,Ammonium oxalate monohydrate,611-933-3,6009-70-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,151,H302:115;H312:115;Not classified:36
64404,4'-chloro-3'-nitroacetophenone,226-769-4,5465-65-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H315:43;H319:43;H335:42;H411:6
64410,"2,8,9-trioxa-5-aza-1-borabicyclo[3.3.3]undecane",206-003-5,283-56-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:43;H319:43;H335:43
64414,Diphenyl phthalate,201-546-4,84-62-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,43,H315:39;H319:39;H335:39;H400:38;Not classified:4;H334:1
64416,"(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-nitrophenyl carbonate",605-685-5,173604-87-0,Ox. Sol. 3;Aquatic Chronic 2,Notified C&L,2,H411:1;H272:1;Not classified:1
64420,C.I. Reactive Yellow 81,611-795-4,59112-78-6,Not Classified,Notified C&L,1,Not classified:1
64421,Sodium hexahydroxoantimonate,251-735-0,33908-66-6,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,23,H332:13;H411:13;H302:12;Not classified:4;H372:4;H360:8;H412:6
64422,"9,10α-dihydro-12'-hydroxy-2',5'α-diisopropylergotaman-3',6',18-trione monomethanesulphonate",238-162-1,14271-04-6,Repr. 2,Notified C&L,1,H361:1
64423,"4-(5-butyl-1,3-dioxan-2-yl)benzonitrile",278-000-7,74800-54-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
64427,nickel tellurium trioxide,239-967-0,15851-52-2,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H334:0;H400:0;H317:0;H372:0;H350:0;H410:0
64429,(E)-oct-2-en-1-ol,242-288-2,18409-17-1,Not Classified,Notified C&L,177,Not classified:138;H315:39;H319:39;H335:39
64432,"2,2-Dimethoxycyclohexanol",613-331-6,63703-34-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,121,H315:83;H302:83;H318:83;H226:38
64444,"(2-hydroxy-1,1-dimethylethyl)ammonium chloride",221-713-5,3207-12-3,Not Classified,Notified C&L,39,Not classified:39
64449,"Fatty acids, C16-18 and C18-unsatd., esters with pentaerythritol",288-305-7,85711-45-1,Not Classified,REACH registration C&L,96,Not classified:96
64451,"7-(2-bromoethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione",245-454-2,23146-05-6,Acute Tox. 4,REACH registration C&L,5,H302:5;H334:1
64453,(+)-bornan-2-one,207-355-2,464-49-3,Flam. Sol. 2;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 2,REACH registration C&L,1734,H315:106;H228:1729;H318:44;H332:1587;H371:1670;H302:1480;H330:84;H335:57;H319:63;H411:35;H226:3;Not classified:2;H225:1
64457,Durasyn 164X,700-184-9,,Not Classified,Notified C&L,1,Not classified:1
64462,"4,4a,5,6-tetrahydro-7-methylnaphthalene-2(3H)-one",252-079-8,34545-88-5,Not Classified,Notified C&L,89,Not classified:89
64466,"Fuel oil, No 4;Gasoil - unspecified;[A distillate oil having a minimum viscosity of 45 SUS at 37,7 °C (100 °F) to a maximum of 125 SUS at 37,7 °C (100 °F).]",270-673-5,68476-31-3,Carc. 2,Harmonised C&L,0,H351:0
64468,"2-(bromomethyl)-1,4-difluorobenzene",285-651-0,85117-99-3,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,46,H225:40;H314:46;H319:1;H224:1;H318:1;H290:1;H335:1
64469,Ethyl 4-[[(ethylphenylamino)methylene]amino]benzoate,265-932-4,65816-20-8,Skin Irrit. 2,Notified C&L,38,H315:38
64470,"1,4-Dithia-7-azaspiro[4.4]nonane-8-carboxylic acid, hydrobromide, (S)-",616-260-9,75776-79-3,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,11,H318:10;H315:10;H317:10;Not classified:1
64476,"5,5-diphenyl-2-thioxoimidazolidin-4-one",244-201-3,21083-47-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
64481,"1,8-dihydroxy-4,5-dinitroanthraquinone",201-360-3,81-55-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,74,H315:43;H319:43;H335:42;Not classified:31
64482,cadmium hydroxide;cadmium dihydroxide,244-168-5,21041-95-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H400:0;H372:0;H302:0;H350:0;H410:0;H340:0;H332:0
64487,antimony pentachloride,231-601-8,7647-18-9,Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H314:0
64492,"2-bromospiro-9,9'-bifluorene",605-609-0,171408-76-7,Not Classified,REACH registration C&L,1,Not classified:1
64495,"2,4-difluorophenol",206-688-0,367-27-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,46,H315:42;H312:46;H302:46;H335:41;H318:41;H332:42;H314:4;H228:4;H226:3;H319:1
64496,"3,5-dichloro-4-hydroxybenzonitrile",217-572-4,1891-95-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,43,H315:42;H301:39;H311:39;H335:42;H331:39;H319:42;H312:4;H302:4;H332:4
64500,Chlorodifluoroacetyl chloride,206-551-5,354-24-5,Skin Corr. 1B,Notified C&L,2,H314:2
64504,5-chloro-2-(4-chlorophenoxy)phenol;[DCPP],429-290-0,3380-30-1,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H318:0
64505,"(3,3-diphenylpropyl)(1-phenylethyl)ammonium chloride",237-121-5,13636-18-5,Acute Tox. 4,Notified C&L,38,H302:38
64510,"Reaction product of Phenol, 2,2'-[(1-methylethylidene)bis[(2,6-dibromo-4,1-phenylene)oxymethylene]]bisoxirane and 4,4'-(1-methylethylidene)bis[phenol], Ph ethers with 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane",600-581-6,1045809-53-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H315:1;H319:1;H317:1
64512,"3,3,4,4,5,5,6,6,7,7,8,8-dodecafluorodeca-1,9-diene",217-288-0,1800-91-5,Aquatic Chronic 4,REACH registration C&L,4,H413:1;H226:1;H373:1;H412:1;H315:1;H319:1;H335:1
64513,"α,α,α-trifluoro-o-tolyl isocyanate",218-925-5,2285-12-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,77,H226:44;H319:44;H335:42;H315:44;Not classified:33;H334:6;H330:6;H302:2
64515,1-(4-chlorophenyl)pyrazol-3-ol,616-307-3,76205-19-1,Aquatic Chronic 2,REACH registration C&L,93,H411:2;H315:91;H319:91;H335:91
64516,Cinchophen,205-067-1,132-60-5,Acute Tox. 4,Notified C&L,45,H302:45
64520,C.I. Reactive Blue 13,602-655-3,12236-84-9,Not Classified,Notified C&L,1,Not classified:1
64523,2-(2-hydroxyethoxy)ethyl benzoate,243-895-5,20587-61-5,Not Classified,Notified C&L,63,Not classified:63
64524,Sodium dithionate,231-550-1,7631-94-9,Not Classified,Notified C&L,1,Not classified:1
64526,trans-hexahydroterephthalic acid,210-614-2,619-82-9,Eye Irrit. 2,Notified C&L,14,H319:14;H315:5;H335:3;H302:1
64527,"Phosphoric acid, magnesium salt",233-142-9,10043-83-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,12,H311:10;H331:10;H302:10;H314:10;Not classified:2
64531,Phenylamidine,210-546-3,618-39-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,246,H319:246;H315:205;H302:246;H335:205
64535,"1-ETHOXY-2-(TRIFLUOROMETHYL)-1,1,2,3,3,3-HEXAFLUOROPROPANE AND 1,1,1,2,2,3,3,4,4-NONAFLUORO-4-ETHOXYBUTANE",639-027-3,163702-06-5,Eye Irrit. 2,Notified C&L,1423,H319:1325;Not classified:52;H413:46;H315:38;H335:38
64536,(triethoxymethyl)benzene,216-771-3,1663-61-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H315:41;H319:41;H335:41;H302:1
64540,"1-(1,3-benzodioxol-5-yl)acetone",225-128-6,4676-39-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H319:2;H335:2
64543,Tamoxifen,234-118-0,10540-29-1,Acute Tox. 4;Carc. 1A;Repr. 1A;Lact.,REACH registration C&L,10,H362:6;H350:10;H302:7;H360:10;H400:4;H372:4;H410:4;H341:1
64545,Tris(2-cyanoethyl)phosphine,223-687-0,4023-53-4,,Notified C&L,6,H315:6;H330:4;H301:5;H335:6;H319:6;H311:1;H331:2;H302:1;H350:1
64547,[2H4]ammonium chloride,234-607-9,12015-14-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
64551,Disodium L-glutamate,240-733-5,16690-92-9,Eye Irrit. 2,Notified C&L,29,H319:28;Not classified:1
64552,Nifuratel,225-576-2,4936-47-4,Not Classified,Notified C&L,2,Not classified:2
64554,4-[(4-chloropyrimidin-2-yl)amino]benzonitrile,607-384-4,244768-32-9,Not Classified,REACH registration C&L,3,Not classified:2;H315:1;H312:1;H302:1;H319:1;H332:1
64557,Dihexyl hydrogen phosphate,223-452-2,3900-13-8,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,84,H411:83;H318:83;H314:83;Not classified:1
64559,"methyl (16β,17α,20α)-17-hydroxyyohimban-16-carboxylate hydrochloride",228-279-6,6211-32-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H331:38;H301:39;H311:38
64561,"Castor oil, hydrogenated, ethoxylated",500-147-5,61788-85-0,Not Classified,REACH registration C&L,2027,Not classified:1550;H319:476;H332:1
64570,"trans,trans-4-((Z)-Propen-1-yl)-4'-propyl-bicyclohexan",922-166-1,,Aquatic Chronic 4,REACH registration C&L,1,H413:1
64571,"3,4-Dimethoxybenzenesulfonylchloride",607-197-8,23095-31-0,Skin Corr. 1B,Notified C&L,43,H314:43
64572,"Sodium 4,4'-bis(4-phenyl-2H-1,2,3-triazol-2-yl)stilbene-2,2'-disulphonate",286-163-0,85187-75-3,,Notified C&L,33,Not classified:33
64574,"5,5-dimethyl-1,3-dioxane",212-834-4,872-98-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
64575,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, disodium salt, reaction products with 4-[(4-aminophenyl)azo]benzenesulfonic acid monosodium salt",256-783-6,50814-31-8,Not Classified,REACH registration C&L,24,Not classified:10;H319:14;H412:14
64576,Dodecanedioic acid,211-746-3,693-23-2,Eye Irrit. 2,REACH registration C&L,469,H319:424;Not classified:45;H315:48;H335:47
64579,2-amino-2-methylpropiononitrile,242-989-3,19355-69-2,,Notified C&L,2,H331:1;H301:1;H311:1;H330:1;H315:1;H312:1;H302:1;H335:1;H319:1
64595,Edta Fe(II),927-442-5,15651-72-6,Not Classified,REACH registration C&L,1,Not classified:1
64596,"Quillaja saponaria, ext.",273-620-4,68990-67-0,Eye Irrit. 2;STOT SE 3,REACH registration C&L,1527,H319:1353;H335:1351;Not classified:170;H317:3;H226:3;H225:1;H315:1;H331:1;H318:1
64598,4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime,405-260-2,94050-51-8,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0;H317:0
64600,"L-xylo-Hexosulose, bis(amidinohydrazone) sulfate (1:1)",607-833-4,2595-26-8,Not Classified,Notified C&L,1,Not classified:1
64601,"N,N-dibutyldodecanamide",438-530-3,5343-44-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 2,Notified C&L,1,H411:1;Not classified:1;H315:1;H317:1
64602,Brompheniramine,201-657-8,86-22-6,Acute Tox. 4,Notified C&L,39,H302:39
64605,"reaction product of boric acid, 2-aminoethanol and 2,2'-Iminodiethanol",923-704-8,,Not Classified,Notified C&L,1,Not classified:1
64606,hydroxylamine ....% [> 55 % in aqueous solution];hydroxylamine ...% [≤ 55% in aqueous solution],232-259-2,7803-49-8,,,0,H315:0;H312:0;H317:0;H373:0;H400:0;H302:0;H335:0;H351:0;H200:0;H318:0;H290:0
64608,(E)-oct-2-en-4-ol,243-532-0,20125-81-9,Not Classified,Notified C&L,113,Not classified:113
64612,"4,4,6-trimethyl-2-pentyl-1,3-dioxane",264-160-5,63449-89-8,Skin Sens. 1,Notified C&L,10,H317:10
64613,"Cytidine 5'-(tetrahydrogen triphosphate), 2'-deoxy-, disodium salt",600-356-2,102783-51-7,Not Classified,Notified C&L,2,Not classified:2
64614,"2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4-[2-[4-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]azo]-4-hydroxy-, potassium salt, compd. with 2,2',2''-nitrilotris[ethanol]",286-556-7,85269-32-5,,Notified C&L,33,Not classified:33
64615,"Amyris balsamifera, ext., acetylated",281-091-6,83863-22-3,Not Classified,Notified C&L,1,Not classified:1
64619,"1H-1,3-benzodiazole-5-carboxylic acid",605-112-9,15788-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H315:46;H319:46;H335:45
64621,(4-methoxyphenyl)urea,216-368-2,1566-42-3,Acute Tox. 4,Notified C&L,39,H302:38;H315:1;H319:1
64622,(2-hydroxypropyl)ammonium dihydrogen orthoborate,268-109-8,68003-13-4,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H302:1
64623,"N-(3,4-dimethylphenyl)acetamide",218-597-3,2198-54-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,43,H302:43;H318:38
64624,"Disodium 1-amino-4-[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulphonatoanilino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",224-797-1,4499-01-8,Eye Irrit. 2,Notified C&L,62,H319:61;H412:1;Not classified:1
64625,9917 E,432-690-8,,Not Classified,Notified C&L,44,Not classified:44
64626,"triasulfuron (ISO);1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea",617-298-9,82097-50-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
64628,"1,2-dichlorobutane",210-469-5,616-21-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H226:43;H319:38;H335:38;H315:38;Not classified:3
64629,"1,2,3-Propanetriol, reaction products with epichlorohydrin",617-696-2,852638-58-5,Not Classified,Notified C&L,59,Not classified:59
64634,3-chloropropionamide,227-542-2,5875-24-1,Acute Tox. 3,Notified C&L,39,H301:39;H319:1
64635,"4,4,15,15-tetraethoxy-3,16-dioxa-8,9,10,11-tetrathia-4,15-disilaoctadecane",254-896-5,40372-72-3,Not Classified,Notified C&L,106,Not classified:99;H315:7;H319:7;H335:6;H320:1;H412:1
